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Thesis summary  
              
Chapter 1 Provides a detailed overview of the current literature of APC and 
centrosomes. This includes the tumour suppressive roles of APC, functions and the 
composition of the centrosome, the intimate link between centrosome and microtubules 
(MTs), and how APC and Wnt proteins could have an important role at the centrosome, 
especially in cancer.  
Chapter 2 Incorporates the methods and general techniques conducted in the project. 
These include details of the reagents and protocols used in the project.   
Chapter 3 The confirmation of APC localisation in various cancer cell lines including 
SW480, a colorectal cancer cell line harbouring truncated APC1-1309. This chapter 
focuses on the dynamics and retained populations of full-length APC (APC-FL) and 
mutant APC at the centrosome. While APC innately binds to MTs, it does not require 
MTs for its localisation or retention. The APC carboxyl half of the protein is however 
required to transport to the centrosome efficiently.  
Chapter 4 Explores possible functions of APC in regulating the centrosome. Here 
detailed experiments reveal a stabilising role in MT nucleation by APC-FL, since MT 
growth is slowed when APC-FL is depleted.  
Chapter 5 APC-FL and its truncated mutant are able to bind the potent MT nucleator γ-
tubulin. γ-tubulin interacts with APC at the N-terminal domain. γ-tubulin also modestly 
regulate APC transport to the centrosome.  
Chapter 6 APC has been found to be retained at the mother centriole. In this chapter, 
binding studies with mother centriole localising proteins was conducted and it was found 
that APC binds to CEP110 but not ninein.  
Chapter 7 The centrosome localising sequence (CLS) is mapped out in this chapter 
which is confined to the armadillo region (APC-ARM).  This region was then used as 
bait for mass spectrometry analysis in cancer cells for novel binding partners. Several 
interesting candidates was found to bind the APC-ARM including PCNT-B and NuMA. 
APC binding to these two proteins was confirmed by immunoprecipitation and proximity 
ligation assay (PLA).  
Chapter 8 Provides a model and comprehensively discusses the contributory effects of 
APC in MT nucleation, regulation and stabilisation stemming from interphase 
centrosomes. Furthermore, we conclude that the known functions of APC in MT 
regulation in sub-cellular destinations of the cell spans to the minus-ends of MTs, that is 
the centrosome. When this regulation is disrupted, cause functional consequences as 
seen in SW480 colorectal cancer cells harbouring the mutant APC1-1337.  
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1.1 BACKGROUND 
Colorectal cancer (CRC) is the third most common cancer in the world and constitutes 
approximately 9% of cancer deaths. Approximately 16,000 new cases of CRC cancer 
were diagnosed in Australia in 2012 ranking it the second most common cancer, 
affecting mainly patients over 70 years of age  (AIHW2010; AIHW2012; TCGA2012). 
Adenomatous polyposis coli (APC) mutation is an early indicator of tumourigenesis. In a 
long term study of 41 colorectal tumour of different sizes, APC mutation was detectable 
throughout most of these tumours including adenomas and carcinomas as small as 0.5 
cm (Powell et al., 1992). APC gene mutations are a known predisposition of CRC 
development. The single most frequent mutation introduces a termination codon after 
amino acid 1309 causing expression of a truncated protein product, which is well-
characterised in the familial polyposis coli (FAP) syndrome (Galiatsatos and Foulkes, 
2006; Half et al., 2009; Kinzler and Vogelstein, 1996).  
APC germline and somatic mutations in CRC frequently occur in the mutation 
cluster region (MCR). Based on genomic DNA analysis, 95% of APC cancer mutations 
cause either a deletion or an insertion of a premature stop codon that ultimately 
truncates the APC protein (Miyoshi et al., 1992b; Nagase and Nakamura, 1993; Powell 
et al., 1992).  A similar occurrence is observed in FAP for 92% of patients (Miyoshi et 
al., 1992a). A screening of genomic DNA from peripheral blood retrieved from FAP 
patients described the APC1-1309 site as a mutational “hot spot”  where 90% of de 
novo mutations are detected (Aretz et al., 2004), and in the “two-hit” model such 
mutations prime mutation of the second APC gene allele. A screening of various CRC 
cell lines indicated that over 80% of these cell lines support the two-hit hypothesis. More 
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recently, a three-hit hypothesis has now been described where alterations in mRNA and 
protein levels appear to promote tumourigenesis (Birnbaum et al., 2012; Cheadle et al., 
2002; Lamlum et al., 1999; Latchford et al., 2007; Segditsas et al., 2009).  
In CRC mouse models, different length APC truncations correlate with severity of 
polyp formation (McCart et al., 2008). For example, APCmin/+ (Δ850) and APCΔ716/+ 
mutations produce >100 polyps in mice (Fodde and Smits, 2001; McCart et al., 2008).  
These preclinical models have given rise to some currently available treatments for 
CRC. Non-steroid anti-inflammatory drugs (NSAIDs) and Cytooxygenase-2 (COX-2) 
inhibitors are two core therapeutics used to reduce polyp size and potentially prevent 
cancer. Doses of Sulindac, a NSAID, has been seen to decrease polyp number and 
increase apoptosis in colonic biopsies of FAP patients (Keller et al., 1999). Patients 
treated with another type of NSAID, aspirin have a 20% reduced risk of CRC compared 
to non-aspirin treated patients (Ahnen, 1998; Din et al., 2010; Ruder et al., 2011).  COX-
2 mRNA is ovexpressed in human intestinal adenomas and COX-2 inhibitors are 
commonly used for CRC treatment (Roelofs et al., 2014).  APCΔ716 (+/-) mice treated with 
the COX-2 inhibitor, MF-tricyclics effectively reduced the number of polyp formation, 
and this effect was also apparent in CRC patients (Koehne and Dubois, 2004; Oshima 
et al., 1996). However, both classes of drugs have potential cardiovascular side effects 
and are therefore unsuitable for long term use (Manzano and Perez-Segura, 2012).   
Mitotic poisons have also proven to be effective therapeutics of CRC. Vincristine 
(alkaloid) and Paclitaxel (taxane) that target mitotic spindles are commonly used in 
cancer therapy and can reduce the amount of cell replication (Swanton et al., 2006), 
however, their specific targeting for cancer cells are still lacking. There remains a need 
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to increase specificity of these drugs to reduce debilitating side effects, such as 
neurotoxicity and resistance to treatment is also a problem (Gomber et al., 2010; Lee et 
al., 2014; Swanton et al., 2007). Recently, a new tubulin-binding alkaloid-noscapine 
reagent known as EM011 was shown to stall mitosis by targeting dynamic microtubules 
(MTs), which can potentially reduce genetic errors in cell replication (Li et al., 2012a). 
Chromosome separation is a timely process that is cell-cycle regulated, for example, 
bubR1 kinases act as mitotic checkpoints that delays the progression of mitosis until all 
appropriate spindle to chromosome attachments have established prior to their 
separation (Lampson and Kapoor, 2005; Rahmani et al., 2009). Treatment with EM011 
in mouse embryonic fibroblast (MEF) cells from mice was effective in decreasing 
adenoma formation. This drug also decreased nuclear β-catenin concentration and 
increased apoptosis in APC min/+ mice (Li et al., 2012a). APC closely regulates MT 
stability in both interphase and mitotic cells and this connection with MTs may be worth 
additional exploration (see section 1.2.3 and 1.2.4). Combination therapy remains the 
most effective treatment for advanced stage CRC, and APC is a promising target for 
CRC therapy (Cunningham et al., 2010; Lesko et al., 2014).  
This literature review aims to encapsulate our current understanding of APC 
functions at the centrosome, how these functions are regulated and how proteins of the 
Wnt signalling pathway have gained some attention on their roles at the centrosome. 
APC could possess additional tumour suppressive properties by regulating the 
centrosome involved in the regulation of centrosome splitting, MT nucleation and 
centrosome number at interphase and mitosis.   
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1.2  THE APC TUMOUR SUPPRESSOR AND CANCER   
1.2.1 Protein interaction domains of the APC protein  
APC is a large protein (310 kDa) comprised of 2843 amino acids with multiple protein 
binding and functional domains. APC is involved in numerous cellular processes either 
directly or through its binding partners, including β-catenin degradation in the Wnt 
signalling pathway (see section 1.2.2), and regulation of the cytoskeleton (Aoki and 
Taketo, 2007; Fearnhead et al., 2001).  
 
 
Figure 1.1 The adenomatous polyposis coli (APC) protein and the commonly 
truncated mutant APC1-1309. Full-length APC (APC-FL) consists of 2843 amino acids 
with various binding domains. APC is commonly mutated at the mutation cluster region 
(MCR). The common protein mutation that predisposes familial adenomatous polyposis 
(FAP) patients to colorectal cancer (CRC) occurs at the 1309 amino acid. The 
truncation of APC C-terminal sequences result in the loss of numerous binding sites 
leading to mis-regulated cellular processes (Brocardo and Henderson, 2008).  
 
1.2.1.1 Microtubule associations  
APC can directly or indirectly associate with MTs through different domains. The APC 
“basic” domain (~APC2200-2400) can directly bind to α/β tubulin heteromers and 
stimulate efficient MT assembly and bundling as demonstrated in biochemical assays 
and in animal cells, respectively (Deka et al., 1998; Munemitsu et al., 1994). APC2130-
2843 co-localised with MTs when overexpressed in HEK293 cells, however expression 
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of fragments that lack the APC-basic domain showed no co-localisation (Munemitsu et 
al., 1994). While these experiments also incorporated the end binding-1 (EB1) binding 
domain, the APC-basic domain was the only fragment found to stabilise MTs when 
overexpressed in the presence of nocodazole (MT toxin). Expression of APC with 
deletion of the basic domain caused MTs to become scattered with nocodazole 
treatment in PtK2 cells (Zumbrunn et al., 2001). On the other hand, the EB1 domain 
does not assemble MTs. Expression of the EB1 binding fragment of APC continued to 
co-localise with MTs but failed to stabilise or cause them to cluster (Zumbrunn et al., 
2001). APC tended to accumulate at cortical clusters, however neither domain was 
required to target APC to these sites (Barth et al., 2002). A later study showed that 
deletion of the -catenin binding site of APC, or knockdown of -catenin, reduced APC 
accumulation at membrane clusters, therefore APC transport and its MT associating 
function are independent of each other (Sharma et al., 2006). 
The significance of the APC to EB1 association in MT regulation is unclear. 
Purified APC and EB1 can assemble tubulin polymers in vitro and do so more 
effectively when expressed together  (Nakamura et al., 2001). However, a counter study 
suggested that the two do not interact under physiological conditions in the cytoplasm 
where MT nucleation can occur (Niethammer et al., 2007). Both APC and EB1 are 
known MT plus-end binding proteins that regulate MT dynamics (Akhmanova and 
Steinmetz, 2008), but they may not work together to do so as observed in live cell 
imaging of MTs. The depletion of EB1 by RNAi did not prevent APC from associating 
with MTs or vice-versa  when EB1 was  assessed in APC-deficient cells,  and APC was  
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Figure 1.2 The APC protein domains. The APC protein can be divided into three 
regions: The N-terminus that includes the oligomerisation domain and armadillo (ARM) 
domain; the central domain that contains 15 and 20-amino acid repeats that bind β-
catenin, and SAMP repeats that bind axin/conductin; and the C-teminus encompasses 
the APC-basic region and EB1 binding domain associated with microtubules (MTs). The 
ARM domain is known to bind to numerous proteins. Schematic diagram adapted from 
(Aoki and Taketo, 2007) 
 
able to stabilise MT plus ends without the need to co-localise along MTs with EB1 in 
canine epithelial MDCK cells (Kita et al., 2006). Whether this is the same at MT minus-
ends is yet to be investigated. EB1 is known to cap the minus-end of MTs to anchor 
them at centrosomes where APC also localises and so EB1 and APC could be 
regulating one another and stabilising MT minus ends (Askham et al., 2002; Louie et al., 
2004; Yan et al., 2006).  
While cancer-associated truncated mutant forms of APC lose their C-terminal 
binding sites for EB1 and MTs, they do retain the armadillo (ARM) domain which allows 
APC to indirectly associate with MTs through binding to the kinesin-associating protein 
3A (KAP3A–kinesin motor complex) (Jimbo et al., 2002). KAP3A is part of the kinesin 
family that also facilitates an interaction with kinesin interacting factors (KIFs) allowing 
APC to be transported along MTs in a plus-end directed manner towards the 
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membrane, including membrane protrusions (Barth et al., 2002; Jimbo et al., 2002). In 
canine epithelial cells (MDCK) and rat fibroblasts (NIH 3T3), KAP3A co-localised with 
APC in clusters at the tip of membrane protrusions, although this was not observed in 
CRC cell lines with APC mutations where both APC localisation at membrane clusters 
and formation of these MT-dependent structures is reduced (Jimbo et al., 2002; Sharma 
et al., 2006). At the C-terminus of APC near the EB1 binding site is a domain that binds 
the discs large tumour suppressor protein (DLG), a protein that has been reported to 
maintain the integrity of cell-to-cell contact in intestinal cells (Laprise et al., 2004). APC 
C-terminal domain (amino acids 2475-2843) was shown to directly bind DLG by in vitro 
pull-down assay and in embryonic mouse brain extracts (Matsumine et al., 1996). In 
fact, APC facilitates the localisation of DLG at the membrane clusters in non-polarised 
MDCK cells that may play a role in cell migration (Iizuka-Kogo et al., 2005). APC is 
therefore able to associate with various proteins to mediate MT stabilisation, dynamics, 
and facilitate cell migration (see section 1.2.3.2).   
1.2.1.2 Wnt protein interactions  
The central region of APC mediates binding to proteins that regulate the Wnt signalling 
pathway. Axin, the Wnt scaffolding protein binds to APC at the SAMP repeats through 
its RGS domain, and the axin homologue axin2/conductin is also believed to bind APC 
in the same way (Behrens et al., 1998; Fagotto et al., 1999; Spink et al., 2000). The loss 
of the APC SAMP repeats that occurs when APC is mutated in CRC was first thought to 
explain the disassembly of the Wnt ‘β-catenin destruction complex’ (see section 1.2.2), 
however, recently a new binding site was found for axin known as 20R2 (20 amino acid 
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repeat number 2) that can facilitate the binding of axin to APC independent of the SAMP 
repeats (Schneikert et al., 2014). The most common APC mutation, at residue 1309, 
truncates APC just prior to this 20R2 sequence, thus eliminating all binding of axin but 
retaining sufficient binding to -catenin through its 15 amino acid repeats to modulate β-
catenin transcriptional activity (Schneikert, 2007). Given that the central -catenin 
binding domain involves such a large array of repeat elements and is regulated by post-
translational modifications such as phosphorylation and ubiquitination as discussed in 
Gao’s review (Gao et al., 2014), it has been suggested in recent years that truncating 
mutations within this region of APC are most often selected for ability to regulate -
catenin turnover to a  ‘just right’ concentration  for tumour formation and maintenance in 
CRC (Albuquerque et al., 2002; Chandra et al., 2012).  
The Wnt signalling regulatory kinase glycogen synthase kinase 3β (GSK3β) 
phosphorylates APC by binding to its central region, promoting interaction with -
catenin and subsequently GSK-mediated phosphorylation of -catenin resulting in its 
ubiquitination and degradation by the proteasome (Rubinfeld et al., 1996). Similarly, the 
multi-subunit protein phosphatase 2A (PP2A) negatively regulates Wnt signalling by 
limiting the concentrations of β-catenin through increased turnover (Ratcliffe et al., 
2000). The association of PP2A at the -catenin destruction complex is at least partly 
mediated by its middle regulatory subunit B56α which contributes to -catenin turnover 
in cells expressing wild-type APC (full-length form/APC-FL), but not in APC mutant cells 
(Seeling et al. 1999). B56 was found to bind to the APC-Armadillo (APC-ARM) domain 
(at repeats 1-4) and in addition to its association with the -catenin/APC/axin 
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degradation complex, was reported to stimulate the nuclear localisation of APC (Galea 
et al., 2001). Thus, it is possible that B56α may, through regulation of APC localisation, 
also contribute to the sub-cellular localisation of -catenin.  
1.2.1.3 Armadillo domain and the cytoskeleton  
The coiled ARM region of APC is one of its few structured domains and represents a 
primary protein interaction site (Zhang et al., 2011). The ARM sequence binds to the 
cytoskeletal regulatory protein IQGAP1 which can bind and regulate actin 
polymerisation and influence cell migration (Johnson et al., 2009). IQGAP1 is an 
effector of the Rho-GTPases Rac1 and Cdc42 that are critical for cell polarisation and 
migration. Co-localisation of APC and IQGAP1 could be observed along with their 
effectors at the leading edge of Vero fibroblast cells (Watanabe et al., 2004). It is 
thought that IQGAP1-APC complexes act to capture and crosslink MTs and actin 
filaments at the cell periphery to mediate cell polarisation and movement (Howell et al., 
2004).  
ASEF, another actin regulator also binds to the APC-ARM. ASEF is small 
guanosine-nucleotide binding G-protein exchange factor. The overexpression of APC 
stimulates ASEF and promotes membrane ruffling possibly by capturing focal adhesions 
(Kawasaki et al., 2000). More importantly, overexpression of mutant APC1-1309 was 
proposed to stimulate migration via ASEF by reducing the E-cadherin-mediated cell to 
cell adhesion in MDCK epithelial cells (Kawasaki et al., 2003). In relation to cancer, 
ASEF depletion significantly reduced the number and size of adenomas in APCmin/+ 
mice that are heterozygous for an APC mutation, reduced invasion rate by half, and the 
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mice showed an increased trend of survival (Kawasaki et al., 2009). Alternatively, one 
group actually showed that APC can inhibit ASEF activity that activates cdc42 and acts 
as a tumour suppressor in this way, and this property is lost when APC is truncated 
(Mitin et al., 2007).  
A recent publication shows that APC is able to interact with intermediate 
filaments (IFs) in glioblastoma and epithelial cancer cells. Normally, cells that express 
APC-FL such as HCT116 cells display a spread out morphology of IFs in the cell, 
however components of this network are disrupted with APC truncation, which was 
perturbed in SW480 cells where the vimentin network shows retractions while keratin 
filament organisation is unaffected (Sakamoto et al., 2013). APC binds vimentin and not 
keratin demonstrated by immunoprecipitation assays in SW480 cells, which could 
explain the specific disruption. Purified APC (APC-GST) was shown to bind both the IF 
proteins vimentin and glial fibrillary acidic protein (GFAP) via its ARM domain 
(Sakamoto et al., 2013), although this does not explain why in SW480 cells, the IF are 
disorganised given that the APC mutant1-1337 in these cells retains the N-terminal 
ARM domain. The data so far indicate that while APC can associate with IF components 
through its ARM domain, its ability to stabilise and regulate the IF network requires 
additional C-terminal sequences. 
1.2.2 Role of APC in the Wnt signalling pathway  
The canonical Wnt signalling pathway regulates embryonic development and in adult 
cells it signals a range of tissue processes through stimulation of cell differentiation, 
migration and other events. Disruption of the Wnt pathway caused by mutations in 
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specific genes (eg. APC, -catenin, axin) is linked to the onset of cancer, including CRC 
(see reviews) (Anastas and Moon, 2013; de Sousa et al., 2011; Polakis, 2012). 
Normally, Wnt signals are mediated from the plasma membrane by -catenin which 
becomes stabilised and moves to the nucleus to control transactivation of a broad gene 
network. APC mutations disrupt the normal turnover of -catenin, causing its prolonged 
stabilisation and nuclear accumulation, thus permanently “activating” the Wnt signal and 
a spectrum of genes that under these conditions drive cell transformation and tumour 
development. In the normal physiological state, Wnt signalling is ‘off’ and 
transmembrane receptors including the “frizzled receptors” and its co-receptor low-
density lipoprotein receptor related protein 6 (LRP6) remain intact allowing the 
assembly of the destruction complex, that is comprised of core proteins APC, GSK3β, 
CK1 along with axin (Cong et al., 2004; MacDonald et al., 2009; Niehrs, 2012). 
Ultimately, this complex targets cytoplasmic β-catenin for proteasomal degradation 
through phosphorylation of N-terminal residues that lead to -TRCP mediated 
ubiquitination and degradation (Fig. 1.3B) (also see 1.2.1.2). However, when the Wnt 
pathway is activated (“on”), the Wnt ligand binds to and activates the membrane 
receptors LRP and Frizzled the recruitment and phosphorylation of Dishevelled (Dsh) 
that subsequently signals LRP6 for downstream targeting in a phosphorylation-
dependent manner (Fig. 1.3B) (Cong et al., 2004; Gao and Chen, 2010). The 
destruction complex apparently either does not form due to their recruitment to the 
plasma membrane, or becomes insufficient for β-catenin degradation. As a result, 
excess β-catenin is translocated into the nucleus which then interacts with LEF-1/TCF 
transcription factors promoting the transcription of Wnt target oncogenes such as c-myc  
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Figure 1.3 The Wnt signalling pathway. In the normal Wnt signalling pathway, β-
catenin concentration is tightly regulated by the destruction complex formed from 
several proteins (A) that target β-catenin for proteasomal degradation. However, when 
Wnt is ‘on’ (B), the receptors frizzled and LRP6 are activated that inhibits the formaton 
of the destruction complex allowing β-catenin to accumulate in the cytoplasm. Excess β-
catenin are translocated into the nucleus promoting the transactivation of proto-
oncogenes (Eisenmann, 2005). 
 
and cyclin D1, promoting uncontrolled cell proliferation and differentiation (Anastas and 
Moon, 2013; Rao and Kuhl, 2010). Additionally, a non-canonical pathway involving 
signal transduction via Rho A and Calmodulin external to β-catenin regulation by the 
destruction complex has also been described but will not be discussed in detail here 
(Bryja et al., 2009; Gomez-Orte et al., 2013; Topol et al., 2003).  
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The exact role of APC in the destruction complex is not entirely clear, but its 
independent control of β-catenin has been shown on numerous occasions.  Firstly, 
regardless of how APC is activated, it can independently regulate β-catenin 
concentrations in the nucleus as it contains nuclear export (NES) and localising signals 
(NLS) allowing it to shuttle in and out of the nucleus (Henderson and Fagotto, 2002). 
This was evident when the inactivation of NES within APC by leptomycin B (LMB), a 
CRM1 inhibitor, increased the nuclear accumulation of β-catenin. However, the re-
introduction of APC-FL was able to export β-catenin back into the cytoplasm 
(Henderson, 2000). However, APC persistently binds to β-catenin even when APC is 
truncated at the MCR. One idea is that APC can act as a scaffold for complex formation 
allowing for β-catenin to be destroyed since deletion mutants are still able to regulate β-
catenin concentration (Chandra et al., 2012). A close examination into a range of CRC 
cell lines with and without APC truncations show that the obliteration of truncated APC 
in mutant-harbouring cell lines not only reduced proliferation but also increased β-
catenin levels (Chandra et al., 2012). On the other hand, APC was thought to facilitate 
the assembly/scaffold function of axin by restricting its recruitment to the plasma 
membrane by Dsh. One study suggested that axin induces so-called ‘degradasomes’ 
that are reduced in Drosophila embryos when APC is mutated. This concept was again 
illustrated in HeLa cells, where the overexpression of APC can displace Dvl2 (normally 
assembled by axin) from axin puncta, which shows that APC could indirectly regulate 
assembly of axin complexes (Li et al., 2012b; Mendoza-Topaz et al., 2011). More recent 
findings in Drosophila and colon cancer cell lines proposed that the binding of β-catenin 
to APC is not required for β-catenin destruction but rather enhances the efficiency of the 
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destruction complex (Yamulla et al., 2014).  Another plausible explanation is that APC 
may be required for tumour maintenance such as that seen in the phenomenon of 
oncogene addiction with other tumour suppressors including HER2, PDGFP, c-kit and 
EGFR (Sharma and Settleman, 2007; Torti and Trusolino, 2011). This would be 
consistent with a recent study that showed that tumours with truncated mutant APC 
induced cell arrest as a result of β-catenin inhibition by inducible shRNA. When Wnt 
was reactivated, proliferation resumed and cells reacquired a crypt progenitor 
phenotype (Scholer-Dahirel et al., 2011).  
 The balance between APC and β-catenin concentrations in the colonic crypt 
may be considered as an indication of tumourigenesis. A mouse study comparing APC 
deficient transgenic mice display perturbed crypt villus architecture, and histology 
revealed that timing of this change corresponded with when elevated nuclear β-catenin 
levels were detected. Cre+APC+/+ mice were used and showed increased migration from 
villus, increased proliferation and cell density (Sansom et al., 2004). It was suggested 
that in the colonic crypt, a balance must be maintained between signal gradients from 
the villus base to the lumen between Wnt signalling and the ability of APC to suppress 
them, termed as the “sweet spot”. When the sweet spot is moved higher in the crypt, 
less Wnt signalling is suppressed leading to an increase in immature stem cells in the 
crypt to drive colon tumorigenesis (Boman and Fields, 2013). This could be evidence 
that shows Wnt signalling-mediated control of APC to orchestrate spindle orientation, 
particularly in mitosis (see section 1.2.4).  
Chapter 1 Literature review 
35 | P a g e  
 
1.2.3 How APC functions as a tumour suppressor 
The hallmarks of cancer are cogently summarised in recent reviews (Hanahan and 
Weinberg, 2011), and it is mentioned how several properties of cancer cells are 
regulated by APC (Fig. 1.4). APC-controlled events include the regulation of 
proliferation by controlling β-catenin concentrations (Chandra et al., 2012; Li et al., 
2012b), cell polarisation and migration through its interactions with MTs and actin 
(Kawasaki et al., 2003; Munemitsu et al., 1994; Watanabe et al., 2004; Yamashita, 
2009), apoptosis through interactions with caspases (Chen et al., 2003; Huang and 
Guo, 2006) and chromosome instability by regulating mitotic spindles (Caldwell et al., 
2007).  
 
Figure 1.4 APC regulates several aspects of what has been classified to be the 
hallmarks of cancer. APC is involved in various aspects of tumour suppression, 
including the control of proliferation by controlling β-catenin concentrations; migration 
through interactions with the cytoskeleton; apoptosis by interacting with proteins of the 
apoptotic pathway and cell polarisation through interaction with spindles and possibly 
the microtubule organising centre (MTOC).  
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1.2.3.1 Proliferation  
The major tumour suppressive function of APC is its regulation of β-catenin 
concentrations (see section 1.2.2).  Excess nuclear β-catenin in the Wnt active pathway 
leads to the transactivation of proto-oncogenes that promote proliferation and cell 
differentiation, such as the activation of c-myc through LEF/TCF (Barker and Clevers, 
2000; Polakis, 1999). While some earlier reports suggested that nuclear localisation of 
APC is linked to cell density where confluent cells were associated with strong nuclear 
staining in kidney MDCK, thyroid and CRC cell lines (Fagman et al., 2003; Zhang et al., 
2001), later studies clarified that these observations were actually incorrect due to the 
use of antibodies that cross-reacted with proteins other than APC in microscopy staining 
assays (Brocardo et al., 2005). A study of six CRC cell lines with truncated APC showed 
that while proliferation is inhibited, an increase in β-catenin levels could still be detected 
in the cell lysates by Western blot, suggesting that perhaps a certain concentration of β-
catenin is pertinent in tumour maintenance (Chandra et al., 2012).  
1.2.3.2 Migration  
APC mediates polarisation and cell migration in two ways. In one part, APC interacts 
with the actin cross-linking factor, IQGAP1, which localises to the lamellipodia (leading 
edge) of migrating Vero cells towards a scratch wound (Watanabe et al., 2004). 
Depletion of either APC or IQGAP1 with siRNA reduced the accumulation of the other 
protein at the leading edge and reduced directional cell migration in live cells. The 
centrosome (referred to in these studies as the MT organising centre [MTOC]) 
orientation was also affected. MTOCs visualised by staining for α-tubulin are typically 
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oriented by dynein/dynactin (MT motors) and position in front of the cell facing the 
wound, however in the case of APC and IQGAP1 knockdown, this orientation is 
reduced by up to 30% (Watanabe et al., 2004). This is consistent with the involvement 
of E-APC in orienting mitotic spindles within the epithelial plane and the APC2 mutant is 
associated with 16-21% of mis-positioned centrosomes and mis-oriented spindles (Lu et 
al., 2001; Yamashita et al., 2003). Similarly, APC-FL could also mediate migration 
through ASEF since APC-mutant inactivates ASEF (Kawasaki et al., 2009; Mitin et al., 
2007).  
1.2.3.3 Apoptosis  
Evidence from drug treatment studies indicated a direct correlation between APC and 
apoptosis. Histone deacetylase (HDAC) inhibitors are typically used in the treatment of 
malignant cancer. More interestingly, APC appears to sensitise cancer cells to these 
drugs since cells that express the full-length APC such as in the colon cancer HCA-7 
cells, are more sensitive to apoptosis than SW620 and HT-29 cells that express the 
mutant form of APC. Re-expression of APC-FL in the mutant cell lines was able to 
restore drug sensitivity (Huang and Guo, 2006). This is consistent with several studies 
that show that APC can interact with proteins of the apoptotic pathway, particularly at 
the mitochondria. In mice with numerous polyps, mRNA expression of caspases 3 and 7 
was reduced in APCmin/+ mice, with a similar trend observed in APC mutant cell lines 
(Chen et al., 2003). Clusterin is a marker for apoptosis where elevated levels of 
clusterin mRNA and protein are often seen in tissues. Low levels of clusterin is found in 
colon cancer tissues devoid of APC-FL, however this level can be elevated with the re-
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expression of APC-FL which also increases the degree of apoptosis (Chen et al., 2004). 
Moreover, a combined fractionation and immunofluorescence study of mitochondria in 
HEK293 cells expressing different sizes of truncated APC mutants (1-750, 1-1309) 
showed for the first time detectable levels of APC in mitochondria fractions and co-
localisation with the mitochondria marker cytochrome C (Brocardo et al., 2008). This 
study also showed that APC can complex with the B-cell lymphoma protein, Bcl-2 (an 
important inhibitor of apoptosis) and the depletion of APC1-1337 in SW480 cells 
increased apoptosis and reduced Bcl-2 protein levels at the mitochondria (Brocardo et 
al., 2008).   
1.2.4 Role of APC in chromosome mis-segregation  
Chromosome mis-segregation refers to defects in the separation of duplicated 
chromosomes in mitosis. This can be caused by either chromosome misalignment by 
the spindles, or inefficient chromosome separation to opposite ends of the spindle poles 
and ultimately leads to an uneven distribution of genetic material in the daughter cells. 
This consequently promotes the chromosome instability (CIN) phenotype and generates 
aneuploid cells (Draviam et al., 2004; Nigg, 2002; Thompson and Compton, 2008).  
 The truncation of APC results in chromosome aberrations as seen by Fodde 
(Fodde et al., 2001), which have been linked to many precursors of CIN. In mouse 
embryonic stem cells comparing APC-FL and APC mutant expression via multicolour 
fluorescence in situ hybridisation (FISH) analyses, it was revealed that APC1-1638 
expressing cells in metaphase show structural and chromosomal aberrations 
characterised by shorter and more displaced chromosomes compared to cells with 
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APC-FL (Fodde et al., 2001). This is particularly interesting since the β-catenin binding 
site is retained which means that aberrant chromosomes could be caused by loss of the 
C-terminal domains of APC rather than a regulation via β-catenin. In another  study, 
analysis of spindle orientation and cytokinetic defects in both stable cell lines and 
histological staining of APCmin/+ small intestine epithelium in mice, revealed that indeed 
both mitotic spindles and centrosomes become mis-oriented, which induces 
chromosome misalignment (Caldwell et al., 2007). Stably transfected HEK293 cells 
expressing APC1-1450 caused the formation of mis-oriented spindles without obvious 
spindle anchoring. Frequent sliding of spindle poles was observable in >80% of live 
cells. This mis-orientation was also evident in histological staining of APCmin/+ mice 
epithelium where dividing crypt cells show a higher degree of mis-orientation (Caldwell 
et al., 2007). Cytokinetic failure was also seen in the same cells that show an increase 
in multinucleate/tetraploid cells, consistent with observations in HEK293 cells 
expressing APC1-1450 compared to control (Caldwell et al., 2007).  
 The regulation of chromosome separation by APC could be attributed to its role 
as a MT plus-end tracking protein (TIP) protein since the β-catenin domain is not 
involved. Fodde and colleagues suggested that EB1 could be responsible for the 
docking of APC to MT plus ends that could mediate MT to kinetochore attachment since 
truncated mutants of APC are less efficient at localising to the spindle plus-ends in 
mitosis (Fodde et al., 2001; Green et al., 2005). However, evidence showed that the 
localisation of APC to MT plus-ends is independent of EB1, at least in interphase cells 
(Kita et al., 2006), and whether APC interacts with EB1 specifically at the spindles plus- 
end is difficult to quantify. APC mediates mitotic spindles to kinetochore attachments by 
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forming a complex with the checkpoint bub kinases. The truncation of APC from either 
overexpression of APC1-1450 and APC1-750 or in APCmin/+ cells indicates a higher 
degree of spindle collapse, disrupted MTs and interferes with MT attachments to 
kinetochores, all of which leads to an increase in aneuploidy and CIN (Green and 
Kaplan, 2003; Tighe et al., 2004). How APC contributes to CIN will be further discussed 
in section 1.5.3.  
1.3 THE CENTROSOME: PROTEIN COMPOSITION, DYNAMICS, 
STRUCTURE AND FUNCTIONS  
1.3.1 The centrosome duplication cycle and basic roles in microtubule 
assembly  
The centrosome is a 1 µm wide non-membranous organelle comprised of a mother and 
a daughter centriole held together by a dynamic fibrous linker (Fig. 1.5A). The mother 
can be identified by the presence of subdistal appendages (anchor MTs) and distal 
appendages (anchor basal bodies in ciliogenesis) located at the distal end of the 
centriole barrel away from the linker (Ibrahim et al., 2009). The centriole barrel is 
organised as a nine-fold symmetry of MT triplets in a cartwheel shape around a central 
hub (Cottee et al., 2013; van Breugel et al., 2011). Found along the barrels are proteins 
such as α/β-tubulin, centrin, and glutamylated γ-tubulin that are thought to maintain its 
structure (Errabolu et al., 1994; Fu and Glover, 2012; Fuller et al., 1995). Both centrioles 
have unique functions and behaviour. In high magnification time-lapsed imaging 
comparing movements of the two centrioles, the mother displayed little movement 
whereas the daughter was much more mobile, particularly in G1 phase (Piel et al., 
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2000). While the mother centriole has been associated with MT anchoring, the daughter 
does not possess this function but rather controls the symmetry of the centrioles 
regulated by the protein centrobin (Deane et al., 2001; Januschke et al., 2013; 
Kobayashi and Dynlacht, 2011). The centrioles are surrounded by the pericentriolar 
material (PCM), which was previously thought to be an amorphous electron-dense 
cloud. This was recently redefined with the use of improved high-resolution microscopy 
techniques and antibody specificity, showing that the PCM contains three distinct layers 
(inner, intermediate and outer) (Mennella et al., 2012; Sonnen et al., 2012). Different 
PCM associated proteins occupy specific layers, for example the scaffold protein 
 
Figure 1.5 Centrosome structure and duplication cycle. (A) Centrosomes are 
comprised of a mother and daughter centriole that are connected by a fibrous linker 
surrounded by a cloud of structured pericentriolar material (PCM), where MTs are 
nucleated. The mother centriole is uniquely decorated with subdistal appendage where 
MTs are anchored, as well as distal appendages for basal body functions. (B) The 
centrosome duplication cycle involves the disengagement of two centrioles in G1/S- 
phase, followed by duplication in the S-phase coordinated with DNA replication. 
Centrosomes mature by collecting additional PCM during G2–phase before their 
separation in M-phase to act as spindle poles that generate mitotic spindles to facilitate 
chromosome separation. Images from (Doxsey, 2001; Kobayashi and Dynlacht, 2011).  
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pericentrin (PCNT) A/B spans across all layers of the PCM while the MT nucleator γ-
tubulin  primarily occupies the intermediate layer (Sonnen et al., 2012). Both proteins 
are important in MT nucleation and it is unclear as to whether each layer is linked to a 
separate function (Pereira and Schiebel, 1997; Wiese and Zheng, 1999; Wiese and 
Zheng, 2006). The centrosome duplication cycle is synchronised with the DNA 
replication cycle and the two are regulated by the same set of cell cycle-dependent 
kinases (cdk-cyclins). 
 In G1-interphase there is one centrosome (2 centrioles) tethered to the nucleus 
that duplicates to form two centrosomes (4 centrioles) in S-phase (Doxsey et al., 2005a; 
Doxsey et al., 2005b) (Fig. 1.5B). The mother centriole acts as a template for the 
formation of the daughter (pro-centriole) positioned orthogonally to the mother where 
duplication is triggered by centriole disengagement. Centrosome maturation occurs 
during S/G2 transition phase when the new centrioles are elongated as the PCM 
undergoes rapid growth and protein recruitment, ready for mitotic spindle formation in 
mitosis (Doxsey et al., 2005b; Sluder and Khodjakov, 2010). In M-phase, the mitotic 
centrosome otherwise known as the ‘spindle pole body’ in yeast, undergoes drastic 
architectural changes facilitated by a change in behaviour of its localising proteins. For 
example, PCNT-B and CG-NAP form a scaffold at the onset of mitosis at the 
centrosomes. Moreover, the dynamics of important proteins including γ-tubulin 
frequently change (Khodjakov and Rieder, 1999; Shimizu et al., 2008) (also see 1.3.3). 
The centrosome duplication cycle is therefore a highly coordinated process involving 
many proteins including checkpoint proteins and tumour suppressors such as the breast 
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cancer protein BRCA1, p53 and Chk1 (Fukasawa, 2005). Any faults in the process 
could lead to oncogenic consequences (for details see section 1.5.1).  
1.3.2 The centrosome proteome: integral and transient-regulatory 
proteins and their general roles  
More than 200 proteins have been identified at the centrosome by mass spectrometry 
(Andersen et al., 2003; Jakobsen et al., 2011), most are often described as either 
“integral” or “transient” based on whether MTs are required for their targeting or their 
levels of centrosome retention. However, most centrosome proteins are in fact dynamic 
(see section 1.3.3) and it is this mobility that enables them to be recruited at different 
stages of the cell cycle to mediate specific processes, including centrosome duplication, 
cohesion/separation and MT nucleation and anchoring (Table 1.3.2.1). ‘Integral’ 
proteins persist at the centrosome throughout the cell cycle, and prime examples 
include PCNT-A/B, γ-tubulin, centrin and the recently discovered CDK5RAP2. The 
consistency of their location has resulted in use of these factors as centrosome markers 
for cell imaging experiments. “Transient” proteins are recruited temporarily in order to 
regulate or complete a process, and most proteins at the centrosome fall into this 
category. Several of the key centrosomal regulatory proteins are discussed below in 
regard to their roles in specific stages of centrosome activity, assembly or duplication.  
1.3.2.1 Centriole duplication  
The centriole duplication process is complex requiring coordination by numerous 
proteins for the initiation to duplicate, recruitment of centriole components, and the 
subsequent assembly of the new centriole. This is to strictly maintain accurate 
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centrosome number in each cell. Firstly, “centriole disengagement” between two 
centrioles is required to trigger the separation of two centrioles and act as a license for 
daughter centriole duplication in G1/S phase facilitated by the protease separase. This 
may be facilitated by its corresponding substrates, such as the proteins PCNT-B and 
the Akt kinase interacting (Aki1) protein (Nigg, 2007) (Table 1.1). This is believed to 
initiate the recruitment of centriole components and regulators, such as SAS-4 (role in 
centriole assembly in C. elegans), which undergoes constant exchange with a 
cytoplasmic pool depending on the stage of the cell cycle (Dammermann et al., 2008). 
One perception is  that the mother centriole acts as a template to guide the 
assembly of pro-centrioles (Azimzadeh and Marshall, 2010), however daughter 
centrioles can also form de novo, independent of the mother centriole clearly shown 
when the overexpression of SAK (PLK4) was sufficient to induce centriole duplication 
demonstrated in C. elegans, among other studies in human cell lines (Habedanck et al., 
2005; La Terra et al., 2005; Rodrigues-Martins et al., 2007; Uetake et al., 2007). 
Therefore, a crucial control in centriole duplication could be in the assembly of its 
barrelled structure (Fig. 1.5A). PLK4 (polo-like kinase 4) and SAS-6 are the most well-
established in centriole assembly (Azimzadeh and Marshall, 2010; Bettencourt-Dias and 
Glover, 2009; Loncarek and Khodjakov, 2009). In human cell lines, the overexpression 
of PLK4 in U2OS cells resulted in the formation of multiple centrioles (Kleylein-Sohn et 
al., 2007). Consistently, the PLK4 homologue, ZYG-1 in C. elegans  when bred with 
mutations to this gene, no formation of daughter centrioles were observed by electron 
microscopy (O'Connell et al., 2001). On the other hand, SAS-6 may be solely 
responsible for the assembly of centriole barrels. C. elegans studies involving the use of  
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Table 1.1 Centrosome localising proteins and their corresponding roles.  
Centrosome 
protein 
Integral or 
transient Location Role / Regulation References 
Centrosome duplication
Aki1 Transient L Centriole disengagment (Nakamura et al., 2009) 
CEP110 NC M Centriole duplication Centrosome assembly 
(Guasch et al., 2000; Ou et al., 
2002) 
ε-tubulin NC SD Centriole duplication MT organisation (Chang and Stearns, 2000) 
ODF2 
(Cenexin) NC M 
Primary cilia formation 
Centriole maturation 
(Huber et al., 2008; Steere et 
al., 2012) 
bubR1 Transient NC Centrosome duplication (Izumi et al., 2009) 
PLK1 Transient NC Centrosome duplication (Tsou et al., 2009) 
PLK4 
SAK` Transient NC 
Centriole duplication 
Centrosome maturation (Habedanck et al., 2005) 
Centrobin ND D Centriole duplication (Zou et al., 2005) 
Centrin II Integral C Centriole duplicatiuon (Salisbury et al., 2002) 
Centrosome separation / cohesion 
Rootletin Integral L Centrosome cohesion (Bahe et al., 2005; Yang et al., 2006) 
NEK2 Transient L Centrosome separation Centrosome duplication 
(Bahmanyar et al., 2008; Fry, 
2002) 
C-nap1 
(CEP250) Integral L 
Centrosome cohesion 
MT anchoring 
Centrosome number 
(Mayor et al., 2000; Nishimura 
et al., 2005; Takahashi et al., 
1999; Takahashi et al., 2002) 
Separase Transient L Centriole disengagement (Matsuo et al., 2012) 
β-catenin Transient  NC  Centrosome separation  (Bahmanyar et al., 2008) 
MT nucleation / organisation 
γ-tubulin Integral / transient 
PCM 
C MT nucleation (Kollman et al., 2011) 
PCM-1 Transient Near PCM Protein recruitment 
(Dammermann and Merdes, 
2002) 
NEDD1 
GCP-WD* Transient 
Near 
PCM 
γ-tubulin recruitment to 
centrosomes 
(Haren et al., 2006; Manning 
et al., 2010) 
Ninein Transient SD MT anchorage (Bouckson-Castaing et al., 1996; Mogensen et al., 2000) 
EB1 Integral SD MT organisation MT anchorage 
(Askham et al., 2002; Piehl et 
al., 2004) 
Structural proteins 
PCNT-A Integral PCM γ-tuRC anchoring (Doxsey et al., 1994) 
PCNT-B Integral PCM Scaffold for γ-tuRC (Matsuo et al., 2010; Shimizu 
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PLP* Centrosome cohesion 
Centriole maturation 
et al., 2008; Takahashi et al., 
2002) (Lerit and Rusan, 2013) 
AKAP450 
(CG-NAP) Integral PCM Protein anchoring (Witczak et al., 1999) 
centrin Integral C Structural component (Paoletti et al., 1996) 
CDK5RAP2 
Centrosomin* Integral PCM 
MT nucleation; MT 
anchoring in mitosis; 
Centrosome assembly 
(Barr et al., 2010; Choi et al., 
2010; Fong et al., 2008) 
(Conduit et al., 2014; Megraw 
et al., 1999) 
PCM – pericentriolar material; C – centrioles; M – mother ; SD – subdistal appendage; 
DA – Distal appendage; D – daughter; L – dynamic fibre linker; Asterisk (*) – Drosophila 
homologue; brackets – alias; Apostrophe (`) – C. elegans homologue; NC = not 
confirmed 
X-ray crystallography combined with electron microscopy revealed that SAS-6 not only 
localises to the centre of the cartwheels to form the base of pro-centrioles, but can self 
associate to create such a structure (Hilbert et al., 2013; van Breugel et al., 2011). The 
phosphorylation of SAS-6 by ZYG-1/PLK4 is required for centriole formation since the 
expression of a SAS-6 phosphorylation mutant (S123A) impaired centriole formation, 
which could be rescued by the re-expression of this domain, suggesting that PLK4 may 
act as the master control of centriole formation (Kitagawa et al., 2009). Centrosome 
proteins such as CEP110, ninein and ε-tubulin have also been linked to centriole 
duplication based on their localisation patterns. The former two proteins were 
consistently mapped to sites where the pro-centriole is formed throughout the cell cycle 
using multi-colour antibody staining (Ou et al., 2002). ε-tubulin, a protein that localises 
only to the mature centriole was observed to asymmetrically localise to the subdistal 
appendages but only after S-phase where its concentration spikes, and its expression 
falls at the onset of mitosis suggesting a role in centriole duplication (Chang et al., 
2003).  
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1.3.2.2 Centrosome cohesion / separation  
In the transition from G2 to M-phase, coordination between centrosome cohesion and 
separation exists as the lack of separation will induce the formation of monopolar mitotic 
spindles, and premature separation of the centrosomes can lead to mis-oriented spindle 
formation (see section 1.5.1). Both will cause problems in chromosome alignment and 
separation (see section 1.4.3 and 1.5.1) (Silkworth et al., 2012; Tajbakhsh and 
Gonzalez, 2009; Tanenbaum and Medema, 2010).  
The two centrosomes duplicated in S-phase (two pairs of centrioles) are held 
together by centriole associated filaments as determined by electron microscopic 
images of isolated centrosomes from human lymphoid cells (Bornens et al., 1987; 
Mardin et al., 2011). Centrosome cohesion and splitting depends on Nek2 kinase and 
its substrates C-Nap1 and rootletin (Bahe et al., 2005; Mayor et al., 2000; Yang et al., 
2006). Nek2 phosphorylates its substrates to promote their delocalisation which 
promotes centrosome separation. C-Nap1 localisation can be regulated by other 
centrosome proteins such as CEP135 (Kim et al., 2008). All of this is orchestrated by 
PLK1 that controls the Nek2A activity at the linker (Mardin et al., 2011). Conversely, 
negative regulators such as nucleophosmin can promote the splitting of centrosomes 
when its phosphorylation is inhibited (Lacey et al., 1999). β-catenin is a substrate of 
Nek2A kinase, implicating the involvement of the Wnt pathway in centrosome cohesion 
(Bahmanyar et al., 2008), which is interesting since uncontrolled centrosome duplication 
or premature splitting is linked to tumourigenesis (see section 1.5.1).  
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1.3.2.3 Microtubule nucleation / anchoring  
The centrosome is the MT organising centre (MTOC) of the cell that nucleates and 
stabilises MT minus-ends by anchoring them to the subdistal appendage. Therefore, 
recruitment of specific proteins to regulate each function is paramount to correct MT and 
spindle formation at interphase and mitotic centrosomes, respectively. MT nucleation 
and anchoring will be discussed in detail in section 1.4.2.  
1.3.3 Dynamics of proteins at the centrosome and its importance 
As mentioned earlier, many centrosome proteins have been described as either integral 
or transient in nature, conclusions which sometimes are based on very little 
experimental evidence. The best approach to track movement of proteins is to tag them 
with green fluorescent protein (GFP) and follow their movement with time-lapse 
microscopy in live cells (Diekmann and Hoischen, 2014; Reits and Neefjes, 2001). 
Several studies used this model with photobleaching experiments to measure the 
kinetics of GFP-protein exchange rates at the centrosome, and found that almost all 
proteins display, to varying degrees, both a retained pool and a dynamic mobile pool at 
the centrosome (see Table 1.2 and 1.3). Of these, the “integral” proteins are more often 
retained while the “transient” factors are mostly in dynamic exchange. The most 
informative technique is called fluorescence recovery after photobleaching (FRAP) and 
when applied to centrosomal proteins it has revealed that most proteins are largely quite 
dynamic and mobile at the centrosome, most likely reflecting their role in signalling and 
regulation and catering to the centrosome’s dynamic nature in the duplication cycle 
(Table 1.2 and 1.3). The FRAP technique provides information on the rate of protein 
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recruitment to the centrosome, the level of protein stably retained at the centrosome 
and whether these parameters are cell cycle or MT-dependent. These parameters could 
change between interphase and mitosis.  
1.3.3.1 Proteins that regulate microtubule nucleation and dynamics at the 
centrosome 
γ-tubulin is the main priming molecule for nucleation and assembly of MTs, and locates 
both in the cytoplasm and at the centrosome (Moudjou et al., 1996). However, FRAP 
revealed that the mobility/dynamics of γ-tubulin when recruited to the centrosomes 
differed between interphase and mitotic centrosomes (Khodjakov and Rieder, 1999). 
Intriguingly, after photobleaching the GFP-tagged γ-tubulin recovered in fluorescence 
intensity to a level only 50% of that measured before bleaching in interphase, implying 
that half the protein was stably resident while the other half was highly mobile 
(Khodjakov and Rieder, 1999). As cells progressed to mitosis this balance changed, 
and almost 100% of the γ-tubulin was mobile at mitotic spindle pole bodies, possibly to 
meet the demands of the rapid nucleation of mitotic spindles (Khodjakov and Rieder, 
1999).  Tagged with a red fluorescence protein (RFP) PCNT-C241 on the other hand, is 
highly retained as exhibited by only a 30% fluorescence maximal recovery at the 
centrosome, albeit only the C-terminal domain was used in the FRAP experiment 
(Brodie et al., 2012). This high level of retention is consistent with its presumed role in 
the anchorage and activation of γ-tubulin ring complexes (γ-tuRCs) (see section 1.4.2). 
The anchoring of MTs at both interphase and mitotic centrosomes appears to require  
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Table 1.2 Summary of fluorescence recovery after photobleaching (FRAP) data 
for centrosomal proteins from the literature in interphase. 
Protein Functional Role T1/2 
% 
Retained 
pool  
% Recovery 
(mobile 
pool) 
Reference 
Resident proteins 
-tubulin 
(interphase) 
structural; MT 
nucleation long ~50 ~50 
(Khodjakov and Rieder, 
1999) 
PtkG cells 
Centrin II 
structural; 
centriole 
duplication 
> 5 min ~85 ~15 
(Bahmanyar et al., 
2010; Hames et al., 
2005) 
U2OS & MDCK cells 
PCNT C241 Centro scaffold 2.4 s 70 30 (Brodie et al., 2012) MCF-7 cells 
C-Nap1 Intercentriolar linker ~40 s 90 10 
(Hardy et al., 2014) 
HeLa cells 
Rootletin Intercentriolar 
linker 
No 
recovery 100 0 
(Hardy et al., 2014) 
HeLa cells 
Kinases 
Cdc20 
(interphase) 
mitotic 
checkpoint 
regulator 
6.9 s 15 85 (Kallio et al., 2002) HeLa cells 
Aurora A 
(interphase) 
mitotic 
checkpoint 
kinase 
2.1 s 0 100 (Stenoien et al., 2003) HeLa cells 
Nek2A Centro cohesion 3.2 s 27 73 (Hames et al., 2005) U2OS cells 
PLK1 
(interphase) 
Centro 
maturation ~20 s 50 50 (Kishi et al., 2009) 
Wnt proteins 
B56α (PP2A 
subunit) unknown 1-2 s 70 30 
(Flegg et al., 2010) 
HeLa cells 
APC unknown Unknown Unknown Unknown (see Chapter3) 
β-catenin MT organisation Centro cohesion 5 s 10 90 
(Bahmanyar et al., 
2008) U2OS cells 
β-catenin 
(mutated) 
MT organisation 
Centro cohesion 4 s 30 70 
(Bahmanyar et al., 
2008) U2OS cells 
Centrosome regulators 
Ninein MT anchorage ND 2 98 (Moss et al., 2007) PtK2 cells 
Ninein 
+noco MT anchorage ND 76 24 
(Moss et al., 2007) 
PtK2 cells 
Nudel MT anchorage 2.1 min 4 96 (Guo et al., 2006) Cos7 cells 
Nudel 
+noco MT anchorage ND 8 92 
(Guo et al., 2006) 
Cos7 cells 
Dynamin II 
mid region 
structural; 
centrosome long 50 50 
(Thompson et al., 2004) 
FR cells (fibroblasts) 
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cohesion 
CDK5RAP2 Centro scaffold 1 min 40 60 (Jia et al., 2013) HEK293T cells 
Buf2 & Hec1 Centrosome to centromere 5 s 50 50 
(Hori et al., 2003) 
DT40 chicken cells 
* ND = not determined 
 
Table 1.3 Summary of fluorescence recovery after photobleaching (FRAP) data 
for centrosomal proteins from the literature in mitosis. 
Protein Functional Role T1/2 
% 
Retained 
pool 
% 
Recovery
(Mobile 
poll) 
Reference 
-tubulin 
(mitosis) 
structural; mitotic 
spindle formation long 0 100  
(Khodjakov and Rieder, 
1999) 
PtkG cells 
NuMA 
(mitosis) 
structural; mitotic 
spindle 30.7 s 100 0 
(Stenoien et al., 2003) 
HeLa 
Cdc20 
(mitosis) 
mitotic checkpoint 
regulator 4.7 s 15 85 
(Kallio et al., 2002)  
HeLa 
Aurora A 
(mitosis) 
mitotic checkpoint 
kinase 3.2 s ND ND 
(Stenoien et al., 2003) 
HeLa 
PLK1 
(mitosis) Centro maturation 7 s ~28 ~72 
(Kishi et al., 2009) 
U2OS 
* ND = not determined 
highly mobile proteins, such as ninein (responsible for MT anchorage at subdistal 
appendages) with almost complete fluorescence recovery detected in interphase. 
Similarly, nuclear mitotic apparatus (NuMA) that anchors mitotic spindles to the spindle 
poles is also completely in constant exchange with its cytoplasmic pool (Table 1.2 and 
1.3). Both proteins display a relatively low T1/2 (time required to reach half maximal 
recovery after photobleaching) which could signify that MT anchoring requires a rapid 
recruitment of regulators to stabilise MTs at their minus-ends. FRAP experiments were 
also able to provide insight as to whether the mode of transportation of proteins to the 
centrosome was MT-dependent. Proteins such as ninein and CDKRAP5 were reported 
to require MTs to be recruited to the centrosome. Normally, ninein undergoes rapid 
turnover/exchange at the centrosome as illustrated by a complete recovery in 
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fluorescence intensity after photobleaching of the GFP-ninein in PtK2 cells, however 
this recovery was prevented after MTs disruption by nocodazole (Moss et al., 2007). 
Similarly CDK5RAP2, a protein believed to attach γ-tuRCs to the centrosome to 
stimulate MT nucleation (Choi et al., 2010; Fong et al., 2008), also requires MTs to be 
targeted to the centrosome. In a stable cell line expressing GFP-tagged CDK5RAP2, 
FRAP analysis indicated that there is ~60% retention of CDK5RAP2 with recovery of the 
mobile pool showing a T1/2 of around 1 min. However, after drug-induced 
depolymerisation of MTs, the fluorescence did not recover at the centrosome, 
suggesting that at least some centrosome targeting of the mobile pool is MT-dependent 
(Jia et al., 2013). Interestingly, CDK5RAP2 was found to interact with dynein light chain 
(subunit of dynein) by biochemical assays in HEK293T cells, which could explain its 
MT-dependent transport (Jia et al., 2013). By contrast, ninein interactions with dynein 
have not been established and ninein was proposed to move bi-directionally along MTs 
in time-lapse experiments (Moss et al., 2007). The application of FRAP in these studies 
allowed the teams to look beyond the constant centrosome localisation observed by 
light microscopy and to identify both anchored and high turnover pools and, in addition, 
determine which of these were dependent on MT integrity.  
1.3.3.2 Dynamics of Wnt proteins at the centrosome 
Several proteins in the Wnt signalling pathway are known to localise to the centrosome, 
some with known functions (see section 1.5.2). For example, β-catenin is a Nek2 kinase 
substrate that localises to the inter-centriolar fibrous linker and possesses a role in 
centrosome separation (Bahmanyar et al., 2008). Interestingly, the retention of β-
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catenin was found to differ between phosphorylation states. From the measurement of 
FRAP recovery of GFP-tagged β -catenin and a mutant form containing a deletion at the 
GSK phosphorylation site, the retention of β-catenin increased from 10% to 30% when 
mutated (Bahmanyar et al., 2008). However, no change in recovery rate was detected 
suggesting that Wnt activation (mimicked by the mutation) may lead to protein retention 
at centrosomes. On the other hand, the B56α subunit of PP2A kinase stably occupies 
the interphase centrosome with a high 70% retained/stable pool as measured in HeLa 
cells, implying a functional role or its ability to regulate other Wnt proteins at the 
centrosome (Flegg et al., 2010). The dynamics of B56α is particularly interesting as it 
contrasts with most of the centrosome regulating enzymes that mostly possess a high 
degree of mobility, such as cdc20 and Aurora A kinases (Tables 1.2 and 1.3), which 
could perhaps signify a role for protein anchorage.  
The study of protein dynamics at the centrosome is informative and imperative as 
most centrosome localising proteins in fact only associate transiently. The observation 
of changes in mobility between cell cycle phases and movement toward the centrosome 
could provide clues to characterise protein functions at this site. While FRAP is a 
powerful technique, caution needs to be taken when interpreting the results given that it 
relies on overexpression of fluorescent-tagged protein which may not behave identically 
to endogenous pools of the same protein, and the fact that centrosome dynamics and 
protein composition changes as cells progress through the cell cycle. For instance, a 
detailed analysis of Nek2A showed that its dynamics changed depending on the stage 
of the centrosome duplication cycle (paired or split) (Hames et al., 2005).  
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1.4 THE CENTROSOME AND MICROTUBULE ASSEMBLY IN 
INTERPHASE AND MITOSIS   
1.4.1 A dynamic network in the cell  
1.4.1.1 Centrosome mediates cell migration and polarity  
The cytoskeleton is comprised of actin, IFs and MTs that combine to maintain the 
structural integrity of cells. MTs are mostly nucleated from, and anchored at, the 
centrosome (see section 1.4.2) to create a highly co-ordinated dynamic network that 
mediates cell orientation and migration of interphase cells, and drives chromosome 
separation and cell division in mitosis and cytokinesis, respectively (Fig. 1.6) (Cowan 
and Hyman, 2004; Hyman and Karsenti, 1998; Small et al., 2002). Therefore, MT-
associated processes have long been targetted by drugs to combat cancer (Field et al., 
2014; Hadfield et al., 2003; Jordan and Wilson, 2004). However, understanding the 
intricate mechanisms that regulate MT assembly and dynamics are far from complete. 
This section illustrates our current understanding of MT nucleation at the centrosome.  
Directional cell migration requires the cell to be polarised and oriented and this is 
largely dependent on the centrosome which, when correctly positioned, forms the 
appropriately oriented network of MTs. The loss of cell polarity and of directed migration 
contributes to the initiating steps of tumourigenesis (Fukasawa, 2005; Lolkema et al., 
2007; Royer and Lu, 2011) (more details in section 1.5.1). One study that analysed  
centrosome patterns in 35 high grade breast tumour cells recognised a significant 
disorganisation of duct epithelial cells associated with cells that suffered centrosome 
hypertrophy (centriole number increased up to 12 centrioles) and scattered PCM (Lingle 
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et al., 1998). Moreover in Drosophila, spatial cues that localise along apical cell 
membranes (eg. “Inscuteable”) and centrioles (eg. “Dsas-4”) were found to be 
responsible for spindle orientation in asymmetric cell division of neural progenitor cells 
(Siegrist and Doe, 2006). The link between centrosome and polarisation was 
strengthened by work in C. elegans. When centrosomes were ablated in C.elegans 
oocytes, the ability to initiate polarisation was abrogated as indicated by use of the 
marker protein, PAR2 (Cowan and Hyman, 2004). 
Centrosome orientation and polarisation is mediated through the Par complex, 
the Scrib complex and the Crb complex, all of which are regulated by Rho-GTPase 
cdc42 at the leading edge of migrating cells, as summarised in several reviews 
 
Figure 1.6 The dynamic nature of microtubules in the cell cycle and the 
centrosome. (A) Interphase MTs (red) determine cell shape and regulate cell adhesion 
and migration. The centrosome (green) also mediates cell orientation by controlling the 
nucleation of MTs. (B) Mitotic MTs (red), also known as spindle MTs (red), are anchored 
at the negative end of the centrosome. These special MTs bind to kinetochores (green) 
to align chromosomes to the equator of the cell in metaphase of mitosis. (C) MTs (red) 
mediate cell division at the point of cytokinesis by facilitating formation of the cleavage 
furrow. The newly formed nuclei of the daughter cells are shown in green.  (Images 
acquired from the ‘human protein atlas’; Jane Stout; and Iain Porter). (D) Schematic of a 
migrating cell showing the positioning of the centrosome (red), nucleus (purple), and the 
array of MTs (blue) (Small et al., 2002).  
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(Etienne-Manneville and Hall, 2001; Etienne-Manneville et al., 2005; Gomes et al., 
2005; Lee and Vasioukhin, 2008; Vega and Ridley, 2008). However, whether the 
function of the polarity complex is required at the centrosome is unclear, given that 
depletion of upstream proteins Par3a and protein kinase C (PKC) was found not to alter 
levels of Par6, despite the role of Par3-Par6 in regulating spindle orientation through 
MTs (Dormoy et al., 2013; Lee and Vasioukhin, 2008). Indeed, Rho-GTPase cdc42 can 
influence the MT network by signalling downstream proteins GSK3β and APC to affect 
cell polarisation (Etienne-Manneville and Hall, 2001; Palazzo et al., 2001; Raftopoulou 
and Hall, 2004). However, it is yet to be determined exactly how centrosomes and MTs 
are co-ordinated as centrosomes can release signals that disrupt the association 
between actinomyosin and the polarity complex Par3/Par6/aPKC independent of its 
function as the MTOC (Sumiyoshi and Sugimoto, 2012). Furthermore, the nucleus 
requires specific positioning during cell migration and dynein, a minus end-directed MT 
tracking protein, is sufficient to rotate the nucleus and to help centre the centrosome via 
the cdc42 pathway (Burakov et al., 2003; Osmani et al., 2010; Wu et al., 2011a; Wu et 
al., 2011b). The prevailing hypothesis is that cell polarisation requires the polarisation 
complex and proper orientation of the nucleus, and is orchestrated by the centrosome-
nucleated MT network to provide both structure and efficient transport of protein 
regulators (Fig. 1.6D). The positioning of the centrosome and the nucleus forms an axis 
in interphase, and in migrating cells the centrosome is positioned ahead of the nucleus 
facing the movement. The position of the centrosome at the movement leading edge 
allows the formation of an array of MTs to facilitate migration. However, the orientation 
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of the nuclear-centrosome axis can vary slightly between different cell types (Burakov et 
al., 2003; Gomes et al., 2005; Luxton and Gundersen, 2011).  
Once oriented, migration of the cell requires the formation of membrane 
protrusions at the leading edge, adhesion, and finally the contraction and retraction of 
the lagging edge at the rear of the cell (Small et al., 2002). Proteins such as EB1, APC, 
CLIP-170 are recruited to the peripheral membrane/cell edge to reduce MT shrinkage 
and thereby promote the extension of cellular protrusions during migration (Al-Bassam 
et al., 2010; Kaverina and Straube, 2011; Kita et al., 2006; Munemitsu et al., 1994; 
Nakamura et al., 2001). MT regulation of focal adhesions has also been described 
through the activation of Rac1-associated complexes and the delivery of proteins such 
as integrin (Gu et al., 2011; Rooney et al., 2010). Strict regulation of the nucleation, 
assembly and dynamics or stability of MTs is paramount to appropriate cell polarisation 
and migration, and any de-regulation of this system will create opportunities for aberrant 
cell organisation as is often seen in cancer cells, where cells are mis-oriented and prone 
to  invasion through cell layers and tissue (Fukasawa, 2005).   
1.4.1.2 The role of the centrosome at the midbody in cytokinesis  
Cytokinesis is the final step of cell division where a unique densely-packed MT bridge 
called the midbody, is formed between the two daughter cells, and requires abscission 
to allow the daughter cells to separate (Fig. 1.6C) (Doxsey, 2005; Elad et al., 2011). 
Centrosomes were thought to be involved in cytokinesis based on their repositioning 
during cytokinesis in live HeLa cells. Centrioles were seen to be rapidly migrate from the 
centre of duplicated daughter cells post-anaphase to the midbody bridge, and to 
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reposition at the conclusion of cytokinesis (Piel et al., 2001). Furthermore, ablation of 
centrosomes in kidney epithelial BSC1 cells was also observed to instigate an increase 
in cytokinetic failure, which corroborates with time-lapsed observations of centrosome 
ablated in another cell lines, PtKG cells where the cleavage furrow can form but 
abscission is incomplete (Khodjakov and Rieder, 2001).  
Interestingly, several centrosome proteins such as γ-tubulin, centriolin, and 
CEP55 localise to the midbody and contribute to the abscission process (Fabbro et al., 
2005; Gromley et al., 2003; Gromley et al., 2005; He et al., 2013; Shu et al., 1995; Zhao 
et al., 2006). Abscission, or the severing of two daughter cells, is powered by an 
actomyosin contractile ring that is termed the ‘midbody ring’ to allow severing proteins 
(aforementioned) to be recruited (Green et al., 2013; von Dassow and Bement, 2005). 
γ-tubulin is seen at the midbody bridge of vertebrate cells by electron microscopy, 
possibly to stabilise MT minus-ends, and indeed the antisense inhibition of γ-tubulin 
results in failure of the midbody to develop thus increasing the number of bi-nucleate 
cells (Shu et al., 1995). Centriolin localises to the central part of the midbody to anchor 
complexes required for abscission. These complexes were reduced at the midbody 
when centriolin was depleted by siRNA (Gromley et al., 2003; Gromley et al., 2005). 
Similarly, Cep 55 is localised to the central midbody region to promote cytokinesis in a 
phosphorylation-dependent manner controlled by PLK1 (Fabbro et al., 2005). Together, 
these studies imply a degree of control of cytokinesis through the combined and 
potentially coordinated action of centrosome localising proteins.   
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1.4.2 Microtubule nucleation and anchorage in interphase  
The centrosome is the MTOC responsible for the growth of MTs, a process that 
includes nucleation (the priming and initiation step of MT formation), stabilisation and 
anchoring (tethering to centrosomes at the minus-end) (Fig. 1.7B). MTs nucleated from 
the centrosome are unique in that they are mostly nucleated with 13 protofilaments (Fig. 
1.7A) as opposed to the 14 detected in spontaneous MT nucleation scored using 
electron microscopy (Evans et al., 1985). More importantly, MTs are nucleated more 
efficiently from the centrosome than any other cellular site, where the centrosome can 
initiate tubulin assembly below critical concentrations of MT subunits available possibly 
by providing nucleation sites in the PCM (Mitchison and Kirschner, 1984; Pereira and 
Schiebel, 1997; Wiese and Zheng, 2006).   
MTs comprise protofilaments of α-tubulin and β-tubulin heterodimers that 
undergo constant assembly (polymerisation) and disassembly (catastrophe) (Fig. 1.7A). 
MTs can nucleate spontaneously, however the most efficient nucleation occurs at 
centrosomes that anchor the γ-tubulin ring complex (γ-tuRC), which primes/initiates 
nucleation and stabilises MTs as observed by immune-gold labeling (Kollman et al., 
2011; Moritz and Agard, 2001; Moritz et al., 2000; Moritz et al., 1995). γ-tuRCs are 
composed of γ-tubulin small complexes (γ-tuSCs) composed of γ-tubulin, γ tubulin-
complex-proteins (GCP), GCP2 and GCP3, as well as GCP4-6, GCP-WD and GCP8 
(Kollman et al., 2011; Salaycik et al., 2005). The γ-tuRCs are recruited to the PCM of 
centrosomes and this is likely to be a tightly regulated process given that live cell 
imaging studies identified GFP-tagged γ-tubulin as a highly dynamic protein. Whether 
this degree of mobility applies to other components of the γ-tuRCs remains to be 
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determined. Nonetheless, γ-tuSCS or γ-tubulin alone could be recruited individually and 
are regulated by a number of proteins. For example, NEDD1 (homologue of the 
Drosophila Dgp71WD) directly binds to γ-tubulin via residues 572-660 and the over-
expression of this fragment reduced γ-tubulin centrosome staining in NIH 3T3 
fibroblasts when detected by immunofluorescence staining (Manning et al., 2010). With 
a possibly similar role in the recruitment of centrosome components, the knockdown of 
PCM-1 using siRNA in U2OS cells reduced detectable amounts of PCNT and centrin II, 
as well as γ-tubulin (Dammermann and Merdes, 2002). However, the above-mentioned 
studies require careful interpretation as most have not actually proven that the “rate” of 
movement of -tubulin is diminished using live cell photobleaching assays (see section 
1.3.3). Together, centrosome targeting of -tuRC can therefore be influenced by a 
number of proteins and factors.  
The extent to which MT nucleation at centrosomes depends on protein 
recruitment is unclear as nucleation activity can still occur in isolated centrosomes of 
Xenopus eggs which could be regulated by phosphorylation (Ohta et al., 1993), 
suggesting there is a pool of stably anchored proteins at the centrosome that is 
sufficient to induce MT nucleation. Once γ-tuRCs are recruited, these complexes are 
apparently activated and stabilised by proteins such as PCNT-B and CG-NAP to initiate 
nucleation (Takahashi et al., 2002; Witczak et al., 1999) (discussed further in Chapter 
8). However, this form of stabilisation should not be mistaken as MT anchorage at the 
PCM by PCNT and AKAP450 (Table 1.1), rather it enables the assembly of γ-tuRCs to 
facilitate MT nucleation (Dictenberg et al., 1998; Witczak et al., 1999).  
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Figure 1.7 The centrosome functions as a microtubule organising centre. (A) MTs 
are mostly nucleated at the centrosome, which functions as a MTOC. (A) MT minus- 
ends are stabilised by γ-tubulin ring complexes (γ-tuRCs) that initiate the recruitment of 
 tubulin heterodimer subunits that form the MT polymers. Continuous MT elongation 
is a dynamic and balanced process and requires stabilisation of the growing plus-end to 
counteract MT catastrophe (breakdown). (B) γ-tuRCs are recruited to the centrosome 
and become activated to initiate MT nucleation. Most MTs are anchored at the minus- 
end to the subdistal appendages of the mother centriole, while other MTs that are not 
well anchored may over time become released from the centrosome and disperse into 
the cytoplasm.  
The mother centriole plays a crucial part in anchoring MTs to the centrosome. 
After nucleation, MTs at the centrosome can either remain in the PCM, be released and 
captured by other MT-requiring sites such as the apical-membrane (Bornens, 2002; 
Mogensen, 1999), or more stably anchored to the subdistal appendage of the mother 
centriole (Fig. 1.7B) (Mogensen et al., 2000; Piel et al., 2000). That is, MTs are 
nucleated in the PCM by γ-tuRCs and the MT minus-ends are subsequently transported 
to the appendage structures as seen in epithelial cells (Delgehyr et al., 2005), although, 
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the number of MTs that require anchoring may vary  between cell types (Bornens, 
2002).  
Several protein complexes can localise to and regulate anchorage at the mother 
centriole,  these include ninein, EB1, KIF and p150 glued/dynactin (Askham et al., 2002; 
Delgehyr et al., 2005; Kodani et al., 2013; Yan et al., 2006). For example, cell staining 
of ninein and α-tubulin revealed an asymmetric MT anchoring at the centrosome where 
MTs converged to a central point that coincided with ninein staining (Piel et al., 2000). 
Detection of this convergence is often used to quantify MT anchorage by assessing 
whether MTs are “focused” (anchored) or “diffused” (not-anchored) (see section 
2.2.10.1). One idea is that anchorage could be orchestrated upstream by dynein, since 
ninein recruitment can be inhibited by nocodazole, and EB1 and KIF interact with dynein 
subunits (Askham et al., 2002; Berrueta et al., 1999; Kodani et al., 2013; Moss et al., 
2007). In support of this, observations from time-lapse video in epithelial Vero cells 
illustrate the dissociation of MTs from the centrosome after antibody-mediated inhibition 
of dynein (Burakov et al., 2008). The dynamics and transport of centrosome proteins is 
therefore crucial in regulating MT nucleation and anchoring, but is an area that remains 
poorly understood. Other potential regulators of MT nucleation include CDK5RAP2, 
which was thought to act as a scaffold based on its interaction and co-localisation with 
AKAP450 (Barr et al., 2010), but later claimed to act within the γ-tuRCs to stimulate the 
nucleating function (Choi et al., 2010). Depletion of CDK5RAP2 however, inhibited the 
nucleation of MTs at centrosomes , but not in the cytoplasm (Choi et al., 2010; Fong et 
al., 2008).  
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MT elongation describes the process of MT extension/polymerisation away from 
the centrosome in a plus-end directed manner, where the nascent MTs require 
stabilisation, similar to the more mature MTs stabilisation in the cytoplasm (Fig. 1.7B). 
Numerous proteins such as EB1, APC and GSK3β decorate MTs by localising along 
nucleated MTs (Bouissou et al., 2009; Dayanandan et al., 2003; Kita et al., 2006; 
Zumbrunn et al., 2001). However, most of these proteins also minimise dynamic 
instability by binding to the growing plus-ends of MTs (Akhmanova and Steinmetz, 
2008; Lansbergen and Akhmanova, 2006).   
1.4.3 Microtubule spindle formation in mitosis  
The mitotic spindle pole bodies play several roles in the cell: (1) attachment/anchoring 
of both polar (attach to kinetochores) and astral (do not attach to kinetochores) MTs at 
the minus end, (2) nucleation of the astral MTs and their connection to the cell cortex to 
help orient and position the spindle, and (3) connection of MTs to the kinetochores 
(Sharp et al., 2000). The spindles are regulated by specific proteins that co-ordinate 
aspects such as tensile strength of spindles, and the anchoring and rate of MT growth 
needs to be co-ordinated with DNA duplication to ensure appropriate DNA separation is 
achieved (Rieder and Salmon, 1998; Sharp et al., 2000).   
Unlike interphase centrosomes that form a large radial array with long range 
stable MTs, mitotic MTs are short and the astral MTs are highly dynamic. These 
differences in MT dynamics are regulated by a range of MT +TIP proteins inclusive of 
EB1, APC and CLIP170, and it is believed that a change in regulation by these proteins 
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mediates the switch in MT dynamics between interphase and mitosis (Niethammer et 
al., 2007).  
Mitotic centrosomes possess greater MT nucleating capacity producing robust 
mitotic spindles rapidly. This is to ensure that chromosome alignment and separation 
progress in a timely fashion although mis-regulation of specific steps can lead to cancer 
(see section 1.5.1). However, it is certainly not the sole regulator of chromosome 
fidelity, as normal chromatid and cell division were observed to continue even when 
centrosomes were ablated in PtKG cells at metaphase (Khodjakov and Rieder, 2001). 
Mitotic centrosomes, when compared to those of interphase, increase in size and MT 
nucleation rates increase by up to 7-fold and peak in metaphase (Piehl et al., 2004). 
Protein localisation and composition change as the centrosome progresses from 
interphase to mitosis. Firstly, the PCM undergoes maturation from early G2-phase, 
increasing the recruitment of proteins, especially γ-tubulin. The mobility of γ-tubulin is 
increased by ~50% from interphase to mitosis (Khodjakov and Rieder, 1999) (see also 
section 1.3.3). This sudden recruitment allows rapid nucleation of the spindle MTs, and 
supports a previous observation of γ-tubulin’s preferential localisation to mitotic spindles 
rather than the spindle pole in a range of cells confirmed with a range of γ-tubulin 
targeting antibodies (Lajoie-Mazenc et al., 1994). In mitosis, γ-tubulin or γ-tuRCs are 
likely recruited rapidly while other proteins such as NuMA (discussed later) collect and 
anchor γ-tuRCs to form robust spindles. Here, PCNT is a scaffold protein for γ-tuRCs at 
the PCM (Takahashi et al., 2002). Close examination of its morphology during cell cycle 
transitions illustrates its progressive enlargement of the PCM lattice from G1 to G2-
phase during centrosome maturation (Dictenberg et al., 1998). Recent studies have 
Chapter 1 Literature review 
65 | P a g e  
 
added two more proteins recruited at the onset of mitosis that contribute to assembly of 
centrosome scaffold. These are centrosomin (CDKRAP2 in humans) in flies and 
CEP215 that cooperates with PCNT in maturation (Conduit et al., 2014; Kim and Rhee, 
2014). This is consistent with the need to produce a higher number of MTs at the 
spindle poles.  
Recent evidence observing the orientation of PCNT-B (kendrin) using super 
resolution imaging has implicated PCNT-B as a PCM organiser (Mennella et al., 2012). 
The switch between protein recruitment and activity is likely to be regulated by 
phosphorylation. One thought was that phosphorylation-dependent targeting by 
regulating dynein association, since PLK1 actually reduces ninein-like-protein (Nlp) 
interaction with dynein, thereby displacing it from the centrosomeas seen at the onset of 
mitosis (Casenghi et al., 2005; Casenghi et al., 2003). Indeed minus-end directed 
movement of cargo and regulatory factors along astral and spindle MTs is thought to be 
important not only for maturation of the spindle but also for its positioning relative to the 
cell membrane and nucleus. This is consistent with the function of PLK1 that instigates 
the maturation of centrosomes, driving the expansion of PCM scaffold by incorporating 
the centrosomin protein (Conduit et al., 2014; Lee and Rhee, 2011).  Additionally, PLK1 
can co-ordinate the recruitment of γ-tuRCs to mitotic centrosomes by phosphorylating 
PCNT and CDK5RAP2 (Haren et al., 2009b).  
The anchoring and focussing of mitotic spindles is also regulated by large 
scaffold proteins such as NuMA, which moves from the nuclear matrix in interphase to 
become an integral component of the mitotic centrosome. The knockdown of NuMA 
causes chromosome misalignment through loss of spindle focussing, orientation and 
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suppressed spindle regrowth from centrosomes (Bowman et al., 2006; Fant et al., 2004; 
Haren et al., 2009a). Hence a range of different factors mediates integrity and MT 
assembly/dynamics during mitosis. 
1.5 RATIONALE FOR A ROLE OF APC AND WNT PROTEINS AT THE 
CENTROSOME  
1.5.1 Links between centrosome defects and cancer 
 CIN and aneuploidy have causal links to cancer development which can be detected in 
various sporadic and hereditary cancers (Albertson and Pinkel, 2003; Lengauer et al., 
1997; Lengauer et al., 1998; Negrini et al., 2010). The CIN phenotype can arise from 
defects in the number or structure of centrosomes as detected in a range of human 
tumours including colon, lung and prostate cancers (Ganem et al., 2009; Ghadimi et al., 
2000; Zyss and Gergely, 2009). One oncogenic consequence of centrosome mis-
regulation is the uncontrolled increase in centrosome number known as “centrosome 
amplification”. This can result either from a deregulation of centrosome duplication, or 
cytokinetic failure such that duplicated centrosomes do not separate forming tetraploid 
cells with excess centrosomes (Fig. 1.8) (Anderhub et al., 2012; Caldwell et al., 2007; 
Korzeniewski et al., 2013; Lv et al., 2012). As a result, the mitotic centrosomes do not 
form proper spindles and are unable to carry out the task of chromosome alignment and 
correct chromosome separation, leaving daughter cells with uneven number 
chromosomes (aneuploidy) that are vulnerable to genetic instability (Bakhoum and 
Compton, 2009; Holland and Cleveland, 2009; Matzke et al., 2003; Nigg, 2002).  
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Figure 1.8 Centrosome defects can lead to tumourigenesis. Centrosome mis-
regulation often leads to the amplification of centrosomes and increased centrosome 
number. This can occur through an over-duplication or defects in cell division leading to 
an accumulation of centrosomes. (A) In interphase, centrosome amplification leads to a 
change in cell polarity affecting cell migration and adhesion, whereas in mitosis, 
multipolar spindles are formed thereby affecting spindle-chromosome attachment and 
alignment, leading to chromosome mis-segregation and instability (CIN), increasing the 
chance of oncogenic mutations. (B) Checkpoints can be evaded when centrosomes are 
clustered to mimic bipolar spindle poles, as cells that form multipolar spindles mostly do 
not survive the next round of cell replication.  
 Centrosome amplification often occurs in interphase and gives rise to multipolar 
spindle formation at mitosis following centrosome separation at the G2/M transition 
phase. Since mitotic centrosomes orchestrate chromosome alignment and separation 
via nucleated spindles, more than two centrosomes provoke a multipolar cell division 
where genetic material is distributed unevenly to more than two spindle poles (Silkworth 
et al., 2009).  It has been suggested that these cells are vulnerable to genetic instability. 
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However, another argument has been that they cannot reproduce more than two 
progeny, possibly due to the limited genetic material available to maintain cell viability 
(Gergely and Basto, 2008; Leber et al., 2010). It is likely that centrosome amplification is 
only a partial cause of aneuploidy, as mitotic spindle multi-polarity can occur even 
without centrosome amplification as discussed in a recent review (Maiato and 
Logarinho, 2014).  
One mechanism to combat multipolar spindles by cancer cells is “centrosome 
clustering”, where excess centrosomes group together to mimic the normal bipolar 
spindle poles to escape cell cycle checkpoints (Kwon et al., 2008; Marthiens et al., 
2012). Overexpression of the SAK (PLK4) protein in flies induced centrosome 
amplification that initially led to multipolar spindles, but then clustered together after a 
pause in mitosis by the spindle checkpoint protein SAC (Basto et al., 2008). The human 
tumour suppressor p53 prevents the clustering of centrosomes by modulating the 
RhoA/ROCK signaling pathway that regulates cytoskeletal organisation, and the 
assumption that centrosome clustering can promote tumourigenesis has led to the 
development of centrosome declustering drugs for cancer therapy (Castiel et al., 2011; 
Ogden et al., 2014; Yi et al., 2011). Additionally, the loss of p53 correlates with 
centrosome hyperamplification (increased centrosome number) believed to be 
synergistic with cyclin E expression, therefore p53 regulates centrosome number in a 
cell cycle-dependent manner as observed in mouse fibroblast MEF cells (Mussman et 
al., 2000; Tarapore and Fukasawa, 2002). Regulation of centrosome number and 
clustering in CRC cell lines has also been seen with NuMA and BRCA1 (Leber et al., 
2010; Quintyne et al., 2005) (see Table 1.4).   
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Table 1.4 The links between tumour suppressors and centrosome regulation.  
Tumour 
suppressor Effect 
BRCA1 
 
- BRCA1 dependent ubiquitination of -tubulin at Lys-48 and Lys-344 residues directly 
inhibits MT nucleation, leading to centrosome hypertrophy (Sankaran et al., 2005). 
- BRCA1 deficient cells show 50% centrosome amplification after IR treatment in 
HCC1937 cells (Brodie and Henderson, 2012). 
- Silencing expression of BRCA1 in cancer cell lines increases centrosome number 
(Starita et al., 2004).  
p53 - Loss of p53 correlates with centrosome hyperamplification in a cell cycle 
dependent manner correlating with cyclin-E expression in MEF cells (Mussman et al., 
2000; Tarapore and Fukasawa, 2002). 
NuMA - Overexpression of NuMA declusters centrosomes by promoting multipolar spindle 
formation in oral cancer cells. siRNA induced NuMA depletion also decreased spindle 
multipolarity (Quintyne et al., 2005).   
Arpc1b - An aurora A interacting protein localises to the centrosome and is upregulated in 
breast cancer and pancreatic cancer cells (Molli et al., 2010).  
 
“Merotelic MT-kinetochore attachments” is an error that occurs at the junction 
where spindle MT plus-ends make contact with the chromatids, which could either be 
weakened, uncoordinated or unstable, resulting in chromosome misalignment and  
asymmetric chromosome separation (Ganem et al., 2009; Gregan et al., 2011; Guerrero 
et al., 2010). Tumour suppressors also regulate centrosomes and nucleation of MTs to 
ensure correct chromosome separation (Table 1.4). For example, depletion of the 
tumour suppressor BRCA1 in breast cancer cells not only induces centrosome 
amplification, but also increases the size of MT asters by ~3 fold due to the lack 
ubiquitination of γ-tubulin by BRCA1 (Sankaran et al., 2005; Starita et al., 2004). This 
was consistent with a study of 35 high grade breast adenomas that showed a 10-fold 
increase in the number of MTs produced per centrosome as well as the centrosome 
size, compared to the normal duct epithelial cells (Lingle et al., 1998).   
Interphase centrosomes and MTs are important for cell polarity and migration 
(see section 1.4.1), and therefore centrosome amplification could perturb cell 
Chapter 1 Literature review 
70 | P a g e  
 
orientation. Defects in interphase centrosomes often relate to the premature splitting of 
centrosomes which can result from a reduced cohesiveness causing a mis-regulation of 
Nek2A or separase related proteins (see section 1.3.2.2). Premature centrosome 
separation prior to the onset of mitosis is also an antecedent event of abnormal spindle 
orientation (Matsuo et al., 2010; Silkworth et al., 2012). A centrosome declustering drug 
known as EM011 has recently shown high efficacy to promote multipolar spindle 
formation by inhibiting the binding of TIP proteins to MTs, to promote cell death (Karna 
et al., 2011). Since centrosome defects that occur in interphase cells can directly affect 
chromosome separation in mitosis, expanding our understanding of the biology of 
tumour suppressor regulation of centrosomes (Table 1.4) is an important area for 
continued research.  
1.5.2 Wnt proteins at the centrosome  
A number of proteins important in the Wnt signaling pathway localise to the 
centrosomes in both interphase and mitosis with specific functions (Table 1.5). 
However, whether these proteins work together to carry out their roles at the 
centrosome is unclear. In this section, proteins of the destruction complex (GSK3β, β-
catenin, PP2A, axin1/2 and APC) and their contributions to centrosome regulation are 
discussed.  
1.5.2.1 Interphase  
In interphase, almost all of these Wnt proteins have been associated with MT regulating 
functions such as MT growth and MT stabilisation through phosphorylation (Table 1.5). 
Confocal microscopy revealed that phospho-forms of GSK3β are initially scattered in 
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the cytoplasm in interphase but later accumulate at the mitotic spindle and centrosomes 
facilitated by the Akt/PKB-pathway that is often altered in cancer (Cheng et al., 2005; 
Wakefield et al., 2003). GSK3β can phosphorylate APC to regulate MT dynamics and 
stability, and is critical for β-catenin degradation (Miller and Moon, 1996; Morin et al., 
1997; Zumbrunn et al., 2001). However, it is unclear how GSK3β regulates Wnt proteins 
at the centrosome. GSK3β can directly bind to γ-tuRC subunits, where it is shown that 
HA and FLAG-tagged GSK3β can co-precipitate with GCP5 in HeLa cells, possibly 
involved in the recruitment of γ-tuRC components since GCP5 could recruit γ-tubulin 
(Izumi et al., 2008). Moreover, GSK3β can affect MT anchoring by facilitating the 
interaction between the protein ‘bicaudal-D’ (MT-cargo adaptor) and dynein. The 
depletion of GSK3β by siRNA attenuated MT anchorage to the centrosome by 4-fold in 
HeLa and U2OS cells as seen by the loss of “focused” MTs (Fumoto et al., 2006). 
GSK3β is likely to act upstream of effectors such as β-catenin. A similar effect was also 
observed in fibroblast 3Y1 cells where loss of GSK3β increased the number of diffused 
astral MTs by 7-fold (Huang et al., 2007). Like GSK3β, β-catenin also co-fractionates 
with γ-tubulin from centrosome isolates which implies that this interaction is specifically 
at the centrosome, and can regulate MTs irrespective of GSK3β (Kaplan et al., 2004). 
Both β-catenin and the degradation complex scaffold protein, axin1, were reported to 
regulate MT nucleation, as demonstrated by a 3-5-fold reduction in the  number of 
nucleated MTs and fluorescence intensity of the MT aster in MKN-1 and 3Y1 cells, 
respectively, after silencing of either protein (Fumoto et al., 2009; Huang et al., 2007).  
 Proteins of the Wnt pathway appear to possess additional roles at the 
centrosome. β-catenin is a substrate of the Nek2 kinase that acts as a linker for the 
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duplicated centrosomes in S-phase, also co-localising with rootletin and C-Nap1 at the 
linker in order to maintain centrosome cohesion (Bahmanyar et al., 2008) (see also 
Table 1.1). This is consistent with the observation that overexpression of human Nek2  
Table 1.5 Centrosome localisation and functions of Wnt proteins.   
  GSK3β β-catenin PP2A Axin1/2 APC 
In
te
rp
ha
se
 
Localisa
-tion 
YES 
(Moss et al., 
2007) 
YES 
(Huang et 
al., 2007) 
YES 
(Sontag et al., 
1995) 
YES (B56α) 
(Flegg et al., 
2010) 
YES 
(Fumoto et al., 
2009; Hadjihannas 
et al., 2010) 
YES 
(Barth et al., 
1997; Nathke 
et al., 1996) 
Function 
MT focusing 
(Fumoto et al., 
2006) 
Promotes 
centrosome
cohesion 
(Bahmanya
r et al., 
2008) 
Focus and 
anchors 
MTs 
(Huang et 
al., 2007) 
Associates with 
MTs 
(Sontag et al., 
1995) 
Inhibits 
centrosome over-
duplication  
(Kotadia et al., 
2008) 
Regulates 
centriole 
formation  
(Kitagawa et al., 
2011) 
Axin1 Stimulates 
MT nucleation  
(Fumoto et al., 
2009) 
Axin2 promotes 
centrosome 
cohesion 
(Hadjihannas et al., 
2010) 
unknown 
M
ito
si
s 
Localisa
tion 
YES  
GSK3β* 
(Wakefield et 
al., 2003) 
NO 
(Olmeda et 
al., 2003) 
YES* 
(Huang et 
al., 2007) 
YES 
(Horn et al., 2007)
YES 
Spindle pole and  
spindles 
(Kim et al., 2009) 
YES 
(Dikovskaya 
et al., 2004) 
Centros
ome 
Spindles 
Chromosome 
alignment 
(Wakefield et 
al., 2003) 
(Ong Tone et 
al., 2010) 
GCP5 and γ-
tubulin 
recruitment to 
spindles 
(Izumi et al., 
2008) 
Stimulates 
formation of 
biopolar 
spindle 
(Kaplan et 
al., 2004) 
Regulates mitotic 
exit 
(Schmitz et al., 
2010) 
Maintains 
chromatid 
cohesiveness 
(Porter et al., 
2013) 
Axin1 Regulates 
GSK3β-spindle 
association 
(Kim et al., 2009) 
Axin1 Associate 
with γ-tubulin 
(Ruan et al., 2012) 
Axin1* increases 
centrosome 
number 
(Ruan et al., 2012) 
MT 
nucleation/ 
stabilisation 
(Dikovskaya 
et al., 2004) 
Green = localisation ; Orange = MT related function and protein associations ;  
Blue = centrosome regulating functions ; (*) asterisk indicates phosphorylated forms 
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in cancer cells increased β-catenin levels and stimulated centrosome separation (Das et 
al., 2013). Axin2 also shows a similar localisation pattern with C-Nap1 and maintains 
centrosome cohesiveness. In axin-knockout MEF (mouse fibroblast) cells and axin 
siRNA treatment increased centrosome splitting by at least 3-fold in a phosphorylation-
dependent manner (Fumoto et al., 2009; Hadjihannas et al., 2010).    
Another debilitating consequence of centrosome deregulation is centrosome 
amplification that promotes the CIN phenotype (see section 1.5.1). It is interesting that 
axin phosphorylation by PLK1 (kinase that regulates centrosome duplication) causes an 
increase in centrosome number (Ruan et al., 2012), while PP2A inhibition by SV40 
tumour antigen can induce a 20% increase in cells with increased centrosome number 
(Kotadia et al., 2008). β-catenin mutations lead to the formation of extra-centrosome like 
structures in interphase containing γ-tubulin and centrin, but not other crucial proteins 
such as PCNT, PLK4 or SAS-6 (Bahmanyar et al., 2010). All these clues support the 
notion that there is a degree of control of centrosome regulation by Wnt proteins during 
interphase, which when misregulated could directly interfere with mitosis and DNA 
separation that is normally orchestrated by the mitotic spindle poles.  
 
1.5.2.2 Mitosis  
The activity and localisation of proteins at centrosomes can differ between interphase 
and mitosis. For example, GSK3β rapidly accumulates at the mitotic spindle poles after 
interphase and can be seen to localise along mitotic spindles in HeLa cells, contributing 
to chromosome alignment post-phosphorylation (Wakefield et al., 2003). The inhibition 
of GSK3β using lithium or other drugs significantly increased irregular DAPI staining at 
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the metaphase plate, possibly attributed to a deregulation of cytoskeletal dynamics 
(Ong Tone et al., 2010; Wakefield et al., 2003). There have been inconsistencies 
regarding the localisation of β-catenin at mitotic centrosomes, however its depletion by 
RNAi impedes centrosome separation that ultimately leads to monopolar spindle 
formation, which can be rescued with the stable expression of myc-tagged β-catenin in 
β-catenin deficient HeLa cells (Kaplan et al., 2004; Olmeda et al., 2003). Defects in 
mitotic spindle orientation and cell polarity are also associated with low concentrations 
of β-catenin observed in neural progenitor cells (Chilov et al., 2011). Since the depletion 
of GSK3β and β-catenin show similar consequences, and given that β-catenin is a 
substrate of GSK3β, it is reasonable to assume that certain centrosome functions of 
GSK3β may be mediated by its phosphorylation of β-catenin. This could also apply to 
other phospho-targets of GSK3β including APC. The ectopic expression of axin, the 
primary scaffolding protein of the -catenin degradation complex, can inactivate the 
GSK3β that localises along the mitotic spindles, and its localisation is regulated by the 
aurora kinases that maintain bipolar spindles and chromosome alignment (Fu et al., 
2007; Kim et al., 2009). However, whether axin contributed to the assembly of a β-
catenin pre-degradation complex at the centrosome is unknown.  
1.5.3 APC at the centrosome in mitosis 
In mitosis, cells that harbour APC mutations develop misaligned/misoriented 
chromosomes, disorganised mitotic spindles, inadequate chromosome separation and 
aberrant cytokinesis, all contributing to chromosome mis-segregation and CIN (Caldwell 
et al., 2007; Green and Kaplan, 2003; Kaplan et al., 2001; Tighe et al., 2001; Tighe et 
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al., 2004). The APC truncated mutant is linked to CIN. The expression of the min APC 
phenotype induces aneuploidy in embryonic cell lines to cause a radical change in 
chromosome number (mostly increased) compared to the wild-type cell line (Kaplan et 
al., 2001). 
There is evidence that APC-FL contributes at multiple levels to integrity of the 
mitotic spindle, including nucleation of the mitotic MTs from the mitotic centrosome 
(from in vitro data) (Dikovskaya et al., 2004), and attachment of the spindle MT plus-
ends at kinetochore sites where they contact the chromosomes. Moreover, mutations in 
APC appear to disrupt normal mitotic processes in distinct ways, including – but not 
restricted to – lessening of spindle MT stability, attachments and dynamics, and of 
polarity and orientation/positioning of the actual spindle itself such that upon division 
both chromosome number and integrity are impaired. APC is a known MT TIP protein 
and is apparently also pivotal to MT kinetochore junction regulation in mitosis, acting by 
localising with the kinetochore junction/checkpoint protein bub3 at the kinetochores (Fig. 
1.8) (Kaplan et al., 2001). It was hypothesised that the truncation of APC reduced 
stabilisation of MT plus-end to kinetochore attachments, as bub kinases only 
phosphorylated the C-terminal half of APC as indicated by in vitro kinase reaction 
assays (Kaplan et al., 2001). It is interesting that phosphorylation sites for cyclin-
dependent kinase cdc2 and GSK3β also exist in the C-terminal half of APC (Trzepacz et 
al., 1997). These additional factors might also regulate mitotic spindles through APC, 
especially since GSK3β mediates APC-MT association in a phospho-dependent 
manner, and APC is phosphorylated during interphase but to a lesser extent than in M-
phase (Trzepacz et al., 1997; Zumbrunn et al., 2001).  
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In fact, APC seems to control the orientation and production of robust mitotic 
spindles. Spindles observed in live epithelial HEK293 cells expressing the truncated 
mutant APC1-1450 become mis-oriented and unanchored (Caldwell et al., 2007). 
Measurements of spindle rotation indicated an increase particularly at G2/M-phase, and 
this was thought to depend on cyclin A/cdk2 (Beamish et al., 2009; Caldwell et al., 
2007). This would certainly contribute to the significant increase in chromosome 
misalignment and aberrant MT attachments observed in tumour cell lines carrying APC 
mutations and the CIN phenotype. An examination of chromosomes in such cell lines 
(eg. SW480, HT29) using DAPI staining revealed a reduced organisation at the 
metaphase plate indicative of chromosome misalignment (Green and Kaplan, 2003). In 
agreement, a recent study reported that APC negatively regulates the ‘compaction’ of 
chromatin. In APC depleted HeLa cells, a fluorescence proximity assay (FRET assay) 
was used to detect its closeness to histones. Results revealed an increase in 
fluorescence response, which implies an increase in chromatin compaction upon APC 
loss (Dikovskaya et al., 2012). It is clear that APC can therefore regulate chromosome 
alignment via MT plus-ends through more than one mechanism. However, what is 
unclear is whether APC can also control MTs at their minus-ends. Interestingly Green 
and colleagues indirectly showed that APC affected MT regrowth in mitosis. While 
spindle MT nucleating ability and rate of nucleation did not differ between mitotic 
HCT116 (APC-FL) and SW480 cells (APC mutant) cells initially, measurement of the 
number of astral MTs and length of MTs reaching the midzone at 90 s after washout 
from nocodazole treatment showed that MT projections were reduced in SW480 cells 
(Green and Kaplan, 2003). In fact, when assessing the spindle production in Xenopus 
Chapter 1 Literature review 
77 | P a g e  
 
cells lacking APC, fluorescence intensity of MTs was significantly reduced in the 
absence of APC-FL, while the repression of MT growth could be rescued by over-
expression of a C-terminal APC fragment (1015-2843) (Dikovskaya et al., 2004). The 
reason for this remains unclear. Together, these disparate findings suggest that APC is 
important in safe-guarding the integrity of chromosome separation in mitosis by 
regulating mitotic spindles at multiple levels. 
1.5.4 APC at the interphase centrosome 
APC localises to the centrosome in interphase (Louie et al., 2004; Tighe et al., 2001), 
but its exact role is undefined and may or may not be similar to that in mitosis, as 
centrosome protein composition and dynamics can shift between cell cycle phases (see 
section 1.3.3) (Fig. 1.9). Some studies have linked APC to a MT nucleation role based 
on an in vitro tubulin assembly assay with EB1 and isolated centrosomes from APC 
depleted Xenopus extracts. The previous results suggest that APC could potentially 
assemble MTs in interphase (Dikovskaya et al., 2004; Nakamura et al., 2001). However, 
this idea has not been directly proven in mammalian cells. APC was reported to interact 
with γ-tubulin which suggests that MT stabilisation could occur at the centrosome 
(Mahadevaiyer et al., 2007), our own testing of this concept is described later in 
chapters 4 and 5.  
 On the other hand, APC could be involved in centrosome duplication or cohesion 
(Fig. 1.9). Examination of APC localisation at the centrosome in interphase revealed an 
accumulation at mitosis in several cell lines (mouse and human cancer cells), which 
disappeared at the beginning of the cytokinesis, and is consistent with APC being a 
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dynamic protein (Olmeda et al., 2003). However no studies to track movement of APC 
or β-catenin were actually performed in that study, and there are no current reports of 
APC dynamics at the centrosome (investigated here in Chapter 3). Nonetheless, this 
localisation pattern actually conflicted with other papers that reported APC to localise at 
interphase centrosomes, and this localisation pattern was shown to require mainly the 
N-terminal 700 amino acids of the protein (Louie et al., 2004; Tighe et al., 2004). The 
discrepancy could be attributed to the use of an unreliable antibody (N-15 from Santa 
Cruz) used to detect APC in the Olmeda publication, as reported later by others 
(Brocardo et al., 2005).   
 
Figure 1.9 The possible roles of APC at the centrosome. A schematic of the 
centrosome duplication cycle and predicted roles of APC at the centrosome in 
interphase and mitosis. In interphase, APC could function in the centrosome duplication 
cycle possibly by localising to centrioles or its linker (green). The close association of 
APC to MTs suggests that APC could also regulate MT nucleation and stabilisation at 
interphase centrosomes (red). APC regulates spindle-chromosome attachment and 
could be regulating the minus-end/anchoring of the MTs at mitotic centrosomes 
(orange). Schematic adapted from (Bettencourt-Dias and Glover, 2007). 
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A number of Wnt signaling proteins seem to regulate centrosome cohesion and 
duplication (Table 1.5), however the involvement of APC is yet to be demonstrated. 
Embryonic stem cells that are homozygous Min (intestinal neoplasia) or expressing 
APC1-1638 experience an increase in the centrosome number and the amount of 
abnormal centrosomes in mitosis (Fodde et al., 2001), a consequence of centrosome 
over-duplication occurring in interphase (see section 1.5.1), thereby linking APC to 
centrosome number. Another area worth exploring is a role for APC in centrosome 
cohesiveness or splitting. APC regulates β-catenin levels in the cell, and cells 
expressing truncated APC (SW480 cells) show increased concentrations of β-catenin 
that can be subsequently regulated again upon re-expression of APC-FL (Munemitsu et 
al., 1995). Interestingly, the stabilised or unphosphorylated form of β-catenin, such as 
that seen in the active Wnt pathway, can induce premature centrosome splitting in 
interphase cells (Bahmanyar et al., 2008), suggesting the possibility that APC may 
regulate β-catenin activity also at the centrosome. Currently there is no evidence to 
suggest the involvement of APC in centrosome cohesion/separation. APC has never 
been seen to localise to the centrosome linker with proteins such as C-Nap and rootletin 
but rather favours a co-localisation with the mother centriole (Louie et al., 2004). It 
therefore remains uncertain whether APC could regulate centrosome cohesion like β-
catenin or another function at the mother centriole, such as MT anchorage of 
centrosome duplication.  
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1.6 AIMS OF STUDY 
This study aims to contribute to our growing knowledge of how APC truncation perturbs 
the non-canonical Wnt pathway by defining the significance of APC at the centrosome. 
A vast amount of work hypothesised that APC-FL facilitates processes such as polarity, 
migration and cell positioning by its association with the MT network, however the 
control of MTs begins at the centrosome. Given that the centrosome orchestrates 
numerous cellular processes in interphase, and that most of the literature has focussed 
on APC at the mitotic centrosome, this study aims to illuminate the contribution of APC 
to centrosome functions and test if these functions are deregulated by the mutation of 
APC at interphase centrosomes. Firstly, the centrosome targeting, dynamics, pools and 
retention status will be characterised comparing the APC-FL and APC-truncated 
mutant. Next is to identify the contribution of APC to vital centrosome functions including 
centrosome amplification, splitting and MT nucleation. Given that APC is a 
multifunctional protein through its various binding domains, the project also aim to 
elucidate centrosome-related functions of APC by examining its interaction with known 
centrosome integral proteins, and further expand it to a proteomic approach to find 
novel partners of APC of any significance.  
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2.1 MATERIALS 
2.1.1 Reagents  
Table 2.1 Reagents and Suppliers  
Reagent Supplier 
Acetone Merck 
Acrylamide solution, 40 % 29:1 Merck 
Ammonium persulphate (APS) Sigma 
Ampicillin Calbiochem 
Bacto-agar Oxoid 
Bacto-tryptone Oxoid 
Bacto-yeast extract Amresco 
Bovine serum albumin Sigma 
3-[(3-Cholamidopropyl) 
dimethylammonio]-1-propanesulfonate 
(CHAPs) 
Sigma 
Coomassie brilliant blue (R250) dye Thermoscientific 
Dulbecco’s Modified Eagles Medium 
(DMEM) Sigma 
Dimethyl Sulphoxide (DMSO) Amresco 
Duolink kit (green and red) Sigma (Olink) 
ECL Western blotting detection 
reagents GE Healthcare 
Ethanol (absolute) Merck 
Ethidium bromide Sigma 
Ethylenediaminetetra-acetic acid 
(EDTA) Amresco 
Fetal bovine serum ThermoTrace 
Formaldehyde (Formalin; 37%) Sigma 
Fugene HD Promega 
Glucose (20%) Amresco 
Glutamine (200 mM) SAFC Biosciences 
Glycerol Amresco 
Glycine Amresco 
HEPES buffer (1 M) SAFC Biosciences 
Isopropanol Amresco 
Isopropyl β-D-1-thiogalactopyrnaoside 
(IPTG) Sigma 
Kanamycin Boehringer Manheim 
Leptomycin B Sigma 
Lipofectamine 2000 Invitrogen 
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Magnesium chloride AJAX Chemicals 
Magnesium sulphate AJAX Chemicals 
-Mercaptoethanol Sigma 
Methanol (absolute) Fronine 
MG-132 Calbiochem 
Nocodazole Sigma 
Non-fat milk powder Diploma 
Nonidet NP-40 Roche 
OPTI-MEM reduced serum medium Invitrogen 
Penicillin G (5000 U/ml)/Streptomycin 
sulphate (5000 µg/ml) CSL Biosciences 
Phosphate buffered saline tablets Amresco 
PLA probes plus (rabbit) Sigma (Olink) 
PLA probes minus (mouse) Sigma (Olink) 
Poly-L-lysine Sigma 
Ponceau S Sigma 
Protease inhibitor cocktail tablets 
(complete) Roche 
Protein A-Sepharose CL4B beads GE Healthcare 
Protein-G-Beads Roche 
RPMI 1640 medium ThermoTrace 
Sodium lauroyl sarcosinate (Sarkosyl ) Sigma 
Sodium acetate Amresco 
Sodium bicarbonate (7.5 %) Sigma 
Sodium chloride Univar 
Sodium dodecyl sulphate (SDS; 20%) Amresco 
TEMED Amresco 
Tris Amresco 
Triton X-100 Astral 
Trypsin JRH Biosciences 
Tween-20 Astral 
Vecta Shield mounting medium Vector Laboratories 
Vincristine Sigma 
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2.1.2 Cell lines 
Table 2.2 Cell line source information and genetic characteristics 
Cell Line Source and characteristics 
U-2OS Human epithelial osteosarcoma cell line. 
Wild-type p53 
APC-full length  
SW480  Human colon epithelial carcinoma cell line from 
adenocarcinoma of the colon containing wild-type p53. 
APC-mutant (1-1337) 
HeLa Human cervical cancer isolated from adenocarcinoma of 
epithelial origin 
All cell lines were obtained from the American Type Culture Collection (ATCC)  
2.1.3 Antibodies and Dyes 
Primary antibodies, secondary antibodies and dyes are outlined in tables 2.3, 2.4 and 
2.5 respectively. 
Table 2.3. Primary antibodies 
Primary antibody Species and isotype 
Epitope 
(amino 
acids) 
Working 
Dilution Supplier 
GFP Rabbit 
polyclonal 
Whole 
antiserum 
IF: 1:2000 
WB: 1:1000 
Invitrogen 
 
GFP Mouse 
monoclonal 
Whole 
antiserum 
IF: 1:1000 
WB: 1:1000 
Roche 
IgG Rabbit 
polyclonal 
IgG WB: 1:1000 
IP: 2 µg/mg 
protein 
Sigma 
IgG Mouse 
monoclonal 
IgG WB: 1:1000 
IP: 2 µg/mg  
Sigma 
-tubulin Mouse 
monoclonal 
C-terminus IF: 1:1500 
WB: 1:2500 
Sigma 
β-tubulin Mouse 
monoclonal 
281-446 IF: 1:1000 Sigma 
ε-tubulin Mouse 
monoclonal 
352-336 WB: 1:800 Sigma 
-tubulin Mouse 
monoclonal 
38-53 IF: 1:800 
WB: 1:1500 
Abcam 
-tubulin Rabbit 38-53 IF: 1:800 Sigma 
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polyclonal WB: 1:1500 
APC (H290) 
 
Rabbit 
polyclonal 
2-289 IF: 1:300 
WB 1:500 
Duo: 1:300 
Scanta 
Cruz 
APC-NT Rabbit 
polyclonal 
1-61 IF: 1:500 Dr Maree Faux 
(Gift) 
APC1 Rabbit 
polyclonal 
1-219 IF: 1:400 Dr Maree Faux 
(Gift) 
APC2 Rabbit 
polyclonal 
1011-1470 IF: 1:400 Dr Maree Faux 
(Gift) 
APC (Ab7) Mouse 
monoclonal 
1-226 IF: 1:50 
Duo: 1:50 
Merck 
Ab1 Mouse 
monoclonal 
1-35 WB: 1:100 Merck 
Ab5 Mouse 
monoclonal 
1-226 IP : 1 g/ml Merck 
C20 Rabbit 
polyclonal 
2823-2843 IP : 1 g/ml Santa Cruz 
Centrin II Rabbit 
polyclonal 
185-175 IF: 1:500 
WB: 1:1000 
Abcam 
CEP110 (H-300) Rabbit 
polyclonal 
2026-2325 IF: 1: 500 
WB: 1:500 
Duo: 1:300 
Santa Cruz 
 
Glutathione 
(GST) 
Goat 
polyclonal 
Whole 
antiserum 
WB: 1:6000 Abcam 
MAP1B Rabbit 
polyclonal 
2221-2350 IF: 1:250 
WB: 1:500 
Santa Cruz 
Ninein 
 
Rabbit 
polyclonal 
Whole IgG IF: 1:500 
WB: 1:800 
Duo: 1:500 
Bethyl 
 
NuMA 
 
Rabbit 
polyclonal 
1-309 IF: 1: 2000 
WB: 1:2000 
Abcam 
 
PCNT-B 
(kendrin) 
Rabbit 
polyclonal 
3286-3336 IF: 1:3000 
WB: 1:3000 
Duo: 1:3000 
Abcam 
PCNT-A/B Rabbit 
polyclonal 
100-600 IF: 1:1000 
WB: 1:2000 
Duo: 1:1500 
Abcam 
Vinculin 
 
Rabbit 
polyclonal 
1100-C-
terminus 
WB: 1:1800 Sigma 
IF: Immunofluoresence; WB: Western blotting; IP: Immunoprecipitation; Duo : Duolink 
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Table 2.4. Secondary antibodies 
Secondary antibody Working Dilution Supplier 
AlexaFluor 488 anti-mouse IF: 1:500 Invitrogen 
AlexaFluor 488 anti-rabbit IF: 1:500 Invitrogen 
AlexaFluor 594 anti-mouse IF: 1:1000 Invitrogen 
AlexaFluor 594 anti-rabbit IF: 1:1000 Invitrogen 
Hoechst 33258 (200 µg/ml) IF: 1:200 (2ug/ml) sigma 
   WB: Western blotting, IF: Immunofluoresence 
  
2.1.4 Small Interference RNA 
   Table 2.5. siRNA target sequences 
Target Gene siRNA name Target sequence/catalogue number
APC 
 
siAPC-d 
siAPC-2 
AGG GGC AGC AAC TGA TGA AAA 
AACGAGCACAGCGAAGAATAG 
(Qiagen – custom made) 
PCNT-A/B siPCNT TTG GAC GTC ATC CAA TGA GAA 
(Qiagen – custom made) 
γ-tubulin siγ-tubulin γ-tubulin siRNAs (pooled) 
 #sc-29323 (Santa Cruz) 
NuMA siNuMA NuMA siRNA (h) 
# sc-43978 (Santa Cruz) 
CEP110 siCTNL siGENOME SMARTpool siRNA  
#M-06841-01-0005 (Themo Scientific) 
2.1.5 Plasmids 
Table 2.6.  List of plasmids  
Gene Construct Tag/ 
vector 
Length 
(amino acids) 
µg/w
ell 
Source 
APC APC-FL EGFP 1-2843 3 Dr Angela Barth 
 APC1-1309 
mutant 
EGFP  1-1309 2 Dr Myth Mok 
 APC1-302 EGFP  1-302 2 Dr Manisha 
Sharma 
 APC1-453 EGFP 1-453 2 Cloned here 
 APC1339-
2345 
EGFP  1339-2345 2 Dr Manisha 
Sharma 
 APC EB1 
binding 
EGFP  2650-2843 2 Dr Manisha 
Sharma 
 APC1-625 EGFP 1-625 2 Cloned here 
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 APC old ARM EGFP  334-900 2 Dr Manisha 
Sharma 
 APC ARM EGFP 453-727 3 Dr Myth Mok 
 APC ARM1-4 EGFP 453-628 2 Dr Myth Mok 
 APC ARM5-7 EGFP 629-767 2 Dr Myth Mok 
 APC334-625 EGFP 334-625 2 Cloned here 
 APC-FL pCMV 1-2784 3 Dr Angela Barth 
PCNT- B PCNT-C241 RFP 3259-3500 1 Dr Sean Munro 
Rev pRev (1.4) GFP - 0.5 A/Prof Beric 
Henderson 
 pRev-NES 
mut 
GFP - 0.5 A/Prof Beric 
Henderson 
RFP-pericentrin (PCNT)-C241 was supplied as a generous gift from Dr. Sean Munro 
(Gillingham and Munro, 2000). APC-FL-GFP was kindly supplied by Dr Angela Barth 
(Barth et al., 2002).  
2.1.6 Drugs 
Table 2.7 Drugs used in thesis 
Drug Concentration/
dose 
Target action Time of 
treatment 
Nocodazole 
(Sigma) 
33 µM Interferes with tubulin 
assembly 
1 h 
Leptomycin B 
(Sigma) 
5 ng/ml Antibiotic that blocks 
CRM1 nuclear export 
pathway 
3 h 
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2.2 METHODS 
2.2.1 Bacterial Culture 
2.2.1.1 Overnight bacterial cultures 
2-yeast tryptone (2-YT) medium containing the appropriate antibiotic (ampicillin or 
kanamycin 50 µg/ml) was inoculated with a single colony from a 2-YT agar plate or 5 µL 
of a frozen bacterial stock in glycerol (see section 2.2.1.2) and incubated at 37 C for 
14-16 h at 250 rpm. 
2-YT Medium  
Bacto-tryptone 15 g 
Bacto-yeast 
extract 
10 g 
NaCl 5 g 
Dissolved in 1 L distilled water and autoclaved to sterilise. For agar plates, 15 g bacto-
agar was added prior to autoclaving and allowed to cool to 50 C prior to adding 
antibiotic and pouring into sterile Petri dishes (~20 ml/dish) to set at room temperature 
(RT). 
2.2.1.2 Freezing bacterial/glycerol stocks 
Frozen bacterial stocks were made by mixing 700 µl of logarithmic phase E. coli culture 
to 300 µl of sterile glycerol (100%) to a screw cap cryogenic vial. Cultures were 
vortexed briefly then snap frozen on dry ice and stored at -80 °C. 
2.2.1.3 Preparation of XL10-gold and BL-21 competent cells 
2-YT medium (5 ml) without antibiotic was inoculated with one colony of XL10-gold or 
BL-21 cells and incubated at 37 C for 12-16 h at 250 rpm. 300 µL of this overnight 
culture was added to 30 ml of 2-YT, which was then incubated at 37 oC until the optical 
density (O.D). at 600 nm was in the range of 0.2 and 0.4. Cells were centrifuged at 4000 
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rpm in a bench top centrifuge for 8 min at 4 C and re-suspended in cold TB buffer (see 
recipe below) to half the original culture volume (15 ml). After 30 min incubation on ice, 
cells were centrifuged at 4000 rpm for 5 min at 4 C and re-suspended in cold TB buffer 
to one-tenth the original culture volume (3 ml). Cells were either transformed 
immediately or 16 % v/v sterile glycerol was added before aliquoting cells on ice and 
storage at -80 C for up to 3 months. 
TB Buffer  
PIPES 10 mM 
MnCl2 55 mM 
CaCl2 15 mM 
250 mM KCl 250 mM 
pH adjusted to 6.7 with KOH, filter sterilised (0.45 µm) and stored at 4 C. 
2.2.1.4 Heat shock transformation of XL10-gold or BL-21 competent cells 
–mercaptoethanol (4 µL) was added to 100 µL of XL10-gold or BL-21 competent cells 
(prepared as in section 2.2.1.3.) followed by incubation on ice for 10 min with gentle 
mixing every 2 min. Plasmid DNA (50 ng) was then added to the cells and mixed gently 
before incubation on ice for 30 min. Cells were then heat pulsed for 90 s in a water bath 
at 42 C and incubated on ice for 2 min. Warm NZY medium (900 µL) (see recipe 
below) was added and the cells incubated at 37 C for 1 h with shaking at 250 rpm. 
Cells were centrifuged briefly (15 s) at 4000 rpm. Most of the medium was removed, 
leaving 100 µL remaining. Cells were re-suspended in this 100 µL of medium and then 
plated onto 2-YT agar plates containing the appropriate antibiotic (either ampicillin or 
kanamycin 50 µg/ml). Plates were incubated at 37 C for 16 hours. 
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NZY Medium  
NZ amine (Casein hydrolysate) 10 g 
Bacto-yeast extract 5 g 
NaCl 5 g 
Dissolved in 1 L distilled water, pH adjusted to 7.5 with NaOH and autoclaved to 
sterilise. Fresh 12.5 mM MgCl2, 12.5 mM MgSO4 and 20 mM glucose were added 
immediately prior to transformation. 
 
2.2.2 Preparation of Plasmid DNA 
2.2.2.1 Plasmid mini-preps 
Plasmid DNA was prepared using the Wizard® Plus SV Mini-prep Kit (Promega) 
according to manufacturer instructions. All steps were performed at RT. In brief, a 10 ml 
overnight culture (see section 2.2.1.1.) was centrifuged at 4000 rpm for 8 min. The 
bacterial pellet was re-suspended in Re-suspension Buffer (250 µL) and transferred to a 
2 ml eppendorf tube. Lysis Buffer was added (250 µL) to the cell suspension incubated 
at RT for 4 min. Alkaline Protease Solution was added (10 µL) incubated for 5 min at 
RT. 350 µL of Neutralization Solution was added until a precipitate was formed, then 
centrifuged at 13000 rpm for 10 min. Mixture was mixed by inversion 4-6 times after the 
addition of each solution. The supernatant was applied to the spin column and the DNA 
allowed to bind to the resin for 5 min. The column was then centrifuged at 13,000 rpm 
for 60 s and the flow-through discarded. The column was washed by adding 750 µL of 
Column Wash Solution and centrifuging for 60 s at 13,000 rpm. The wash procedure 
was repeated with 250 μL of Column Wash Solution and centrifugation at 13,000 rpm 
for 2 min. The column was placed in a clean 1.5 ml microcentrifuge tube. 100 μL of 
nuclease water was used to elute the DNA, which was added to the centre of the spin 
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column and was allowed to stand for 1 min before centrifugation at 13000 rpm for 2 min 
to collect the plasmid DNA. 
2.2.2.2 Plasmid midi-preps 
Large-scale plasmid DNA preparations were obtained using the PureYieldTM Plasmid 
Midi-prep Kit (Promega) according to manufacturer instructions. In brief, a 50 ml 
overnight culture (see section 2.2.1.1.) was centrifuged at 4000 rpm for 8 min. The 
bacterial pellet was re-suspended in Resuspension Buffer (3 ml). Lysis Buffer (3 ml) 
was added to the cell suspension incubated for 4 min. Neutralization Solution (5 ml) was 
added incubated for 5 min. Cell suspension was mixed by inversion 4-6 times and 
incubated at RT after addition of solutions. A PureYieldTM Clearing Column was placed 
into a 50 ml Falcon tube and the lysate was allowed to stand in the column for 2 min. 
The column was centrifuged for 5 min at 2000 rpm at RT. A PureYieldTM Binding 
Column was placed into a new 50 ml Falcon tube and the filtered lysate added. The 
column was centrifuged at 2000 rpm for 3 min. Endotoxin Removal Wash (5 ml) was 
added to the binding column followed by centrifugation at 2000 rpm for 3 min. The flow-
through was discarded and the column reassembled. Column Wash Solution (20 ml) 
was added to the binding column, which was then centrifuged for 5 min at 2000 rpm. 
The flow-through was discarded and the column was centrifuged for another 10 min at 
2000 rpm to remove all excess liquid. The column was then placed in a clean 50 ml 
Falcon tube. To elute DNA, 500 μL of nuclease free water was added to the centre of 
the binding column. The column was allowed to stand for 1 min at RT before 
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centrifugation at 2000 rpm for 5 min. The filtrate was collected and transferred to a 1.5 
ml microcentrifuge tube.  
2.2.2.3 Quantification of plasmid DNA 
The concentration of plasmid DNA was determined using the Warburg-Christian 
protocol on a Beckman DU-64 spectrophotometer. Ultraviolet radiation absorbance at 
260 nm and 280 nm was measured and a ratio of A260:A280 ranging from 1.8-2.0 was 
considered highly purified with minimal protein contamination.  
DNA concentration (ng/µL) = A260 x dilution factor x 50 ng/µL constant 
 
2.2.2.4 Resolving DNA fragments on an agarose gel 
DNA was mixed with 2-5 µL of loading buffer (Promega) and loaded onto an ethidium 
bromide-containing agarose gel (0.8 – 1.5 %, depending on the size of the DNA 
fragment). DNA fragments were electrophoresed for 30 min - 1h at 100 V in TBE buffer 
(see recipe below). BenchTop 1 kb and 100 bp DNA ladders were used as size 
standards (Promega). 
1 x TBE Buffer  
Tris-HCl pH 7.5 89 mM 
Borate 89 mM 
EDTA 2 mM 
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2.2.2.5 DNA Sequencing 
Plasmid identity was confirmed by sequencing at the Westmead Millennium Institute 
Sequencing Facility.  Sequencing reactions contained 200 ng DNA, 50 ng of each 
primer and distilled water to a total volume of 12 µL. 
2.2.3 Cloning  
2.2.3.1 Cloning of APC fragments into pEGFP  
APC-FL pcmv was used as a template to construct APC fragment APC1-453-GFP and 
APC334-625 in the pEGFP-N1 vector (Clontech). The APC cDNA insert sequences (1-
453 and 334-625 amino acids) were amplified by PCR using the appropriate primers 
listed in Table 2.8. The resulting PCR products were used to then cloned into pEGFP-
N1.  
Table 2.8 Primer table 
Construct Amino 
acids 
Forward primer Reverse primer Cloning 
site 
APC334-625-
GFP 
334-625 GA TCG AGG TCG ACG ATG 
CTA GCT ATG TCT AGC TCC 
CAA GAC 
TAC TTA TGG ATC CCG 
CTG GCT CCG GTA 
AGT AAG AGT GC 
Sal Bam 
APC1-453-
GFP 
1-453 GAT CGA CGT CGA TGG CTG 
CAG CTT CAT ATG ATC AG 
TAC TTA TGG ATC CCG 
TAG AAC ACA CAC 
AGC AGG ACA G 
Sal Bam 
 
2.2.3.2 Restriction digestion of plasmid DNA 
Plasmid identity was confirmed by restriction enzyme analysis. Plasmid DNA (4-6 µg) 
was digested with the required restriction enzyme (20-30 units) in a 30 µL reaction 
according to manufacturer’s instructions. The reaction was incubated for 2 h at the 
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recommended optimal temperature and 2 µL of digest was run on an agarose gel to 
confirm complete digestion. PCR products were resolved on an agarose gel (see 
section 2.2.2.4). DNA sequencing was used to confirm cloned products (see section 
2.2.2.5).  
2.2.4 Cell Culture 
2.2.4.1  Reviving cells from liquid nitrogen 
T25 tissue culture flask was prepared with 5ml of DMEM. A frozen cryovial of cells was 
thawed in a 37 C water bath and added to a T25 flask with fresh, warm growth 
medium. Following cell attachment to the new flask (6 h), medium was removed and 
replaced with 5ml of DMSO-free media. 
2.2.4.2 Propagation of cell lines 
HCT116, U-2OS, SW480 and HeLa cell lines (see Table 2.2) were maintained in DMEM 
(see Table 2.9). All cells were grown at 37 C in a humidified 5% CO2 atmosphere. For 
propagation, the culture medium was removed and the cells were washed with 
phosphate buffered saline (PBS). Cells were detached from the culture flask by 
incubation with 1 ml trypsin/EDTA at 37 C /5 % CO2 for 5 min. Cells were then re-
suspended in culture medium and either seeded onto sterile glass coverslips for 
immunofluorescence; 8-well chambers for proximity ligation assay (PLA) commercially 
known as “Duolink”; 2-well chamber slides for fluorescence recovery after 
photobleaching (FRAP) or a new flask for continued propagation. 
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Table 2.9 Cell culture media ingredients  
Reagents Volume 
1 x DMEM 500 ml 
1 M HEPES 11.9 ml 
L-Glutamine (200mM) 11.9 ml 
Fetal Calf Serum 59 ml 
Pennicillin/Streptomycin  11.9 ml 
Cell lines were cultured in DMEM, 10 % foetal bovine serum, 4 mM L-glutamine, 20 mM 
HEPES, 100 units/ml penicillin and 100 μg/ml streptomycin. All cell lines were subjected 
to routine mycoplasma testing.  
2.2.4.3 Freezing cells (Cryopreservation) 
Following trypsinisation (see section 2.2.4.2), cells from an 80 % confluent T75 flask 
were centrifuged at 4 C for 5 min  at 1500 rpm and re-suspended in 4 ml of warm 
DMEM (see Table 2.9) supplemented with 20 % FBS and 10 % DMSO. Cells were 
aliquoted into 4 cryovials and incubated on ice for 10 min, followed by slow freezing at -
80 C before storage in liquid nitrogen. 
2.2.4.4 Transfection of cell lines (plasmids and siRNA) 
Plasmids - Plasmid DNA was transfected into cells using either Lipofectamine 2000 
(Invitrogen) or Fugene HD (Promega) according to manufacturer’s instructions. For 
Lipofectamine transfections, plasmid DNA was diluted in serum-free OptiMEMTM. In a 
separate tube, Lipofectamine was diluted in serum-free OptiMEMTM and incubated for 5 
min. The Lipofectamine mixture was added dropwise to the DNA mixture, followed by 
incubation at RT for 20 min. The DNA/Lipofectamine mixture was then added dropwise 
to cells of 50-60% confluency which were incubated at 37 C/ 5% CO2 for 6 h before the 
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Table 2.10 The amount of plasmid DNA and transfection reagent used for 
transfecting cell lines in various culture dishes. 
 Amount 
DNA (µg)
Amount 
Lipofectamine 
2000 (µL) 
Amount 
Fugene 
HD (µL) 
Volume of serum-
free OptiMEMTM 
(µL) 
Single 8-well 1 2 2 100 
Single 6-well 2 4 4 200 
T25 flask 6 12 12 1000 
T75 flask 18 36 36 1000 
T150 flask 36 72 72 2000 
 
Table 2.11 The amount of siRNA and amount of Lipofectamine 2000 used for 
transfecting cell lines in various culture dishes. 
 Amount 
siRNA 
(µg) 
Amount 
Lipofectamine 
2000 (µL) 
Volume of serum-
free OptiMEMTM 
(µL) 
Single 6-well 3 6 200 
T25 flask 9 18 1000 
T75 flask 18 36 1000 
 
transfection mix was removed and replaced with fresh, warm medium containing 10 % 
FBS. For Fugene HD transfections, plasmid DNA was diluted in serum-free OptiMEMTM 
and Fugene was added dropwise directly to the DNA mixture. After incubation for 15 
min, the DNA/Fugene mixture was added dropwise to cells of 50-60% confluency. Cells 
were incubated at 37 C/ 5 % CO2 for 6 h before the transfection mix was removed and 
replaced with fresh, warm medium containing 10 % FBS. All transfections were 
performed in a laminar flow hood and were scaled up or down according to Table 2.10 
and Table 2.11. 
RNA interference - Double-stranded 21-mer RNA oligonucleotides homologous to 
control sequences or sequences for protein of interest (see Table. 2.5). Cells were 
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plated at low-medium density for siRNA transfection. 3ug of siRNA and 6 ul of 
Lipofectamine were used per transfection. Cells were either fixed and processed for 
immunofluorescence 48h post-transfection for image analysis or harvested for protein 
analysis. 
2.2.5 Protein Analysis by Western Blot 
2.2.5.1 Total protein extraction 
Cells were detached from culture flasks by trypsinisation (see section 2.2.4.2.) and 
harvested by centrifugation at 1500 rpm for 5 min at 4 C. Cells were lysed in RIPA 
buffer (see recipe below) (50 µL for an 80 % confluent T25 flask) for 30 min on ice and 
then cleared of insoluble components by centrifugation at 13000 rpm at 4 C for 10 min. 
RIPA Buffer 
NP-40 1 % 
0.5 % sodium deoxycholate 0.5 % 
0.1 % SDS 0.1 % 
Diluted in PBS and fresh protease inhibitors (Roche) added prior to lysis. 
2.2.5.2 Centrosome protein enrichment (nuclear fractionation) 
This enrichment protocol for centrosome proteins used here was adapted from a study 
conducted for nuclear and cytoplasmic fractionation where centrosome proteins could 
be enriched in the nuclear fraction (Matsuda et al., 1995).   
 Cells were trypsinised, spun down and the cell pellet was washed with PBS at RT as 
described in 2.2.5.1. Cells were then spun down again and re-suspended in 200 µl of 
“cytoplasmic buffer” (see recipe below) for lysis, incubated on ice for 20 min followed by  
Chapter 2 
98 | P a g e  
 
Cytoplasmic 
Buffer 
 
Tris-HCl (pH7.5) 20mM 
MgCl2 3mM 
EDTA 1mM 
PMSF 0.5mM 
Triton 0.05% 
 
centrifugation at 3000rpm for 5 min. The supernatant was collected to form the 
cytoplasmic fraction. The pellet was re-suspended in 200 µl of “nuclear” buffer and was 
allowed to incubate on ice for over 20 min. Cells were pelleted by centrifiguation at 
13,000 rpm for 10 min at 4o C, the nuclear fraction was collected containing the main 
centrosome proteins. 
2.2.5.3 Quantification of protein concentration in lysates 
The protein concentration of cellular fractions was determined using the Bradford 
protein assay. Standards of 0, 3, 6, and 9 µg BSA/µL were prepared in 1 ml of Protein 
Assay Dye Reagent (Bio-Rad), measured at 595 nm using a DU 800 spectrophotometer 
and used to create a standard curve of concentration versus optical density. Sample 
(1µl) was added to 1 ml of Protein Assay Dye Reagent. The optical density at 595 nm 
was measured and the standard curve used to determine the protein concentration of 
the sample. 
2.2.5.4 Resolving proteins on an SDS-PAGE gel   
Cell extracts in 1 x Laemmli buffer were denatured at 95 C for 8 min and resolved by 
sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE), using a 
Mini-Protean II Electrophoresis System (Bio-Rad). Different percentages of acrylamide  
Nuclear Buffer  
(Centrosome enrichment) 
Tris-HCl (pH7.5) 50mM 
NaCl 150mM 
EDTA 1mM 
PMSF 0.5mM 
Nonidet 40 1% 
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Stacking Gel (10 ml)  
Polyacrylamide (29:1, 40 %) 1.25 ml 
1 M Tris-HCl (pH 6.8) 1.25 ml 
20 % sodium dodecyl sulphate (SDS) 50 µL 
distilled water 7.4 ml 
10 % ammonium persulphate (APS) 50 µL 
TEMED 10 µL 
 
Laemmli buffer 
 
Tris-HCl (pH 6.8) 125 mM 
Glycerol 20 % 
-mercaptoethanol 10 % 
SDS 5 % 
Bromophenol blue 0.005 % 
 
Running Buffer (10 x)  
Tris 25 mM 
Glycine  250 mM 
SDS 0.01 % 
 
Table 2.12 Separating gel for SDS-PAGE 
Ingredients 5% 7.5% 10% 12.5% 
AA Stock (ml) 5 7.5 10 12.5 
H2O (ml) 21.5 17.05 14.55 12.05 
1M Tris pH=8.7 
(ml) 
15 15 15 15 
20% SDS (µl) 200 200 200 200 
10% APS (µl) 200 200 200 200 
TEMED (µl) 40 40 40 40 
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(6-12 %) or commercial “All KD” precast gels (Biorad) were used depending on the size 
of the protein to be detected (see recipe above). For nuclear/cytoplasmic samples 30 µg 
of nuclear extract and 90 µg of cytoplasmic extract were loaded for comparison. For 
immunoprecipitation 50-100 µg of input was used. For total protein extracts 50-100 µg 
was loaded. The protein extracts were resolved for 2 h in 1 x Running Buffer at 100 V. 
Precision Plus Dual Colour Standards (Bio-Rad) were used as molecular size 
standards. 
2.2.5.5 Western blot transfer 
Following SDS-PAGE, the gel and other transfer components were pre-equilibrated in 
transfer buffer for 10 min before assembly of the transfer apparatus. The gel and 
membrane were sandwiched between two pieces of Whatman 3MM chromatography 
paper and 2 thin sponges and submerged in transfer buffer inside a Mini-Trans-Blot cell 
(Bio-Rad). Proteins were transferred from the gel to the membrane at 300 mA for 1-3 h 
at 4 C depending on the size of the protein to be detected. Transfer efficiency was 
confirmed by staining the membrane for 1-2 min with Ponceau S stain. Membranes 
were stored in PBS at 4 C until blotting.  
Transfer Buffer 
Tris 25 mM 
Glycine  192 mM 
Methanol 20 % 
 
2.2.5.6 ECL Western blotting 
Membranes were washed three times for 10 min in Tris buffered saline (TBS) containing 
Ponceau S Stain 
Acetic Acid 5 % 
Ponceau S 0.01 g 
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0.1 % Tween-20 (TBST) between each step. Membranes were blocked for 1 h in 
blocking buffer (5 % skim milk powder/TBST) prior to 2 h incubation with a specific 
primary antibody (see Table 2.3) diluted in 2.5% skim milk/TBST. Membranes were 
subsequently incubated for 1 h with a secondary HRP-conjugated antibody (see Table 
2.4) diluted in blocking buffer.  Finally, equal volumes of each ECL reagent (GE 
Healthcare) were combined, added to the membrane in a darkroom and incubated for 1 
min. Excess reagent was removed from the blot and the membrane was exposed to film 
(X-0Mat BT, Kodak) at different time intervals. Films were developed using a CP1000 X-
ray film processor (AGFA).  
2.2.5.7 Protein interaction analysis by immunoprecipitation 
2.2.5.7.1  Protein extraction for immunoprecipitation  
Cells were harvested by trypsinisation (see section 2.2.5.1) and centrifuged at 1500 rpm 
for 5 min at 4 C. The pellet was re-suspended in 5 ml of PBS and centrifuged at 1500 
rpm for 5 min at 4 C to remove all culture media. Cells were lysed in lysis buffer for 30 
min on ice followed by centrifugation at 13,000 rpm for 10 min at 4 °C, The supernatant 
was collected as “cell lysate” and the concentration determined by the Bradford assay 
(see section 2.2.5.3). 100 μg was removed, denatured in 4 x Laemmli buffer and run as 
an input sample. 
           Lysis Buffer  
NaCl 100 mM 
Tris-HCl pH 7.5 50 mM 
NP-40 0.5 % 
  Protease inhibitors (Roche) were added immediately prior to lysis. 
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2.2.5.7.2 Preparation of sepharose A beads  
Protein A-Sepharose CL4B beads (GE Healthcare Bio-Sciences) were swollen and 
equilibrated in lysis buffer containing protease inhibitors (Roche). Beads (30 
µL/reaction) were then pre-coated with 2 µg of antibody of interest or mouse IgG 
(Sigma-Aldrich) for 1.5 h at 4 C, with continuous end-over-end mixing. Beads were 
washed of excess antibody with 500 µL lysis buffer and then centrifuged three times at 
2000 rpm at 4 C. 
2.2.5.7.3 Immunoprecipitation  
Cell lysate (1 mg) was incubated with the prepared beads for 1.5 h at 4 C, with 
continuous end-over-end mixing. The immunocomplexes were pelleted by centrifugation 
at 1000 rpm for 1 min at 4 C and the supernatant was kept for running on SDS-PAGE 
to determine the amount of binding. Immunocomplexes were washed three times in 
RIPA, mild-RIPA lysis or centrosome enrichment buffer (see section 2.2.5.1, 2.2.12.5 
and 2.2.5.2) for 5 min at 4 C before centrifugation at 1000 rpm for 1 min. 
Immunocomplexes were denatured at 95 °C for 10 min in Laemelli buffer. The 
immunocomplexes were subjected to SDS-PAGE (see section 2.2.5.4), followed by 
immunoblotting (see section 2.2.5.6). 
2.2.6 Fluorescence microscopy  
Cells grown on glass coverslips were first washed three times gently with PBS to 
remove culture medium. Cells were washed with PBS three times between each step of 
immunofluoresence staining. For centrosomal staining, cells were grown on coverslips 
to 70-80% confluence and fixed with ice-cold acetone:methanol (1:1) (see section 
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2.2.6.1). GFP-tagged protein transfected cells were fixed and mounted for direct 
detection of the auto-fluorescent protein. For centrosomal retention assays, cells were 
permeabilised by detergent extraction to remove soluble and loosely bound proteins 
with cytoskeletal (CSK) digest buffer for 0 min, 8 min or 40 min prior to fixation (see 
2.2.9). 
2.2.6.1 Standard fixation 
Cells were grown on glass cover-slips in 6-well or 8-well dishes (Nunc). Media was first 
removed from wells, carefully washed with PBS three times before fixation. Pre-chilled 
at 20OC of methanol : acetone (1:1) was applied to cells for 3 min at RT. Fixation was 
terminated by the removal of methanol: acetone followed by three PBS washes.  
2.2.6.2 Immunostaining  
For immunostaining, cells were blocked using 3% bovine serum albumin (BSA) in PBS 
(blocking solution) for 1 h followed by incubation for 1 h with specific primary antibody in 
blocking solution. Bound antibodies were detected with either AlexaFluor 488 or 
AlexaFluor 594-conjugated secondary antibodies (see Table 2.4). Hoechst DNA dye 
33285 (Sigma) was used to highlight nuclei. Coverslips were mounted using 
Vectashield aqueous mountant (Vector Laboratories) and observed using an Olympus 
BX-51 fluorescence microscope at 60X magnification followed by confocal imaging. 
Scoring was performed either the fluorescence microscope or confocal images. An 
average score was obtained more than three individual experiments, and for each 
experiment at least 100 cells were scored for each treatment. Statistical significance of 
sample variation was determined by applying Student’s t-Test using two-tailed 
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distribution of two-sample unequal variance type.  
2.2.6.3 Confocal microscopy 
For live imaging, an Olympus FV1000 confocal laser-scanning microscope with a 60x 
water objective. The confocal microscope was also used to take z-stack images at 0.5-
0.75 µm intervals. Similarly, optical cross-sections were also taken using 60X oil 
objective for co-localisation studies.  
2.2.6.4 Quantification of Confocal fluorescence images  
To compare measurements of fluorescence intensities between conditions, images 
were taken from Olympus FV1000 confocal microscope as described in section 
(2.2.6.3) such that laser and colour intensity parameters are kept constant at the time of 
imaging. Using the confocal Olympus FV-10 software version 1.6a, drawing tools (eg. 
circle or polygon) was used to select the area of interest to measure the fluorescence 
intensity of the region. For every measurement, the fluorescence intensity was also 
measured for the image, and in some cases the cell background. To score for co-
localisation different channels was used to overlay the staining from various channels. 
To measure the area size, the drawing tools were used to select area of interest.  
2.2.7 Localisation Assays 
2.2.7.1 Preparation of cells for immunofluoresence microscopy  
Fixation, immunostaining and imaging detailed in 2.2.6.2. 
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2.2.7.2 Scoring for localisation to the centrosome 
Confocal FV-1000 was used to imaging fixed slides to gather an optical section of cells 
stained with dual-colours to assess protein localisation to centrosomes. Olympus FV-10 
confocal program version 1.6a was used to score and analysis the localisation of protein 
to centrosomes. The centrosome were marked with a centrosome marker (γ-tubulin or 
PCNT-A/B). The number of cells colocalised over the number cells scored for 
centrosome localisation was converted to a percentage.  
2.2.8 Proximity ligation assay (Duolink)  
2.2.8.1 Duolink assay 
The proximity ligation assay, commercially known as the “Duolink” assay (Olink, 
Bioscience) was used to assess the “closeness” between two proteins. When two 
proteins are in proximity of less than 40nm, the assay produces a fluorescent signal 
which appears as one fluorescent dot (referred to as a “PLA dot/reaction”. This degree 
of closeness is interpreted as binding between two proteins.  
 Cells were seeded onto 8-well chambers coated with poly-L-lysine (Sigma) 
overnight and fixed at ~80-90% confluence with methanol: acetone (1:1) for 3 min (see 
section (2.2.6.1). Duolink assay involves several steps using different reagents in the kit 
(Fig. 2.1A). All incubations were carried out at 37oC in the dark. Cells were first blocked 
with Duolink blocking buffer, followed by the addition of primary antibodies for 60 min. 
Cells were then incubated with PLA-probes (1:5) anti-rabbit plus (Sigma) and anti-
mouse minus (Sigma) for 60 min.  The Duolink diluents provided by the kit was used in 
all   dilutions.  Cells  are   subsequently   washed  using  Duolink  buffer  A  (2 x 5 min) 
Chapter 2 
106 | P a g e  
 
Duolink buffers  
Duolink Buffer A Duolink Buffer B 
Tris pH8.0 - 0.01M 
 
10 ml Tris pH7.5 – 1M 200 ml 
NaCl – 0.15M 
 
30 ml NaCl – 0.1M 20 ml 
Tween 20 – 0.05% 
 
2.5 ml Baxter irrigation 
water 
780 ml 
Baxter irrigation 
water 
957.5 ml   
Total 1000 ml Total 1000 ml 
 
 
Figure 2.1 The Duolink assay. (A) Schematic of steps of Duolink assay. Two primary 
antibodies are used to probe for an interaction (red and blue). PLA probes are added 
and in close proximity, these probes ligate. This signal is then amplified and visualised 
as a fluorescent dot.  (B) Example of Duolink assay imaged using the Olympus FV-1000 
confocal microscope. The Duolink assay was performed between APC using mouse 
mAb Ab7 and rabbit poly-Ab ninein using the red kit, followed by co-staining of 
centrosomes using mouse mAb PCNT-A/B (green).  
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(see above for ingredients) before adding ligase (1:40) for 30 min. Buffer A (2 x 5 min) 
was used to wash off the ligase and polymerase (1:80) was added will amplify a 
fluorescence signal of interaction producing a green or red dot per interaction. Duolink 
mounting media was used that incorporated a DAPI dye was used to mount cover-slips 
onto the slides and sealed with nail polish.  
2.2.8.2 Quantification and analysis of PLA dots 
Optical z-sections (0.75µM X 3) were acquired as described in 2.2.6.3 using the 
Olympus FV-10000 confocal microscope and analysed using the Confocal Olympus FV-
10 version 1.6a software. The DIC channel was used to define the periphery of each 
cell, which was then over-layed with either the green (FITC) or red (TEXAS RED) 
channel to score the number of dots within each cell (yellow dotted lines in Fig. 2.1B). 
Manual scoring was performed in over 100 cells per condition, and the scoring from at 
least three experiments was included in the statistical analysis. Data was represented 
as the number of dots per cell. For each interaction, a reaction containing individual 
antibodies was also included as part of the Duolink assay reaction as background 
control.  
2.2.8.3 Counterstaining after Duolink assay 
To analyse specific localisation of protein interactions, the Duolink co-stain protocol was 
used (provided by O-link). To examine the localisation of Duolink dots to the 
centrosome, cells were then co-stained with either antibody against γ-tubulin or PCNT- 
A/B, followed by a secondary antibody (AlexorFluor 488 or AlexorFluor 594). Images 
were acquired using confocal microscopy (see section 2.6.3). PLA interactions per cell 
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and per centrosome were scored over three experiments. An example of the Duolink 
dots (red) centrosome marker PCNT-A/B (green) is shown in Figure 2.1B.  
2.2.8.4 Duolink interaction with ectopically expressed proteins 
Ectopic expression of GFP-tagged plasmids is described in 2.2.4.4 using only half the 
amount normally used to transfect in 6-well plates. The Duolink assay was then 
performed as described in 2.2.8.1. An antibody for GFP (mouse or rabbit) was used in 
the reaction. This was also combined with the counter staining protocol using again the 
GFP antibody (mouse or rabbit) to identify the transfected cells.  
2.2.8.5 Scoring of centrosome specific interactions 
To score for centrosome specific interactions, cells were processed and imaged as 
described in 2.2.8.1-2.2.8.3. PLA signals at the centrosome were either scored as 
positive or negative. The number of centrosome localising signals over the total number 
of centrosomes scored was converted to a percentage. As an internal control to validate 
that the assay is working, only the centrosomes in cells with positive Duolink dots were 
scored.   
2.2.9 In situ CSK retention assay at the centrosome 
To compare the endogenous retention of APC-FL and mutant APC1-1337 in HeLa and 
SW480 cells (see Table 2.2), respectively, a detergent extraction assay was used to 
remove soluble proteins from cells before fixation with methanol: acetone. Cells were 
first grown on poly-L-lysine (0.1 mg/ml, Sigma) coated coverslips and then incubated in 
CSK extraction buffer (ingredients below) for 0 min, 8 min and 40 min at 32oC. Cells 
Chapter 2 
109 | P a g e  
 
were gently washed with PBS and then fixed with methanol:acetone (1:1) at RT for 3 
min. Cells were blocked in 3% BSA/PBS and probed with Ab7 to detect APC and γ-
tubulin as a centrosome marker as previously described (see Table 2.3). Cells were 
scored for centrosome localisation using Olympus BX-51 fluorescence microscope at 
40X magnification. Images were taken using a Spot RT slider camera 23.1 connected to 
the microscope or by confocal microscopy which was also used for scoring. Data was 
collected from three independent experiments with over 100 cells per treatment 
condition.  
CSK extraction buffer  
PIPES, pH 6.8 10 mM 
Sucrose 300 mM 
MgCl2 5 mM 
Triton X-100 0.5 % 
 
2.2.10 Centrosome Functional Assays 
2.2.10.1 Microtubule regrowth assay  
U2OS cells grown on coverslips were treated with siCTRL, siAPC-d or siAPC-2 
(Qiagen) for 72 h. Cells were then treated with 33 µM of nocodazole for 1 h at 37oC 
before washing out with media mixed three times. Microtubules (MTs) were allowed to 
re-polymerise for 0, 5, 10, 15, 20 min at RT. Cells were then fixed with methanol: 
acetone for 3 min (see section 2.2.6.1). Immunofluorescence was performed using α-
tubulin to mark the MTs and APC-NT to assess the level of APC knockdown per cell 
(see section 2.2.6.2). For analysis, a combination of images and z-stacks were  taken 
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Figure 2.2 Microtubule depolymerisation using nocodazole. Typically MTs in the 
cell form focused MT radial array that converge at a central point toward the 
centrosome (left). In the MT regrowth assay, cells were treated with 33 µM of 
nocodazole for 1 h at 37oC to depolymerise MTs. Immunofluorescence was conducted 
using mouse mAb α-tubulin to visualise MTs in the cell (red). Cells treated with 
nocodazole lack visible MT radial arrays and little filamentous architecture in the 
cytoplasm (right). When nocodazole is washed out using fresh media, MTs start to re-
polymerise.  
   
Table 2.13 Literature summary quantification methods used to determine MT 
regrowth.  
APC binding 
protein 
Timepoints 
measured 
Nocodazole 
Treatment 
Method of 
quantification Treatment 
Axin 
(Fumoto 2009) 
5 min 
 
20 µM 
Regrowth at 
37oC 
FI was reduced 
(FI units) 
Axin siRNA 
MKN-1 and HeLa 
S3 
Axin 
(Fumoto 2009) 
10 min 
(observation) 
33 µM  
Regrowth at 
37oC 
MT density  
(Qualitative scoring) 
Axin siRNA 
 MKN-1 and 
HeLa S3 
-catenin 
(Huang et al., 2007) 
2 min 
15 min  
30 min 
33 µM on ice 
Regrowth at 
37oC 
FI of radial aster 
measured 
(FI units) 
β-catenin siRNA 
3Y1 cells 
EB1 
(Louie 2004) 
20 min 
(uM2) 
33 µM on ice 
Regrowth at 
RT 
Area  
(µm2) 
EB1 siRNA 
HeLa 
AKAP350 
(Larocca et al., 
2006) 
10 min 5 µM on ice 
Regrowth at 
37oC 
MT average length 
(µm) 
AKAP350 siRNA 
HeLa 
 
EB1 MT anchoring 
(Louie 2004) 
No nocodazole NA Focused or diffused 
(Qualitative scoring by %) 
 
EB1 siRNA 
Cos-7 
-catenin 
(Huang et al., 2007) 
No nocodazole NA Focused or diffused 
(Qualitative scoring by %) 
 
β-catenin siRNA 
3Y1 cells 
BRCA1 
(Sankaran et al., 
2005) 
2 min 
5 min 
4oC 
 
% cells with large asters 
(>10 µm) 
 
BRAC1 siRNA 
Hs578T cells 
MT = Microtubules; RT= RT; FI = Fluorescence intensity; NA = Not Applicable 
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from the Olympus FV1000 confocal laser-scanning microscope at 40X and 60X oil 
magnification and quantification was done using the Olympus FV-10 Version 1.6a 
software. Methods of quantification of MT regrowth and morphology are been adapted 
from the literature (see Table 2.13). To assess the rate of the initial MT aster formation, 
the fluorescent intensity of the “core”, before MT spread was measured. This aimed to 
assess whether APC affected the co-factors required to initial MT formation at the 
centrosome. Measurements of these cells were only measured after 5-10 min regrowth. 
The rate of MT formation was also assessed with cells re-grown for longer periods, that 
is, 15-20 min. The area of MT regrowth was measured and compared between siCTRL 
and siAPC (more details in Chapter 4.2).  
2.2.10.2 Centrosome amplification assay 
To analyse the ability APC to regulate centrosome duplication, cancer cell line U2OS 
was transfected with APC targeting siRNA (see section 2.2.4.4). Centrosomes were 
detected using γ-tubulin by immunostaining after fixation (see section 2.2.6.1 and 
2.2.6.2). The number of centrosomes was scored per cell using Olympus BX-51 and 
compared before and after knockdown.  
2.2.10.3 Centrosome splitting assay 
To analyse the ability of APC to maintain the cohesion of duplicated centrosomes, 
asynchronous cell cultures of U2OS cells were plated on coverslips and transfected with 
either control siRNA or siRNA targeting APC for 48 h (see section 2.2.4.4).  Methanol: 
acetone was used for cell fixation and immunofluorescence (see section 2.2.6.1-2.2.6.2) 
was performed to stain for centrosomes using γ-tubulin. Confocal microscope was used 
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to acquire images which were used for scoring. The distance between two centrosomes 
in each cell, defined by γ-tubulin was measured using the Confocal program FV-10. For 
U2OS cells, the threshold of 2 µm was have been used as the threshold for centrosome 
splitting as described in previous studies (Bahe et al., 2005; Hadjihannas et al., 2010). 
Comparisons of APC-depleted and control cells were performed in asynchronous cells. 
This experiment was performed at least three times.   
2.2.11 Fluorescence Recovery After Photobleaching (FRAP)  
2.2.11.1 FRAP Assay 
FRAP was performed on HeLa cells expressing moderate levels of transiently 
expressed proteins co-expressed with the fluorescent centrosome marker, RFP-PCNT- 
C241, at 24-30 h post-transfection in a humidified CO2 chamber at 37 °C. Analysis was 
performed on an Olympus FV1000 confocal laser-scanning microscope with a 60X
 
Figure 2.3 Schematic diagram of FRAP experiments. FRAP was performed in HeLa 
cells overexpressed with GFP-tagged APC plasmids. A high powered laser from the 
confocal microscope was used to bleach a region of interest (ROI). Pre-bleached 
images were acquired as a standard, followed by bleaching of the ROI, which is the 
centrosome. Series of images were sequentially taken over time at around 1.3 s 
intervals for a total of up to 200 s. Fluorescence recovery of the APC was organised 
analysed using Microsoft excel and Graph Pad Prism 5.0.  
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water objective. For GFP-tagged construct FRAP, a cell was scanned with laser power 
(10-13%), and the region of interest (ROI) then photo-bleached at 100% laser power for 
3 s (see Fig. 2.3). For the RFP-tagged PCNT-C241 construct, 20% laser power was 
used for scanning and 100% laser power was used for bleaching. Each FRAP 
experiment started with 2 pre-bleach image scans followed by bleaching 90-100% of the 
centrosome for 4 s. Images were collected every 4 s for at least 60 s and the size of the 
scan region and digital zoom (3.2X) was kept constant during each experiment. 
2.2.11.2 FRAP data acquisition 
To detect baseline fluorescence levels,  2 pre-bleach image scans followed by 
bleaching of the centrosome consistently for ~3 s. Post-bleach images were then taken 
at 1.2 s intervals for over 100 s. Average intensities in all regions of interest including 
background signal were calculated using Olympus Fluoview Ver. 1.7b software, before 
data was exported into Microsoft Excel (2007). The fluorescence recovery curves and 
kinetic analyses were processed using Graph Pad Prism 5.0 software as the raw data 
was not suitable for direct quantitative analysis. 
2.2.11.3 Data acquisition and analysis 
FRAP analysis was based on over 10 cells from at least three independent 
experiments. Average intensities in all regions of interest including the background 
signal and whole cell fluorescence bleaching were calculated using Olympus Fluoview 
Version 1.6a software, before exporting to Microsoft Excel (2010). In Microsoft Excel, 
bleaching from imaging and background fluorescence were deducted for each cell and 
an average recovery curve generated. These data were then entered into Graph Pad 
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Prism 5 for curve analysis. T1/2 (the time taken to recover to half the plateau value) and 
plateau (recovery percentage compared to pre-bleach fluorescence) values were 
determined and used to compare initial speed of recovery and the recovery percentage 
at the centrosome, or ‘mobile fraction’ fraction. Spot-bleaching of the cytoplasm was 
carried out for each construct and showed that background fluorescence recovery due 
to diffusion was <10% for APC-GFP proteins and <5% for RFP-PCNT-C241. The 
timeline for each sequence tested by FRAP was between 2 and 3 weeks (depending on 
transfection efficiency) from initial transfection, photobleaching and image acquisition, 
experiment repetition to statistical analysis.  
2.2.12 Fusion-protein purification assay 
Cloning and transformation of pGEX vectors into BL-21 E.coli bacteria is as described in 
section 2.2.3.1 and 2.2.1.4.  
2.2.12.1 Bacterial induction and expression of protein 
GST vector (pGEX-5X) expressing glutathione and GST-APC-ARM (446-880) (Gift from 
Akiyama’s group) was first plated onto ampicillin containing 2-YT agar plates (see 
section 2.2.1.1) (Fig. 2.4). A single colony was inoculated into 10 ml of 2-YT media 
(ingredients described in 2.2.1.1). Ampicillin was added (1:1000) and was incubated 
overnight in a shaker at 37oC at a speed of 220-230 rpm.  
 For the expression of APC-ARM-GST fusion protein, the 10 ml starter culture 
was added into a conical flask of 100 ml of 2-YT media with ampicillin as above and 
incubated at 37oC shaking until a concentration of optical density (OD) of 1.0 (previously  
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Figure 2.4 Schematic diagram of bacterial induction process of protein 
expression in E.coli. Protein cloned into pGEX-5X vector was transformed into BL-21 
strain of E.coli bacteria on 2-YT agar plates. A single colony is selected and inoculated 
into 2-YT broth supplemented with ampicillin and incubated overnight at 37oC shaking. 
This small culture was then used to inoculate a 100 ml broth. Induction with IPTG 
occurred when the OD reached 0.5-1.0 and the protein expression was induced for 3-4 
h until OD reached ~2.0. Bacterial was pelleted using high speed centrifugation and the 
pellet was either processed for cell lysis, or stored at low temperatures.  
 
optimised) followed by the addition of 1mM isopropyl β-D-1-thioglactopyrnaoside (IPTG) 
to induce protein expression for 4 h. Cells were pelleted on the same day by high speed 
centrifugation at 20,000 rpm using the sorval rotor (SLA1500). 
2.2.12.2 Protein purification 
The bacterial pellet was re-suspended and washed in 10 ml of Salt-Tris-EDTA (STE) 
(see recipe below) buffer twice and cells were spun down at 4000 rpm for 5 min at RT. 
Cell pellet was re-suspended in freshly made bacterial lysis buffer with ingredients as 
listed below. 
STE Buffer x 1  
Tris-HCl pH8.0 1 M 10 mM 
NaCl 5 M 150 mM 
EDTA 500 mM 1 mM 
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STE = Salt, Tris, EDTA Buffer 
To disrupt the formation of insoluble inclusion bodies bacterial lysis buffer was 
supplemented with 2% of Sarkosyl (Sigma) (see optimisation in Chapter 7 
supplementary section). The mixture was sonicated on ice at 10% amplitude until clear 
(~60 s), then incubated for 30 min on ice. The lysate was subjected to centrifugation at 
13,000 rpm at 4oC, and the protein supernatant was collected for protein purification 
(see section 2.2.12.3).   
2.2.12.3 Affinity and ion exchange chromatography (GST-tag) 
Prior to protein purification, 1 ml of lysate was collected to be used for input control. In 
preparation of the column, 10 ml of STE buffer was added to equilibrate a column 
packed with GST agarose beads. To purify for GST alone or ARM-GST protein, the 
protein lysate was poured into an affinity column coated with glutathione (GST) agarose 
beads (GE Healthcare).  GST alone or ARM-GST protein was allowed to bind to the 
column, and the flow through was collected, followed by two washes of 10 ml of STE x 1 
passing through the column twice. Elution buffer (ingredients listed below) containing 
glutathione was added 50 µl at a time for 5 times and the protein eluates were collected  
 
Bacterial lysis Buffer  
PMSF 1M 1: 1000 
Sodium Orthovanadate1M 1: 1000 
25 x Protease inhibitor 
cocktail 
1:  25 
Lysozyme 8mg/ml 1: 10 
Dithiothreitol (DTT) 1: 200 
Diluent - STE 
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Elution buffer   
Glutathione 50 mM 
DTT 1:200 
25 x Protease inhibitors 1:25 
PMSF 1:1000 
Sodium orthovanadate 1:1000 
Diluent – Bacterial lysis buffer 
 
in separate eppendorf tubes. The protein concentration was determined using the 
Bradford assay as detailed in section 2.2.5.3. The column was then washed twice with 
10ml of STE. 
2.2.12.4 SDS-PAGE electrophoresis  
Coomassie staining and Western blot analysis was used to assess the quality and 
concentration of protein expression. Samples of input, flow through, pellet and eluates 
were processed for SDS-PAGE analysis as described in 2.2.5.4 and proteins were 
separated by electrophoresis.  
 For Coomassie staining, after proteins have migrated to the bottom of the 
resolving gel, Coomassie brilliant blue staining buffer (see ingredients below) was used 
to stain the gel for 20 min, followed by an overnight destaining using the destaining 
buffer (see ingredients below). Goat polyclonal antibody against GST (1:6000) was 
used for immunoblotting (See section 2.2.5.3 and 2.2.5.6 for procedure on Western blot 
analysis).  
Coomassie staining 
buffer  
 
Coomassie blue R-250 0.1%
acetic acid 10 %
methanol  40 %
distilled water 50 %
 
Destaining buffer   
acetic acid 7 %  
methanol  25 % 
distilled water 68 %  
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2.2.12.5 In vitro pull-down assay 
Agarose beads were equilibrated by washing with STE twice. To assist with protein 
binding to the beads, 2% Triton X-100 and 40 mM of CHAPs (Sigma) was added to the 
lysate. Then the beads were either coated with glutathione alone or ARM-GST-fusion 
protein overnight by mixing agarose beads with each respective purified protein lysate 
(2.2.12.2.1) rotating at 4oC. Beads were pelleted by low speed centrifugation at 3000 
rpm for 5 min. U2OS cells were harvested following the protocol detailed in section 
2.2.5.1 using either RIPA or mild-RIPA buffer (see ingredients below). Total lysate was 
then added to the coated agarose beads and incubated at 4oC for 3 h rotating to allow 
protein interactions to form. To elute bound proteins, 2 X Laemmlli SDS loading buffer 
was heated to 95oC for 5 min. Samples were centrifuged at 13,0000 rpm to pellet the 
beads and the supernatant was loaded onto SDS-PAGE gels.  
Mild-RIPA buffer 
 
“Mild” RIPA Buffer   
Tris.HCl pH 7.4 10 mM 
NaCl  100 mM 
EDTA  1 mM 
EGTA  1 mM 
NaF  1 mM 
Na3OV4 (add fresh)  2 mM 
trition-X-100  1% 
glycerol  10% 
SDS 0.1% 
deoxycholate 0.5% 
*Buffer recipe from Dasso’s group (Murawala et al., 2009).  
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2.2.12.6 Preparation for Mass Spectrometric analysis 
Following the in vitro pulldown assay, proteins complexes were separated by SDS-
PAGE followed by Coomassie staining. Clear high molecular weight bands with low 
background (>100 kDa) was cut out with its corresponding control band and was stored 
at 4oC. These bands were sent to our collaborator A/Prof Mark Molloy for mass 
spectrometric analysis.  
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SUMMARY OF CHAPTER 3  
 
The protein composition of the centrosome changes during the cell cycle, and moreover 
changes in the localisation and dynamics of centrosome-associated proteins can impact 
centrosome functions.  In this chapter, the targeting and dynamics of both full-length 
APC (termed APC-FL) and cancer-truncated mutant (endogenous APC1-1337 or 
ectopic APC1-1309) were characterised at the centrosome. Using immunofluorescence 
microscopy, endogenous APC was detected at the centrosome in 80% of cells, in 
different tumour-derived cell lines (HCT116, HeLa, SW480 and U2OS). APC-FL and 
APC1-1337 were found to equally accumulate at the centrosome at different stages of 
the cell cycle. Using fluorescence recovery after photobleaching (FRAP) assay  to 
measure dynamics of GFP-tagged APC in live cells,  two distinct pools of APC were 
identified at the centrosome, a dominant mobile pool (86-91% of the total) and a small 
9-14% immobile pool that is stably retained at the centrosome.  The dynamics of APC-
FL and mutant APC were indistinguishable. Moreover, in vitro detergent extraction 
assays also showed that ~20-30% of endogenous APC (FL or 1-1337 mutant) remained 
immobile at the centrosome. Interestingly, in the presence of nocodazole (microtubule 
[MT] depolymerising agent), the centrosome recovery dynamics of APC-FL, more so 
than mutant APC, were significantly delayed after photobleaching. A similar trend was 
displayed in the FRAP recovery of APC-FL after treatment with leptomycin B (LMB), an 
inhibitor of the nuclear export receptor CRM1 (chromosome region maintenance 1). 
Together, these results indicate that targeting of APC to the centrosome is fully 
determined by sequences within the N-terminal half of the protein, and thus conserved 
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in both normal APC and many cancer-associated forms of APC. In contrast, the C-
terminal half of APC appears to contribute more to MT regulation of APC dynamics.  
3.1 INTRODUCTION  
APC is a multifunctional protein that localises to various sub-cellular compartments such 
as cytoplasm, nucleus, plasma membrane, growing end of MTs, mitochondria and the 
centrosome (Bienz, 2002; Brocardo et al., 2008; Henderson, 2000; Louie et al., 2004; 
Lui et al., 2012). The functions of APC at most of these sites have been well defined, 
and include the following: control of β-catenin concentration and turnover (Polakis, 
1997; Polakis, 2007), the bundling of MTs at the cell cortical membrane and  migrating 
edge (Akiyama and Kawasaki, 2006; Mimori-Kiyosue et al., 2000), the stabilisation of 
MTs and cell protrusions (Kita et al., 2006), and correct chromosome separation in 
mitosis (Green and Kaplan, 2003; Green et al., 2005; Kaplan et al., 2001). In fact, 
functions such as chromosome alignment and MT growth at the mitotic spindle are 
controlled by centrosomes positive for APC staining (see section 1.5.3), however, APC 
functions at the centrosome remain ill-defined, especially during interphase (see section 
1.5.4).  
The protein composition of the centrosome is intimately linked to its activity at 
specific stages of the cell cycle (see section 1.3.2). There are hundreds of proteins that 
are both integrally attached or transiently associated with the centrosome and they differ 
in the kinetics of their on- and off-rates (see section 1.3.3). Their dynamic exchange 
profiles often reflect the specific functions they perform at the centrosome. For example, 
resident proteins such as γ-tubulin and pericentrin (PCNT), that are highly retained, form 
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structural components of the centrosome, while others like ninein and Nek2A kinase are 
highly dynamic and serve a regulatory role. It is often the case that proteins highly 
retained at specific structures play a structural role, as opposed to the regulatory 
function ascribed to proteins with a high level of exchange (see section 1.3.3). Several 
proteins can also use the dynein-kinesin machinery for transport to and from the 
centrosome via MTs (Dammermann and Merdes, 2002; Jia et al., 2013; Moss et al., 
2007). 
 APC is a tumour suppressor and several groups have convincingly shown that 
when APC is truncated, commonly seen in colorectal cancer (CRC), causes a loss in 
MT integrity in mitosis. Truncated APC destabilises the MT to kinetochore attachment 
leading to chromosome misalignment, and cytokinetic defects thereby produce 
multipolar nuclei in cells (Caldwell et al., 2007; Green and Kaplan, 2003; Green et al., 
2005; Kaplan et al., 2001). Despite this, investigations have not yet expanded to 
compare the localisation and dynamic behavior of full-length and truncated APC at the 
interphase centrosomes. Interestingly, several other proteins of the Wnt signaling 
pathway have not only been detected at centrosomes, but play crucial roles. These 
include the protein phosphatase 2A subunit B56α, axin, β-catenin and EB1, as 
discussed in more depth in the literature review (see section 1.5.2). Several groups 
have provided clues to the localisation patterns of APC at the centrosome, revealing 
that the N-terminal half of APC can localise to the centrosome (Tighe et al., 2001; Tighe 
et al., 2004), localisation appears to occur after S/G2-phase in mouse squamous 
carcinoma cells (Olmeda et al., 2003), and APC preferentially localises to the mother 
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centriole as suggested by 3D rendered microscopy (Louie et al., 2004). However, these 
clues provide little functional insights.  
APC is intrinsically a motile protein that can shuttle to various sub-cellular 
destinations. Bienz described in an earlier review the existence of four pools of APC in 
the cell, at the cytoplasm, nucleus, plasma membrane and at MT plus-ends (Bienz, 
2002). More recently APC has further been detected at centrosomes and mitochondria 
(Lui et al., 2012). In this study, a range of experiments were utilised to characterise APC 
localisation, dynamics, and retention at the centrosome, comparing APC-FL and the 
truncated mutant APC (ectopic APC1-1309 or endogenous APC1-1337 in SW480 cells). 
APC associates with MTs via its armadillo (ARM), basic and EB1 binding domains, and 
here the dynamics of APC exchange at the centrosome were assessed following the 
drug-induced depolymerisation of MTs. Finally, to determine how the availability of 
cytoplasmic APC affects its localisation and dynamics at the centrosome, experiments 
were performed with LMB to assess the role of CRM1 on APC centrosome targeting.  
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3.2 MATERIALS and METHODS  
3.2.1 Cell Culture and transfection  
Human cancer cell lines HeLa, HCT116, U2OS and SW480 were cultured in 
supplemented Dulbecco’s modified Eagle’s medium (DMEM) (see section 2.2.4.2).  For 
fixed cell experiments to be analysed by fluorescence microscopy cells were seeded 
onto coverslips in 6-wells plates, and for fluorescence recovery after photobleaching 
(FRAP) cells were seeded into 2-well chambers slides. At 16 h after seeding, cells were 
transfected with 2 µg plasmid DNA using Fugene HD (Promega) or Lipofectamine 2000 
transfection reagent (see section 2.2.4.4). Cells were fixed and processed 30 h post-
transfection for FRAP.  
3.2.2 Drug treatment 
Nocodazole and LMB were used to treat cells prior to cytoskeletal (CSK) extraction or 
FRAP assays. For LMB treatments, cells were treated with 5 ng/ml (Sigma) for 3 h prior 
to each experiment. For nocodazole treatments, cells were treated with 33 µm of 
nocodazole for 1 h at 37oC before each assay. 
3.2.3  Immunofluorescence microscopy 
Centrosomal protein immunostaining was performed as previously described in section 
2.2.6.2 using the following primary antibodies: rabbit poly-Ab PCNT, mouse mAb PCNT, 
mouse mAb -tubulin, rabbit poly-Ab -tubulin as centrosome markers. Mouse mAb Ab7 
(Merck) was used to detect for APC (see Table 2.3 for dilutions). To assess for 
centrosome localisation following the protocol described in section 2.2.7. Accumulation 
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of APC staining at the centrosome above the background cytoplasmic fluorescence was 
scored as positive localisation (see section 2.2.7). Slides were observed and optical 
sections were imaged using Olympus FV1000 confocal microscope at 60X 
magnification as described in section 2.2.6.3. Analysis of localisation and scoring was 
performed using the Olympus Fluoview Version 1.6a software. For each experiment, an 
average score was obtained from over three individual experiments, and at least 100 
cells were scored for each treatment.   
3.2.4 Plasmids  
All plasmids used in this chapter are detailed in materials and methods section (Table 
2.6). 
3.2.5 Retention assay  
To determine the retention of APC at centrosomes, HeLa or SW480 cells were grown in 
6-well trays on poly-L-lysine coated coverslips. Cells were washed with PBS at room 
temperature and treated with CSK buffer for 0 min, 8 min or 40 min. Detergent 
extraction (using CSK buffer) prior to fixation was used to determine strength of 
association with the centrosome, by co-staining APC (Ab7) with -tubulin (see section 
2.2.9). Immunofluorescence was performed as described above in 3.2.3. Slides were 
observed and localisation was scored using an Olympus BX-51 fluorescence 
microscope at 60X magnification. Images were taken using a spot RT slider camera 
23.1 or confocal microscopy as described in section 2.2.9.  
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3.2.6 Construction of GFP-tagged APC fragments 
To comprehensively study the centrosome targeting sequence of APC, an array of 
GFP-tagged APC fragments were used as previously published in Sharma et al., 2006 
(Sharma et al., 2006). Details of cloning are detailed in section 2.2.3. Additionally, N-
terminal fragments APC1-453 and APC1-625, as well as APC334-625 fragments were 
cloned into pEGFP vector to be used in the mapping experiments of centrosome 
targeting domain of APC. The newly cloned N-terminal fragments APC1-453 and APC1-
625 (Table 3.1) were first validated by immunofluorescence where they were ectopically 
expressed and co-stained with Ab7 antibody (see Table 2.3 for details)(Fig. S3.1A). All 
three fragments were overexpressed in U2OS cells and the protein size tagged with 
GFP was validated using Western blot (Fig. S3.1B). Anti-GFP mAb (see Table 2.3) was 
used to detect each fragment. The results indicate that all band corresponded to correct 
predicted sizes (Table 3.1).  
 Table 3.1 Predicted sizes of GFP-tagged cloned fragments.   
APC fragment Predicted size (kD) 
334-625-GFP 68 
1-453-GFP 86 
1-625-GFP 105 
 
3.2.7 Fluorescence recovery after photobleaching (FRAP) 
FRAP was performed in HeLa cells transfected with GFP-tagged APC-FL or APC1-
1309 described in section 2.2.4.4. Red fluorescence protein (RFP)-PCNT-C241 was co-
transfected to mark the centrosome in live cells. In experiments with drug treatments, 
cells were pre-treated (as detailed in 3.2.2) and FRAP was performed in the presence of 
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the drugs. The FRAP analysis was performed using an Olympus FV1000 confocal 
laser-scanning microscope (as described in section 2.2.11.1) and data was analysed 
with Olympus Fluoview Version 1.6a software before exporting data to Microsoft Excel 
(2007). In Microsoft Excel, bleaching from imaging and background fluorescence were 
deducted for each cell and an average recovery curve generated. These data were then 
entered into Graph Pad Prism 5 for curve analysis (see sections 2.2.11.2 and 2.2.11.3). 
Fast and slow phase T1/2 values (for the first 40 s) and plateau values were determined 
and used to compare initial speed of recovery and the recovery percentage at the 
centrosome.  
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3.3 RESULTS 
3.3.1 Full-length and truncated APC localises to the centrosome 
throughout the cell cycle  
The role of APC at the interphase centrosome has been unclear. The aim here was to 
define clearly the centrosome localisation and targeting domains of wild-type APC 
(APC-FL) and a cancer-truncated mutant (1-1337). Firstly, the localisation of APC was 
confirmed in four different cell lines including HCT116 that expresses APC-FL, and 
SW480 that expresses only truncated mutant APC1-1337. Using immunofluorescence 
microscopy, endogenous APC was stained with Ab7 mouse mAb (green), previously 
verified to be specific (Brocardo et al., 2005), along with PCNT rabbit polyclonal antisera 
(red) to mark the centrosome (Fig. 3.1A). For accurate scoring, optical sections were 
taken by confocal microscopy and analysed with the Olympus FV-10 program version 
1.6a for which a positive was scored when APC overlapped the centrosome (see 
section 3.2.3). On average, APC was detected in 80% of cells in all cell lines studied 
(Fig. 3.1B). The truncated APC detected in SW480 cells also localised to centrosomes 
in 80% of cells imaged, which is consistent with previous studies detecting 
overexpressed N-terminal fragments of APC at the centrosome (Tighe et al., 2001; 
Tighe et al., 2004).   
 Centrosome functions vary with each phase of the cell cycle, coinciding with 
recruitment of specialised proteins. For example, β-catenin at the centrosome is thought 
to promote centrosome cohesion following centrosome duplication in S-phase 
(Bahmanyar et al., 2008). To study APC localisation at the centrosome during the cell 
cycle, centrosomes were marked with γ-tubulin antibody and cells were co-stained for 
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Figure 3.1 APC localises to the centrosome in various cancer cell lines. Using 
immunofluorescence, APC was detected at the centrosome in four cancer cell lines by 
staining for endogenous APC using Ab7 mAb antibody (green), and a poly-Ab antibody 
against pericentrin (PCNT) (red) as a centrosome marker. Images were taken with an 
Olympus FV1000 confocal microscope and cells (n>200; mean ± SD) were scored for 
APC staining at the centrosome.  Scores were pooled from at least three independent 
experiments and a students t-test was used to determine statistical significance. All cell 
lines showed more than 80% co-localisation, however there was no significance 
difference in the degree APC localisation between them (mean ± SD).   
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Figure 3.2 The centrosomal retention of endogenous full-length APC (APC-FL) is 
moderately low during interphase but high at mitosis as revealed by in situ 
detergent extraction. (A) HeLa cells were treated with cytoskeletal (CSK) buffer (to 
wash out soluble proteins) then washed out after 0 min, 8 min and 40 min, followed by 
fixation with methanol: acetone. APC was detected using Ab7 mAb (green) co-stained 
with γ-tubulin (red) antibody to detect centrosomes shown in the merged frames (white 
arrows). The localisation of retained APC was scored at different stages of the cell cycle 
according to the centrosome (Go/G1=1 centrosome, S/G2=2 centrosomes, late 
G2=separated centrosomes but have not yet matured, M=divided centrosome with 
increased γ-tubulin at the centrosome). Scores were pooled from at least three 
independent experiments (mean ± SD) and the statistical significance was tested using 
students t-test. (B) Interphase APC shows a significantly lower retention than APC at 
mitotic centrosomes after 40 min CSK treatment (P<0.0001). Over 200 cells were 
scored per stage and condition using Olympus BX-51 microscope and converted to a 
percentage. (C) Schematic of the detergent extraction assay where CSK buffer is used 
to remove the soluble proteins (blue) and the insoluble pool of proteins (orange) remain 
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anchored to cellular structures. The nucleus is shaded in grey and centrosomes are 
depicted in purple.  
 
Figure 3.3 The centrosomal retention of endogenous APC1-1337 increases at 
mitosis. (A) SW480 cells were treated with CSK buffer then washed out after 0 min, 8 
min and 40 min, followed by fixation with methanol: acetone. APC was detected using 
Ab7 mAb (green) and cells co-stained for γ-tubulin (red) to detect centrosomes as 
shown in the merged frames (white arrows). The quantification and statistical analysis 
performed is as described in Fig. 3.2 (B) Interphase APC shows a significantly lower 
retention than APC at mitotic centrosomes after 40 min CSK treatment (P<0.0001). 
Over 200 cells were scored per stage and condition from three independent 
experiments (mean ± SD).  
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endogenous APC (analysing APC-FL in HeLa cells and mutant APC1-1337 in SW480 
cells). The cell cycle was separated into four stages based on centrosome number and 
morphology as outlined in previous studies (Louie et al., 2004; Olmeda et al., 2003): (1) 
G0/G1 - cells with one centrosome, (2) S/G2 - two centrosomes attached, (3) late G2 - 
substantially separated centrosomes with accumulating pericentriolar material (PCM) 
indicated by increasing amounts of γ-tubulin, and (4) M-phase - when γ-tubulin 
decorated the spindle poles. Scoring was performed using an Olympus BX-51 
fluorescence microscope at 60X magnification. APC localised highly and equally at the 
centrosome at all stages of the cell cycle (see “No CSK” cell images in Figs. 3.2 and 
3.3) in 90-100% of cells. Furthermore, localisation in SW480 cells showed a similar 
pattern to HeLa cells. These results indicate that localisation to the centrosome does 
not change throughout the cell cycle when APC is truncated.   
 The retention of APC at interphase and mitotic centrosomes revealed a very 
interesting difference. To assess how well a protein is retained, a detergent extraction 
assay previously optimised in our lab was employed (Fig. 3.2C). The CSK buffer 
contains 0.1% Triton X-100 (for composition see section 2.2.9) and is used to remove 
soluble/mobile proteins from cells and enable detection of the insoluble/immobile 
proteins that are usually anchored to cellular structures. Both HeLa and SW480 cells 
were treated with CSK buffer for 8 min or 40 min, followed by fixation with methanol: 
acetone (see section 3.2.5). Retained APC was detected at centrosomes in CSK-
treated cells by immunofluorescence using specific antibodies. The degree of retained 
APC was measured by microscopy, scoring APC localisation to centrosomes. The 
retention pattern of APC-FL in HeLa cells was very similar to that of the APC1-1337 in 
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SW480 cells, and both forms of APC were retained in only a fraction of cells (20-40% of 
total) in G1, S or G2-phase (Figs. 3.2 and 3.3). In contrast, both forms of APC were 
strongly retained at centrosomes in mitosis, with >90% of all cells scored exhibiting APC 
anchorage after CSK treatment. This is suggestive of a change in function and in 
protein complex formation of APC at the centrosome as it progresses into mitosis, and 
that these functions are likely to be conserved in CRC since the APC mutant showed no 
change in the retention pattern.  
3.3.2 Mapping the core centrosome targeting sequence of APC to the 
armadillo domain containing sequence 334-625   
A repertoire of GFP-tagged APC peptide fragments were transiently expressed in U2OS 
cells co-staining for the centrosome with PCNT. Optical cross-sections were taken by 
the confocal microscope and images were analysed using the Olympus FV-10 software 
and scored for centrosome co-localisation. APC1-1309-GFP localised strongly and 
consistently to the centrosome in >90% of cells as expected, and this high level of co-
staining is indicated by the score ‘+++’ (Fig. 3.4). In contrast, a similar analysis of C-
terminal APC fragments, namely the sequences 1379-2080, 1339-2345 and 2650-2843, 
revealed no significant centrosomal co-localisation and were comparable to the GFP-
only control. This was consistent with an earlier study where the N-terminal APC 
fragment 1-750 amino acids localised to the centrosome (Tighe et al., 2004). 
 A more detailed fine-mapping of the 1-1309 sequence was initiated (for newly 
cloned APC fragments see Fig. S3.1). Two N-terminal fragments of APC, 1-302 and 1-
453, were first tested. These sequences are located just upstream of the ARM domain  
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Figure 3.4 Mapping APC centrosomal targeting domains. (A)  Schematic diagram of 
APC mutant (1-1309) and shorter protein fragments including N-terminal domains and 
C-terminal domains. All fragments were GFP-tagged (green) and overexpressed in 
U2OS cells followed by a co-staining of PCNT (red) to mark the centrosome. Optical 
sections were acquired with an Olympus confocal FV1000 microscope and subsequent 
images were then used to score co-localisation. Representative images (cell and 
centrosome zoom) are shown for each expressed construct. (B) Scoring was based on 
the % of transfected cells with APC localised to the centrosome (see section 2.2.7.2). 
Data was collected from three independent experiments, scoring at least 100 cells per 
experiment (mean ± SD). Students t-test analysis reveal the centrosome localisation of 
APC1-1309 was significantly higher than GFP control (P<0.0001).  
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Figure 3.5 Fine mapping of the centrosome targeting sequence surrounding the 
APC-armadillo (ARM) region. (A)  Schematic diagram of GFP-tagged APC-ARM. APC 
constructs (green) were overexpressed in U2OS cells followed by a co-staining of 
PCNT to mark the centrosome (red). Images were acquired and the method of scoring 
was performed as described in Fig. 3.4. (B) Scoring was based on the percentage of 
transfected cells with APC localised to the centrosome (see section 2.2.7.2). Data was 
collected from three independent experiments, scoring at least 100 cells per experiment 
(mean ± SD). Results show the smallest centrosome localising fragment to be 334-625 
amino acids students t-test analysis show all but ARM5-7 show significantly higher 
centrosome localisation compared to the GFP control (P<0.0001). 
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and when analysed were found to display extremely poor staining at the centrosome 
(rated “-“ in Fig. 3.4). Therefore, further investigation into regions surrounding the ARM 
proceeded as illustrated in Fig. 3.5. A large fragment, 334-900, that encompasses the 
ARM domain and flanking sequence displayed a very strong staining at centrosomes 
(+++), as did the N-terminal sequence 1-625 which comprises the first half of the ARM  
repeat domain (Fig. 3.5). This suggested that centrosome targeting might require part of 
the ARM sequence. A further series of ARM-containing sequences were constructed 
(see section 3.2.6), revealing slightly reduced but good centrosome localisation of the 
ARM region itself (453-767) (rated ++), and a weaker localisation activity in a fragment 
containing the first 4 armadillo repeats (scored as +), which located at the centrosome in 
only 20% of cells. By contrast, the second half of the ARM domain (repeats 5-7; 
sequence 629-767) was negative. The minimal core targeting sequence was finally 
mapped to the sequence 334-625, containing a combination of N-terminal flanking 
sequence and ARM repeats 1-4. This newly defined sequence recruited GFP to the 
centrosome in 60% of cells, and its N-terminal location explains why truncated cancer 
mutant forms of APC are often detected at the centrosome.  
3.3.3 Full-length and cancer-truncated mutant APC display similar 
dynamics at the centrosome: Identification of mobile and 
immobile pools of APC  
As previously noted, APC is a highly mobile protein with the ability to shuttle between 
the nucleus and cytoplasm (Henderson, 2000; Rosin-Arbesfeld et al., 2000). We 
wondered if APC is also dynamic at the centrosome. To test this property, FRAP was 
optimised to compare the mobility and retention of GFP-tagged forms of APC at the 
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centrosome in live cells (see Fig. 3.6). In the FRAP assay, GFP-tagged proteins are 
expressed in cells then subjected to laser-induced photobleaching at a specific 
compartment (e.g. centrosome), following which recovery of the fluorescent protein is 
measured accurately on the confocal microscope by image acquisition at specific time 
intervals (see section 3.2.7). This allows for the quantification of protein exchange 
dynamics, in particular on-rates and degree of retention. In the case of centrosomes 
that are non-membranous, the dynamics measured after bleaching at the centrosome 
represent a direct exchange between centrosome and the cytoplasm  (Prosser and Fry, 
2009). GFP-tagged APC constructs were co-expressed with a RFP-tagged PCNT 
marker, (RFP-PCNT-C241) (Gillingham and Munro, 2000), in HeLa cells (Fig. 3.7B). 
The FRAP assay was measured and analysed in Graph Pad Prism 5 to determine the  
 
Figure 3.6 Outline of fluorescence recovery after photobleaching (FRAP) assay 
used to determine protein dynamics at the centrosome. GFP-tagged APC 
constructs are transiently transfected and co-expressed with RFP-tagged PCNT-C241 
(centrosome marker) in live HeLa cells. Using the Olympus FV1000 confocal 
microscope with enclosed CO2 chamber, two pre-bleach images are acquired, followed 
by the laser bleaching of the region of interest (ROI=region of interest, that is, the 
centrosome). Fluorescent images are subsequently acquired post-bleach at 1.5 s 
intervals for a period of 150-200 s. Fluorescence recovery is calculated as outlined in 
methods chapter (see section 2.11.3).   
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rate of fluorescence recovery over time, and the relative size of dynamic and immobile 
pools of APC.    
First, it was important to determine the minimal bleaching time required to 
completely diminish the centrosome pool of APC. GFP-tagged APC-FL and APC1-1309 
were overexpressed in HeLa cells (to be used in FRAP experiments) which were then 
fixed using methanol: acetone and mounted on glass slides. Centrosomes were marked 
by co-expression of RFP-PCNT-C241 and used to locate APC there (the RFP bleached 
more slowly over time). The minimal bleach time for both forms of GFP-tagged APC 
was 3 s with 100% laser intensity.  On average, 15-20 cells were pooled for each APC 
construct from at least three independent experiments for FRAP analysis. The main 
discovery, and which was a little unexpected, was that the GFP-tagged APC-FL and 
APC1-1309 shared a similar dynamic profile at the centrosome (Fig. 3.7C). In each 
case, the fluorescence recovery curves revealed two quite distinct pools of APC at the 
centrosome, a mobile pool and a retained pool. The rapid fluorescence recovery 
observed within the first 10 s (see recovery curve, Fig. 3.7C) represents the more 
dominant mobile pool, which reflected 86.3% of total centrosomal APC-FL and 91.3% of 
centrosomal APC1-1309 (also see Fig. S3.2 [Table]). The mobile pools exhibited a rapid 
recovery which could be further divided into two distinct phases, a fast and slow phase 
with kinetics as described in Fig. S3.2 (Table) in the supplementary section. The fast 
phase kinetics of APC had a low T1/2 of around 3 s (Fig. 3.7C). In addition to the 
dynamic pool, a small fraction of APC was retained or immobile at the centrosome, and 
this is indicated by the difference between maximal recovery plateau and the pre-bleach 
value  on  the  recovery  curves.  The   retained  pools   measured  here  in  living  cells 
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Figure 3.7 GFP-tagged APC-FL and APC1-1309 display similar dynamics at the 
centrosome in live cells. (A) Schematic diagram of APC-FL and truncated APC1-
1309. The centrosome targeting sequence 334-625 is shown by the black bar. (B) APC-
FL-GFP and APC1-1309-GFP (green) were independently co-transfected with RFP-
PCNT-C241 (red) into HeLa cells and expressed for 48 h prior to analysis. FRAP was 
performed by live cell confocal microscopy using the laser for photobleaching of 
centrosome fluorescence, followed by fluorescence time-lapse image capture (60X 
magnification). The baseline fluorescence was acquired by taking a pre-bleached 
image, followed by sequential imaging at 0 s, 12 s, 21 s, 36 s and 60 s post-bleach. The 
insets show higher magnification views of the centrosome. (C) Fluorescence recovery 
curves were plotted and shown for both forms of APC at the centrosome (left panel), 
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indicating relative rates of recovery and equilibration (plateau) at the centrosome for up 
to 100 s after bleaching. Quantitative analysis of image recovery parameters was 
performed using Graph Pad Prism 5 software and Excel (see section 2.2.11 and section 
3.2.7 for details). Analysis of the maximal extrapolated recovery as indicated by the 
curve plateau data indicates that a dominant mobile (86-91% of total) and a smaller 
retained pool (9-14% of total) occupy the centrosome for both APC forms. The fast-
phase half time in seconds (T1/2 ± SD) and the retained fraction (% ± SD) are shown for 
each protein from a pooled average of 15-20 cells (right panels) based on Graph Pad 
Prism analysis (see Table S3.2 in supplementary section for further details). The 
dynamic profiles of APC-FL and APC1-1309 were not significantly different.  
 
comprised 8.7% and 13.8% of the total centrosomal pools of full-length and truncated 
mutant APC, respectively (see also Fig. S3.2). This is within a similar “minority” range 
as the retained pools observed after in situ detergent extraction (see Fig.’s. 3.2 and 
3.3). Overall, these recovery rates shown for APC are comparable to that of other 
centrosomal proteins such as aurora A and nek2A kinases (see section 1.3.3). This 
data is the first to illustrate the dynamics of APC. Not only is the centrosome targeting 
signal unaltered after APC truncation, but dynamic exchange rate at the centrosome is 
also unaffected.   
3.3.4 Intact microtubules stimulate the rate of transport of APC to the 
interphase centrosome  
Some proteins such as ninein and ninein-like protein require MTs for transport to 
centrosomes (Casenghi et al., 2005; Moss et al., 2007), while others such as γ-tubulin 
and EB1 can localise to the centrosome even when MTs are depolymerised (Khodjakov 
and Rieder, 1999; Louie et al., 2004). Since APC is an MT-binding protein, in situ and in 
vivo experiments were designed to determine whether treatment of cells with the MT 
depolymerising agent, nocodazole, altered the localisation, retention or dynamics of 
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APC at the centrosome. To examine if APC retention at the centrosomes in situ was 
MT-dependent, the detergent extraction assay (CSK buffer) was used to remove soluble 
proteins after nocodazole treatment (drug concentration optimisation see Fig. S3.3). 
HeLa cells were grown on poly-L-lysine coated coverslips, incubated with 33 µM of 
nocodazole for 1 h at 37oC and treated with CSK buffer at 32oC for 0 min, 8 min and 40 
min prior to fixation and staining. 
Full-length APC:  Microscopy revealed that the amount of APC localised to the 
centrosome in untreated HeLa cells was unaltered by nocodazole, and furthermore 
nocodazole treatment did not significantly change the level of APC retained at the 
centrosome after 8 min or 40 min CSK treatment (Fig. 3.8A and B). This indicates that 
loss of MTs do not impede localisation of APC-FL at the centrosome, similar to an 
observation made previously where the treatment of nocodazole did not alter the 
centrosome localisation of APC in MDCK cells (Louie et al 2004).  
 The localisation of APC reflects mostly a dynamic population that exchanges 
rapidly (Fig. 3.7), and it is thus possible that MTs might regulate the dynamic rate of 
exchange without affecting the overall appearance of APC at the centrosome. To 
address this FRAP experiments were performed. Following the same protocol described 
in Fig. 3.6, FRAP was performed on APC-FL-GFP expressed in HeLa cells in the 
presence and absence of nocodazole (for confirmation of MT depolymerisation see Fig. 
S3.4). Cells were treated with 33 M of nocodazole for 1 h prior to the commencement 
of the FRAP assay (photobleaching of the centrosome-localised fluorescence and 
measurement of recovery). FRAP analysis revealed that the fluorescence recovery of 
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Figure 3.8 (Legend on following page)  
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Figure 3.8 Evidence for a role of microtubules (MTs) in stimulating APC-FL 
movement to the centrosome. The MT polymerisation inhibitor, nocodazole, was used 
to treat HeLa cells and study its impact on localisation and dynamics of APC at 
centrosome. (A) Retention assay of APC +/- nocodazole treatment. HeLa cells were first 
treated with 33 M of nocodazole for 1 h and then treated with CSK buffer for 0 min, 8 
min and 40 min before washing with PBS. The retention of endogenous APC-FL was 
assessed by immunofluorescence microscopy as in Fig. 3.2. (B) The degree of APC co-
localisation at centrosomes was scored, and was unaffected by nocodazole as shown. 
Furthermore, the loss of MTs did not alter the retention of APC at centrosomes. Over 
200 cells were scored over at least three experiments (mean ± SD) (C) FRAP 
experiment. GFP-tagged APC-FL was transiently expressed in HeLa cells and 
subjected to FRAP analysis (details similar to Fig. 3.7) at centrosome in cells treated +/- 
nocodazole (n=20-30 from at least three independent experiments).  A series of tiled 
cell images with the pre-bleach and post-bleach localisation of APC-FL-GFP (green) in 
live cells is shown. Centrosome were identified by the co-expressing of RFP-PCNT-
C241 (red) (D) FRAP recovery curves comparing the dynamic profile of APC-FL-GFP at 
the centrosome in cells +/- nocodazole show that the rate of recovery is significantly 
reduced by the drug (P<0.0001, for details of stats see section 2.2.11.3). The impact of 
drug on APC T1/2 values of the fast recovery pool (T=0–40 s), and retention at 
centrosome, was calculated from the recovery curve data using Graph Pad Prism 
software (see also Tables S.3.2). The % retention of APC-FL at the centrosome 
appears to be lowered by nocodazole treatment but not reflected in the fluorescence 
recovery curve as the curve has not reached its maximum within the 100 s, it is 
predicted to plateau around 95% as extrapolated by the Graph Pad Prism 5 program.  
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Figure 3.9 (Legend on following page)  
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Figure 3.9 Centrosome targeting and dynamics of APC1-1309 mutant is modestly 
influenced by MTs, but less so than for APC-FL. (A) Retention assay of APC with +/- 
nocodazole treatment. SW480 cells were treated with 33 M of nocodazole for 1 h and 
then treated with CSK buffer for 0 min, 8 min and 40 min before washing with PBS. APC 
was stained using Ab7 mAb (green) and centrosomes were marked using PCNT (red) 
(B) The centrosome localisation of endogenous mutant APC1-1337 was scored by 
fluorescence microscopy. The percentage of cells in which APC localised to the 
centrosome, or was retained there after CSK treatment, was slightly reduced by 
nocodazole (P<0.001) (n=15-25 from at least three independent experiments). (C) 
Panel of images showing FRAP recovery of GFP-tagged APC1-1309 in HeLa cells +/- 
nocodazole. More details in Fig. 3.8. (D) FRAP recovery curves comparing the dynamic 
exchange profile of APC at the centrosome +/- nocodazole showed a small difference in 
the dynamic rate of recruitment compared to untreated cells (P=0.0447). When the 
recovery data were analysed by Graph Pad prism software there was a small but 
significant difference in T1/2 value, however no change in retention after nocodazole 
treatment (see also Table S3.2) 
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APC-FL-GFP was significantly slowed at the centrosome after disruption of MTs by 
nocodazole treatment (see Fig. 3.8C and quantification of recovery rates or retention in 
Figure 3.8D). The T1/2 was increased significantly by three-fold from ~2 s to~7 s. While 
nocodazole caused a delay in the rate at which ectopic APC-FL moved toward the 
centrosome, it also modestly altered the general level of retained APC within the100 s 
time post-bleach time period measured (Fig. 3.8D) consistent with the retention assay 
(Fig. 3.8B). However, under these conditions the GFP-tagged APC in nocodazole-
treated cells did not quite reach plateau (Fig. 3.8D) and thus it is possible that the 
decrease in the level of retention by nocodazole will be more obvious when analysed 
over a longer period. In conclusion, loss of MT coherence elicits a marked delay in the 
rate of APC-FL movement to the centrosome.  
Mutant APC1-1309: The same experimental approach was applied to the truncated 
cancer mutant forms of APC. In SW480 CRC cells, the endogenous form of APC1-1337 
was analysed by CSK retention assay, and in this set of experiments the level of 
centrosomal retention was quite low for endogenous mutant APC (Fig. 3.9A and B), and 
reduced further to some extent by nocodazole treatment (P<0.001). Live cell 
experiments were then performed with the mutant APC. APC1-1309-GFP was analysed 
for dynamics at the centrosome by FRAP (Fig. 3.9C). As shown, while there was some 
small reduction in the rate of recovery after nocodazole treatment for the ectopic mutant 
APC (Fig. 3.9D), it was not as pronounced as the delay observed for APC-FL. However, 
the difference in fluorescence recovery is detectable and is statistically significant (Fig. 
3.9D). Notably, retention of the GFP-tagged APC1-1309 was unchanged with 
nocodazole treatment (Fig. 3.9D). In summary, while drug induced MT depolymerisation 
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does not affect the overall localisation of APC at the centrosomes, it does cause a 
slowing down of the rate of APC movement to the centrosome, but this is more 
pronounced for the full-length protein. 
3.3.5 CRM1 inhibition slows the dynamics of full-length APC at the 
centrosome 
APC is found in the nucleus as well as the cytoplasm (Neufeld and White, 1997). 
Centrosomes are tethered to the nucleus while remaining in the cytoplasmic space 
(Sitaram et al., 2012). Indeed APC is often found at the centrosome, however, currently 
there is no information about whether the mobile pool of APC could originate from the 
nucleus. APC is known to shuttle in and out of the nucleus due to the action of its 
nuclear export signal (NES) and nuclear localising signal (NLS) via CRM1 (Henderson, 
2000; Rosin-Arbesfeld et al., 2000). Furthermore, chromosome region maintenance 1 
(CRM1) is a protein that not only localises to the centrosome, but also directs the 
localisation of crucial proteins such as PCNT to the centrosome (Liu et al., 2009). Since 
>80% of centrosomal APC undergoes dynamic exchange or “shuttles” to and from the 
centrosome (Fig. 3.7), the potential role of  CRM1 on the APC centrosome pool was 
addressed.  
 To retain the nuclear population of APC in the nucleus, leptomycin B (LMB) was 
used to inhibit CRM1 activity (Fig. 3.10A). GFP-tagged APC-FL and APC1-1309 were 
overexpressed for 48 h in HeLa cells, which were either untreated or pre-treated with 5 
ng/ml of LMB (concentration was optimised, see Fig S3.5) for 3 h prior to performing the 
FRAP assay. The recovery curves and comparison of T1/2 and retention data are shown  
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Figure 3.10 (Legend on following page) 
 
 
 
 
The image cannot be displayed. Your computer may not have enough memory to open the image, or the image may have been corrupted. Restart your computer, and then open the file again. If the red x still appears, you may have to delete the image and then insert it again.
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Figure 3.10 CRM1-dependent nuclear export modestly stimulates the on-rate of 
APC-FL at the centrosome. (A) Schematic diagram of the mechanism of action  of 
CRM1 inhibitor (LMB) and its effect on APC. GFP-tagged APC-FL (B) and APC1-1309 
(C) were overexpressed in HeLa cells. After 48 h, cells were treated with 5 ng/ml of 
LMB for 3 h before FRAP analysis. GFP-tagged APC was bleached at the centrosome 
and fluorescence recovery was monitored (see section 2.2.11). As shown in the 
fluorescence recovery curves and T1/2 value graphs, the inhibition of CRM1 significantly 
reduced the rate of centrosome recovery of APC-FL (n=11) compared to untreated cells 
(n=24) (P=0.0004). The retention was not significantly changed (see also Table S3.2). 
However, CRM1 inhibition did not alter the fluorescence recovery curve for APC1-1309; 
there was little to no change in T1/2 and retention with (n=18) or without LMB (n=20) 
treatment. (D-E) CSK retention assay. HeLa and SW480 cells were untreated or 
pretreated 3 h with LMB, then permeabilised with CSK buffer and centrosome staining 
of APC was scored. The retention assay indicated that centrosome retention of APC 
was significantly reduced by LMB treatment in both APC-FL (D) and APC1-309 mutant 
(E) expressing cells after CSK washout. Scoring was performed using Olympus BX-51 
microscope in three independent experiments with a total cell population of 100 cells 
per condition (mean % ± SD).  
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in Fig.’s 3.10B and C, and reveal that LMB had little effect on retention of APC at the 
centrosome. In contrast, LMB did retard the rate of recovery of APC-FL compared to 
untreated cells when measured over a post-bleach period of 100 s (P<0.0001) (Fig. 
3.10B). The recovery of APC1-1309 however, was unaffected by the treatment of cells 
with LMB with no statistical significance compared to untreated cells (Fig. 3.10C).  
To complement the above in vivo assay, we also performed an in situ CSK 
extraction assay. HeLa and SW480 cells were pre-treated with 5 ng/ml of LMB for 3 h 
before treating with CSK buffer for 0 min, 8 min and 40 min. Cells were stained for 
endogenous APC and pericentrin antibody was used to mark the centrosomes, and 
cells then scored to compare with the in vivo data. It was found that LMB treatment 
caused a significant reduction in the “detergent-resistant” retained pool of endogenous 
APC in both HeLa and SW480 cells (Fig. 3.10D and E). Thus, it appears that blocking 
nuclear export of APC does impact on its level of retention at least for the endogenous 
protein, which would be expressed to a much lower degree than the ectopic APC-GFP 
forms studied by FRAP. The fact that both full-length and mutant 1-1337 forms of APC 
responded to LMB is consistent with the fact that both contain the NES signal found at 
the N-terminus of APC (Henderson, 2000).  
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3.4 DISCUSSION  
In this study, the previously reported centrosomal localisation of truncated APC (Tighe 
et al., 2001; Yamashita et al., 2003) and APC-FL in U2OS cells (Langford et al., 2006; 
Louie et al., 2004) was confirmed by fluorescence microscopy in a range of different cell 
lines expressing full-length or truncated mutants forms of APC. This is the first study to 
map the precise N-terminal sequence that targets APC to centrosomes, define its cell 
cycle retention patterns and compare in detail the dynamic exchange rates of APC-FL 
and mutant APC at centrosomes.  
The centrosome localising sequence for APC includes the armadillo 
domain 
The transport of proteins to the centrosome is poorly defined. In order to map the 
targeting sequence in APC, short GFP-tagged APC fragments were transiently 
expressed in cells and scored for co-localisation at the centrosome using confocal 
microscopy. In addition to our existing knowledge that the fragments APC1-1309 and 
APC1-750 can be targeted to the centrosome (Langford et al., 2006; Louie et al., 2004; 
Tighe et al., 2004), this time-consuming approach refined the minimal core centrosome 
localising region to the sequence 334-625 amino acids. The optimal targeting of APC to 
centrosomes may require additional flanking sequence given that APC334-900 localised 
slightly more consistently at the centrosome (Fig. 3.5).  
Currently no universal centrosome targeting motifs have been defined. The 
pericentrin AKAP centrosome targeting (“PACT”) domain common to the coiled-coil 
proteins PCNT and AKAP450 has been shown to act as a centrosome localising 
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sequence (CLS) in certain proteins (Gillingham and Munro, 2000). Others have defined 
a CLS common to cell cycle regulators such as cyclin A and cyclin E that can mediate 
their centrosome localisation in a cell cycle dependent manner (Ferguson et al., 2010; 
Matsumoto and Maller, 2004; Pascreau et al., 2010). The CLS defined in this study 
(APC334-625) lies within the structured ARM region of APC. In fact, only the first four 
(out of seven) ARM repeats are required for targeting (Fig. 3.5). Interestingly, β-catenin 
has also been cited (data not shown) to be targeted to the centrosome via its ARM 
domain (Bahmanyar et al., 2009). The ARM domain would make an interesting new 
class of CLS because of its flexible nature. This coiled-coil domain forms a superhelix 
with a positively charged groove able to bind a variety of proteins (Morishita et al., 2011; 
Xing et al., 2004). In addition to APC and β-catenin being targeted to the centrosome 
via the ARM, it would be interesting to examine other ARM-containing APC binding 
partners such as KAP3A (Jimbo et al., 2002; Tewari et al., 2010) and assess whether it 
could also be targeted in the same way. The APC “CLS” (334-625)  lies within the N-
terminal structured region of APC, and contains the coiled region 453-625 
corresponding to the first four ARM repeats (Zhang et al., 2011). This ARM sequence 
had a modest centrosome-targeting activity on its own (Fig. 3.5) and was previously 
shown to interact with the protein phosphatase 2A subunit B56α (Galea et al., 2001). 
However, while B56α does locate at centrosomes (Flegg et al., 2010), its staining was 
less consistent than that of APC and is unlikely to play a major role in mediating the 
localisation of APC. A screen for APC ARM binding partners with links to centrosome 
targeting is performed later in the thesis (see Chapter 7). 
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The centrosomal retention of full-length and mutant (1-1337) APC is 
different between interphase and mitosis  
The study of localisation and retention patterns of proteins during centrosome 
duplication and the cell cycle has provided valuable clues to their centrosomal function. 
For example, the protein -tubulin localises to the mother centriole only after S-phase to 
cap and stabilise the centrioles after duplication (Chang et al., 2003) (see Table 1.1). 
The retention of γ-tubulin was shown to decrease from ~50% to 0% when shifting from 
interphase to mitotic centrosomes, implying that a rapid and ongoing recruitment of γ-
tubulin becomes necessary for sudden spindle nucleation at the onset of mitosis 
(Khodjakov and Rieder, 1999). Here, the cell cycle centrosome localisation pattern of 
APC in HeLa (APC-FL) and SW480 (APC1-1337) cells was examined by 
immunofluorescence microscopy, revealing that both full-length and truncated mutant 
forms of APC localised strongly and to a similar degree at the centrosome throughout 
the cell cycle (Figs. 3.2 and 3.3). Furthermore, using a detergent extraction assay the 
centrosome retention of APC initially was found to be low (~20%) at interphase 
centrosomes but was dramatically increased at mitosis in both cell lines (~90%) (Figs. 
3.2 and 3.3) (also see Fig. 4.11), suggesting differences in APC mobility and formation 
of APC-protein complexes as cells enter mitosis, reminiscent of differences observed 
previously with γ-tubulin.  
Dynamics of APC at the centrosome 
One factor that is not accounted for in fixed cell studies is that sub-cellular structures 
often contain more than one protein pool. Most centrosome regulatory proteins are 
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dynamic and are in constant exchange with the cytoplasm (Hames et al., 2005; 
Khodjakov and Rieder, 1999; Moss et al., 2007). In this study, the endogenous forms of 
both APC-FL and truncated mutant APC1-1337 were easily dislodged from the 
centrosome of interphase cells by detergent buffer treatment in situ (Fig. 3.9), 
suggesting that a large pool of centrosomal APC is mobile. To verify this possibility in 
live cells, the FRAP photobleaching method was used to observe the dynamic 
behaviour of the soluble pool of APC at the centrosome. The maximum fluorescence 
recovery of ~86% of the pre-bleach values confirms that only a small fraction (~14%) of 
APC-FL at the centrosome is retained (Fig. 3.7). The large dominant pool is therefore 
highly dynamic and showed a rapid recovery within the first 10 s (Fig. 3.7). This was 
similar to another Wnt protein, β-catenin, which was reported by others to exhibit a 
maximum fluorescence recovery of 95% after photobleaching and a T1/2 of ~ 5 s 
(Bahmanyar et al., 2008). A major difference is seen in the regulation of -catenin by 
GSK3β. FRAP analysis of the stabilised form of β-catenin, where the N-terminal GSK3β 
phosphorylation sites were mutated and thus non-phosphorylated, indicated that 
centrosome retention was increased by up to ~30% of total with a plateau in 
fluorescence recovery (after photobleaching) of ~70% (Bahmanyar et al., 2008). GSK3β  
phosphorylation sites are also contained within the central region of APC (Trzepacz et 
al., 1997), and therefore mutations in these sites might be interesting to test in future 
studies.  
The dynamics of APC also resemble that of certain kinases. FRAP studies of 
cdc20 and Nek2A at the centrosome in HeLa and U2OS cells show rapid fluorescence 
recovery with t-half values of less than 10 s (see Table 1.2), similar to that seen for 
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APC-FL and APC1-1309 (Fig. 3.7). Nek2 is a cell cycle regulated kinase that modulates 
centrosome separation in S/G2-phase and cdc20 is a checkpoint protein that regulates 
the anaphase promoting complex in mitosis (Hames et al., 2005; Kallio et al., 2002). In 
this context of cell cycle, it is interesting to note that APC has functional roles in both 
interphase cells (eg. cytoskeleton regulation) and mitotic cells (spindle integrity), and the 
increased retention of APC observed in mitotic centrosomes (Figs. 3.2 & 3.3) is likely to 
correlate with changes in its centrosomal function during the cell cycle.   
The regulation of APC dynamics at the centrosome is conserved in 
the truncated cancer mutant 
The impact of cancer-linked mutations, MTs and nuclear export on APC dynamics at the 
centrosome was investigated through the combined use of in situ detergent extraction 
and in vivo FRAP assays. The results in some cases were surprising. For instance, the 
complete loss of the large C-terminal half of APC (~1500 amino acids) actually made no 
difference to the size of the mobile pool or its rate of dynamic exchange. Thus, as 
mentioned above, the key sequences determining both localisation, anchorage and 
transient dynamic exchange are contained within the N-terminus of APC, common to 
many APC cancer mutants seen in CRC (Chandra et al., 2012). Given the exquisite 
sensitivity of the FRAP analysis, particularly at the early time-points after bleaching that 
map the rapid recovery response of the protein at the centrosome, it appears that the C-
terminus of APC makes no significant contribution even to the transient contacts 
between APC and centrosome protein partners (to be identified in Chapters 5 and 6). It 
will therefore prove interesting to determine whether C-terminal sequences contribute to 
APC function at the centrosome (Chapter 4). 
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The microtubule system stimulates transport of APC to the 
centrosome  
APC is able to bind MTs directly through its basic domain (Munemitsu et al., 1994) and 
indirectly through kinesins (Jimbo et al., 2002), and therefore it is conceivable that the 
MT network influences APC localisation at centrosomes. A previous study by Louie and 
colleagues tested this by treating cells with nocodazole to disrupt the MT network, only  
 
 
Figure 3.11 Chapter 3 summary model. APC is targeting to the centrosome via its 
armadillo (ARM)-domain. There are two pools of APC at the interphase centrosome 
where ~80% of APC is mobile (orange circles). This applies for both APC-FL and the 
APC truncated mutant. At spindle pole bodies in mitosis, both forms of APC become 
highly resistant to detergent extraction and its retention is increased from ~20% to 
>90%. The localisation of APC is unaffected by nocodazole or LMB treatment. Only the 
dynamics of APC-FL (more than the mutant) is affected by nocodazole and LMB 
suggesting that MTs and the availability of the nuclear pool of APC is important to the 
efficient accumulation of APC-FL at the centrosome.  
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to find that APC was still detectable at centrosomes (Louie et al., 2004). In this chapter, 
simple antibody staining and fixation of cells confirmed that nocodazole did not 
dramatically alter the steady-state localisation at centrosomes (Figs. 3.8B & 3.9B). 
However, an in-depth FRAP analysis of cells treated with nocodazole showed that APC-
FL on-rate dynamics was significantly delayed as illustrated by a two-fold increase in its 
T1/2 (Fig. 3.8D). This means that loss of MT integrity caused a slowing of recruitment of 
the mobile APC pool to the centrosome. A somewhat similar result was observed for 
APC1-1309, although to a lesser extent, with its T1/2 also significantly increased. 
Notably, the loss of MTs did not affect the level of APC-FL retention at centrosomes but 
modestly reduced that of mutant APC. These findings suggest that while MTs are not 
absolutely necessary for centrosome delivery of APC, the presence of an intact MT 
network “stimulates” APC transient movement to the centrosome (Fig. 3.11).  
While MTs stimulated APC movement to the centrosome, some proteins such as 
ninein are more dependent on MTs for centrosome accumulation. FRAP analysis of 
GFP-tagged ninein revealed that after photobleaching the centrosome in nocodazole-
treated cells, ninein fluorescence only recovered to 20% compared to 100% recovery 
seen in cells with intact MTs (Moss et al., 2007). CDK5RAP2, a protein that interacts 
with light chain 8 (DLC8)  of the motor protein, dynein involved in the regulation of γ-
tubulin ring complexes (γ-tuRCs), also displayed a significant reduction in fluorescence 
recovery in FRAP analysis with cells exposed to nocodazole treatment (Jia et al., 2013). 
In comparison, nocodazole based disruption of MTs had no effect on centrosome 
dynamics of the tumour suppressor BRCA1 or the MT nucleator γ-tubulin (Brodie and 
Henderson, 2012; Khodjakov and Rieder, 1999). APC C-terminal domains were 
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previously found, when overexpressed, to influence vesicle transport along axonal MTs 
in both directions in neurons. In squid giant axons treated with recombinant APC1034-
2130 or APC2130-2844 the velocity of vesicle movement was reduced in both 
anterograde and retrograde transport on individual MTs (Ratner et al., 1998).  
Retrograde MT transport is normally mediated by minus-end-directed motors 
such as dynein, however there is no known evidence that APC interacts with dynein. 
While initial tests for binding of APC to dynein light chain were negative (data not 
shown), more detailed studies are required to determine if dynein complexes mediate 
APC tracking along MTs in a minus-end directed manner to the centrosome. In addition 
to MT dependent and independent transport of proteins to the centrosome, PCM-1, a 
centriolar satellite protein has also been suggested to target proteins to centrosomes. 
The depletion of PCM-1 by siRNA and antibodies reduces the targeting of important 
centrosome proteins including PCNT, ninein, centrin and C-Nap1 (reduced by up to 
60%) at the centrosome in U2OS cells, classified by reduced fluorescence intensity, 
while γ-tubulin is unaffected by PCM-1 (Dammermann and Merdes, 2002; Hames et al., 
2005). Although I did not specifically test for APC localisation with PCM-1, satellite 
staining of APC around the centrosome was not observed. In summary, FRAP studies 
performed here confidently show that the efficient transport of APC is stimulated by, but 
is not dependent on, the MT system.  
CRM1 stimulates the on-rate of APC dynamics at the centrosome 
The ARM domain of APC is regarded as the primary mobile targeting domain of APC 
(reviewed in Lui et al 2012), and the first four ARM repeats were shown here to be part 
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of the CLS. APC is also a nuclear-cytoplasmic shuttling protein (Henderson, 2000; 
Neufeld et al., 2000; Rosin-Arbesfeld et al., 2000) and while the N-terminal ARM 
repeats 1-4 contribute to nuclear import of APC (Galea et al., 2001) and weakly to 
nuclear export (Sharma et al., 2012), other NESs, particularly at the N-terminus, 
mediate its nuclear export through the export receptor, CRM1 (Henderson and Fagotto, 
2002). To determine whether CRM1 affects APC dynamics at the centrosome, FRAP 
and detergent extraction assays were performed (Fig. 3.10). These showed, in turn, that 
CRM1 stimulates the dynamic on-rate of ectopic APC-FL, and slightly increases the 
retention of endogenous cellular APC, at the centrosome. These findings are 
remarkably similar to the recently reported role of CRM1 in stimulating dynamic 
movement of the BRCA1 tumour suppressor to the centrosome (Brodie and Henderson, 
2012). CRM1 locates at the centrosome throughout the cell cycle of Xenopus XTC 
fibroblasts and HeLa cells, and affects MT nucleation where the overexpression of its 
centrosome targeting domain (CRIME domain) disrupts the γ-tubulin and PCNT 
interaction at centrosomes (Liu et al., 2009). The small delay in APC-FL dynamics 
caused by CRM1 inactivation (Fig. 3.10B) suggests that CRM1, which binds to five 
distinct NESs on APC as discussed in a previous review (Brocardo and Henderson, 
2008), could likely mediate some of the weak transient interactions between the mobile 
APC pool and the centrosome (Liu et al., 2009; Liu et al., 2010).  
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3.3S SUPPLEMENTARY 
 
Figure S3.1 Confirmation of newly cloned GFP-tagged APC constructs. APC334-
625, APC1-453 and APC1-625 were excised from a pCMV construct and inserted into a 
pEGFP vector (details see section 2.2.3). (A) Newly cloned GFP-tagged APC1-453 and 
APC1-625 was overexpressed (green) in HeLa cells. Ab7 mAb (red) (that only detected 
the N-terminus of APC) was used to detect APC however APC334-625 was unable to 
be confirmed using this method. (B) All cloned fragments were ectopically expressed in 
HeLa cells and cells were lysed using RIPA lysis buffer. 50 ug the total lysate was used 
for Western blot to confirm the correct size of the new clones. GFP-tagged proteins 
were detected using GFP rabbit antibody. The sizes shown in the figure indicated the 
correct sizes for each clone. β-actin was detected as loading control.  
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Figure S3.2 (Table) FRAP Summary of T1/2 and retention of APC-FL and APC1-
1309 at the centrosome. The analysis of fluorescence recovery of APC-FL and APC1-
1309 at the centrosome was measured using a combination of excel and algorithms 
from the Graph Pad Prism 5 program. The table shows values for centrosome retention 
and recovery rates of fast and slow population with and without treatment. In brief, HeLa 
cells were transfected with either GFP-tagged APC-FL or APC1-1309, co-transfected 
with RFP-PCNT-C241 as the centrosome marker. The GFP probe was bleached and 
the GFP fluorescence recovery was quantified using excel Graph Pad Prism 5 software. 
All fluorescence recovery curves fitted to a two-phase recovery curve producing two T1/2 
values (fast and slow). For more information of FRAP analysis refer to methods (see 
section 2.2.11.3).   
APC with 
treatments 
Mobile pool 
(%) 
Retained pool 
(%) 
T1/2  - Fast pool 
(s) 
T1/2  - Slow pool 
(s) 
APC-FL 86.23 13.77 2.77 25.58 
APC-FL 
+ noco 97.30 2.70 6.789 42.67 
APC-FL 
+ LMB 87.18 12.82 4.225 37.17 
APC1-1309 91.31 8.69 3.098 27.82 
APC1-1309 
+ noco 90.39 9.61 5.997 25.79 
APC1-1309 
+ LMB 92.77 7.23 4.262 23.61 
* Mobile/retained pools: plateaus reached on the curves were used to determine the 
distribution of mobile and retained pools measured by the % of maximum fluorescence 
recovery by the Graph Pad Prism 5 program.   
* Rate of recovery: The table indicates the speed of recovery of fluorescence for the  
two populations of APC at the centrosome. The fast population was measured from 
based on the recovery speed from the first 40 seconds, that is, T=0-40 s. The slow 
population was gathered over the 100 seconds measured, which was calculated by 
Graph Pad Prism 5.   
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Figure S3.3 The optimisation of nocodazole concentration for FRAP in HeLa cells. 
(A) Nocodazole concentrations of 10 µM and 33 µM were selected for testing. Time-
points of 15 min, 30 min and 60 min were tested in HeLa cells (A). β-tubulin (green) was 
used to mark MTs and γ-tubulin (red) for centrosomes. Treatment using 33 µM for 60 
min was optimal for the depolymerisation of MTs.  
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Figure S3.4 The optimisation of nocodazole used in cells with ectopic APC 
expression. GFP-tagged (A) APC-FL and (B) APC1-1309 were ectopically expressed 
(green) in HeLa cells for 48 h followed by nocodazole treatment using 33 µM for 1 h. To 
confirm whether MTs were sufficiently depolymerised in cells with overexpressed APC 
cells were fixed with methanol: acetone, followed by immunofluorescence. β-tubulin 
(red) was used to detect MTs. 33 µM for 1 h nocodazole was sufficient for MT 
depolymerisation.  
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Figure S3.5 The optimisation of LMB concentration for FRAP. (A) Rev-NES-GFP or 
Rev-GFP was ectopically expressed in HeLa cells, followed by the treatment of 5 ng/ml 
of LMB for 3 h. Cells were fixed using formalin followed by permeabolisation using 0.2% 
triton. (B) Cells were scored for Rev localisation in three categories, nucleus (N), 
nuclear-cytoplasmic (N/C) and cytoplasmic (C).  
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  CHAPTER 4 
 
A role for full-length APC 
in microtubule nucleation, 
elongation and 
stabilisation 
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SUMMARY OF CHAPTER 4 
 
Centrosomes require regulation throughout the cell cycle to control microtubule (MT) 
growth, centrosome number, and the timed separation of centrosomes at G2/M-phase. 
In this chapter, the potential roles of APC in these functions are explored. First, the rate 
of MT growth was meticulously analysed in cells at different time points after 
nocodazole-induced disruption of MT polymers (using the MT regrowth assay).  
Two important parameters to quantify MT growth were used: (1) the fluorescence 
intensity of α-tubulin at the aster core, and (2) the area of newly elongating MTs around 
the centrosome. In APC-depleted U2OS cells, rate of MT growth was significantly 
reduced compared with control, as evidenced by a decrease in core aster intensity and 
also the initial area of MT elongation. This delay in MT growth was observed even at 
later time-points up to 40 min, revealing a clear role for full-length APC (APC-FL) in MT 
nucleation and elongation in the cytoplasm. In SW480 (APC1-1337) colorectal cancer 
(CRC) cells, the rate of MT nucleation and elongation was stunted and was not further 
reduced by loss of mutant APC. However, the overexpression of APC-FL stimulated MT 
regrowth in the SW480 cells. Together, this data suggests that loss of the C-terminal 
half of APC contributes to a delay in MT nucleation, and this delay is perpetuated over 
time. Investigations indicated no significant role for APC in centrosome amplification or 
cohesion.  
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4.1 INTRODUCTION  
APC is involved in various MT-associated functions. It accumulates at MT plus-ends in 
live migrating Xenopus epithelial cells (Mimori-Kiyosue et al., 2000a), purified APC C-
terminal fragment have shown to promote the assembly of tubulin molecules in vitro 
(Munemitsu et al., 1994), and APC also facilitates polarised cell migration by stabilising 
MTs and cortical actin at the leading edge of cells (Watanabe et al., 2004). Despite 
knowledge of APC locating at the centrosome, the primary MT organising centre, it is 
still not known whether APC can regulate MTs there. Centrosome amplification and 
centrosome splitting have been linked to cancer (Fukasawa, 2005), and since APC is a 
multifunctional tumour suppressor protein, exploration in these areas could revolutionise 
our understanding of how APC might regulate MT and centrosome functions that could 
promote tumourigenesis.  
MTs undergo a constant interplay between polymerisation and catastrophe. MT 
polymerisation is an energy-dependent process that is stabilised by MT plus-end 
tracking proteins (TIPs) (Schuyler and Pellman, 2001; Tamura and Draviam, 2012). 
APC together with other TIP proteins such as CLIP170 facilitates the MT stabilisation 
process in mammals (Akhmanova and Steinmetz, 2010).  Stabilisation at MT ends is 
particularly important in CRC as deletion of the C-terminal MT associating domain of 
APC reduces MTs stability seen in PtK2 cells  (Zumbrunn et al., 2001). Early 
observations by immunofluorescence microscopy showed that APC-FL co-localised with 
cytoplasmic MTs and with some staining emanating from what is thought to be the 
centrosome when overexpressed, however the APC1-1309 showed a more diffused 
cytoplasmic staining in RKO (colorectal) and NIH3T3 (mouse fibroblast) cells (Smith et 
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al., 1994). Unfortunately, observations were based only on snapshot images and the 
study lacked comprehensive quantification to define any role of APC on the rate of MT 
growth. However, in later studies APC was found to decorate MTs and was suggested 
to stabilise them in various phases of MT growth (Kita et al., 2006; Zhou et al., 2004). 
More interestingly, in live and fixed mouse fibroblasts and MDCK cells, endogenous 
APC decorates MT plus ends despite the loss of EB1 expression by siRNA treatment 
(Kita et al., 2006). By comparing APC decorated and APC non-decorated MTs using 
duo-colour tracking, APC was found to associate with TIPs and is present at all phases 
of MT catastrophe and rescue. Furthermore, by measuring the distance travelled by the 
MTs through time,  those decorated with APC spend more time in growth phase and are 
more resistant to shortening showing that APC can stabilise their growth (Kita et al., 
2006).  
APC can directly affect MT dynamics in vitro. A study using cytostatic factors 
(CSF) of Xenopus laevis extracts show that the depletion of APC reduced MT density in 
mitosis, and the re-addition of APC-FL was able to rescue this defect. Isolated 
centrosomes with depleted APC in metaphase meiosis II of arrested cells also showed 
a reduction in aster size based on pixel density measurements (Dikovskaya et al., 2004) 
The overexpression of an APC sequence (1015-2843) containing the MT-binding basic 
domain was able to rescue the reduction in robust spindle formation. Similarly, in an in 
vitro assay using rhodamine-conjugated tubulin, the addition of purified APC peptides 
containing the APC-basic domain (APC2130-2843) produced strong branching of MT 
arrays (Munemitsu et al., 1994). The interpretation of these experiments is limited due 
to their use of in vitro assays which may not be an accurate depiction of physiological 
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conditions. The experiments described used purified tubulin, isolated centrosomes and 
more importantly the experiments were performed in Xenopus laevis extracts, yeast or 
sf9 insect cells, rather than in human cells. Moreover, the majority of such studies have 
focused on the role of APC in mitotic cells, rather than interphase cells. 
 Different studies suggest that when APC is truncated, as it is in CRC cells, MT 
stabilisation is impaired. For instance, Nakamura and colleagues showed that 
overexpression of a the APC C-terminal EB1 binding domain in SW480 CRC cells 
promoted MT aster formation (Nakamura et al., 2001), although how this occurred 
through competition of APC-EB1 interaction is unclear. However, MT nucleation, aster 
formation, and extension are highly dynamic processes and to study it requires various 
measurements to form an objective conclusion (Job et al., 2003; Kollman et al., 2011; 
Pereira and Schiebel, 1997; Wiese and Zheng, 2006). Therefore, the direct impact of 
APC on MT formation in vivo remains indistinct and warrants a comprehensive analysis.    
APC mutations have been shown to directly cause chromosome instability (CIN) 
as a result of merotelic MT attachments to kinetochores and spindle orientation in CRC 
cell lines and APC +/- min cells (Caldwell et al., 2007; Green and Kaplan, 2003; Tighe et 
al., 2004). However, both mitotic defects can arise prior to mitosis. For example, spindle 
mis-orientation can stem from inadequate centrosome separation after interphase which 
has been shown to influence the position of resultant daughter cells after division 
(Pease and Tirnauer, 2011).  The presence of supernumerary centrosomes also 
contributes to the CIN phenotype, as seen in most cancer cells (Leber et al., 2010). In 
HEK293 cells, the destabilisation of astral MTs by the knockdown of APC, or 
transfection of a dominant-negative fragment of APC results in significant spindle mis-
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orientation (Green et al., 2005; Schuyler and Pellman, 2001). Finally, as a substrate of 
bub kinases, which are negative regulators of centrosome over-duplication (Kaplan et 
al., 2001), APC could also serve a role in centrosome cohesion or control of over-
duplication (amplification) (see section 1.5.4).  
In chapter 4, we clarify the significance of both APC-FL and APC1-1309 mutant 
in the nucleation and stabilisation of MTs in vivo using a range of measurements. We 
also investigate the possible participation of APC in centrosome cohesion and 
amplification.   
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4.2 MATERIALS & METHODS  
4.2.1 Cell Culture and transfection  
Human cancer cell lines U2OS and SW480 were cultured in supplemented Dulbecco’s 
modified Eagle’s medium (DMEM) (see section 2.2.4.2).  For fixed cell experiments 
used for fluorescence microscopy cells were seeded onto coverslips in 6-wells plates, 
on to coverslips. At 16 h after seeding, cells were transfected with 2 µg of APC targeting 
siRNA (siAPC-d or siAPC-2) using Lipofectamine 2000 transfection reagent (see 
section 2.2.4.4). Both siRNAs were previously optimised in these cell lines in the 
Henderson lab are have proven specific for APC silencing (Brocardo and Henderson, 
2008). In experiment to analyse MT regrowth, centrosome amplification and centrosome 
splitting, cells were grown to around 80-90% confluence before fixation (see section 
4.2.3).  
4.2.2 Plasmids 
All plasmids used in this chapter are detailed in materials and methods section (Table 
2.6). 
4.2.3 Immunofluorescence microscopy 
Immunostaining of MTs and centrosome was performed as previously described in 
section 2.2.6.2 using the following primary antibodies: mouse mAb α-tubulin for MTs; 
rabbit poly-Ab or mouse mAb γ-tubulin; and either rabbit poly-Ab APC-NT or rabbit poly-
Ab H290 for staining APC (see Table 2.3 for dilutions). Slides were observed and 
optical z-sections (3 x 0.75 µM) were imaged using Olympus FV1000 confocal 
microscope at 60X magnification as described in section 2.2.6.3. Analysis of 
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fluorescence pixel intensity, area and centrosome distance was performed using the 
Olympus Fluoview Version 1.6a software. Measurements were compared between cells 
transfected with control siRNA or siRNA targeting APC. For each experiment, an 
average score was obtained from over three individual experiments, and at least 100 
cells were scored for each treatment condition. 
4.2.4 Microtubule regrowth assay 
Details of the MT regrowth assay are detailed in section 2.2.10.1. The student t-test was 
used to compare between treatments of siRNA for all measurements outlined below. 
The standard of measurements was adapted from various papers in the literature (see 
Table 2.13) and acts as the general way of quantifying various stages of MT regrowth. 
4.2.4.1 Aster formation 
Aster formation is the measurement of MT nucleation and initial MT anchoring to 
centrosomes. To measure aster formation, the confocal Olympus Fluoview Version 1.6a 
software was used to measure fluorescence intensity. Method of measurement was 
standardised to measure only the centre of the aster (using the circle tool), here after 
known as the “aster core”, that is, when the aster has not yet spouted any elongation of 
MTs. This is because the core intensity is reduced at the onset of MT elongation and 
measurements will no longer be accurate. To account for staining variations, 
fluorescence intensity of the image background and the cell cytoplasm was also 
collected for each cell as an internal control. Average intensity measurements were 
pooled together from over five experiments and student t-test was used for statistical 
analysis.  
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4.2.4.2 Microtubule elongation 
MT elongation is usually measured at later time-points that occurs after the aster 
formation. To measure the elongation rate of MTs, the confocal Olympus Fluoview 
Version 1.6a software was used to measure the area (µm2) of elongation using the 
“polygon tool” to select area of the aster since the radial aster may not be circular in 
shape. Optical z-sections were collected and flattened using the confocal program to 
gauge the most accurate measurement of MT elongation that radiate outwards from the 
centrosome. To account for the variation in the degree of APC knockdown, that causes 
MT areas to become heterogeneous, the area size were subdivided into groups to 
detect changes in area size. ANOVA was used to assess the statistical significance 
between conditions. 
4.2.4.3 Microtubule anchorage “long term” 
MT anchorage is measured by assessing the morphology of the radial MTs attached to 
the centrosome after nocodazole washout for an extended amount of time (~40 min). 
These can be classified as either “focussed” (where MTs converge at the centrosome) 
or “diffused” (where MTs become scattered with no attachments to the centrosome).  
4.2.4.4 Microtubule stabilisation   
To assess if MT stabilisation or re-polymerisation in the cytoplasm are affected by MT 
regrowth at the centrosome after the knockdown of APC, cells were fixed at 40 min after 
nocodazole washout. The morphology of the MTs in the cytoplasm was identified by the 
formation of either a structural network (stabilised), or the MTs remained diffused in the 
cytoplasm with a “grainy” appearance (depolymerised).  
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4.2.5 Centrosome amplification assay 
To analyse the effect of siRNA knockdown of APC to regulate centrosome duplication, 
cancer cell line U2OS was first transfected with the specific siRNA (as described in 
section 2.2.4.4). γ-tubulin was used for immunostaining (see section 2.2.10.2). The 
number of individual centrosomes were scored per cell and compared between 
conditions 
4.2.6 Centrosome splitting assay 
Asynchronous U2OS cells were plated and transfected on coverslips for 48-72 h with 
either control siRNA or APC targeting siRNA (siAPC-d) before fixation with methanol: 
acetone and processed for immunofluorescence staining. Centrosomes were detected 
with γ-tubulin antibody. Cross-sectional images were acquired using 60X objective via 
confocal microscopy and the distance between centrosomes were measured using the 
confocal Olympus Fluoview Version 1.6a software. The percentage of cells showing 
splitting was determined in cells containing two well-defined γ-tubulin-marked 
centrosomes and the distance between them was measured. Following a previous 
study, the threshold for U2OS to be classified as split was 2 µm (Bahe et al., 2005; 
Hadjihannas et al., 2010). Only cells in interphase were scored and all mitotic cells, 
indicated by the formation of mitotic spindle network were not scored. Measurements 
were collected from three independent experiments with over 100 cells was measured.  
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4.3 RESULTS  
4.3.1 Colorectal cancer cells with mutant APC have a slower rate of 
microtubule nucleation 
APC associates with MTs directly via its C-terminal basic domain that bundles MTs, and 
indirectly through its N-terminal ARM domain that facilitates binding to kinesins and 
plus-end directed transport (Jimbo et al., 2002; Munemitsu et al., 1994). However, the 
role of APC in MT nucleation and growth from the centrosome has not been explored. In 
order to investigate the influence of APC on MT nucleation, a well established and 
widely used MT regrowth assay was employed (outlined in Fig. 4.1). Cancer cells were 
treated with 33 µM nocodazole for 1 h at 37oC followed by a washout using fresh DMEM 
media supplemented with fetal bovine serum (see sections 2.2.10.1 and 4.2.4). Cells 
were allowed to grow at room temperature (25oC) and fixed with methanol: acetone at 
various time-points to capture each stage of MT growth, which are subsequently 
explained in more detail throughout the chapter. Methods to study MT nucleation vary 
broadly, and the method used here was adapted from previous papers studying Wnt 
proteins (Fumoto et al., 2009; Huang et al., 2007; Louie et al., 2004) (see also Table 
2.13). Several parameters were meticulously optimised over a period of months prior to 
testing, including the temperature for MT regrowth and the best time-points to detect MT 
elongation (Fig. S4.1-S4.3). The MT growth process, subdivided here into (i) aster 
formation (after initial MT nucleation), and (ii) elongation (including stabilisation) and (iii) 
long-term MT anchorage was studied in U2OS and SW480 cells.   
The MT regrowth assay was performed on both cell lines in parallel to directly 
compare rates of growth. Cells were fixed at 2 min and 5 min to capture MT nucleation 
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and aster formation. Series of optical z-sections were taken using the Olympus FV1000 
confocal microscope. Cell images were used to measure the fluorescence intensity of 
the aster core (defined as the area at the centre of aster where α-tubulin monomers first 
accumulate, but prior to the extension of astral MTs) (see Fig. 4.1) using γ-tubulin as a 
marker for the centrosome. In U2OS cells, MT nucleation occurred at 2 min after 
release from nocodazole, as indicated by detection of α-tubulin within the centrosome 
area, and MTs then expanded to a full and robust aster by 5 min (Fig. 4.2A). The MT 
growth  was  quantified  by  measuring  the  fluorescence intensity of α-tubulin (red). In  
 
Figure 4.1 Schematic summary of the microtubule (MT) regrowth assay. U2OS 
cells are first treated with 33 µM of nocodazole for 1 h to depolymerise MTs followed by 
a washout using drug-free DMEM media. Cells are then supplemented with fresh media 
and incubated at room temperature for durations of 5-10 min to detect MT aster 
formation. Longer time-points of 15-25 min are used to detect MT elongation. Cells are 
then fixed with methanol:acetone and stained with antibodies against α-tubulin (red) to 
detect MTs and γ-tubulin (green) to mark centrosomes. Optical z-sections are taken 
using a confocal microscope to evaluate fluorescence intensity of the aster core (yellow 
dashed line at ‘aster formation’) and the area of MT growth during elongation (yellow 
dashed line at ‘elongation’), as shown.  
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Figure 4.2 MTs grow slower in SW480 than in U2OS cells. (A) MT regrowth assay 
was performed on U2OS (APC-FL) and SW480 (APC1-1337) cells. Cells were fixed at 2 
min and 5 min after nocodazole washout. Immunofluorescence microscopy was used to 
detect MTs (α-tubulin in red) and centrosomes (γ-tubulin in green). (B) Optical z-
sections of cells were captured by confocal microscopy. Fluorescence intensity of α-
tubulin at the centrosome was analysed using Olympus FV-10 software at 2 min and 5 
min post-washout, to determine the degree of core aster formation. MT aster formation 
was slower in SW480 cells than in U2OS cells. More than 100 centrosomes (mean ± 
SD) were measured from three independent experiments. Student’s t-test revealed that 
the difference between U2OS and SW480 cells is statistically significant at both time-
points.  
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contrast, no aster formation was detectable in SW480 at 2 min and only a low level was 
observed at 5 min after nocodazole washout (Fig. 4.2A). The aster intensity at both 
early time-points was significantly higher in U2OS than in SW480 cells (P<0.0001) (Fig. 
4.2B). Thus, the centrosome-based accumulation of -tubulin monomers required for 
MT nucleation and assembly appears to be impaired in APC1-1337 SW480 cells. 
4.3.2 Full-length APC contributes to microtubule nucleation at the 
centrosome 
The CRC cell line SW480 expresses the truncated APC1-1337, however it also 
harbours several other gene mutations that might impede MT nucleation including p53 
(Rodrigues et al., 1990). To address the role of APC in this process, an APC targeting 
siRNA was used to silence the APC gene before the MT regrowth assay was 
performed.  Cells were transfected with a control siRNA (siCTRL) and APC siRNAs 
(siAPC-d or APC-2) for 72 h (see supplementary Fig. S4.6). Cells were treated with 33 
µM of nocodazole for 1 h followed by a washout with drug-free media. Here, MTs were 
allowed to grow for 2 min and 5 min in both U2OS and SW480 cells and revealed a two- 
fold reduction in the early stage of aster formation (optimisation see Figs. S4.2 and 
S4.3). Methanol: acetone was used to fix cells before immunofluorescence microscopy 
was carried out. In this experiment cells were immunostained to identify cells where 
APC (green) was silenced using APC-NT polyclonal antibody (gift from Dr M Faux’s 
group) for optimisation see Fig. S4.4), and those cells were assessed for MT aster 
formation by staining of α-tubulin (red) (see Fig. 4.3A). Cells with little APC depletion 
after APC siRNA treatment were not measured. For accuracy and consistency, only the 
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Figure 4.3 Knockdown of APC reduces the rate of initial MT accumulation (aster 
formation) at the centrosome. (A) U2OS cells were transfected with CTRL siRNA and 
siRNA specific for APC (siAPC-d) for 72 h. Cells were treated with 33 M nocodazole 
for 1 h and aster regrowth was allowed for ~5 min for U2OS and ~10 min for SW480 
cells.  Cells were stained for APC (APC-NT poly-Ab; green) and α-tubulin (red). 
Confocal images were taken using the Olympus FV1000 confocal microscope. (B) 
Representative Western blot analysis to confirm that quality of APC depletion in one 
experiment in U2OS and SW480 cells. Ab1 mouse mAb was used to detect APC, with 
vinculin rabbit poly-Ab was used as loading control (C,D) Graphs represent 
fluorescence intensity mesurements of the aster core after APC depletion in U2OS and 
SW480 cells. Only cells with visible APC knockdown were quantified and fluorescence 
intensity was measured using the FV-10 program. (C) U2OS cells transfected with APC 
siRNA (n=152) showed a reduction in MT aster formation after nocodazole release 
compared to CTRL siRNA (n=94). Results were pooled from over three independent 
experiments. (D) SW480 cells show not differences in aster formation after APC 
depletion. The concentration of α-tubulin was signficiantly reduced in U2OS (P=0.0082).  
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asters overlapping the nucleus (area without staining) were measured to avoid 
background interference. In parallel, the efficiency of APC silencing by siRNA was 
validated by Western blot analysis, using vinculin as a loading control (Fig. 4.3B). MT 
asters were measured for fluorescence intensity (as outlined in Fig. 4.1), and the size of 
aster formation was found to be reduced in U2OS cells after silencing APC-FL as 
shown by the three-fold reduction in intensity of α-tubulin (P=0.0082) (Fig. 4.3C) (also 
see Fig. S4.6). In contrast, in SW480 cells treated with siAPC to knock down the mutant 
APC there was no significant difference in the fluorescence intensity of the aster core 
measured when compared with control (p=0.8727) (Fig. 4.3D). This result shows that 
APC-FL contributes to the very earliest stage of MT formation at the centrosome, and 
suggests that the C-terminal half of APC may be important in promoting the rate of α-
tubulin assembly or MT nucleation at centrosomes. Moreover, the reduction in aster 
formation observed in U2OS cells after silencing APC is likely to be an underestimate, 
because while the majority of APC is reduced, the full depletion of APC at the 
centrosome where it normally accumulates is partial.  
4.3.3 Microtubule elongation is generally slower in SW480 cells.  
If MT nucleation is intrinsically delayed in SW480 compared to U2OS, one would 
assume that this hindering will continue as MTs extend in the process of elongation 
(refer also to Fig. 4.1). However this is difficult to predict since both MT nucleation/aster 
formation and elongation are intricately regulated in different ways (Bornens, 2002; 
Delgehyr et al., 2005). MTs are first nucleated by the γ-tubulin ring complex (γ-tuRC) 
and the negative ends of MTs are anchored which precedes elongation/extension (for 
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Figure 4.4 MT elongation is slower in SW480 than U2OS. (A) MT regrowth assay 
was performed using U2OS and SW480 cells and cells were fixed at 10 min and 20 min 
time-points after nocodazole washout. Immunofluorescence microscopy was used to 
stain for MTs (α-tubulin in red) and centrosomes (γ-tubulin in green).  Optical z-sections 
of cells were imaged by confocal microscopy. (B) The area of extended MTs was 
analysed using Olympus FV-10 software. The graph shows an average of data scored 
from more than 100 centrosomes (mean ± SD) measured from three independent 
experiments. In SW480 cells the MTs extend over lower average area compared to 
U2OS cells at the same time-points. Student’s t-test revealed that the difference 
between U2OS and SW480 cells is statistically significant.  
details of process see also sections 1.3.1 and 1.3.2.3). During elongation the MTs 
extend outward as they polymerise and this process also requires stabilisation. APC is a 
known MT TIP protein capable of stabilising MTs at cortical regions of the cell (de 
Forges et al., 2012; Kaverina and Straube, 2011). Here we explore its role in MT 
elongation and how it might promote and stabilise MTs during this initial phase of the 
MT assembly.  
 The intrinsic rates of MT elongation were compared in a similar way to that for 
the rates of MT aster formation (Fig. 4.2). The MT regrowth assay was performed in 
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U2OS and SW480 cell lines in parallel where elongated MTs are captured at 10 to 20 
min after nocodazole washout. The MTs extend radially outwards from the centrosome 
in 3D space, therefore, optical z-sections (3 x slices of 0.75 M thick) were taken using 
confocal microscopy (Fig. 4.4A). Z-planes were then flattened and the area of MT 
extension surrounding the centrosome was measured in µm2. Measurements were only 
performed on elongated MTs overlapping the nucleus for accuracy. Over 100 cells were 
measured in three independent experiments. The area of extended MTs was on 
average significantly lower in SW480 than in U2OS cells at both time-points (P=0.0001) 
(Fig. 4.4). Since the cells were untreated, the area was quite consistent in each cell 
population and between experiments (Fig. 4.4B). This result indicates that MT 
elongation is intrinsically slower in SW480 (APC1-1337) than U2OS (APC-FL) cells.  
4.3.4 Full-length APC stimulates microtubule elongation  
APC depletion reduced the rate of MT aster formation in U2OS cells (Fig. 4.3), and here 
it was determined whether this effect extended to MT elongation at later time-points. 
Control and APC-specific siRNAs (siCTRL, siAPC-d or siAPC-2) were transfected in 
U2OS and SW480 cells which were processed 72 h later for the nocodazole MT 
regrowth assay. U2OS cells were fixed at 15 to 20 min after nocodazole washout to 
assess the degree of MT elongation, whereas due to their slower rate of MT growth, 
SW480 cells were fixed at 20 to 25 min after drug release (see Fig. 4.5A). Optical z-
sections of cells (0.75 um x 3) were again acquired by confocal microscopy to measure 
the change in area of extended MTs. To account for possible variability in APC 
depletion  levels   that  could  directly  affect  MT  elongation  measurements,  the  cells 
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Figure 4.5 Knockdown of APC delays the regrowth of MTs after nocodazole 
washout. Cells were transfected with siCTRL and siAPC-d for 72 h. MT regrowth assay 
was performed in U2OS and SW480 cells by treating with 33 µM nocodazole for 1 h at 
37oC. To capture MT elongation cells were fixed at 15 min and 20 min after washing out 
with drug-free media for U2OS and SW480, respectively. Immunofluorescence 
microscopy was used to detect MTs using α-tubulin mAb (red) and γ-tubulin poly-Ab 
(green) for centrosomes. Optical z-sections of cells were imaged by confocal 
microscopy and the area of elongated MTs was measured using Olympus FV-10 
software. (B-C) The area measured per cell was categorized into groups to observe a 
trend shift in area size. More than 100 centrosomes (mean ± S.D) were measured from 
three independent experiments. Repeated measures of ANOVA revealed that the 
difference between control and in APC depleted U2OS cells, but not in SW480 is 
statistically significant (P<0.0001).  
measured were grouped by area, ie. cells with MT area of less than 60 µm2 up to >120 
µm2. This method of data presentation was used previously (Louie et al., 2004). In this 
way, any shift in the level of MT regrowth could be detected within populations of cells. 
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The results of the MT regrowth assay were intriguing. In U2OS cells transfected with 
siCTRL, a majority of the population displayed a robust rate of MT regrowth with ~50% 
of cells showing an MT area >80 µm2 (Fig. 4.5B). In contrast, in cells transfected with 
siAPC, most MT elongation was stunted and in >80% of cells the MTs did not extend 
beyond an area of 60 µm2 (P<0.0001). Examination of SW480 cells revealed no 
significant change in MT area after silencing the mutant APC  (Fig. 4.5C). These 
findings were confirmed by the use of another APC-specific siRNA (APC-2, see 
supplementary Fig. S4.6). Hence, MT elongation was significantly delayed  after 
depletion of APC-FL, but not mutant APC(1-1337), indicating that the C-terminus of 
APC is important also in MT elongation.  
4.3.5 Reconstitution of full-length APC rescues the microtubule 
nucleation defect in SW480 colorectal cancer cells 
Since APC-FL indeed regulates MT nucleation and elongation, an experiment was 
performed to determine if the reintroduction of APC-FL into SW480 cells, that only 
express a truncated mutant APC, increases the rate of MT growth. To test this, pCMV-
APC-FL was transiently overexpressed in SW480 cells. An APC anti-rabbit poly-Ab 
(H290; Santa Cruz) was used to locate transfected cells (ectopic APC was clearly 
detected in the cytoplasm and at centrosomes and membrane, readily distinguishing it 
from endogenous mutant APC) and α-tubulin mAb was used to detect MTs. Cells were 
treated for 1 h with 33 M nocodazole and then released into drug-free medium, and 
MTs were allowed to regrow for 15 to 25 min to detect elongation. Only moderately 
transfected cells were measured because an overexpression of truncated APC mutant 
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Figure 4.6 Reconstitution of APC-FL into SW480 cells increases the rate of 
regrowth of MTs. pCMV-APC-FL plasmid was transfected into SW480 cells and 
expressed for 48 h prior to nocodazole treatment and washout. MT regrowth assay was 
performed at later time-points (~15-20 min) to measure the area of MT regrowth in 
transfected and non-transfected cells. (A) APC transfected cells were stained in green 
and MTs (red) where stained using -tubulin. Trransfected cells were detected using 
H290 rabbit poly-Ab that is specific for APC (green). Optical z-sections of cell images 
were acquired with the confocal microscope. (B) The area of MT elongation was 
measured using  Olympus FV-10 software and placed in groups of area size comparing 
moderately transfected cells and untransfected cells (see section 4.2.2.2 for methods of 
measurement). More than 50 cells transfected cells were analysed per condition over 
three independent Repeated measures of ANOVA revealed that the difference between 
control and in APC depleted U2OS cells (P<0.0001). 
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Figure 4.7 Delay in MT stabilisation in APC siRNA U2OS cells after 40 min 
regrowth.  U2OS cells transfected with APC siRNA and siCTRL were treated with 33 
M of nocodazole for 1h and analysed after 40 min from washout (A) MTs were 
detected with α-tubulin(green) and centrosomes probed with γ-tubulin (red). 
Representative images show stabilised morphology (red circle) and non-stabilised MTs 
(white circle).  Z-stack confocal images were acquired (B) Cells were scored for 
stabilised or non-stabilised MT network in the cytoplasm. as shown in panel A.  More 
than 100 cells were scored over three independent experiments (mean ± S.D) 
(P<0.0001). 
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has been shown in previous papers to have a dominant negative effect, possibly from 
competing out the endogenous protein and inhibiting regular functions when 
overexpressed (Dihlmann et al., 1999; Green et al., 2005). Indeed, in cells with highly 
overexpressed APC-FL, minimal MT elongation was detected (data not shown). In 
untransfected SW480 cells, the majority of cells displayed MT growth  corresponding to 
an area of 60-120 µm2 with only ~22% of cells extending their MTs to an area of >120 
µm2 (Fig. 4.6B). However, when APC-FL was introduced into SW480 cells to restore 
APC-FL functions, the pattern of MT elongation shifted and more than 50% of cells 
displayed MT elongation in the higher range >120 µm2. This result not only confirms that 
APC-FL promotes MT elongation, but provides evidence that the primary MT 
nucleation/elongation defect in SW480 cells is at least partly caused by mutation of the 
APC gene and its protein product.  
4.3.6 Loss of full-length APC disrupts de novo assembly of 
microtubule network 
APC is known to stabilise MT polymers (Mimori-Kiyosue et al., 2000b; Zumbrunn et al., 
2001) and, we have shown above for the first time in interphase cells, is also important 
for nucleation and elongation of nascent MTs. To determine how the loss of APC 
impacts on the assembly of newly synthesised MTs at 40 min after release from 
nocodazole-induced depolymerisation, a MT regrowth assay was performed in cells 
transfected with control or APC siRNAs. The morphology of the cytoplasmic MTs was 
scored as either stabilised (Fig. 4.7A - red circle) or not stabilised (Fig. 4.7A - white 
circle). As shown in Fig. 4.7, the knockdown of APC reduced the frequency of assembly 
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of mature MT networks by 50% compared to control cells. The most likely explanation 
for the impairment of MT network formation in APC-silenced cells is a combination of 
delays in MT nucleation/elongation at the centrosome and a reduced stabilisation of the 
MTs that do form.   
4.3.7 APC depletion does not affect microtubule anchorage at the 
centrosome.  
MTs nucleated from the centrosome require constant anchorage to create radial polarity 
for appropriate extension to the membrane. Proteins such as ninein and dynein have 
been shown to support this process (Burakov et al., 2008; Mogensen et al., 2000). Our 
interest was to test if APC facilitates this process since it is capable of regulating MT 
growth. Centering on the attachment of grown “mature” MTs (observed as converging 
MT arrays) at the centrosome, the morphology of the MTs was scored as either 
“focused” or “diffuse” as classified in other papers (Huang et al., 2007; Louie et al., 
2004). U2OS cells were first transfected with either siCTRL or siAPC, and anchorage 
was observed in untreated cells and in cells treated with nocodazole and fixed after 40 
min washout (Fig. 4.8A).  In either case, and scoring only those cells with a mature MT 
network, the loss of APC was found to have no effect on the centrosome anchorage of 
MTs (Fig. 4.8B and C).  
4.3.8 APC does not regulate centrosome number.  
Centrosome amplification is often found in cancer cells. In normal cells, there is one 
centrosome in G1 and it is duplicated into two in S-phase, remaining as a pair through 
the rest of the cell cycle.  Centrosome  amplification  is defined  as when there is more 
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Figure 4.8 Long-term anchorage of MTs are unaffected by APC knockdown. (A) 
U2OS cells were transfected with control or APC siRNA and were either treated with the 
nocodazole or untreated. Immunofluorescence microscopy was used for MTs (green) 
detection using α-tubulin , and γ-tubulin for centrosomes (red), and DAPI dye for nuclei 
(blue). Regrowth was analysed after 40 min after washout by scoring for MT long-term 
anchorage at the centrosome where “focussed” (anchored) MTs were scored as 
positive, and “diffused” (unanchored) scored as negative. To test if APC is involved in 
long-term anchorage, cells depleted of APC was scored in untreated cells (B), as well 
as with nocodazole treatment and regrowth after 40 min. Over 100 cells was scored in 
three independent experiments (mean ± SD).  
than two centrosomes found. This occurs when there is DNA damage or centrosomes 
are misregulated (Saladino et al., 2009). Therefore, a potential role of APC in controlling 
centrosome amplification was evaluated. U2OS cells were transfected with either 
control or APC siRNA for 48 h. Cells were fixed with methanol: acetone, and stained for 
APC and centrosomes. Over 500 cells were scored and each score was categorised 
into groups into either 1, 2, 3, 4, and 5 or more centrosomes (eg. 20% of scored cells in 
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Figure 4.9 APC does not regulate centrosome number. (A) U2OS cells were 
transfected with either control or APC-targeting siRNA for 72 h, and then fixed with 
acetone: methanol (1:1).  Cells were stained with γ-tubulin to visualise centrosomes. (B) 
The number of centrosomes in each cell were scored from five independent 
experiments (n=500) (% ± SD).  
both siCTRL and siAPC contained only one centrosome; 65-70% of cells contained a 
centrosome pair and 20% contained one centrosome) (Fig. 4.9). When APC was 
silenced, there was no significant change to the number of centrosomes among the cell  
population, with only 10% containing more than three centrosomes. Thus APC does not 
seem to regulate centrosome amplification.  
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4.3.9 APC does not regulate centrosome cohesion in interphase 
Centrosome separation just before the onset of mitosis is important for chromosome 
fidelity, and is a highly co-ordinated process. If the spindle poles separate too late, for 
example before nuclear envelope breakdown, then there is a higher rate of kinetochore 
mis-attachments and chromosome mis-segregation (Silkworth et al., 2012). Centrosome 
splitting occurs when there is increased distance between parental centrioles in 
interphase cells due to decreased cohesion (Meraldi and Nigg, 2001). The truncation of 
APC is known to cause merotelic spindle-kinetochore attachments, described as 
“weakened” (Green and Kaplan, 2003). In this study, the method to study centrosome 
separation in U2OS was adapted from Matsuo and colleagues (Matsuo et al., 2010).  
Duplicated centrosomes in interphase can “split” when their cohesion is mis-regulated. 
To assess if APC contributes to the regulation of centrosome cohesion in interphase, 
U2OS cells were treated with siCTRL or siAPC-d for 72 h. Cells were fixed with 
methanol:acetone, and stained for γ-tubulin to mark the centrosomes. To check the 
knockdown of APC, cells were also co-stained with Ab7 mAb for APC. Distances of 3 
µm or more prior to mitosis is regarded as increased centrosome separation. Over 300 
centrosome pairs was scored for distance (µm) using Olympus FV-1000 confocal 
software version 1.6a. When APC was silenced, there was no significant change in 
centrosome distance (Fig. 4.10), indicating that APC does not affect centrosome 
separation in interphase cells.   
Chapter 4 
193 | P a g e  
 
 
Figure 4.10 Centrosome splitting after APC knockdown. (A) U2OS cells were 
transfected with either control or APC targeting siRNA for 72 h. Centrosomes were 
stained with γ-tubulin to mark centrosomes. Images were taken by confocal microscopy. 
(B) The distance between duplicated centrosomes was measured in asynchronous 
cells. Data was compiled from more than three independent experiments with n=248 for 
control and n=271 in APC depleted cells. Measurements were pooled and separated 
into 3 groups based on distance. < 3 m was considered as normal and >12 m was 
either classified as a split centrosome or moving towards mitosis.  
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4.4 DISCUSSION  
The previous chapter illustrated that both APC-FL and APC1-1309 are dynamic at the 
centrosome and rapidly exchange with the cytoplasmic pool, suggesting a regulatory 
function more than a structural role. APC mutations have been linked to defects at 
mitotic spindles (Green and Kaplan, 2003; Kaplan et al., 2001). In this chapter, we 
endeavour to find the role that APC plays in interphase centrosomes and test if the 
truncation of APC impacts on the regulation of MTs, centrosome number or centrosome 
cohesion, all of which have been linked to cancer when mis-regulated (Fukasawa, 2005; 
Nigg and Stearns, 2011).  
There are several lines of evidence in the literature that suggest, but do not 
demonstrate, that APC might regulate MT growth at the centrosome of interphase cells. 
Firstly, APC is known to bind and stabilise MT polymers as shown by time-lapse 
confocal imaging of APC localising to polymerising MTs at cell membrane protrusions, 
and dissociating during MT catastrophe in interphase MDCK cells (Kita et al., 2006). 
Secondly, the C-terminus of APC promotes MT polymerisation in vitro. In a yeast 
biochemical assay, the mixture of purified tubulin subunits,  his-tagged APC2560-2843 
(the EB1 binding domain) and GST-tagged EB1 protein elicited a significant increase in 
turbidity within 10 min of incubation, indicative of MT polymerisation (Nakamura et al., 
2001). In fact, APC is particularly important in promoting the formation of robust mitotic 
spindles. The depletion of APC by APC-targeted antibody in Xenopus laevis cystostatic 
factor (CSF) egg extracts was reported to reduce the length and intensity (measured by 
average pixel density) of spindles formed (Dikovskaya et al., 2004). While the study 
demonstrated a role for APC in MT nucleation from mitotic centrosomes, its contribution 
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to MT growth from interphase centrosomes is by no means clear. Moreover, the fact 
that APC centrosome dynamics is very different at interphase than during mitosis (see 
Chapter 3) means that only clear experimental testing could answer this question.   
The growth of MTs originating from the centrosome can be broken down into two 
early phases: (1) MT nucleation/initial anchorage and (2) MT elongation (Fig. 4.11), 
followed subsequently by long-term anchorage of the mature elongated MTs. The 
participation of APC in the initial stages was examined separately here in detail.  
Role of APC in microtubule nucleation  
MT nucleation refers to the de novo formation of MTs usually initiated by γ-tuRCs that 
comprises of subunits called “γ-tubulin complex proteins” (GCPs) and γ-tubulin. At the 
centrosome, these complexes anchor MTs by stabilising the MT minus end, allowing the 
accumulation of α-tubulin and β-tubulin heterodimers to form an “aster”. The continued 
addition of tubulin monomers (polymerisation) can be observed by microscopy as the 
radial MT extends from the centrosome, otherwise known as “elongation” (Job et al., 
2003; Kollman et al., 2011; Wiese and Zheng, 2006) (also see section 1.4.2). Previous 
studies of MT nucleation (eg. Dikovskaya et al. 2004) were limited to experiments 
performed in non-human extracts and mitotic spindles and cannot be translated to the 
function of APC in interphase centrosomes (Dikovskaya et al., 2004). Moreover, in vitro 
studies do not account for physiological occurrences; for example, spontaneous MT 
polymerisation can occur at cellular sites with high concentrations of tubulin molecules 
other than at the centrosome (Kellogg et al., 1994; Mogensen et al., 2000; Zheng et al., 
1995). 
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Figure 4.11 Chapter 4 summary model. Model of the role of APC in the process of MT 
nucleation. APC-FL is able to efficiently stimulate MT growth by either interaction with 
proteins important in MT nucleation (see Chapter 5 and 7), or possibly stabilising MTs 
from the point of aster formation to elongation and eventual stabilisation of the network. 
While APC is imperative to the MT growth, when APC is truncated the mutant loses its 
ability to efficiently regulate the MT growth process leaving a consistent delay in MT 
formation.  
 
In the case of interphase, a previous study reported a contribution of the APC C-
terminal sequence, when overexpressed, to MT growth, however the scoring system 
lacked rigorous controls. A measurement of 5 µm of MT extension was used to score if 
asters were formed and were simply classified as yes or no, however MT asters form 
radially in 3D space and are not necessarily symmetrical (Nakamura et al., 2001). It is 
therefore difficult to accurately predict the effects of APC on aster growth without 
information on the z-plane. To ascertain the role of APC in MT nucleation and aster 
formation, the MT regrowth assay was performed in both U2OS and SW480 cells 
depleted of APC-FL and APC1-1337, respectively. MT regrowth was terminated by 
fixation at the early time-points of 2 min and 5 min for U2OS cells, and 5 min and 10 min 
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in SW480 cells. This enabled the stages before aster formation and MT extension to be 
captured by confocal microscopy (optimisation see Fig. S4.2 and S4.3). The loss of 
APC-FL in U2OS cells caused a significant three-fold reduction in fluorescence intensity 
of α-tubulin relative to cells transfected with control siRNA (Fig. 4.3C). Interestingly, 
even though the level of MT nucleation was unaffected when APC1-1337 was depleted 
in SW480 cells (Fig. 4.3D), the level of fluorescence intensity was similar to that of 
U2OS cells depleted of APC, suggesting that the truncated C-terminus is responsible 
for stimulating MT nucleation.   
Typically, MTs are nucleated by the -tuRCs (see section 1.4.2). These 
complexes are either assembled prior to, or after, recruitment to the centrosome and 
require “activation” to nucleate MTs (Schiebel, 2000). The interaction between APC and 
γ-tubulin is examined in more detail in chapter 5. At the pericentriolar material (PCM), γ-
tuRCs are anchored by coiled-coil proteins such as PCNT and AKAP450 that act as a 
scaffold allowing MT nucleation to be initiated (Takahashi et al., 2002; Zimmerman et 
al., 2004) (see Table 1.1). Nucleated MTs are also anchored to the subdistal 
appendage (regulated by ninein and dynein subunits) to form an aster, or if not 
anchored can be released from the centrosome (see section 1.3.2.3) (Delgehyr et al., 
2005; Mogensen, 1999).  APC preferentially localises to the mother centriole where 
MTs are anchored (Chapter 3), however since the depletion of APC delayed but did not 
inhibit the formation of MT asters or MT morphology even after 40 min, it is unlikely that 
APC regulates MT anchorage.  This is further compounded by the finding that, unlike 
integral centrosomal proteins, the majority of APC is highly mobile at the centrosome 
(Chapter 3). Conversely, the rapid exchange displayed by APC in live cells (Chapter 3) 
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opens the possibility that it plays a role in chaperoning or driving movement of other 
proteins to the centrosome.  
Axin and β-catenin are binding partners of APC that are also part of the Wnt 
signalling pathway and have been shown to positively regulate MT aster formation. 
When axin was depleted with siRNA in MKN-1 cells, the MT regrowth at 5 min showed 
a significant three-fold reduction in fluorescence intensity at the aster core (Fumoto et 
al., 2009). The depletion of β-catenin also caused a reported decrease in MT regrowth 
in 3Y1 rat fibroblasts, however fluorescence intensity was only measured after 30 min 
washout and revealed a ~two-fold reduction of aster fluorescence intensity (Huang et 
al., 2007). The variation in time points used between experiments could be attributed to 
differences in the natural MT growth rates of the cell lines and species studied. An 
interesting observation common to all three proteins is that the depletion of axin, β-
catenin or APC reduced the rate of MT nucleation/aster formation by approximately 
three-fold. It is uncertain whether components of the Wnt destruction complex interact at 
the centrosome to regulate MT assembly at centrosomes, however other tumour 
suppressors have been shown to regulate aster formation. For example, the depletion 
of BRCA1 breast cancer protein induces the hyper-growth of MTs where 75% of 
Hs578T cells treated with BRCA1 siRNA were found to contain large asters (>10 µm) 
compared to 20% in controls (Sankaran et al., 2005). These findings suggest that MT 
nucleation and aster formation at the centrosome requires a balance between proteins 
that promote and inhibit the MT nucleation process.  
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APC gene mutations contribute to defects in centrosome-dependent 
microtubule growth in colorectal cancer cells  
This study showed that SW480 cells are much slower than U2OS cells in their ability to 
(i) sequester α-tubulin monomers at the centrosome to form the initial “core” aster and 
(ii) to elongate MTs to form a radial MT aster. While this correlated with mutations in the 
APC gene, SW480 CRC cells also express elevated levels of mutant p53, whereas 
U2OS cells express wild-type p53 (Niforou et al., 2008; Rodrigues et al., 1990). The 
depletion of both p53 and stathmin (a MT stabilising protein) was previously found to 
increase the rate of MT nucleation and stability (Carney et al., 2012). Thus, in order to 
demonstrate that the MT defect in SW480 cells is at least partly attributable to the APC 
truncation, the full-length form of APC (pcmv-APC-FL) was reintroduced into SW480 
cells (Fig. 4.6).  Cells transfected with the APC-FL exhibited a significant increase in the 
rate of MT elongation compared to untransfected cells, thereby rescuing the inherent 
MT elongation defect of SW480 cells. This reconstitution experiment demonstrates that 
APC mutation is likely to contribute to impairment of MT nucleation and growth in 
SW480 cells.  
 A previous study also observed a reduced rate of MT regrowth in SW480 cells, 
and suggested the defect could be rescued by activation of EB1 through overexpression 
of the APC C-terminal domain (Nakamura et al., 2001). These authors proposed that 
APC can activate EB1 in vitro, however the consequences of overexpressing a C-
terminal EB1-binding fragment of APC are unclear, and the mechanism by which it was 
reported to boost MT regrowth in SW480 cells remains even less well defined. Notably, 
no study has previously tested whether APC-FL can rescue MT nucleation defects in 
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SW480 cells. Given that EB1 itself was reported to influence MT anchorage at the 
centrosome (Louie et al., 2004), one cannot exclude that loss of the APC C-terminal 
sequences in CRC cells impairs MT nucleation at least partly through the loss of APC-
EB1 complexes.  
 Do other APC-mutant CRCs display MT defects? The impairment of centrosome 
function was indeed previously reported in CRC cell lines, but was attributed to changes 
in DNA ploidy status. In one screening study, 10 CRC cell lines were subjected to 
spectral karyotyping and their ploidy status was correlated with centrosome function. 
Cells exhibiting aneuploidy such as SW480 and HT29 cells, when compared to diploid 
cell lines such as HCT116, tended to show impaired aster formation after nocodazole 
washout in regrowth assays (Ghadimi et al., 2000). A closer examination of that study 
actually reveals a striking correlation between APC mutation and MT nucleation defects 
that was not pointed out by the authors. Ghadami et al. (2000) observed a strong defect 
in MT nucleation and regrowth/elongation of the APC-mutant cell lines SW480, HT29 
and Colo-201, but not in CRC cell lines with APC-FL such as HCT116 and SW48. The 
experiments in this chapter explain the previous difference in MT nucleation rates as a 
consequence of APC mutations rather than changes in ploidy.   
The link between APC and microtubule elongation 
The MT elongation process involves the polymerisation of -tubulin and -tubulin 
monomers and their stabilisation at MT plus-ends which is seen as extensions of MTs 
from the initial core aster formed at centrosomes (Bornens, 2002) (see section 1.4.1). 
APC is known to be localised along MTs, and to associate at the growing end of MTs to 
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function as a plus end tracking protein leading to the stabilisation of MTs at the cellular 
cortex (Dikovskaya et al., 2001; Lansbergen and Akhmanova, 2006; Zumbrunn et al., 
2001). Therefore it is logical to hypothesise that APC can stabilise MTs newly elongated 
from the centrosome. The APC C-terminal “basic” domain is implicated in the 
stabilisation of elongated MTs since it is known to stabilise MTs at the membrane 
protrusions (Barth et al., 2008; Munemitsu et al., 1994). In this study, the C-terminal half 
of APC indeed showed a role in stabilising MT elongation. The loss of APC-FL in U2OS 
cells caused a significant reduction in MT elongation area with 80% of APC-knockdown 
cells displaying <60 µm2 of MT area compared to the 80% of control cells with MTs 
growing within the drug release period to >120 µm2 (Fig. 4.5). This delay in MT 
elongation also impacts on the cytoskeletal structure. When assessing the extent of 
APC-dependent MT stabilisation, it was found that even after 40 min of drug washout, 
the MT network had not re-formed in U2OS cells treated with APC siRNA (Fig. 4.7). 
These findings concur with the fact that APC stabilised polymerising MTs (Akhmanova 
and Steinmetz, 2010), and indicate that APC regulation of MTs begins at the 
centrosome.  
The MTs formed can either be anchored to the centrosome or released 
(Bornens, 2002; Keating and Borisy, 1999; Keating et al., 1997). Only anchored MTs 
are able to form radial MT asters and produce an efficient and directional growth 
(Mogensen, 1999; Mogensen et al., 2000). This aspect of MT anchorage is often 
quantified in untreated cells by scoring for attachment of MTs at the centrosome and 
describing them as either focussed (a radial array of MTs remaining centrally attached 
to the centrosome) or diffused (Huang et al., 2007; Louie et al., 2004). In this study, MT 
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anchoring was investigated in U2OS cells transfected with either control or siRNA 
targeting APC.  Quantification was performed in both untreated cells and in cells treated 
with nocodazole and released from drug for 40 min. The local attachment of MTs 
surrounding the centrosome was closely examined, however in all cases, MTs remained 
stably attached to the centrosome with no significant changes after APC depletion (Fig. 
4.8). Thus, APC can regulate MT nucleation and elongation but not long-term 
anchorage at the centrosome. This result differs to findings reported for β-catenin, which 
was reported to  regulate both MT anchoring and MT nucleation, as shown by depletion 
of -catenin causing the % of diffused MTs to increase from 10% to 70% (Huang et al., 
2007).   
APC does not regulate centrosome number or splitting in interphase  
CIN often occurs as a result of centrosome amplification and multipolar spindles. APC 
has been implicated in the stabilisation of MT plus ends and kinetochore attachments, 
and cells carrying the truncated APC gene loses this ability. Truncated APC cannot be 
phosphorylated by bub kinases that regulate its MT attachment in mitosis, resulting in 
chromosome segregation error (Kaplan et al., 2001). Furthermore, bubR1 acts as a 
negative regulator of centrosome over-duplication and amplification via its inhibition of 
Plk1 phosphorylation (Izumi et al., 2009) (see Table 1.1). Since APC is a strong 
substrate for bub kinases, APC could regulate centrosome number. However, when 
tested the knockdown of APC did not significantly increase the number of cells with 
extra centrosome number (Fig. 4.9).  
The lack, or premature splitting, of centrosomes outside of G2 phase can lead to 
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the formation of merotelic MT attachments to chromosomes (Silkworth et al., 2012; 
Tanenbaum and Medema, 2010). Centrosomes are typically held together by a dynamic 
linker involving PCNT-B, rootletin, CG-NAP and Nek2 kinase after duplication (Bahe et 
al., 2005; Matsuo et al., 2010). It was alluded to that APC-linked CIN defects could 
begin at centrosome separation through its association with cortical astral MTs since 
APC2, one of the two drosophila homologues, could promote centrosome separation in 
cytokinesis with axin. This suspicion was also substantiated by the model of prophase 
centrosome separation that could be driven by opposite forces from MT assembly and 
disassembly (Poulton et al., 2013; Tanenbaum and Medema, 2010). The method used 
here to examine centrosome splitting in U2OS cells was similar to that used to study 
axin2 by Behren’s group (Hadjihannas et al., 2010), and the effects of centrosome 
splitting were measured after APC depletion with siRNA (Fig. 4.10). Separated 
centrosomes with excessive γ-tubulin accumulation were indicative of mitotic 
progression and were therefore not measured. No significant change in centrosome 
separation was observed in the absence of APC in U2OS cells.  
 In conclusion, at the centrosome, the major functional consequence of loss (or 
truncating mutation) of APC appears to be reduced MT nucleation indicated by reduced 
initial aster formation and delayed growth of MTs. In the context of the past literature, 
the findings suggest a general role for APC in nucleation, extension and stabilisation of 
MT networks from the centrosome in interphase cells. 
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4.3S SUPPLEMENTARY SECTION 
 
Figure S4.1 Optimisation of antibody and temperature for the MT regrowth assay.  
(A) Recommended optimial concentrations of α-tubulin and β-tubulin were used to 
detect MTs in U2OS cells. Cells were co-stained with γ-tubulin to detect the focus of 
converging MTs at the centrosome. α-tubulin showed the clearer staining of MTs. (B) 
U2OS cells were treated with 33µM of nocodazole for 1 h at 37oC to depolymerise MTs 
released by washing with drug-free media. MTs were allowed to re-grow at either 4oC or 
room temperature (RT=25oC). Control cells were drug treated. All cells were fixed using 
methanol:acetone and MTs and centrosomes were detected using α-tubulin (red) and γ-
tubulin (green), respectively.   
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Figure S4.2 Optimisation of time-point at room temperature (RT) to capture stages 
of MT regrowth in U2OS cells. The timepoints of MT regrowth in U2OS cells was 
further optimised at 25oC to capture aster growth and MT elongation. 33 µM of 
nocodazole was used to treat for 1 h at 37oC, followed by a washout with drug-free 
media. Cells were fixed at 5 min intervals from 0 to 20 min using methanol: acetone. 
MTs and centrosomes were detected by immunofluroescence using α-tubulin (red) and 
γ-tubulin (green), respectively. The optimal and consistent timepoint that captures aster 
formation and MT elongation in U2OS cells was ~5-10 min and ~15-20 min respectively 
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Figure S4.3 Optimisation of timepoint at RT to capture stages MT regrowth in 
SW480 cells. Timepoints for SW480 cells were optimised in parrallel to U2OS to find 
the baseline MT regrowth rate in SW480 cells using the same conditions as described 
in Figure S4.2. The optimal and consistent timepoint to capture aster formation and MT 
elongation in SW480 cells was ~10-15 min and ~20-25 min respectively.   
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Figure S4.4 Titration of various APC targeting antibodies that can clearly detect 
APC at the centrosome. U2OS cell were stained with with (A) APC1 rabbit polyclonal; 
(B) APC2 rabbit polyclonal; (C) APC-NT rabbit polyclonal and (D) Ab7 mouse 
monoclonal at various concentrations (green), and co-stained with γ-tubulin (red) to 
accurately detect APC at the centrosomes.  APC-NT and Ab7 produced the most 
consistent staining of APC at the centrosome and was therefore selected to be used in 
the MT regrowth assay with APC depletion.  
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Figure S4.5 Confirmation of APC knockdown by Western blot analysis. APC 
knockdown was analysed by Western blot in parallel to the MT regrowth assay to 
confirm sufficient APC depletion. (A) U2OS with APC depletion using both siAPC-d and 
siAPC-2 siRNA. (B) In SW480 cells, only the siRNA of siAPC-d is shown. Ab1 mouse 
mAb was used to detect APC and vinculin or α-tubulin was used as loading controls.  
 
 
 
 
 
Chapter 4 
209 | P a g e  
 
 
Figure S4.6 Confirmation of the effect of APC loss on MT aster formation and 
elongation using a second APC targeting siRNA (siAPC-2) in U2OS cells. (A) 
Quantification of APC knockdown efficiency by Western blot. Ab1 mAb was used to 
detect APC-FL in U2OS cells and topo II mAb was used as the loading control. (B-C) 
U2OS cells were transfected with either siCTRL or siAPC-2 for 72 h. MTs were detected 
using α-tubulin mAb and was co-stained for APC using APC-NT poly-Ab. Images were 
acquired from the Confocal microscope Olympus FV-1000. Fluorescence intensity of 
the core aster intensity was measured using the confocal program (n>75). (D-E) MT 
elongation was also quantified by measuring the area of MT extension, these 
measurement were grouped 5 groups based on the MT size (n>75).   
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SUMMARY OF CHAPTER 5 
 
Full-length APC (APC-FL) is important in stimulating microtubule (MT) regrowth from 
the centrosome (Chapter 4), however whether this can be attributed to it’s interaction 
with -tubulin is unclear.  MT nucleation predominantly occurs in the pericentriolar 
material (PCM) by -tubulin ring complexes (-tuRCs). One earlier report demonstrated 
a potential interaction between APC-FL and -tubulin, therefore the aim of this study 
was to confirm and characterise any interaction between -tubulin and APC-FL and the 
truncated mutant. A combination of immunoprecipitation (IP) and proximity ligation 
assay (PLA) (the “Duolink assay”) was performed to test for protein interactions 
between -tubulin and APC-FL in U2OS cells, and APC mutant (1-1337) in SW480 cells. 
Both forms of APC were found to associate with -tubulin.  The Duolink assay 
methodology was used to map the APC binding site for -tubulin to a sequence in the N-
terminus of APC (comprising amino acids 1-453). This N-terminal region forms part of 
the APC centrosome localisation sequence (CLS) as defined in chapter 3, raising the 
possibility that -tubulin helps recruit APC to the centrosome. To test this hypothesis, 
cells expressing GFP-tagged APC1-1309 were subjected to silencing of -tubulin and 
the dynamics of APC then analysed at the centrosome by fluorescence recovery after 
photobleaching (FRAP) assay. APC centrosome recruitment dynamics, but not 
retention, was found to be significantly slowed when -tubulin expression was silenced 
by siRNA. In summary, this chapter shows that APC associates with the main MT-
nucleating factor -tubulin which actually helps drive APC accumulation at the 
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centrosome, indicating and these interactions are likely to contribute to the role of APC 
in the growth of MTs. 
5.1 INTRODUCTION  
-tubulin is an integral protein of the centrosome involved in MT nucleation and protein 
recruitment (Dictenberg et al., 1998; Doxsey et al., 1994; Kollman et al., 2011; Sonnen 
et al., 2012). -tubulin is a core component of the –tubulin ring complex (–tuRC) that 
efficiently nucleates and anchors MTs from the centrosomes, as well as maintaining 
their stabilisation (Moritz and Agard, 2001; Teixido-Travesa et al., 2012; Wiese and 
Zheng, 1999). However, -tubulin appears to exist in different pools, those at the 
centrosome that regulate MTs in the cell and other pools not exclusive to the 
centrosome. For instance, two populations were reported in KE37 T-lymphoblastic cells 
wherein -tubulin was detectable as a Triton X-100-insoluble form and an insoluble 
cytosolic form (Moudjou et al., 1996). In cell extracts enriched in centrosomes, a 
population of -tubulin remained in close association with centrosomes/centrioles and 
was resistant to high salt detergent buffers for centrosome specific functions, such as 
the anchoring of MTs to the centrosome (Moudjou et al., 1996). This may be different to 
the -tubulin pool that needs to be recruited from the cytoplasm. Half of centrosomal -
tubulin is in constant exchange with its cytoplasmic pool based on a 50% fluorescence 
recovery observed using FRAP methods (see Chapter 3) (Khodjakov and Rieder, 
1999). This mobile fraction is likely to carry the MT nucleating function since 
cytoplasmic fractions isolated from Xenopus and human 293 cells detects a large 
complex containing -tubulin that can associate MTs where -tubulin of lymhoblast cells 
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co-precipitates with taxol-stabilised MTs  (Moudjou et al., 1996; Stearns and Kirschner, 
1994) (also see section 1.4.2).   
APC on the other hand, was claimed in one previous study to associate with -
tubulin in only a small cytoplasmic fraction (Mahadevaiyer et al., 2007). In the colorectal 
cancer (CRC) cell line HCT116 that expresses APC-FL, APC was detected in IP 
complexes with -tubulin in the large 60S complex of the soluble fraction along with 
IQGAP1, Rac1, cdc42 and α-tubulin. This fraction was distinct from the 20S protein 
complex where APC was found to co-sediment with Wnt-associated proteins of the -
catenin destruction complex (Mahadevaiyer et al., 2007). Perhaps the APC 60S 
complex, inclusive of -tubulin, mediates cytoskeleton regulatory functions. APC is a 
known cytoskeleton regulator that binds to MTs directly through its C-terminal basic 
domain (Munemitsu et al., 1994) or indirectly via the kinesin family through KAP3A 
(Jimbo et al., 2002). In addition to MTs, APC associates with other cytoskeletal 
systems, and can bind directly to actin through its basic domain (Moseley et al., 2007) 
or regulate the actin cytoskeleton via IQGAP1 (Watanabe et al., 2004), and more 
recently was observed to bind directly to intermediate filaments (IFs) via the armadillo 
(ARM) domain (Sakamoto et al., 2013). Like APC, -tubulin also regulates the 
cytoskeleton. Not only do -tubulin  complexes form a template for MT nucleation 
(Schiebel, 2000), they can co-localise to apical IFs of CACO-2 epithelial cells as seen 
by electron microscopy (Salas, 1999), and -tuRCs can in some instances localise to 
the distal ends of MTs and regulate dynamics in interphase cells of Drosophila S2 cells 
(Bouissou et al., 2009).  Since both APC and -tubulin are dynamic in the cell (Bienz, 
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2002; Stearns and Kirschner, 1994), the aim of this chapter was to confirm and 
characterise their interaction and determine whether -tubulin contributed to the 
centrosomal recruitment of APC.  
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5.2 MATERIALS and METHODS  
5.2.1 Cell Culture and transfection  
Human cancer cell lines HeLa, U2OS and SW480 were cultured in supplemented 
Dulbecco’s modified Eagle’s medium (DMEM) (see section 2.2.4.2).  For fixed cell 
experiments used for fluorescence microscopy cells were seeded onto coverslips in 6-
wells plates, 8-well chambers for Duolink assay and for FRAP cells were seeded into 2-
well chambers slides. At 16 h after seeding, cells were transfected with 2 µg plasmid 
DNA using Fugene HD (Promega) transfection reagent (see section 2.2.4.4). Cells were 
fixed and processed 30 h post-transfection for FRAP and Duolink assay. For 
immunoprecipitation experiments, cells were grown in T150 flasks and harvested at 
~80-90% confluence.  
5.2.2 Plasmids  
All plasmids used in this chapter are detailed in materials and methods section (Table 
2.6). 
5.2.3 Protein extraction, immunoprecipitation and immunoblotting 
For centrosome protein enriched fractions the nuclear protein extraction protocol was 
adapted for protein extraction. Nuclear and cytoplasmic cell separation was performed 
using the a protocol described by Tanaka’s team (as described in section 2.2.5.2) 
(Matsuda et al., 1995).  
 Antibodies that was used to immunoprecipitate APC include Ab5 mAb (see Table 
2.3). 1 mg of nuclear/centrosome enriched extract was used for IP (see section 2.2.5.7). 
Precipitated immunocomplexes was then denatured in 4X Laemmli buffer (see section 
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2.2.5.4) at 95 C for 8 min and resolved by polyacrylamide gel electrophoresis and 
transferred onto nitrocellulose membrane (Millipore) as described in sections 2.2.5.4-
2.2.5.5. Membranes were processed for Western blot analysis (see section 2.2.5.6 and 
2.2.5.7) using antibodies against γ-tubulin and APC using Ab1. Antibody against vinculin 
was used as loading control in knockdown experiments. Optimisation of centrosome 
enrichment was validated by Western blot analysis using antibodies against PCNT-B, 
CEP110, centrin II, -tubulin and α-tubulin. Antibody dilutions are listed in Table 2.3.  
5.2.4 Proximity ligation assay Duolink 
The protocol for the Duolink assay is detailed in section 2.2.8. The antibodies used for 
the Duolink assay include: mouse mAb Ab7 for APC and rabbit poly-Ab γ-tubulin. Rabbit 
poly-Ab H290 for APC and mouse mAb for γ-tubulin were also used for verification. Both 
red and green Duolink kits were used and results were pulled together for analysis.  
 To assess the specific binding of APC and γ-tubulin, EGFP or GFP-tagged 
APC1-1309 was first overexpressed in cells for 36 h prior to fixation with methanol: 
acetone, followed by the Duolink assay as described in section 2.2.8.4. Rabbit poly-Ab 
or mouse mAb GFP was used to probe for GFP. To investigate specific protein 
interactions at the centrosome, the counter staining protocol (supplied by O-link) was 
applied after the Duolink assay using either pericentrin (PCNT) A/B (mouse or rabbit) 
antibody as the centrosome marker (see section 2.2.8.3).   
5.2.5 Fluorescence recovery after photobleaching (FRAP) assay 
FRAP was performed on HeLa cells transfected with GFP-tagged APC1-1309 described 
in section 2.2.4.4 that were pre-treated with various either control siRNA or γ-tubulin 
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targeting siRNA as described in section 2.2.4.4. RFP-PCNT-C241 was co-transfected to 
mark the centrosome in live cells. The FRAP analysis was performed on an Olympus 
FV1000 confocal laser-scanning microscope (as described in section 2.2.11.1) and data 
was analysed with Olympus Fluoview Version 1.6a software before exporting data to 
Microsoft Excel (2007). In Microsoft Excel, bleaching from imaging and background 
fluorescence were deducted for each cell and an average recovery curve generated. 
These data were then entered into Graph Pad Prism 5 for curve analysis (see sections 
2.2.11.2 and 2.2.11.3). Fast and slow phase T1/2 values (for the first 40 s) and plateau 
values were determined and used to compare initial speed of recovery and the recovery 
percentage at the centrosome.  
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5.3 RESULTS  
5.3.1 APC binds to the main microtubule nucleating protein, -tubulin  
-tubulin is a potent regulator of MT nucleation and is an essential component of the γ-
tuRC (see section 1.4.2). In chapter 4, it was revealed that the C-terminal half of APC 
significantly stimulates MT nucleation and elongation (see Chapter 4). To help 
understand this process, the potential interaction between APC and γ-tubulin was 
studied in detail.  
 
Figure 5.1 Interaction between APC and γ-tubulin confirmed by 
imunoprecipitation (IP). Centrosome enriched fractions were used for IP of APC with 
γ-tubulin in vivo. Ab5 mAb (1 g/ml) was used to pull-down full-length (APC-FL) and 
APC-truncated mutant in (A) U2OS cells and (B) SW480 cells, respectively. γ-tubulin 
was detected with a specific mAb. 30 g of protein extract was used in the input to 
detect endogenous levels of γ-tubulin. At least three experiments were performed for 
each cell line, of which two representative experiments are shown here. The Western 
blot analysis illustrates an interaction between APC-FL and γ-tubulin, and to a lesser 
extent with APC-mutant. APC pull-down efficiency was detected using Ab1 mouse mAb.  
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APC was previously shown in a single study to immunoprecipitate with γ-tubulin  
in HCT116 cells (Mahadevaiyer et al., 2007). To confirm the interaction between APC 
and γ-tubulin and extend the investigation to the mutant APC, cell extracts enriched for 
centrosome proteins (see Fig. S5.1) were used for IP experiments in sub-confluent 
U2OS cells (express APC-FL) and SW480 cells (express mutant APC1-1337) (see 
section 5.2.3). In the pull-down of APC-FL in U2OS cells using Ab5 mAb, a measurable 
50 kDa band of γ-tubulin was detected by Western blot (Fig. 5.1A).  The interaction 
between the APC1-1337 and γ-tubulin in SW480 cells was less obvious, and in different 
experiments was consistently just barely detectable above background using Ab1 mAb 
to detect APC (Fig. 5.1B).  Each experiment was performed at least twice with similar 
results and the representative results illustrated in Fig. 5.1. The findings strongly confirm 
that APC-FL associates with -tubulin while the interaction between γ-tubulin and mutant 
APC1-1337 was less consistent.  
5.3.2 Quantitative analysis by Duolink assay reveals that both full-
length and mutant 1-1337 forms of APC interact with γ-tubulin  
APC is a highly mobile protein (see Chapter 3) and γ-tubulin is not only found at the 
centrosome but also detected in cytoplasmic cellular fractions (Moudjou et al., 1996). To 
establish where interactions are occurring, a proximity ligation assay (PLA) 
(commercially known as “Duolink assay”) was used in combination with 
immunofluorescence microscopy. Duolink is a powerful assay to identify interactions 
between two proteins that lie in close proximity to one another (< 40 nm) (Carmena et 
al., 2012; Lodde and Peluso, 2011). It requires the use of two primary antibodies 
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originating from different species followed by the addition of PLA secondary probes of 
opposite nature, that is, an anti-rabbit (minus) and anti-mouse (plus) that will ligate if the 
proteins are in close proximity. This signal is then amplified using a polymerase via 
rolling circle amplification which incorporates fluorescent signal and can be visualised 
as a single microscopic dot (hereafter referred to as PLA dots/signals). Optical image z-
sections (2 x 0.75 M) of cells were acquired using confocal microscopy and the 
interactions were quantified by scoring the number of signals per cell, per condition. 
Nuclear defects are often seen in cancer cells where one cell could contain two nuclei 
(bi-nucleate) or even multiple nuclei (multi-nucleate), hence to favour an unbiased 
scoring system a criteria was set where cells that contained two separated nuclei were 
considered to be separate cells and were scored separately. Using this method, 
endogenous APC and γ-tubulin were found to specifically interact in U2OS cells as 
there were significantly more PLA dots (3-4 dots) per cell when using both APC and -
tubulin specific antibodies, than in the control cells stained with only APC or -tubulin 
antibodies alone (0-1 dot per cell) (Fig. 5.2A & C). More than 100 cells were scored 
from at least three independent experiments. In contrast, a specific interaction was 
detected between endogenous APC1-1337 and γ-tubulin in SW480 cells but less 
obvious than that detected in U2OS cells. In SW480 cells, an average of only one to two 
dots were scored per cell, but was still above background (Figs. 5.2 and S5.3). These 
results complement the IP data and support the notion that while APC-FL does bind -
tubulin, the truncated APC1-1337 appears to display a weaker interaction with γ-tubulin. 
When interpreting these findings, it must be taken into account that SW480 cells are 
inherently smaller in area/volume than U2OS cells which might affect the number of 
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Figure 5.2 (Legend on following page) 
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Figure 5.2 APC interacts with γ-tubulin by Duolink assay in U2OS and SW480 
cells.  Duolink kit (red) was performed between endogenous (A) APC-FL in U2OS and 
(B) APC-mutant in SW480 cells with γ-tubulin. The Duolink assay was performed using 
Ab7 mAb to probe for endogenous APC and γ-tubulin poly-Ab as the other probe. Tests 
with individual antibody alone were also performed in parallel as controls. Scoring of 
PLA dots was performed using images acquired from the Olympus confocal 
microscopy. The DIC channel was used to define cell edges for accurate scoring. 
Around 100-150 cells were scored per reaction sample, over three independent 
experiments. Each red dot was classified as one positive interaction. (C) Graph 
produced from (n>200) showing the trend of γ-tubulin interaction with APC where each 
point represents the number of PLA dots per cell (also see Fig. S5.3). U2OS cells show 
a significantly higher number of APC and γ-tubulin interactions compared to controls 
(P<0.0001). A similar trend was observed in SW480 cells, however, overall less number 
of PLA dots was observed per cell. (D) Schematic diagram of γ-tubulin location within 
the centrosome, that is, in close proximity to the centrioles while occupying the middle 
compartment of the PCM.   
 
Figure 5.3 Ectopically expressed APC1-1309 interacts with γ-tubulin by Duolink 
assay. Plasmids expressing GFP-tagged APC1-1309 or EGFP alone were 
overexpressed in U2OS cells. Duolink assay (red) was performed between APC (using 
anti-GFP mouse mAb), and γ-tubulin (rabbit poly-Ab). At the completion of the Duolink 
assay protocol, cells were counter stained for ectopic APC expression using GFP 
mouse antibody (green). (B) The scoring for the number of positive PLA signals per cell 
was graphed against each condition. In the γ-tubulin and APC1-1309-GFP pairing, the 
number of positive PLA dots was significantly higher than controls indicating a positive 
interaction (P<0.0001).  
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interactions observed. γ-tubulin is commonly found in the PCM (Fig 5.2D) and therefore 
interactions detected are likely to reside in the PCM. The reliability of the Duolink assay 
was verified by testing several positive paired controls comprising known binding 
partners in our lab, including BRCA1 and γ-tubulin; APC and β-catenin; and APC-FL 
and EB1, all of which were shown to produce consistent positive PLA signals (data not 
shown).  
To confirm that the mutant truncated form of APC can bind to -tubulin, albeit less 
well than APC-FL, a Duolink assay was performed in cells transiently expressing GFP-
tagged APC1-1309 (Fig. 5.3). Cells were first transfected with either pEGFP or APC1-
1309-GFP, and Duolink assay was performed using GFP mouse mAb and γ-tubulin 
rabbit poly-Ab. Cells were then counter-stained for ectopically expressed APC1-1309 
using GFP mAb in green. Transfected cells were selectively imaged using confocal 
microscopy (Fig. 5.3). As expected, endogenous γ-tubulin interacted with ectopically 
expressed APC1-1309 with a significantly higher amount of dots scored per cell 
compared to GFP control (Fig. 5.3).  
5.3.3 A small population of APC can interact with γ-tubulin specifically 
at the centrosome.  
In the Duolink assay, interactions detected between APC with γ-tubulin (seen as red 
dots) appear scattered throughout the cytoplasm (Fig. 5.2 and 5.3). It is possible that 
APC forms complexes with different cytoplasmic pools of γ-tubulin (Moudjou et al., 
1996; Purohit et al., 1999). To determine if APC is forming complexes with -tubulin 
atthe centrosome, the Duolink assay was again performed under conditions where the 
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centrosome was also marked by counter staining cells with either γ-tubulin or PCNT 
antibodies in green, as shown in Fig. 5.4. To accurately quantify positive PLA signals at  
the centrosome, which is a very small structure, 3 x 0.75 µM z-plane thickness optical 
sections were imaged by confocal microscopy. Several criteria were adopted for 
scoring:  only cells with a clear centrosome were scored, and only cells that show a 
positive PLA signal(s) in the cell were analysed at the centrosome.  
Somewhat unexpectedly, specific binding of APC and γ-tubulin at the centrosome 
was sometimes difficult to detect. In fact detection of APC--tubulin complexes at the 
centrosome occurred more often in SW480 (Fig. 5.4) than in U2OS cells (data not 
shown). On average  ~ 8% of PLA positive cells displayed a signal at the centrosome in 
 
Figure 5.4 γ-tubulin interacts with APC at the centrosome. (A) To verify that PLA 
signals between APC (Ab7) and γ-tubulin actually occurred at the centrosome, a 
centrosome marker PCNT (white arrow) was used to counter stain (green) cells in 
SW480 cells after Duolink assay (red) was performed. Optical z-sections was acquired 
by Olympus FV1000 confocal microscope (0.75 µm x 3). (B) Cells were scored for 
positive PLA signals at the centrosome and converted to a percentage of the total 
number of Duolink positive cells (>50 cells over three experiments scored) (% ± SD). 
Approximately 10% of APC and γ-tubulin interactions were specifically identified at the 
centrosome.  
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SW480 cells (Fig. 5.4). While it is possible that APC--tubulin complexes are not 
sufficiently stable at the centrosome for detection by this assay, it is perhaps more likely 
that such complexes were not detected for technical reasons, including possibly epitope 
masking by protein interactions that affects the antibody-dependent PLA signal from 
being generated. Alternatively, there could be a masking of the antibody epitope when 
counterstaining with PCNT mAb to study the γ-tubulin interaction in U2OS cells. 
Additional experiments may be required such as purification of centrosomes to 
determine if APC is in the same fraction as γ-tubulin.  
5.3.4 γ-tubulin binds to the N-terminus of APC  
The interaction between APC and -tubulin provides a potential mechanism for APC 
regulation of MT growth as described in chapter 4. Since both APC-FL and truncated 
APC can bind to -tubulin (Fig. 5.2), albeit with different strength, then it is likely that a 
primary component of the binding site lies within the N-terminus. Therefore the Duolink 
assay was used to map the interaction domain of APC. Different GFP-tagged fragments 
of the APC protein were overexpressed in U2OS cells and the Duolink assay (red) was 
performed using γ-tubulin poly-Ab and GFP mAb. The APC peptide fragments 
compared were the N-terminal domain APC1-453, the shortest centrosome targeting 
region APC334-625 and the central -catenin binding region of APC, 1378-2080 (Fig. 
5.5). More than 50 transfected cells per test reaction were scored over three 
independent experiments. The results were unequivocal and identified the APC 
sequence 1-453 as the binding site for -tubulin. An obvious trend was observed in cells 
expressing GFP-tagged APC1-453, which showed a significantly higher number of PLA 
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Figure 5.5 Mapping the γ-tubulin binding domain of APC to the N-terminal 
sequences comprising amino acids 1-453.  (A) U2OS cells were expressed with 
GFP-tagged fragments of APC or EGFP alone as control. Duolink assay (red) was 
performed between APC-domains and endogenous γ-tubulin using GFP and γ-tubulin 
antibodies. After the termination of the Duolink assay, cells were counter-stained for 
APC transfected cells using GFP mAb (green), followed by alexafluor 488 mAb. Images 
were acquired by confocal microscopy. Over 50 transfected cells were scored per 
construct collected from over three independent experiments. PLA signal was found to 
be significantly higher between APC1-453 and γ-tubulin compared to EGFP control 
(P<0.001). See Fig. S5.2 for repeats.   
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signals with endogenous γ-tubulin when compared to the other APC fragments and to 
EGFP alone (P<0.001). PLA dots of low quantity were found in cells expressing 
APC1378-2080, however it was not significantly higher than controls. A relatively high  
amount of background was seen in cells expressing APC1-453-GFP, γ-tubulin or GFP 
alone, however, the amount of PLA signal was dramatically lower than that seen in the 
test interaction. This data suggests that γ-tubulin can bind APC at N-terminus of APC, 
however the possibility of secondary binding sites in the C-terminal half of APC has not 
yet been evaluated, and therefore cannot be totally excluded.  
5.3.5 γ-tubulin stimulates the on-rate dynamics of APC at the 
centrosome  
γ-tubulin is an essential component of the γ-tuRC important in the nucleation of MTs 
(Moritz and Agard, 2001; Teixido-Travesa et al., 2012). It was also established in 
chapter 3 that MTs contribute to the efficient transport of APC to the centrosome (see 
Figs. 3.8 & 3.9). To test if APC movement to the centrosome is affected by the presence 
of γ-tubulin, FRAP analysis was performed in γ-tubulin depleted and control cells.  GFP-
tagged APC1-1309 was co-transfected with RFP-PCNT-C251 into HeLa cells for 24 h, 
followed by control siRNA (siCTRL) or γ-tubulin siRNA (siγ-tubulin) treatment for another 
48 h  (Fig. 5.6A).The  knockdown  efficiency  was  confirmed in a parallel  Western  blot 
analysis (Fig. 5.6C). APC1-1309 was used because it transfects more consistently than 
APC-FL, and it also incorporates the γ-tubulin binding domain of APC1-453 (Fig. 5.5). 
Fluorescence recovery curves revealed that the siRNA-mediated loss of γ-tubulin at the 
centrosome  modestly but  significantly reduced the recovery  of  APC1-1309  to  the 
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Figure 5.6 The knockdown of γ-tubulin reduces the rate of APC1-1309 transport to 
the centrosome. HeLa cells were transfected with either control (CTRL) (n=10) or γ-
tubulin siRNAs (n=9), followed by overexpression of GFP-tagged APC1-1309. FRAP 
was performed at the centrosome in live cells using RFP-PCNT-C241 as a centrosome 
marker (A). Focal bleaching of APC1-1309-GFP at the centrosome was performed by 
the confocal microscope, followed by a sequence of imaging over 40 s. (B) 
Fluorescence recovery curves are shown post bleaching of APC1-1309 for siCTRL 
(blue) and siγ-tubulin. (C) Confirmation of γ-tubulin knockdown by Western blot. (D) 
Graph showing the T1/2 of the fluorescence recovery over 40 s, which was significantly 
increased after the knockdown of γ-tubulin (P=0.0194). (E) There was no change in the 
maximum recovery in both curves indicating there was no significant change in retention 
after γ-tubulin silencing.  
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centrosome in the first 40 s (P=0.019) (Fig. 5.6B). This was reflected in the measured 
T1/2 where γ-tubulin depletion increased the T1/2 by 100% from ~3 s to ~6 s (Fig. 5.6D 
and Fig. S5.5 [Table]). The retention of APC1-1309 was however unaffected by γ-
tubulin loss, with maximal fluorescence recovery at (~83-87%) in both treatments (Fig. 
5.6E). The (~12-16%) retention of APC observed here is consistent with the previous 
FRAP analysis in chapter 3 in siCTRL, but are modestly increased after γ-tubulin 
depletion (Fig. 5.6D). However, this difference is retention was not statistically 
significant (Fig. 5.6E).  
 The notion of γ-tubulin as an anchoring protein for APC at the centrosome was 
also tested by quantifying the accumulation and retention of APC after γ-tubulin 
depletion in HeLa cells. Images were taken with the confocal microscope and 
fluorescence intensity was analysed at the centrosome in cells treated with either 
control or γ-tubulin targeting siRNA, and revealed no significant changes (Fig. S5.4). 
Therefore, I conclude that γ-tubulin does not anchor APC at centrosomes but can 
stimulate its rate of recovery (or on-rate). Since this result corresponds closely to that 
seen after depolymerisation of MTs (Chapter 3), it is possible that the loss of -tubulin 
acts indirectly on APC by reducing MT formation.     
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5.4 DISCUSSION  
APC interacts with γ-tubulin  
While APC had not directly been shown to regulate MT aster formation prior to this 
study, it was shown to form immunoprecipitable complexes with the MT subunit α-
tubulin as well as the MT nucleating protein γ-tubulin (Mahadevaiyer et al., 2007). γ-
tubulin is one of the main components of the γ-tuRCs which are the most efficient MT 
nucleating complexes (Kollman et al., 2011), therefore the binding between APC and γ-
tubulin was further explored here to help explain how APC might regulate aster 
formation (see Chapter 4). 
 First, it was actually very important to confirm that APC interacts with γ-tubulin 
because the only previously described interaction between these two proteins employed 
a questionable antibody reagent (Mahadavaiyer et al. 2007). In that study, IPs for APC 
were performed with a cytosolic fraction of HCT116 cells using  an antibody that targets 
the C-terminus of APC, C-20, which has previously been demonstrated to cross-react 
with other proteins (Brocardo et al., 2005). In addition, the Mahadavaiyer study utilised 
confluent cells, which would likely be growth arrested, and this may alter protein 
associations at the centrosome since the retention of both APC and γ-tubulin are cell 
cycle specific (as shown and discussed in Chapter 3). Furthermore, as discussed in 
previous reviews (Henderson and Fagotto, 2002; Lui et al., 2012), there are several 
distinct pools of APC at sub-cellular locations such as the membrane, centrosome, 
mitochondria and cell membrane, therefore the distribution of APC is likely to change 
according to the cell cycle. In this study, using centrosome enriched fractions of U2OS 
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cells and Ab5 (APC specific antibody), APC-FL was confirmed to interact with γ-tubulin 
by IP (Fig. 5.1A).  
 When the interactions were assessed by Duolink, several PLA positive dots 
could be observed spread out in the cytoplasm with only a small proportion of 
interactions detected at the centrosome, especially in U2OS cells (Fig. 5.4).  This was a 
little unexpected given that APC can regulate MT aster formation (Chapter 4), and was 
assumed to therefore be cooperating with γ-tubulin at the centrosome. First it should be 
pointed out that APC-FL protein interactions are sometimes difficult to detect 
biochemically, for example as seen in the case of APC-EB1 interactions (Green et al., 
2005; Su et al., 1995). Alternatively, APC may be interacting with γ-tubulin only weakly 
or transiently at the centrosome, with more stable interactions potentially occurring at 
other cytoplasmic locations. In this regard it is interesting to note that the majority of γ-
tubulin is in fact soluble in the cell. For instance, when KE37 leukemia cells were 
fractionated into soluble and insoluble pools using Triton X-100 detergent, 80% of the γ-
tubulin was recovered in the soluble fraction that did not, or only weakly, associate with 
the centrosome (Moudjou et al., 1996). This was consistent with observations in FRAP 
studies where ~50% of GFP-tagged γ-tubulin was found to be mobile at the centrosome 
in interphase and 100% mobile at mitotic centrosomes (Khodjakov and Rieder, 1999). 
While the APC-γ-tubulin complexes were detected as PLA dots throughout the cell, a 
sub-population of APC1-1337 formed specific complexes with γ-tubulin at the 
centrosome (~8%) (Fig. 5.4). Therefore, either APC-γ-tubulin interactions are weak and 
do not reside stably at the centrosome long enough for detection, or the lack of signal 
can be attributed to technical issues that might relate to masking of antibody epitopes 
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when the complexes are attached at the centrosome. While further studies will be 
required to resolve these possibilities, the key finding is that APC--tubulin complexes 
can be detected at the centrosome.  
Functional implications of APC- γ-tubulin interaction  
As exemplified in chapter 4, MT aster formation is significantly slowed in SW480 cells 
that express a truncated form of APC, and the efficient stimulation of MT growth in 
these cells could possibly be weakened by a change in the interaction between γ-tubulin 
and APC. For instance, both IPs and Duolink assay data (Figs. 5.1 and 5.2) indicated a 
somewhat reduced interaction between -tubulin and the APC1-1337 mutant compared 
to APC-FL.  However, a Duolink mapping experiment using ectopically expressed GFP-
tagged APC fragments revealed that -tubulin binds to the N-terminal APC sequence 1-
453 which is present in both truncated and APC-FL (Fig. 5.5). Therefore, either a 
secondary γ-tubulin binding domain exists within the C-terminal region of APC, or loss 
of the C-terminus might cause some conformational shift in APC (eg. through altered 
internal interactions or folding), that lessens binding of the APC mutant to -tubulin (Fig. 
5.7). On the other hand, -tubulin does associate with the truncated APC (both 
endogenous 1-1337 and ectopic 1-1309 mutants) and influence its dynamic recruitment 
to the centrosome (discussed later), suggesting that loss of the APC C-terminus may 
disrupt MT nucleation even when bound to -tubulin. 
γ-tubulin is best known as a potent MT nucleator that anchors the minus ends of 
MTs, while APC is normally regarded as a key stabiliser of MT growing (plus) ends. 
Their association, and the ability of each to function at more than one level of MT 
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growth, has important implications for regulating integrity of the MT network in cells. In 
fact γ-tubulin can also regulate MT dynamics and stability. One study showed that 
during interphase γ-tuRCs localise along MTs and that γ-tubulin could localise to MT 
plus ends to inhibit catastrophe (Kita et al., 2006). Live cell analysis expressing α-tubulin 
in Drosophila S2 cells revealed that the depletion of γ-tubulin by RNAi significantly 
reduced the amount of growing MTs by approximately two-fold (Bouissou et al., 2009). 
Relating this back to the MT stimulating role of the APC C-terminus (Chapter 4), it 
seems more  likely that  while  APC1-453 can  bind  γ-tubulin, it is the  APC  C-terminal 
 
Figure 5.7 Summary model for chapter 5. (A) Normally, APC-FL can strongly interact 
with γ-tubulin via its N-terminal domain and possibly a secondary C-terminal binding 
domain that promotes MT nucleation together with stabilisation of nascent MTs at the 
centrosome. In this speculative model, APC could remain at the nucleating complex or a 
small fraction may actually move along the nascent growing MTs and act to stabilise 
them as they elongate, as shown. (B) When APC is mutated, the C-terminal half of the 
APC proteins is lost thereby either attenuating the strength of its interaction with γ-
tubulin (*), or APC continues to bind to γ-tubulin but has a dramatically weakened 
function due to loss of the C-terminal end; both possibilities lead to reduced stimulation 
of centrosomal MT growth.  
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sequence that executes its ability to stimulate MT nucleation, such that while APC 
mutants complex with γ-tubulin, the power to nucleate and stabilise nascent MTs is 
significantly attenuated. How might loss of the APC C-terminus otherwise affect MT 
nucleation? Aside from reduced binding to other potential partners, one critical 
deficiency of truncated APC is that it does not directly bind or stabilise MTs due to loss 
of the “basic” domain (Munemitsu et al., 1994). Hence, one potential scenario is that 
APC normally binds -tubulin (to the -tuRC at the centrosome) through its N-terminus 
and employs its C-terminal “basic” domain to help recruit and stabilise - and -tubulin 
monomers as they assemble into nascent MT polymers. This might explain why APC 
mutants can bind -tubulin and locate at the centrosome, but lack functionality (Fig. 5.7).  
 Another possibility is that APC orients the MT asters at the centrosome once they 
are nucleated by γ-tuRCs since APC can mediate cell polarity (see section 1.4.1). 
Mechanisms involved in the directionality of aster MTs are not well understood, however 
APC seems to negatively regulate axonal branching through several domains. Chen et 
al showed that MTs in APC-null neurons are ‘disoriented’; that is, their growth was not 
directed towards the leading edge of the cells seen in control growth cones (Chen et al., 
2011). In APC knockout mice, the length and the number of axonal branching is three 
times the amount seen in control mice. However, this effect can be partially rescued by 
several APC domains (N-terminal domain before ARM; the ARM-domain with flanking 
regions on either side; EB1 binding domain) (Chen et al., 2011). With evidence found 
here that APC-γ-tubulin complexes are frequently cytoplasmic, and given their ability to 
regulate the cytoskeleton, it is logical that the two could be working together. However, 
as seen in Chen’s study and consistent with the fact that APC stimulates MT growth 
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rather than inhibits it (Chapter 4), it is likely APC is required to bind to additional proteins 
to regulate the cytoskeleton and its interaction with γ-tubulin is only one component of it.  
-tubulin stimulates the rate of APC recruitment to the centrosome 
It is unlikely that the depletion of APC would disrupt γ-tubulin dynamics since γ-tubulin is 
an integral protein of centrosomes and is probably meticulously regulated by more than 
one binding partner (Cho et al., 2010; Haren et al., 2006; Haren et al., 2009; Yokoyama 
et al., 2014). However, FRAP analysis in live HeLa cells showed that γ-tubulin depletion 
caused a significant delay in APC1-1309-GFP fluorescence recovery in the initial 30 s 
after bleaching (Fig. 5.6). This result is reminiscent of the FRAP curve of APC1-1309 
conducted in the presence of nocodazole (see Chapter 3 Figs. 3.9C and D). Given that 
knockdown of -tubulin only impacted on the mobile pool of APC, and caused a clear 
delay in recovery kinetics or “on-rate” at the centrosome, we speculate that APC 
associates transiently with -tubulin through weak affinity interactions. This makes 
sense in that a loss of strong affinity associations would be expected to have affected 
the retained pool of APC, which was not observed. The ability of -tubulin to mediate 
consecutive modest associations with the local APC pool could partly explain difficulties 
in defining a centrosome-localised interaction between these proteins by the Duolink 
technique. Further implications of -tubulin impact on APC dynamics and function will be 
explored in the general discussion (see Chapter 8). 
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5.3S SUPPLEMENTARY SECTION 
 
Figure S5.1 Enrichment for centrosomal proteins in U2OS cells. Cell extracts were 
optimised to extract the most amount of centrosome proteins using buffers previously 
used to isolate cytoplasmic and nuclear/membrane compartments. Proteins were 
separated using SDS-PAGE and the proteins listed above were used to assess the 
level of centrosome fraction enrichment using Western blot analysis. α-tubulin was used 
as loading control. The amounts of lysate loaded onto the SDS-PAGE was of ratio 2:1 
for cytoplasmic: nuclear fraction. The nuclear/membrane fraction appeared to show 
higher detection of centrosome proteins.  
 
Figure S5.2 The mapping of the γ-tubulin binding domain of APC (repeats). The 
method to map the binding domain of γ-tubulin to APC was performed as described in 
Fig. 5.3. Here are the two repeats of the same experiment which illustrates a similar 
trend are shown.  
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Figure S5.3 Alternative representation of the Duolink interaction between APC 
and γ-tubulin in U2OS and SW480 cells (representative graphs). Duolink interaction 
was performed between APC (Ab7) and γ-tubulin. Z-sections (3 x 0.75 µM thickness) 
was acquired using Olympus FV1000 confocal microscope. The number of dots per cell 
was manually scored. Cells were placed into groups based on the number of Duolink 
interactions found. These are representative graphs of two experimental repeats 
performed (>100 cells per condition per experiment).  Despite some background, there 
were more PLA dots per cell for the interaction between APC and γ-tubulin than controls 
with each antibody alone in both cell lines.  
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Figure S5.4 Depletion of γ-tubulin does not alter the accumulation of APC at the 
centrosome. (A) γ-tubulin was depleted in HeLa cells using siRNA for 48 h, followed by 
fixation by methanol:acetone. Immunofluorescence was used to detect APC at 
centrosomes using H290 poly-Ab and PCNT mAb respectively. Images were taken 
using confocal microscopy and the fluorescence intensity of APC at the centrosome 
was measured using Olympus FV-10 program. > 100 cells were scored from three 
independent experiments (FI units ± SD). No significant difference was found between 
γ-tubulin knockdown and control in the centrosome accumulation of APC. (B) The 
retention of APC after γ-tubulin depletion was assessed using the CSK retention assay 
(see Chapter 3). CSK detergent buffer was used to treat γ-tubulin depleted HeLa cells 
for 40 min to remove soluble proteins. Methanol: acetone was used to fix the cells 
followed by immunofluorescence and imaging as described in ‘A’. Fluorescence 
intensity of APC was measured at the centrosome in both cells treated with siRNA 
control and targeting γ-tubulin, with and without CSK treatment. > 100 cells were scored 
from three independent experiments per condition (FI units ± SD). There was no 
significant change in the retention of APC at the centrosome after γ-tubulin knockdown.  
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Figure S5.5 (Table) FRAP Summary of T1/2 and retention of APC1-1309 after siRNA 
induced depletion of γ-tubulin. Analysis of fluorescence recovery curves treated with 
either siCTRL or siγ-tubulin and overexpressed APC1-1309 at the centrosome.  The 
program Graphpad Prism 5 was used for analysis using the same method as described 
in chapter 3. (See Fig. S3.2 for details). 
APC with 
treatments 
Mobile pool 
(%) 
Retained pool 
(%) 
T1/2  - Fast pool 
(s) 
T1/2  - Slow pool 
(s) 
APC1-1309 
siCTRL 87.81 12.19 3.02 23.34 
APC1-1309 
siγ-tub 83.77 16.23 5.44 10.52 
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SUMMARY OF CHAPTER 6 
 
This chapter confirms that APC locates preferentially to the mother centriole and 
explores the relationship of APC with two key mother centriole proteins, ninein and 
CEP110. A range of experiments identify a pool of APC-CEP110 complexes that form at 
the centrosome. CEP110 is an integral protein of the centriole and localises to the 
mother centriole throughout the cell cycle. Ninein shows a similar localisation pattern 
but mostly accumulates at the MT anchoring sites at the mother centriole (subdistal 
appendages). The ability of these proteins to associate with APC and to affect its 
localisation and/or dynamic exchange rate at the centrosome was investigated.   
The ability of APC to bind ninein or CEP110 was examined by 
immunoprecipation (IP) and Duolink assays, and this approach revealed that both 
endogenous full-length APC (APC-FL) and APC truncated mutant (APC1-1337) 
associate with CEP110 in U2OS and SW480 cells, respectively. In particular, PLA 
signals produced by Duolink assay for APC-CEP110 complex could be detected 
specifically at the centrosome in U2OS cells, and to some extent at the growing 
microtubule (MT) aster after nocodazole treatment and washout. This implies a 
functional connection between APC and CEP110, possibly linked to MT nucleation. In 
contrast, APC did not display a clear or consistent association with ninein.  Finally, 
FRAP analysis in CEP110 depleted HeLa cells indicated that APC1-1309 dynamics are 
relatively unchanged compared to control cells.  When considered together, these 
findings demonstrate that APC associates with CEP110 in particular at the centrosome, 
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with a possible role in regulating the mother centrosome and MT growth.  
6.1 INTRODUCTION  
The mother centriole, the older of the centriole pair, plays an instructive role in cell 
geometry pertaining to cell polarity (Feldman et al., 2007), the anchoring of newly 
formed MTs (Bornens, 2002), and serves as a template for centriole biogenesis in 
centriole duplication (Loncarek et al., 2007; Rodrigues-Martins et al., 2007) (also see 
section 1.3). Several clues have suggested that APC could work with the mother 
centriole and contribute to these cellular operations. Firstly, APC has been linked to the 
regulation of cell polarity function through the polarity associated complex involving 
mPar3 (Shi et al., 2004; Zhou et al., 2004). The knockdown of APC-FL expression 
produces a delay in the nucleation of MTs (see Chapter 4), which could be the cause of 
inadequate MT anchorage at the centrosome immediately after its nucleation. 
Furthermore, APC has been detected at the mother centriole by immunofluorescence 
microscopy and 3D rendering of deconvolved cell images (Louie et al., 2004). That 
study, however, had certain limitations that hamper interpretation. For instance, the 
localisation was shown indirectly using an unorthodox mother centriole marker, p150 
glued/dynactin, to confirm EB1 localisation to the mother centriole, followed by a co-
staining of EB1 and APC. However, this is interesting in itself given that dynactin/dynein 
has been shown to anchor MTs at the centrosome (Louie et al., 2004; Quintyne et al., 
1999). It is believed that p150glue/dynactin recruits ninein to the subdistal appendage to 
organise the structure, and to anchor/stabilise de novo MTs at the minus end such that 
MT polymers can maintain directional elongation towards the cell cortex in interphase 
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cells (Burakov et al., 2008; Kodani et al., 2013; Moss et al., 2007). Secondly, the 
number of cells scored in the Louie (2004) study was too low to claim with confidence 
that APC preferentially localises at the mother centriole (Louie et al., 2004).  A more 
detailed characterisation of APC at the mother centriole is warranted.  
Ninein and CEP110 are centrosomal proteins found at the mother centriole 
throughout interphase (Abal et al., 2002; Guasch et al., 2000), and share similar but 
distinct localisation patterns each with their own unique function. Using a combination of 
techniques, including multi-colour staining aided by centrosome markers (CEP250 and 
M4491 that stain an array of centrosome proteins), and visualised using digital confocal 
microscopy combined with deconvolution, other studies refined the localisation of ninein 
and CEP110 to specific sites at the mother centriole. In HeLa cells, ninein and CEP110 
accumulate at, and cap the proximal and distal ends of the mother centrioles (and are 
partially and weakly detected at the daughter centriole) (Ou et al., 2002).  However, 
while ninein lines the outer region of the mother centriole barrel, CEP110 seems to line 
the inner edges of the mother centriole lumen, implicating a role in centriole structure or 
size (Azimzadeh and Marshall, 2010). Additionally, the study by Ou et al. (2002) 
showed that both proteins are spotted at the sites important for centriole duplication, but 
a functional study to illustrate and confirm this hypothesis is still lacking.  
 The function of ninein is better defined than that of CEP110. Observed using 
electron microscopy, ninein is closely associated with subdistal appendages of the 
mother centriole, a site that aids MT anchoring where it is thought to cap the minus-
ends of MTs (Mogensen et al., 2000). MTs nucleated by -tubulin ring complexes-
tuRCs) can either be anchored or released from the centrosome, and ninein, via its C-
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terminus may be responsible for the docking of -tuRCs and MTs to the subdistal 
appendage (Delgehyr et al., 2005; Keating and Borisy, 1999; Keating et al., 1997; 
Meads and Schroer, 1995; Mogensen, 1999). In depth analysis of APC binding to ninein 
would not only illuminate the specific structures of the mother centriole APC is localised 
to, but could render a possible explanation for the APC induced delay of MT nucleation 
as seen in chapter 4, with a link to MT anchorage. The function of CEP110 on the other 
hand, has not been studied in detail, but was found to consistently localise to the mother 
centriole throughout the cell cycle (Guasch et al., 2000). Thus, CEP110 and ninein were 
assessed for their ability to bind and regulate APC at the mother centriole.  
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6.2 MATERIALS and METHODS  
6.2.1 Cell Culture and transfection  
Human cancer cell lines HeLa, U2OS and SW480 were cultured in supplemented 
Dulbecco’s modified Eagle’s medium (DMEM) (see section 2.2.4.2).  For fixed cell 
experiments used for fluorescence microscopy cells were seeded onto coverslips in 6-
wells plates, 8-well chambers for Duolink assay and for FRAP cells were seeded into 2-
well chambers slide. At 16 h after seeding, cells were transfected with 2 µg plasmid 
DNA using Fugene HD (Promega) transfection reagent (see section 2.2.4.4). Cells were 
fixed and processed 30 h post-transfection for FRAP and Duolink assay. For 
immunoprecipitation experiments, cells were grown in T150 flasks and harvested at 
~80-90% confluence.  
6.2.2 Plasmids  
All plasmids used in this chapter are detailed in materials and methods section (Table 
2.6). 
6.2.3 Centriole retention assay 
To determine the retention of APC at the mother centriole of centrosomes, HeLa or 
SW480 cells were grown in 6-well trays on poly-L-lysine coated coverslips. Cells were 
washed with PBS at room temperature and treated with cytoskeletal (CSK) buffer for 0 
min, 8 min or 40 min. Detergent extraction (using CSK buffer) prior to fixation was used 
to determine strength of association with the centrosome, by costaining mouse mAb 
APC (Ab7) with rabbit poly-Ab CEP110 (see section 2.2.9). Immunofluorescence was 
performed as described above in 2.2.6. Slides were observed and localisation was 
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scored using an Olympus BX-51 fluorescence microscope at 60X magnification. Images 
were taken using a spot RT slider camera 23.1 as described.  
6.2.4 Protein extraction, immunoprecipitation and immunoblotting 
For centrosome protein enriched fractions the nuclear protein extraction protocol was 
adapted for protein extraction. Nuclear and cytoplasmic cell separation was performed 
using a protocol described by Tanaka’s team (as described in section 2.2.5.2)(Matsuda 
et al., 1995). Antibodies that was used to immunoprecipitate APC include monoclonal 
mAb Ab5 (see Table 2.3). 1 mg of nuclear/centrosome enriched extract was used for IP 
(see section 2.2.5.7). Membranes were processed for Western blot analysis (see 
section 2.2.5.6 and 2.2.5.7) using antibodies against CEP110, ninein and APC using 
Ab1 (see Table 2.3). Antibody against vinculin was used as loading control in 
knockdown experiments. Antibody dilutions are listed in Table 2.3.  
6.2.5 Proximity ligation assay (Duolink) 
The detailed procedure of the Duolink assay is detailed in section 2.2.8.1-2.2.8.2. The 
antibodies used for Duolink assay include : mouse mAb Ab7 (1:50) for APC and rabbit 
poly-Ab CEP110 and rabbit poly-Ab ninein (see Table 2.3). Both red and green Duolink 
kits have been used and results were pulled together.  
 To assess the direct binding of APC to CEP110 and ninein, EGFP or GFP-
tagged APC1-1309 was first overexpressed in cells for 48 h prior to fixation with 
methanol: acetone, followed by the Duolink assay as described in section 2.2.8.4. 
Rabbit poly-Ab or mouse mAb GFP was used to probe for GFP. To investigate specific 
protein interactions at the centrosome, the counter staining protocol was applied after 
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the Duolink assay using pericentrin (PCNT) A/B (mouse or rabbit) antibody or γ-tubulin 
(mouse or rabbit) as the centrosome marker, and α-tubulin as a marker for aster 
formation.  Centrosome specific interactions was carried out by following the 
counterstaining protocol after the Duolink assay (see section 2.2.8.3) using mouse or 
rabbit antibody against γ-tubulin as the centrosome marker.  
6.2.6 Fluorescence recovery after photobleaching (FRAP) 
FRAP was performed on HeLa cells transfected with GFP-tagged APC1-1309 described 
in section 2.2.3.4 that were pre-treated with various either control siRNA or CEP110 
targeting siRNA as described in section 2.2.4.4. RFP-PCNT-C241 was co-transfected to 
mark the centrosome in live cells. In experiments with drug treatments, cells were pre-
treated prior to performing FRAP  and FRAP was performed in the presence of the 
drugs (as detailed in 2.2.11). These data were then entered into Graph Pad Prism 5 for 
curve analysis (see sections 2.2.11.2 and 2.2.11.3). Fast and slow phase T1/2 values (for 
the first 40 s) and plateau values were determined and used to compare initial speed of 
recovery and the recovery percentage at the centrosome.  
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6.3 RESULTS  
APC was previously found to preferentially localise to the mother centriole (Louie et al., 
2004), therefore this study aimed to assess the retention and dynamics of APC at the 
mother centriole and to identify potential associated proteins there.  
6.3.1 APC localises and is retained at the mother centriole 
First, the localisation of APC to the mother centriole was confirmed by 
immunofluorescence microscopy. HeLa cells (express APC-FL) and SW480 cells 
(express mutant APC1-1337) were co-stained for APC (Ab7 mAb; green) and for the 
mother centriole marker, CEP110 (poly-Ab; red), to establish that both APC-FL and 
APC1-1337 are indeed at the mother centriole (Fig. 6.1), consistent with Louie’s 
previous study (Louie et al., 2004). CEP110 localises to the mother centriole throughout 
the cell cycle (Guasch et al., 2000). More than 300 cells were quantified using an 
Olympus BX-51 epifluorescence microscope, revealing that APC localised to the mother 
centriole in ~95% of cells (Fig. 6.1C; see control group). A second APC dot was often 
found adjacent to the mother centriole and presumed to reflect localisation of APC to 
the daughter centriole, however since it was not the focus of this study no quantification 
was performed.  
Next, to assess whether APC was retained at the mother centriole, cells were 
subjected to detergent extraction with CSK buffer (as described previously in Chapter 3 
Figs. 3.2 and 3.3). Cells were pre-treated with CSK buffer (see section 6.2.3) for either 8 
min or 40 min at 32oC to remove soluble proteins, followed by fixation using acetone: 
methanol, then immunofluorescence staining and microscopy analysis. As expected, 
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the overall detection of APC decreased as the soluble pool was progressively removed 
by the CSK detergent buffer (Fig. 6.1C).  After 8 min of treatment, APC localisation to 
 
Figure 6.1 APC locates and is retained specifically at the mother centriole. (A) 
HeLa and (B) SW480 cells were used to investigate the retention of full-length APC 
(APC-FL) and mutant (APC1-1337), respectively, at the mother centriole. Cells were 
seeded onto poly-l-lysine coated coverslips, followed by a treatment of No CSK buffer, 8 
min or 40 min of CSK at 32oC (for details see section 6.2.3). Cells were then fixed with 
methanol: acetone and stained for APC using Ab7 mAb (green) and CEP110 poly-Ab 
(red). (C) The retention of APC at the mother centriole was assessed by scoring for co-
localisation of APC and CEP110 (merged panels). Retention of APC at the mother 
centriole decreased to 20% after 40 min of CSK treatment. ‘CTRL’ represents the 
control group.  
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the mother centriole was reduced by two-fold, and by 40 min only 20-30% of APC 
remained localised at CEP110-positive centrioles in both cell lines (Fig. 6.1C). APC1-
1337 was slightly less retained at the mother centriole compared to APC-FL in HeLa 
cells, however the difference was statistically insignificant. The data reveal that under 
conditions where CEP110 is quite resistant to detergent and remains stuck at the 
centrosome, only a small pool of APC is stably retained at the mother centriole. 
 To determine whether CEP110 contributes to the anchoring of APC at the mother 
centriole, soluble proteins were removed using CSK detergent extract in cells treated 
with control or CEP110-specific siRNAs, and analysed by microscopy. This experiment 
revealed that localisation of APC at the centrosome (detected using -tubulin) was 
unaltered (Fig. S6.1). In fact, the APC concentration at the centrosome was unaltered 
by CEP110, and the amount retained at the centrosome was also unchanged. In 
summary, CEP110 does not appear to anchor APC to the centrosome.  
6.3.2 APC interacts with the mother centriole protein CEP110, but 
does not interact with the microtubule anchoring protein ninein 
The role of CEP110 is not well defined in interphase, however it is known to cap the 
distal ends of the mother centriole during centriole biogenesis (Ou et al., 2002). Ninein, 
however, is a protein that localises specifically at the subdistal appendages of mother 
centrioles and is responsible for MT anchorage (Delgehyr et al., 2005; Mogensen et al., 
2000). APC binding to these proteins was therefore tested to gather clues into the role 
of APC at the mother centriole by using IP and the Duolink assay as described in 
chapter 5.  
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Figure 6.2 APC interacts with mother centriole protein CEP110, but not ninein, in 
U2OS and SW480 cells. Enriched fractions (see section 6.2.4) of centrosome proteins 
were retrieved from U2OS (A,C) and SW480 (B,D) cells for immunoprecipitation (IP) of 
APC and associated proteins. Endogenous APC complexes were captured with Ab5 
mAb used to pull-down APC-FL and APC-mutant (1-1337). 50 µg of protein lysate was 
used for the input. Immunoprecipitated complexes were separated by SDS-PAGE 
followed by Western blot analysis. The presence of centrosome proteins in the complex 
was evaluated with specific antibodies against the known mother centriole proteins 
CEP110 (A,B) and ninein (C,D). Ab1 mAb was used to verify the pull-down of APC. 
CEP110 was found to interact with APC in U2OS cells, and also weakly detected in 
SW480. Ninein did not show any interactions with APC. Each experiment was repeated 
at least three times producing similar results and the figure shows two representative 
experiments (#1 and #2).  
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Immunoprecipitation assays: Centrosome enriched extracts were isolated from U2OS 
and SW480 cells (as performed in Chapter 5). Endogenous APC was 
immunoprecipitated with Ab5 mAb and the immunocomplexes separated by SDS-PAGE 
and analysed by Western blot (Fig. 6.2). APC was effectively captured in the pull-down 
and detected on the immunoblot by Ab1 mAb as bands of the expected size of ~320 
kDa in U2OS cells and ~143 kDa in SW480 cells. The APC blots were then probed with 
antibodies specific for CEP110 and ninein. A complex was immunoprecipitated between 
endogenous APC-FL and CEP110 in U2OS cell extracts, and this was consistently seen 
in multiple experiments (Fig. 6.2A). Interaction between CEP110 and mutant APC1-
1337, however, was not easily detectable by IP but could be seen after prolonged 
exposure of the autoradiograph (Fig. 6.2B). In contrast there was no evidence for an 
APC interaction with ninein using this approach (Fig. 6.2C & D). 
Proximity ligation assays: If APC is interacting with CEP110 or ninein specifically at 
the mother centrosome (Figs. 6.3D and 6.4D), the detection of the interacting 
complexes might be difficult by IP due to their low concentration. Hence a separate 
assay to test for APC protein interactions was undertaken using the Duolink assay (see 
section 6.2.5). For the assay, detection of an interaction between endogenous APC and 
CEP110 was achieved using specific primary antibodies: Ab7 mAb for APC and a 
CEP110 poly-Ab per reaction (Fig. 6.3). More than 200 cells were scored in over three 
independent experiments. Following the scoring system adopted in chapter 5 (see Figs. 
5.2 and 5.3), a positive signal was detected between APC-FL and CEP110. The PLA 
signals  detected  here  were  specific  relative  to  controls, but interestingly were low in 
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Figure 6.3 Interaction between APC and CEP110 detected by Duolink assay. The 
Duolink assay (green) was performed between APC and CEP110 in sub-confluent 
U2OS (A) and SW480 (B) cells. Images were acquired by confocal microscopy. The cell 
perimeter was identified using the DIC channel. Total number of PLA dots (green) per 
cell was scored. The experiment was performed three times and >200 cells were 
scored. (C) The graph is from a representative experiment showing the general pattern 
of Duolink dots. Control assays were performed using only the APC or CEP110 
antibodies. The use of both antibodies together generated a positive response, and 
more APC-CEP110 complexes were detected in U2OS than in SW480 cells.  (D) 
Schematic diagram showing that CEP110 locates along the mother centriole.  
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Figures 6.4 Duolink assay shows no binding between APC and ninein.  Duolink 
(green) assay was performed between APC and ninein (A-C) in sub-confluent U2OS 
and SW480 cells. Images were acquired using the confocal microscopy. The number of 
PLA dots (green) per cell was scored.  The experiment was performed three times and 
over 200 cells were scored. The graph is of a representative experiment showing the 
general pattern of PLA dots for each protein interaction. The number of PLA dots scored 
for APC to ninein interaction was not above background. (D) Schematic diagram 
showing that ninein locates at the subdistal appendages of the mother centriole.  
Chapter 6 
255 | P a g e  
 
number with an average of only 1-2 signals per cell (Fig. 6.3C). However these signals 
were consistent throughout the cell population and were significantly above background. 
On the other hand, APC1-1337 in SW480 cells generated even less PLA dots (0-1 dot 
per cell on average) with CEP110, suggesting that fewer complexes form. This finding is 
perhaps presented more clearly in supplementary Fig. S6.2 using an alternative 
graphical approach. In both cell lines, the number of PLA signals was above 
background. Since both APC1-1337 and CEP110 are well expressed in SW480 cells 
which would not account for the reduced number of APC-CEP110 interactions detected, 
the Duolink assay data suggests that mutant APC may bind less well to CEP110 in 
SW480 cells than in U2OS cells, a conclusion consistent with the IP data (Fig. 6.2). It is 
possible that the interaction between APC-FL and CEP110 is important in centriole 
biogenesis by capping the ends of the centriole, in which case this function might be 
weakened when APC is truncated (Fig. 6.3D).  
 The proximity ligation assay failed to detect a clear interaction between APC and 
ninein in both U2OS and SW480 cell lines. An average of less than one PLA signal was 
detected in each interaction and was not significantly higher in respect to the controls 
(Fig. 6.4). This data is consistent with the negative interaction detected by IP (Fig. 6.2). 
Ninein typically localises to the subdistal appendage of mother centrioles and is 
responsible for MT anchorage (Fig. 6.4D) (Mogensen et al., 2000). It was demonstrated 
in chapter 4 that the depletion of APC did not affect long-term anchorage of MTs, 
therefore the lack of APC interaction with ninein may be consistent with this lack of 
function. To further confirm these interactions an ectopic Duolink assay was performed 
in U2OS cells expressing GFP-tagged APC1-1309. We used Duolink assay to confirm 
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Figure 6.5  Ectopic APC1-1309 binds with endogenous CEP110 but not ninein. (A) 
EGFP or GFP-tagged APC1-1309 was overexpressed in U2OS cells and Duolink assay 
(red) was performed using GFP mAb and CEP110 poly-Ab. Transfected cells were 
marked by a counter stain using GFP mAb and alexafluor 488 mAb (green). (B) The 
number of PLA dots was scored per cell. The overexpressed APC1-1309 was found to 
interact with CEP110 with an average of 30 dots per cell, which was significantly higher 
than the controls. (C) Ninein on the other hand, did not show a significant change in the 
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number of PLA dots or cells with positive PLA signal. APC-FL and APC1-1309 was 
overexpressed in U2OS and SW480 cells, respectively, and Duolink (red) assay was 
performed between GFP mAb and ninein poly-Ab. EGFP was also used as control for 
both cell lines, only the control for U2OS is shown here (D) Quantification of the Duolink 
assay in U2OS and SW480 cells. Over 200 cells were scored in three independent 
experiments, in either case, a majority of the cells showed little to no PLA signal and 
was not above background controls.  
the modest interaction found between 1-1309 truncated APC and CEP110 in U2OS. 
The assay used a GFP mAb to detect the ectopic GFP-tagged APC proteins and 
CEP110 poly-Ab to detect endogenous CEP110. The amount of PLA signal produced 
by the APC1-1309-GFP and CEP110 interaction was very high compared to EGFP-
transfected control cells and the single antibody-reaction controls. U2OS cells displayed 
an average of 25-30 PLA dots per cell (Fig. 6.5A & B). In contrast, despite the 
overexpression of APC-FL-GFP and APC1-1309-GFP, the amount of PLA signal with 
ninein was not above background (Fig. 6.5 C & D). These data, together with the result 
from IP, confirms that APC-FL and APC1-1309 do not interact with ninein. In contrast, 
APC-FL, and to a lesser extent APC1-1337, does bind to CEP110.   
6.3.3 A pool of APC interacts with CEP110 specifically at the 
centrosome and can be detected at the growing microtubule 
aster 
The Duolink assay often detected only one endogenous APC-CEP110 complex per cell 
(Fig. 6.3), which would be most consistent with the interaction occurring at the 
centrosome, especially since CEP110 is mainly detected at centrosomes  (Ou et al., 
2002). To test this, the Duolink assay was performed again for APC and CEP110 
followed by counter stain of the centrosome using a γ-tubulin antibody. Over 150 cells  
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Figure 6.6  APC interacts with CEP110 at the centrosome. (A) The Duolink assay 
(green stain) was performed between APC (Ab7 mAb) and CEP110 (poly-Ab) in both 
U2OS and SW480 cells. To locate the centrosomes, cells were counter stained to 
detect γ-tubulin as indicated (red). (B) Optical z-sections (0.75 µM x 2) were acquired by 
confocal microscopy and each cell with a positive PLA signal was scored for 
centrosome localisation. Over 200 cells were scored in three independent experiments. 
The localisation of the PLA signal to the centrosome was scored and converted to a 
percentage (% ± SD). APC-CEP110 complexes were found at the centrosome in 17% 
of U2OS cells scored. An average of 5% was found in SW480 cells. The amount of PLA 
signal found between APC and CEP110 was significantly higher than controls in both 
U2OS (P=0.0003) and SW480 (P=0.0307).  
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Figure 6.7 APC-CEP110 complexes can be detected at the nucleating microtubule 
aster. U2OS cells were treated with 33 M of nocodazole for 1 h followed by a wash out 
in drug-free medium. Cells were grown at 25oC for 7 min, then fixed with methanol: 
acetone. The Duolink assay was performed using antibodies specific for APC (Ab7) and 
CEP110 (green). Cells were counter stained with -tubulin mAb (red). 40% of cells were 
positive for a Duolink reaction between APC and CEP110, of which 5% displayed a 
clear positive reaction directly at the growing aster. The total population of cell scored 
was n=200. 
were scored for each condition and only cells with a positive PLA signal were selected 
for scoring of centrosome co-localisation (Fig. 6.6A). As anticipated, a clear pool of 
APC-CEP110 complexes were indeed detected at the centrosome (Fig. 6.6). 
Interestingly, the detection of complexes at the centrosome was not that high (~17%) in 
U2OS cells but well above background controls (P=0.0003) (Fig. 6.6B). There have 
been no previous reports on CEP110 and its localisation at cellular structures other than 
Chapter 6 
260 | P a g e  
 
the centrosome. Thus, it is possible that many of the centrosomal APC-CEP110 
complexes remain undetected due to masking of the APC or CEP110 antibody binding 
epitopes. Again, in SW480 cells the mutant APC1-1337-CEP110 complexes could be 
detected at the centrosome but only in small percentage of cells (~5%) but statistically 
significant (P=0.0307) (Fig. 6.6A). The main finding is a positive one, and this is the first 
evidence for a specific complex between APC and CEP110 occurring at the mother 
centriole.  
 Previously in chapter 4, the truncation of APC was shown to significantly slow 
down the rate of MT aster formation, and since APC was found here to be retained at 
mother centrioles and to interact with CEP110 at this site, there could be a relationship 
between the two observations. To test whether APC-CEP110 complexes could also be 
detected at centrosomes actively nucleating a new MT aster, a complex experiment was 
performed, combining the MT regrowth assay with the proximity ligation assay. First, 
U2OS cells were treated with 33 µM of nocodazole for 1 h, released into drug-free 
media then incubated at room temperature to allow MT regrowth and fixed after 5 min 
with methanol: acetone. The Duolink assay (green dots) was then used to evaluate the 
interaction between APC and CEP110 followed by staining of new MTs using α-tubulin 
antibody (red) (Fig. 6.7A). This complicated experiment was only performed once, 
scoring >200 cells. The data showed that APC-FL-CEP110 complexes can actually be 
detected in cells at centrosomes at the point of aster formation (Fig. 6.7A). However, 
only 5% of cells showed that this PLA signal was specific and the low level of detection 
was anticipated from the rigorous pre-treatment and MT depolymerisation of the cells 
(Fig.  
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Figure 6.8 CEP110 loss does not affect APC movement to the centrosome. A live 
cell FRAP experiment to track the effect of CEP110 on APC dynamics at the 
centrosome. (A) CEP110 was silenced in HeLa cells by siRNA, followed by the over 
expression of APC1-1309-GFP. Using the confocal microscope, FRAP of APC1-1309 at 
the centrosome was performed in live cells with the marker RFP-PCNT-C241 (see also 
Chapter 5, Fig. 5.6 for details). (B) Fluorescence recovery curves of cells exposed to 
control siRNA (n=7) and CEP110 siRNA (n=7).  Pre-bleached images were taken as a 
baseline. The centrosome marker was used to locate the centrosome and the GFP was 
bleached at this region for 3 s. Subsequent images were acquired every 3.4 s for 40 s. 
Post-FRAP analysis was performed using Graph Pad Prism 5 program to compare the 
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fluorescence recovery of APC1-1309 before and after CEP110 depletion. (C) 
Knockdown of CEP110 was confirmed by Western blot and immunofluorescence (See 
Fig. S6.3). Vinculin was used as a loading control. Measurements of (D) T1/2 and (E) 
centrosome retention of GFP-tagged APC1-1309 showed no significant difference 
between siCTRL and siCEP110 treated cells.  
6.7B). This preliminary, finding indicates that, at least in a sub-population of cells, APC-
CEP110 complexes reside at the mother centriole in the vicinity of new and actively 
forming MT asters. This result suggests that the complex contributes to MT regrowth. 
6.3.4 APC dynamics are unaffected by CEP110 depletion  
In chapter 5, it was observed that the depletion of γ-tubulin caused a delay in the 
dynamic recovery rate of APC1-1309 at the centrosome. Since APC interacts with 
CEP110 at the centrosomes, here the effect of CEP110 silencing on APC1-1309 
dynamics and retention was explored. Similar to the previous experiment with γ-tubulin 
depletion (Chapter 5, Fig. 5.6), HeLa cells were treated with CEP110 siRNA and APC1-
1309 dynamics was compared with control cells (Fig. 6.8A and B). The quality of 
knockdown was verified by Western blot analysis conducted in parallel with each FRAP 
analysis experiment, and showed a ~50% CEP110 knockdown, with vinculin used as 
loading control (Fig. 6.8C). Immunofluorescence staining of CEP110 in HeLa cells 
treated with either control or CEP110 siRNA revealed an obvious depletion at the 
centrosome, which confirms there was adequate CEP110 knockdown (Fig. S6.3). 
Surprisingly, the CEP110 depletion did not alter the fluorescence recovery of truncated 
APC at the centrosome (Fig. 6.8B). Moreover, measurements of T1/2 (Fig. 6.8D) and the 
percentage of the retained APC fraction convincingly show that CEP110 does not affect 
APC1-1309 mobility or anchorage at the centrosome (Fig. 6.8E).   
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6.4 DISCUSSION  
APC has been shown to preferentially localise to the mother centriole (Louie et al., 
2004), however little is known of its function there in interphase or of the protein 
complexes it forms. A characterisation of APC dynamics revealed that only 20-30% of 
the total centrosomal APC pool is stably retained when examined in situ or in vivo 
(Chapter 3). As shown in Fig. 6.1, the majority of the retained pool of full-length or 
mutant APC appears to be localised to the mother centriole. The fact that even 
truncated APC is well retained at the mother centriole suggests that the retention sites 
or anchorage partner binding sites lie within the N-terminal half of the protein.  
 To elucidate the functional role of APC, two mother centriole proteins CEP110 
and ninein were selected for binding analysis. Selection was based on localisation and 
characterised functions. CEP110 consistently locates at the mother centriole throughout 
the cell cycle in HeLa cells and has been implicated in centriole maturation (Guasch et 
al., 2000; Ou et al., 2002).  Similarly, while ninein has also been linked to a role in 
centriole maturation, it is better characterised in its localisation to the subdistal 
appendage of the mother centriole and role in anchoring newly formed MTs (Moss et 
al., 2007; Ou et al., 2002). Both proteins were tested for binding to APC by IP assay 
with centrosome enriched cell lysates (see Fig. S5.1) and with the proximity ligation 
assay, with very interesting results. APC was found to interact with CEP110 but not 
ninein (Figs. 6.2 to 6.4). The lack of interaction with ninein is somewhat consistent with 
results from chapter 4, where it was found that the knockdown of APC by siRNA did not 
alter MT anchorage in untreated cells or in cells treated with nocodazole and fixed 40 
min after drug washout. However, a previous study did demonstrate that other Wnt-
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response proteins, axin and β-catenin, play a role in MT anchoring and exhibit a 
connection with ninein. For instance, axin was shown to bind to ninein in purified 
centrosome extracts from HeLa S3 cells, while depletion of β-catenin caused a reduced 
accumulation of ninein at the centrosome of 3Y1 cells (Fumoto et al., 2009; Huang et 
al., 2007).  Here, the binding between APC and ninein was consistently negative by IP 
in both U2OS and SW480 cell lines. This was further confirmed by the Duolink assay 
where even the overexpression of APC-FL-GFP and APC1-1309-GFP showed no 
significant amount of PLA positive interaction above background, leading to the 
conclusion that APC does not detectably bind to ninein. In terms of pin-pointing the 
intra-centrosomal location of APC, since ninein only localises to the subdistal 
appendages of the centrosome (Delgehyr et al., 2005), the lack of association/proximity 
with APC suggests that APC may localise to other regions of the mother centriole away 
from the subdistal appendages.  
 CEP110 seemed a promising candidate for testing initially because of its 
localisation patterns in the cell cycle. First identified by Guasch and colleagues as a 
fusion form protein in leukaemia, CEP110 was found to localise to the mother centriole 
via its C-terminal domain (amino acids 617-787) throughout most of the cell cycle 
including prophase in mitosis, but disappears during metaphase only to reappear after 
division (Guasch et al., 2000). CEP110 is often confused in the literature with the 
centriolin protein that expresses as a 270 kDa protein and localises to the midbody. 
Centriolin facilitates the abscission of duplicated cells at cytokinesis by localising 
endobrevin to the site of abscission, at the cleavage furrow (Gromley et al., 2003; 
Guasch et al., 2000; Rannou et al., 2012). CEP110 shares homology with the C-
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terminus of centriolin (Gromley et al., 2003), however any functional similarities have 
not been defined. In this study, the antibody used targets CEP110 between amino acids 
2026-2325, a domain shared with centriolin. Since only a 110 kDa band was detectable 
by Western blot, the data interpreted would only apply to CEP110. CEP110 is not 
particularly abundant in the cell, localising only to the centrosome, therefore any 
interaction with APC might be predicted difficult to detect by IP. Despite this concern, 
using an APC mAb, Ab5, endogenous APC-FL was able to be detected as a complex 
with CEP110 in U2OS cells. These interactions were equally easy to detect by Duolink 
assay where an average of 1-2 PLA signals were detected per cell (Fig. 6.3). Further 
analysis by co-staining for centrosomes following the Duolink assay indicated that ~20% 
of PLA positive cells displayed a clear interaction between APC-FL and CEP110 at the 
centrosome.  
 In one study using digital confocal microscopy and deconvolution of optical 
sections, CEP110 and ninein were both shown to localise to specific sites of the 
maturing centriole (Ou et al., 2002). CEP110 caps the ends of the mother centriole at 
G1, then disappears in mitosis and reappears when cell division is complete, which is 
suggestive of a structural or organisational role in reforming centrosomes. More 
importantly, both CEP110 and ninein associate with the open end of the centriole tube 
throughout interphase; this is the site of centrosome duplication and implicates these 
factors in the maturation of the centriole (Ou et al., 2002). The finding that APC 
associates with CEP110 at the centrosome could indicate an unexpected role of APC in 
centriole maturation and future experiments to test this possibility would be interesting. 
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To determine if the truncation of APC affects it’s binding to CEP110, IP and PLA 
were used to assess the interaction in SW480 cells. By the Duolink assay, consistent 
PLA signals were detectable at low concentrations with an average of one signal per 
cell, which would explain the false negative result in the IP at times (Fig. 6.2 and 6.3). 
However, Duolink detection of interactions between the overexpressed APC1-1309-
GFP with endogenous CEP110 displayed a highly amplified signal, revealing that the 
CEP110 expression is not rate-limiting in the assay, and that at least part of the 
CEP110 binding domain is common to the full-length and truncated forms of APC. 
When highly overexpressed, APC1-1309-GFP formed up to 40 detectable CEP110-
positive PLA complexes per cell, distributed around the cytoplasm suggesting that the 
two proteins can interact at sub-cellular sites other than the mother centriole, at least 
when the availability of APC is increased (Fig. 6.5).   
The CEP110 protein possesses various coiled-coil domains, a common 
characteristic of centrosome proteins such as PCNT and CP-NAP, and primarily 
accumulates at the centrosome (Guasch et al., 2000). However, in cancer cells when it 
is abnormally expressed as a fusion protein as seen in chronic myeloproliferative 
syndrome, the endogenous CEP110-FGFR1 fusion peptide is predominantly detected in 
the cytoplasm and not at the centrosome (Cross and Reiter, 2002; Guasch et al., 2000). 
How mobile the normal CEP110 is in other cancer cells is yet to be characterised, 
although in the cell lines studied here it appeared quite restricted to the mother 
centriole. The truncation of APC often seen in colorectal cancer cells (such as SW480 
cell line studied here) is unlikely to abolish the ability to bind to CEP110, however 
localised centrosome interactions between APC1-1337 and CEP110 appeared to be 
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less frequent than for APC-FL (Fig. 6.6), suggesting that the lost C-terminus could 
contain a functional domain that contributes to APC interaction with CEP110 at the 
mother centriole.  
 Although APC interacts with CEP110 at the mother centriole, the experiments in 
this chapter indicate that CEP110 is unlikely to be a key anchoring protein, and to 
contribute to the retained APC pool. Firstly, the depletion of CEP110 did not quell the 
ability of APC to accumulate and be retained at the centrosome. Moreover, FRAP 
analysis after the knockdown CEP110 at the centrosome revealed a fluorescence 
recovery pattern no different from cells transfected with control siRNA in live cells (Fig. 
6.8 A and B). Admittedly, the silencing of CEP110 did not appear as effective as that 
seen for other proteins (reached a maximum of 50%), however immunofluorescence did 
display a marked reduction in centrosome dots when treated with CEP110 siRNA (Fig. 
S6.3). Additionally, the FRAP assay is highly sensitive and would detect some change if 
CEP110 is responsible for APC anchorage. CEP110 itself actually does appear to 
remain stably anchored at the centrosome as indicated by its resistance to detergent 
extraction (Fig. 6.1). However, some other mother centriole localised proteins such as 
ninein and nudel display a very dynamic exchange at the centrosome, and when 
examined by FRAP analysis in living cells were found to recover rapidly to 100% of the 
pre-bleach intensity (Guo et al., 2006; Moss et al., 2007). At this point the conservative 
conclusion is that APC-CEP110 complexes can form at the mother centriole, and in 
some cases locate there at the time new MTs are nucleating, however I was unable to 
demonstrate that CEP110 mediates the retention of APC at these structures. Together 
with the fact that only a small population of APC actually interacts with CEP110 directly 
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at the centrosome, it is unclear at this stage whether their interaction regulates MT 
nucleation or other centrosome processes. This study forms the basis of further 
experiments aimed at assessing the functional implications of this novel protein 
interaction.  
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6.3S SUPPLEMENTARY  
 
Figure S6.1 CEP110 depletion had no effect on APC localisation at the 
centrosome. HeLa cells were first treated with either control siRNA or siRNA targeting 
CEP110 for 48 h. CSK detergent buffer (for 40 min) was used to remove soluble 
proteins before fixation using methanol: acetone. Immunofluorescence was used detect 
APC using Ab7 and γ-tubulin. No detergent extraction was performed in control cells. 
Images were acquired by confocal microscope. (A) The localisation of APC to γ-tubulin 
was scored and converted to a percentage (>100 cells per condition pooled from at 
least three experiments). (B) The fluorescence intensity of APC remaining after CEP110 
depletion and CSK buffer treatment was measured at the centrosome using γ-tubulin as 
a guide. CEP110 depletion did not significantly change the localisation nor the retention 
of APC at the centrosome.   
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Figure S6.2 Alternative representation of the Duolink interaction between APC 
and CEP110 in U2OS and SW480 cells (representative graphs). Duolink interaction 
was performed between APC (Ab7) and CEP110. Z-sections (3 x 0.75µM thickness) 
was acquired using Olympus FV1000 confocal microscope. The number of dots per cell 
was manually scored. Cells were placed into groups based on the number of Duolink 
interactions found. These are representative graphs of two experimental repeats (#1 
and #2) performed (>100 cells per condition per experiment).  There were more PLA 
dots per cell for the interaction between APC and CEP110 in both cell lines.  
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Figure S6.3 Confirmation of siCEP110 at the centrosomes. An immunostaining 
performed in parallel to FRAP experiment in Fig. 6.8 to further confirm that the reduction 
in CEP110 staining was sufficient. HeLa cells were either treated with control siRNA or 
siRNA targeting CEP110 for 48 h. Methanol:acetone was used to fix the cells followed 
by immunostaining using CEP110 poly-Ab. DAPI was used to locate cellular staining as 
CEP110 only accumulates at the centrosome. Around 70-80% of cells showed a 
marked reduction in CEP110 staining in CEP110 depleted cells.  
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SUMMARY OF CHAPTER 7
 
The knockdown of full-length APC (APC-FL) expression slows the nucleation and 
growth of microtubules (MTs) (Chapter 4), however the interaction with γ-tubulin and 
CEP110 are maintained even after APC truncation (Chapters 5-6). More importantly, 
the centrosome targeting domain was fine-mapped to the N-terminal APC-Armadillo 
(ARM) region (Chapter 3), suggesting that this sequence is likely to bind proteins 
involved in centrosomal targeting 
 To better understand the role of APC from the perspective of centrosome 
regulation, a glutathione-S-transferase (GST) tagged ARM fragment was expressed in 
bacteria and purified for use as bait in a mass spectrometry screen for novel APC 
binding partners. New binding partners were identified, including the centrosome-
associated proteins pericentrin-B (PCNT-B; also known as kendrin), NuMA and MT- 
associating protein 1B (MAP1B), all of which have roles in centrosome or MT regulation. 
Their association with APC was confirmed by immunoprecipitation (IP). A further 
preliminary characterisation of NuMA and PCNT-B was performed in the context of APC 
localisation/dynamics at the centrosome.  
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7.1 INTRODUCTION  
The rate of MT growth from nucleation to elongation is significantly reduced when APC 
is truncated (see Chapter 4), most likely due to loss of key functional domains such as 
the APC-basic domain that binds and stabilises the cytoskeletal MTs and actin filaments 
(see section 1.2.1). Despite this loss of functionality, most N-terminal fragments of APC, 
including the predominant colorectal cancer (CRC) mutant form APC1-1309, continue to 
localise at the centrosome (Chapter 3). More importantly, the APC1-1309 mutant 
displayed almost identical rates of dynamic exchange and retention as APC-FL at the 
centrosome, indicating that the primary protein interactions that determine on/off-rates 
are mediated by N-terminal sequences. Therefore, this chapter was aimed at using a 
proteomic approach to more directly, and systematically search for such 
localisation/mobilisation regulatory factors that bind within the armadillo (ARM) domain 
sequence. 
 The ARM-domain of APC is important for mediating interaction with a number of 
different protein partners, several of which influence APC sub-cellular localisation and 
function. Firstly, the APC-ARM directly interacts with the kinesin superfamily and can 
travel along MTs by binding to KIF3A-KIF3B via its binding partner KAP3A (Jimbo et al., 
2002). Secondly, actin control of cell adhesion and migration is stimulated by the ARM- 
domain through its binding to the Rac/Rho exchange factor, ASEF, and also through 
association with IQGAP1. In fact, the mutant APC showed stronger stimulation of cell 
migration by stimulating ASEF1 (Akiyama and Kawasaki, 2006; Kawasaki et al., 2003; 
Watanabe et al., 2004). Finally, the APC-ARM is an intrinsically flexible domain that can 
modulate binding to a diverse range of proteins. This is a general characteristic of ARM 
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repeats which is also seen in the ARM repeats of β-catenin (Zhang et al., 2011).  In 
studies using X-ray crystallography to map the structure of  the APC-ARM domain, the 
region of APC407-775 showed that the N-terminal component was able to rotate by 4o 
thereby  accommodating its binding partners (Zhang et al., 2011). Additionally, a recent 
study found that the seven repeats on the APC ARM (residues 396-732) formed an L-
shaped super-helix with a relatively large groove lined with positive charges, and can 
accommodate a polypeptide chain (Morishita et al., 2011). A closer study into ARM 
binding partners is warranted to help define the proteins that influence APC localisation 
at the centrosome, and potentially any co-factors that help regulate MT nucleation or 
serve additional as yet undefined functions of truncated APC mutants.  
This chapter focuses on searching for novel binding partners of the APC-ARM by 
combining protein purification and mass spectrometry, with a focus on larger proteins. 
To study APC-ARM binding partners, a GST fusion construct of ARM-GST (446-880) 
previously used successfully for protein screening (Kawasaki et al., 2003) was 
employed for screening of cell extracts. Interestingly, the APC-ARM was found to bind 
to an important regulatory protein of the centrosome, PCNT-B, among other proteins 
involved in mitotic spindle regulation and MT dynamics regulation.  
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7.2 MATERIALS and METHODS  
7.2.1 Protein purification and optimisation  
The protocol for protein purification is detailed in section 2.2.12. See Figure 7.2 and 
supplementary section for details of protocol optimisation.  
7.2.2 Cell Culture and transfection  
Human cancer cell lines HeLa, HCT116, U2OS and SW480 were cultured in 
supplemented Dulbecco’s modified Eagle’s medium (DMEM) (see section 2.2.4.2).  For 
fixed cell experiments used for fluorescence microscopy cells were seeded onto 
coverslips in 6-wells plates. At 16 h after seeding, cells were transfected with 3 µg of 
siRNA using Lipofectamine 20000 transfection reagent (see section 2.2.4.4). Cells were 
processed 30 h post-transfection for cytoskeletal (CSK) extraction assay and fixed as 
described in section 2.2.6.1 
7.2.3 Immunofluorescence microscopy 
Centrosomal protein immunostaining was performed as previously described in section 
2.2.6.2 using the following primary antibodies: rabbit poly-Ab NuMA and mouse mAb 
Ab7, and mouse or rabbit -tubulin as centrosome markers (see Table 2.3 for dilutions). 
For centrosomal scoring, accumulation at the centrosome above the background 
cytoplasmic fluorescence was scored as positive localisation. Slides were observed and 
optical sections were imaged using Olympus FV1000 confocal microscope at 60X 
magnification as described in section 2.2.6.3. Analysis of localisation and scoring was 
performed using the Olympus Fluoview Version 1.6a software. For each experiment, an 
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average score was obtained from over three individual experiments, and at least 100 
cells were scored for each treatment.   
7.2.4 Plasmids  
All plasmids used in this chapter are detailed in materials and methods section (Table 
2.6). 
7.2.5 Mitotic centrosome retention assay  
To determine the retention of APC at centrosomes, U2OS or SW480 cells were grown 
in 6-well trays on poly-L-lysine coated coverslips. Transfection of siRNA targeting NuMA 
is as described in section 7.2.2. Cells were washed with PBS at room temperature and 
treated with CSK buffer for 0 min, 8 min or 40 min. Detergent extraction (using CSK 
buffer) prior to fixation was used to determine strength of association with the 
centrosome, by co-staining APC (Ab7) with -tubulin (see section 2.2.9). 
Immunofluorescence was performed as described above in 3.2.3. Scoring of slides is as 
described in 7.2.3. Here, only mitotic cells were scored.  
7.2.6 Protein extraction, immunoprecipitation and immunoblotting 
Antibodies that was used to immunoprecipitate APC include mouse mAb Ab5 and rabbit 
poly-Ab C20 (see Table 2.3). Antibodies used for immunoblotting in this chapter include: 
goat polyclonal against GST, mouse mAb PCNT-A/B, mouse mAb Ab1, rabbit poly-Ab 
PCNT-B, rabbit poly-Ab NuMA and rabbit poly-Ab vinculin. See section 2.2.5.7 for full 
details of immunoprecipitation protocol (see Table 2.3).  
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7.2.7 Proximity ligation assay (Duolink) 
The detailed procedure of the Duolink assay is detailed in section 2.2.8.1-2.2.8.2. The 
antibodies used for Duolink include : mouse mAb Ab7 (1:50) for APC and rabbit or 
mouse PCNT-A/B. Both red and green Duolink kits have been used and results were 
pulled together.  
 To assess the direct binding of APC and γ-tubulin, EGFP, GFP-tagged APC1-
1309 or APC-FL was first overexpressed in cells for 36 h prior to fixation with methanol: 
acetone, followed by the Duolink assay as described in section 2.2.8.4. Rabbit poly-Ab 
or mouse mAb GFP was used to probe for GFP. To investigate specific protein 
interactions at the centrosome, the counter staining protocol was applied after the 
Duolink assay using γ-tubulin (mouse or rabbit) antibody as the centrosome marker.  
(see section 2.2.8.3). 
 
.  
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7.3 RESULTS  
7.3.1 Purification of APC-ARM-GST in preparation for mass 
spectrometry analysis  
APC-ARM-GST fusion protein was purified from bacterial (BL-21) lysates using 
glutathione affinity chromatography. BL-21 is an E.coli strain that is protease deficient 
and therefore improves expression of the fusion protein. In this process, the fusion 
protein was first induced to express in bacteria, and then extracted following cell lysis. 
The lysate containing APC-ARM-GST was subjected to affinity purification on a column 
of sepharose beads, and APC-GST protein eluted with buffer containing 50 mM 
glutathione. The concentration and presence of APC-ARM-GST was analysed by SDS-
PAGE on a 10% gel followed by Coomassie stain, in parallel with Western blotting 
probed with goat antibody to GST. In both gels a 74 kDa band was identified in eluate 4 
only clearly visible when 5 µL was loaded (Fig. 7.1A). A 25 kDa band representing GST 
cleaved off the fusion protein was also visible.  
The process of APC-ARM purification and in vitro binding suffered from low 
protein yields, therefore each step was meticulously optimised before the pull-down 
experiment with cell lysate (U2OS). To optimise the yield of APC-ARM-GST in bacteria, 
a range of temperatures (25oC, 32oC or 37oC), time of induction (to achieve an OD of 
0.5 or 1.0) and concentrations of IPTG were compared (see Fig. S7.1). Initially, bacterial 
extracts displayed very low yield of ARM-GST detected in the supernatant after lysis, 
presumed to arise from formation of inclusion bodies (eg. from mis-folded proteins) that 
precipitated   in   the  pellet  (Kopito, 2000; Markossian and Kurganov, 2004).  Previous 
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Figure 7.1 Confirmation of APC-ARM-GST  expression by Coomassie staining and 
Western blot. (A) The GST-tagged APC-ARM fragment (Kawasaki et al., 2003) was 
transformed as a plasmid (pGEX-5X-1) into BL-21 cells, expression was induced, and 
bacterial extracts were purified from a column containing glutathione sepharose 4B 
beads. Eluates were collected and expression of the APC-ARM construct was validated 
by Coomassie blue staining and Western blot. Coomassie staining revealed a clear 
band in eluate 4. The expressed protein was further confirmed by Western blot 
detection using goat antibody to GST to detect ARM-GST and a small of amount of 
cleaved GST protein at 25 kDa. (B) Flow chart to show a structured plan of optimisation 
to efficiently express and purify the ARM-GST protein to be used for mass spectrometry 
analysis. 
Chapter 7 
281 | P a g e  
 
 
 
Figure 7.2 The optimisation of detergents to improve the yield of APC-ARM-GST 
from bacteria. (A) ARM-GST was induced at 37oC in bacteria using 1 mM IPTG and 
expression optimised by use of sarkosyl (amphiphilic ionic surfactant). Different 
concentrations of sarkosyl were added to the bacterial lysis. The pellet (P) was 
solubilised using Laemmli buffer and the concentration of ARM-GST extracted was 
analysed in parallel with the corresponding supernatant by SDS-PAGE followed by 
Coomassie stain and Western blot. A minimum of 2% sarkosyl was required to 
solubilise ARM-GST as shown. (B) The combination of Triton X-100 and sarkosyl was 
tested to yield the highest concentration of purified ARM-GST. The GST fusion was 
then eluted from the bacterial supernatant. (C) A mixture of Triton X-100 and CHAPs 
was tested to improve binding of ARM-GST to glutathione sepharose beads.  Bacterial 
supernatant was treated with various concentrations of CHAPs and Triton X-100 and 
both beads and eluate were analysed. The combination of 2% Triton and 40 mM 
CHAPs yielded the highest amount of protein binding to beads and was therefore 
selected for use (see section 7.2.1 and 2.2.12).  
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studies had utilised a mix of detergents including sarkosyl, an ionic surfactant, to 
solubilise inclusion bodies in bacterial lysates (Frangioni and Neel, 1993; Frankel et al., 
1991). Various concentrations of sarkosyl were thus tested. The supernatant and pellet 
were compared for quality of APC-ARM-GST extraction by Coomassie staining and 
Western blots to identify the 74 kDa fusion protein. A minimum of 2% of sarkosyl was 
required for the solubilisation of aggregates of APC-ARM-GST from the protein pellet 
(P) into the supernatant (SN) (Fig. 7.2A). High concentrations of sarkosyl were avoided 
as its presence in the lysate can inhibit protein binding to the glutathione-resin coated 
column (Tao et al., 2010). Since sarkosyl reduced the binding affinity for purification, 
various concentrations of Triton X-100 was added into the sarkosyl containing lysates 
(Tao et al., 2010), however the mix of the two ingredients alone was insufficient for 
protein binding (Fig. 7.2B).   
 Next, as suggested by Tao’s study, CHAPs (a zwiterion detergent) can work 
synergistically in protein purification and was therefore incorporated here (Tao et al., 
2010). The amount of CHAPs was optimised in combination with Triton X-100 allowing 
for efficient binding of proteins to the glutathione beads (see Fig. 7.2C and section 
7.2.1). The final concentration of optimised detergents was: 40 mM CHAPs ,  2% Triton 
X-100 and 2% sarkosyl. The APC-ARM-GST showed a high affinity to the glutathione 
resin, making its elution difficult, therefore APC-ARM-GST bound beads were directly 
incubated with U2OS lysates to capture and identify potential new binding proteins (Fig. 
7.3). The GST control peptide was expressed from pGEX vector in bacterial lysates in 
parallel to APC-ARM-GST, lysed and purified using gluthione-sepharose beads, which 
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were collected and washed with a stringent buffer to reduce the amount of non-specific 
binding proteins to beads in preparation for protein pull-down (Fig. S7.2).   
7.3.2 Preparation of U2OS lysate for in vitro APC pull-down 
experiment 
U2OS total cell lysates were prepared using two different lysis buffers “RIPA” and a 
“mild- RIPA buffer” containing 0.5% of NP40, to confirmed detection of key centrosomal 
proteins such as PCNT and γ-tubulin (Fig. S7.3). U2OS cell lysates were sonicated 
before lysis to improve protein yield. The APC-ARM-GST or GST coated glutathione-
sepharose beads were independently mixed with U2OS cell lysate. The protein 
complexes bound to the beads were then extracted using Laemmli buffer and proteins 
were separated on a commercial gradient 4-15% SDS-polyacrylamide gel. Beads were 
also processed in the absence of cell lysate as a negative control. Purified protein 
mixed with lysates from RIPA buffer and mild-RIPA buffer were run on independent 
precast gels (Biorad) and stained with Coomassie blue; bands A and C were extracted 
as well as their controls B and D, respectively, and used for mass spectrometry analysis 
by our collaborator A/Prof Mark Molloy (Fig. 7.3).  
7.3.3 Identification of novel APC-ARM domain binding proteins by 
mass spectrometry  
Mass spectrometry analysis of both gel bands were pooled and summarised in Fig. 7.4 
in the form of a table that includes the mascot score retrieved from the analysis. This 
score is indicative of the level of confidence in the prediction of the  identified  binding  
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Figure 7.3 Pull-down of proteins in total U2OS extract with GST-tagged APC-ARM. 
ARM-GST protein was induced in BL-21 E.coli using 1 mM of IPTG. ARM-GST or GST 
alone (CTRL) was then coated onto 5 L of glutathione beads (previously equilibrated 
using STE buffer) overnight at 4oC (sample 4 and 5).  A parallel set of ARM-GST and 
GST coated beads (sample 2 and 3) was then mixed with U2OS total cell extract (1 mg) 
lysed with either RIPA (A) or mild-RIPA (B) lysis buffer, and incubated for 3 h at 4oC 
rotating. Bait-prey protein complexes were first washed with either RIPA or mild RIPA 
lysis buffer, followed by STE. Bound proteins were eluted from beads using 15 L of 4x 
Laemmli buffer. Entire volume was loaded onto gels along with 50 g of cell extract 
input (sample 1). Gels were run on 4-20% gradient gels, stained with Coomassie blue 
for 20 min and destained overnight. Bands A-D were extracted and used for mass 
spectrometry analysis.  
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Figure 7.4 (Table) Mass Spectrometry results, novel binding partners of APC-
ARM. Proteins pulled down using ARM-GST as bait for U2OS cell lysate.  
Protein Full name Mascot 
score 
Status 
NuMA1 (239kDa) Nuclear mitotic apparatus 
protein 1 
1858 Confirmed 
(Fig. 7.8) 
RRBP1 (152kDa) Ribosome-binding protein 1 759 unknown 
SPTA2 (285kDa) Spectrin alpha chain, brain 540 unknown 
SPTB2 (275kDa) Spectrin beta chain, brain 1 531 unknown 
MACF1 (623kDa) Microtubule-actin cross-
linking factor 1, isoforms 
1/2/3/5 (published) 
506 Known 
(Chen et al., 2006) 
MACF4 (673kDa) Microtubule-actin cross-
linking factor 1, isoform 4 
438 unknown 
ZN638 (221kDa) Zinc finger protein 638 398 unknown 
PRC2C (317kDa) Protein PRRC2C 340 unknown 
MAP1B (271kDa) Microtubule-associated 
protein 1B 
280 Confirmed 
(Fig. S7.7) 
PRKDAC (473kDa) DNA-dependent protein 
kinase catalytic subunit 
(DNAPK) 
209 Known 
(Kouzmenko et al., 
2008) 
SON (264kDa) Protein SON 130 unknown 
PCNT-B (380kDa) Pericentrin B, kendrin 40 Confirmed 
(Fig. 7.4-7.6) 
* More information on the protein functions in this table see Fig. S7.8 (Table). 
* To see a recent analysis of the novel protein candidates see Fig. S7.9 (Table)  
 
partner, and was generated based on the number of peptides that matches the protein 
sequence in the SWISSPROT database. The cut-off score for the data to be reliable 
was 35 and any scores lower were not included as a positive interaction. NuMA was a 
novel binding partner that produced a high score suggesting that there is a clear binding 
between NuMA and the APC-ARM, whereas PCNT-B showed a low score suggesting 
that APC-ARM does bind PCNT-B but the degree of interaction was not as high relative 
to the others found in the table. A ‘status’ column was included to indicate whether APC 
is “known” (ie. already reported) to bind to the protein, “confirmed” in this study and 
“unknown” to represent novel protein interactions that are not yet confirmed. 
Chapter 7 
286 | P a g e  
 
Highlighting the specificity of the assay, two of the stronger candidates, MACF1 and 
DNA-dependent PKC, were previously shown to bind APC and have roles in cross-
linking the MT-actin cytoskeletons and in DNA damage, respectively (Chen et al., 2006; 
Kouzmenko et al., 2008).  
7.3.4 Pericentrin-B / kendrin binds to the N-terminal half of APC  
Immunoprecipitation and pull-down assays: The PCNT gene in mammals produces 
several isoforms believed to be a result of alternative splicing, one of which is the better 
defined ~220 kDa murine form known as PCNT-A, and frequently referred to as PCNT 
in the literature. The second isoform is PCNT-B, that encodes a larger isoform of around 
~360 kDa in human cell lines, attributed to an additional C-terminal calmodulin-binding 
site (Flory et al., 2000). There is also an additional isoform that expresses a ~250 kDa 
that incorporates the calmodulin binding domain of PCNT-B known as PCNT-S, but has 
rarely been studied. The mass spectrometry analysis (Fig. 7.4) identified PCNT-B as a 
partner for the APC-ARM based on protein alignment of two identified peptides 
corresponding to the PCNT-B specific C-terminal sequence.  
 IP and in vitro pull-down experiments were performed to compare binding of APC 
to PCNT-A and PCNT-B, using a high affinity monoclonal antibody that detects both 
isoforms. As shown in Fig. 7.5A and B, Western blot analysis showed that both forms of 
PCNT were detectable in the input lane, however interactions with APC were difficult to 
detect consistently in U2OS and SW480 cells. It is possible that APC associates with 
PCNT transiently and therefore is difficult to detect by IP. Additionally, endogenous 
levels of PCNT-B could have been too low for consistent IP detection (some 
Chapter 7 
287 | P a g e  
 
experiments gave a positive result, others were negative).  To validate the initial MS 
result that identified PCNT-B, a pull-down experiment using purified APC-ARM fragment 
was employed. GST and APC-GST were purified and coated on beads, then mixed with 
U2OS total cell lysates or incubated without extract as pull-down controls. In this in vitro  
 
Figure 7.5 Interaction between APC and pericentrin-B (PCNT-B). Centrosome 
enriched fractions were used for immunoprecipitation (IP) of APC with both forms of 
pericentrin in vivo. Ab5 mAb (1 g/ml) was used to pull-down full-length APC (APC-FL) 
and that mutant (APC1-1337) in (A) U2OS cells and (B) SW480 cells, respectively. 
PCNT was detected with a rabbit poly-Ab antibody to the N-terminal region of PCNT 
common to both PCNT-A and PCNT-B. Ab1 mouse mAb was used to detect APC. 30 
g of protein extract was used in the input to detect PCNT. No interaction between APC 
and PCNT was consistently detectable by immunoprecipitation. (C) Alternatively, the 
purified GST-tagged ARM fragment of APC was used to pull down PCNT-B. A relatively 
strong interaction was found between APC-ARM and PCNT-B here that was not 
detected in the pull-down with GST alone. This interaction was specific to PCNT-B. 
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pull-down, GST-tagged APC-ARM was shown to interact with PCNT-B as shown by a 
detectable band at ~360 kDa (Fig. 7.5C). This result suggests that APC binds modestly, 
but with specificity, to PCNT-B.  
Duolink proximity ligation assay : To examine APC interactions with PCNT-B in the 
cell, a Duolink assay was performed using a PCNT rabbit poly-Ab antibody previously 
optimised to detect PCNT by immunofluorescence with minimal background. 
Interestingly, a significant interaction was detected between APC-FL and PCNT in 
U2OS cells, with an average of ~16 dots per cell with a low average background (Fig. 
7.6; also see Fig. S7.5). Whilst this antibody can in theory also detect PCNT-A, it is 
important to note that an APC-PCNT-B interaction was confirmed by Duolink assay in 
U2OS cells using a different antibody that is quite specific for the PCNT-B isoform (see 
Fig. S7.4), however due to inconsistent background issues the PCNT-B-specific 
antibody was not used extensively here. Based on this finding, the specificity of the in 
vitro binding data (Fig. 7.5C) and the MS screening result (Fig. 7.4), it is henceforth 
assumed that APC is binding preferentially to the PCNT-B isoform.  
 The APC1-1337 mutant also displayed interaction with PCNT by Duolink assay, 
however the number of PLA dots detected per cell with the SW480 cell line were much 
lower (~7 dots per cell) than was seen for APC-FL  in U2OS cells (Fig. S7.5). It is not 
possible to directly compare the degree of APC-PCNT-B interaction between cell lines, 
as the U2OS and SW480 cells differ in cell size and concentrations of APC in the cell at 
various compartments, which could influence the number of PLA signals observed. 
However, PCNT-B can certainly associate with the N-terminal half of the APC protein, 
as confirmed by an ectopic Duolink experiment that tested interaction between APC-1-  
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Figure 7.6 (Legend on following page) 
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Figure 7.6 APC interacts with PCNT-B in U2OS cells and, to a lesser extent, in 
SW480 cells as detected by Duolink assay. Duolink kit (red) was used to detect 
interaction between PCNT-B and endogenous (A) APC-FL in U2OS and (B) APC1-1337 
in SW480 cells. Duolink interactions were performed using Ab7 to probe for 
endogenous APC (Ab7 mAb) and PCNT (poly-Ab) antibody used as the other probe. 
Interactions with each individual antibody alone were performed as controls. PLA dots 
were scored using images acquired by confocal. The DIC channel was used to define 
cell edges for accurate scoring. 100-150 cells were scored per interaction over three 
independent experiments. Each red dot was classified as one positive interaction. (C) A 
representative graph of one independent experiment showing the trend of PCNT 
interaction with APC where each point represents the number of proximity ligation assay 
(PLA) dots per cell. U2OS cells show a significantly higher number of APC to PCNT 
interactions compared to controls (P<0.0001). A similar trend was observed in SW480 
cells, however, overall less number of PLA dots was observed per cell. (D) Schematic 
diagram of PCNT location in the PCM area within the centrosome.   
 
 
Figure 7.7 Ectopically expressed APC1-1309 interacts with PCNT by Duolink 
assay. GFP tagged APC1-1309 or GFP alone vector was overexpressed in U2OS cells. 
Duolink assay (red) was performed between APC-GFP and PCNT, using GFP and 
PCNT antibodies. At the completion of the Duolink assay protocol, cells were counter 
stained for ectopic APC expression using GFP anti-mouse in green. The scoring for the 
number of positive PLA signals per cell was graphed against each condition. At least 50 
transfected cells were scored per condition in at least two independent experiments. 
APC1-1309 and PCNT-B show a significantly higher number of positive PLA dots 
compared to controls (P<0.0001), thereby confirming an interaction between the two 
proteins.  
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Figure 7.8 PCNT interacts with APC at the centrosome. To investigate if PLA signals 
between APC (Ab7 mAb) and PCNT-B (poly-Ab) occurred at the centrosome, γ-tubulin 
antibody was used to mark the centrosome (white arrow) by counter staining (green) 
cells in (A) U2OS and (B) SW480 cells after Duolink assay (red) was performed. 
Zoomed images from confocal z-sections show PLA dots (red) that locate at the 
centrosome (green). (C) A population of >100 cells were scored for PLA signals that co-
located at the centrosome and converted to a percentage of the total number of Duolink 
positive cells. Interactions between APC and PCNT-B occurred in up to 50% of the 
positive PLA cell population in U2OS (P=0.0141) and 30% in SW480 (P=0.0039).  
 
1309-GFP and endogenous PCNT and detected ~15 PLA dots per cell which was well 
above background (see Fig. 7.7). Therefore, APC-FL and truncated APC1-1309 are 
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both able to associate with PCNT, which strongly supports the original mass 
spectrometric analysis showing that PCNT-B binds to at least the N-terminal region of 
APC.  
Interestingly, PCNT does not appear to anchor or retain APC at the centrosome. 
In HeLa cells depleted of PCNT, APC continued to localise and accumulate at the 
centrosome to the same level (Fig. S7.6A and B). These experiments may question 
PCNT function as an anchor for APC at the centrosome.   
To determine whether APC is able to associate with PCNT-B at the centrosome, 
a Duolink assay was performed with post-PLA counter staining of the centrosome to 
score the degree of co-localisation. Approximately 50% of PLA positive cells exhibited 
an interaction between APC and PCNT-B at the centrosome in U2OS cells, and 30% of 
SW480 cells displayed a detectable co-localisation (Fig. 7.8). Given that APC-PCNT-B 
complexes were more readily detectable at the centrosome than were APC- γ-tubulin 
complexes, these data support a potential functional role for APC-PCNT-B interaction in 
centrosome processes. Since both APC and PCNT-B can act as scaffold proteins, it is 
possible their association at the centrosome is involved in timed recruitment of other 
proteins or possibly of the -tubulin ring complex (-tuRC) to drive MT formation (Lui et 
al., 2012; Shimizu et al., 2008).  
7.3.5 The nuclear mitotic apparatus protein interacts with APC-ARM  
Nuclear mitotic apparatus (NuMA) protein mainly localises to the nuclear matrix during 
interphase and redistributes to the mitotic spindles at the onset of mitosis. NuMA is 
important in the orchestration of protein recruitment to the mammalian mitotic 
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centrosome and for anchoring mitotic spindles to the centrosome (Compton and 
Cleveland, 1993; Li et al., 2001b; Merdes et al., 2000). The fact that APC-ARM was 
found to bind to NuMA with a high mascot score in the mass spectrometry analysis 
suggests the interaction should be of sufficient strength for detection by IP analysis. To 
confirm this interaction in vivo whole cell U2OS lysate was used to immunoprecipitate 
the APC-NuMA complex. Using Ab5 mAb (or a C20 polyclonal antibody) to pull-down 
APC-FL from U2OS cell extract, a NuMA band was detected at 240 kDa in at least two  
 
 
Figure 7.9 Confirmation of interaction between the nuclear mitotic apparatus 
(NuMA) protein and APC by IP. Two different APC antibodies, (A) Ab5 mouse 
monoclonal and the (B) C20 rabbit polyclonal, were used to immunoprecipitate proteins 
from U2OS cell lysate. The APC antibodies were added to 30 l of sepharose beads for 
binding overnight. Bound beads were then mixed with 1.5 mg of total sonicated (10 s) 
U2OS lysate for 3 h. Cells were lysed (see section 7.2.6), and the captured protein 
complexes were then separated by SDS-PAGE to detect NuMA by Western blotting. A 
240 kDa NuMA band was detectable after APC pull-down but not in the control mouse 
IgG lane.  (C) The GST-tagged APC-ARM fragment described in Fig. 7.2-7.4 was also 
used to confirm in vitro pull-down of NuMA from U2OS cell lysate. GST alone was a 
negative control.  
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Figure 7.10 NuMA may not be an anchor for APC at mitotic centrosomes. Protein 
lysates (50 g) treated with either control or NuMA siRNA was analysed by Western blot 
to confirm the knockdown efficiency in (A) U2OS and (B) SW480 cells. In parallel, both 
cell lines were used to examined for NuMA-dependent APC localisation at the mitotic 
centrosome in asynchronous cells (C and D). Cells were transfected with either control 
or NuMA targeting siRNA for 48 h, followed by a treatment with no cytoskeletal (CSK) 
buffer or 40 min CSK at 32oC to remove soluble proteins. Methanol: acetone was used 
to fix cells and immunofluorescence microscopy was performed using H290 poly-Ab 
(green) to detect endogenous APC and γ-tubulin mAb to detect mitotic spindles to 
locate the centrosome during mitosis. >200 mitotic centrosomes were scored for APC 
co-localisation per condition over two independent experiments using Olympus BX-51 
microscope. Graph (E) and (F) represents the percentage localisation of the retained 
pool of APC at centrosome for U2OS and SW480 cells, respectively.  
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experiments, whereas bands were not detected in the IgG control lane (Fig. 7.9A and 
B). The interaction was then confirmed by in vitro pull-down using the APC-ARM-GST 
(Fig. 7.9C).  
 In chapter 3, it was demonstrated that the centrosomal retention of APC is 
significantly increased at the onset of mitosis, compared to interphase. NuMA is 
important at focusing mitotic spindles and their orientation, and the depletion of APC 
has been shown to disrupt the production of robust mitotic spindles (Dikovskaya et al., 
2004; Haren et al., 2009), therefore it was hypothesised that NuMA might regulate the 
localisation or retention of APC at mitotic centrosomes.  To test this hypothesis, the 
localisation and retention of APC was investigated in NuMA depleted asynchronous 
cells. U2OS and SW480 cells were either treated with control siRNA or NuMA siRNA 
followed by detergent extraction to remove the soluble proteins (Fig. 7.10). Cells were 
fixed with methanol: acetone and immunofluorescence was performed using APC 
(H290 rabbit) antibody and γ-tubulin mAb to mark the centrosomes. APC localisation at 
the mitotic centrosome was scored by fluorescence microscopy (see section 2.2.6.3). 
The knockdown efficiency of NuMA was checked by a parallel Western blot, and 
indicated that at best, NuMA was reduced by up to 50% of total (Fig. 7.10A). It is 
possible that complete loss of NuMA is toxic to cells. Nonetheless, under these 
experimental conditions, the reduced expression of NuMA had little impact on the 
localisation of APC at the mitotic centrosomes (Fig. 7.10). Furthermore, the reduction in 
NuMA expression did not significantly alter the retention of APC-FL or APC1-1337 at 
mitotic centrosomes. At this stage I conclude that a 50% reduction in NuMA does not 
greatly alter APC at the mitotic centrosome, and further experiments are required to 
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determine whether a more complete and targeted loss of NuMA (or competition for the 
interaction by overexpression of the APC ARM domain) alters APC localisation.  
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7.4 DISCUSSION 
 
The ARM domain mediates the ability of APC to bind a range of important protein 
partners, several of which regulate the mobility, localisation and function of APC (see 
section 1.2.1.3). As shown in chapter 3, the APC-ARM also comprises a critical part of 
the centrosome targeting domain of APC. In this chapter, the APC-ARM was used as 
bait to screen for and identify novel binding partners using the glutathione-protein 
purification system.  The current known ARM binding partners are mostly small proteins 
of less than 100 kDa, and here a proteomics approach has identified novel binding 
partners greater than 100 kDa. The centrosomal candidate partner proteins PCNT-
B/kendrin, NuMA and MAP1B were validated for their ability to associate with APC 
(Figs. 7.4 and S7.7).  
APC interacts with pericentrin-B in the cytoplasm and at interphase 
centrosomes  
PCNT is an integral protein of the centrosome (see section 1.3.2), however there has 
been much confusion in the literature regarding the forms of PCNT and their function. In 
brief, there are three isoforms identified for PCNT, they are: (1) PCNT-B (360-380 kDa; 
also known as kendrin), (2) PCNT-A (220 kDa; also known as pericentrin) and (3) 
PCNT-S (250 kDa). Only the former two have been functionally characterised (Flory and 
Davis, 2003; Flory et al., 2000; Miyoshi et al., 2006). A sequence alignment between 
PCNT-A and –B revealed 61% identity and 75% similarity in amino acid sequence, with 
the main difference in the number of coiled-coiled domains (one in PCNT-A and two in 
PCNT-B)(Li et al., 2001a).  
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 PCNT-B localises to the centrosome throughout the cell cycle as seen in HeLa 
cells and breast carcinoma cells (Flory et al., 2000; Li et al., 2001a), however its 
distribution within the centrosome apparently changes between interphase and mitotic 
centrosomes. Contrary to previous views of the PCM as an amorphous cloud of 
proteins, through super-resolution imaging it was observed that the PCM is structurally 
organised into several onion-like ring layers (Sonnen et al., 2012). Interestingly, at 
interphase centrosomes of Drosophila S2 cells, PCNT-B orients itself such that it spans 
across all the layers. When detected using  an antibody targeting the N-terminus (744-
909 aa), visualized by structured-illumination microscopy (SIM) and stochastic optical 
reconstruction microscopy (STORM), PCNT-B was observed in the outer layers of the 
PCM, whereas a C-terminus-specific antibody detected PCNT-B at the inner layer of the 
centrosome, in close proximity to the centriole walls (Mennella et al., 2012). This would 
explain why an earlier study using just the C-terminal antibody only detected PCNT-B at 
the centrioles in fibroblasts (Flory et al., 2000).  
What are the implications for APC and its association with PCNT-B? The Duolink 
data collected from this current study show that not only do endogenous APC and 
PCNT-B interact in the cytoplasm, but PLA signals are also found specifically at the 
centrosome co-localising with γ-tubulin, which places APC at the PCM part of the 
centrosome (Figs. 7.6 and 7.8). One of the functions of PCNT-B in interphase is its 
regulation of centrosome cohesion. Through the PACT domain, PCNT-B can directly 
interact with Nek2A, a cell-cycle kinase known to stimulate centrosome separation or 
“disjunction” (Faragher and Fry, 2003; Fry, 2002). The depletion of PCNT-B by shRNA 
can significantly increase the proportion of U2OS cells with prematurely split 
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centrosomes by >10% (Matsuo et al., 2010). The APC-PCNT-B interaction is unlikely to 
contribute to centrosome cohesion in that siRNA induced APC depletion did not affect 
cohesion (see Fig. 4.10). Another crucial role for PCNT-B is its involvement in centriole 
disengagement (see section 1.3.2). From G1 to S-phase, the duplication of centrioles 
requires the centrioles to disengage and this is regulated by an enzyme called 
‘separase’, however the centrioles do remain connected by a fibrous linker (Nakamura 
et al., 2009; Rodrigues-Martins et al., 2007).  PCNT-B is a direct substrate of separase 
and the cleavage of PCNT-B is required for centriole disengagement at the end of 
mitosis cells before entering G1-S phase again, ready for the next round of centriole 
biogenesis. The expression of a non-cleavable PCNT-B mutant also correlated with a 
reduced occurrence of centriole disengagement after mitosis in U2OS cells (Lee and 
Rhee, 2012; Matsuo et al., 2012). The potential and specific role of APC in centriole 
disengagement (different to centrosome cohesion) has not yet been tested, however it 
is perhaps more likely that PCNT-B and APC complexes are involved in MT associated 
functions given the significance of APC in regulating MT growth in both interphase and 
mitosis (Chapters 1 and 4).  
Intriguingly, there were more detectable APC-PCNT-B complexes than APC-γ-
tubulin complexes detected by PLA throughout the cytoplasm (~5 fold higher) and at the 
interphase centrosome (by ~6 fold higher) (Figs. 5.2 and 7.6), suggesting a more 
frequent cooperation between APC and PCNT-B. This is particularly interesting 
because PCNT-B not only binds to γ-tubulin but also to GCP2, another protein 
component of the γ-tuSC in HeLa cells (γ-tuRC building blocks) (Takahashi et al., 2002) 
(see section 4.4). Furthermore, both APC and PCNT-B are involved in regulating MT 
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aster growth. The depletion of APC-FL reduces the rate of MT nucleation/elongation in 
U2OS cells (see Chapter 4). Similarly, depletion of PCNT-B using targeted antibodies 
significantly reduced the number of MTs nucleated in CHO cells (Takahashi et al., 
2002). It is therefore possible that APC works in concert with PCNT-B to stabilise/recruit 
γ-tuRCs, thereby regulating MTs at interphase centrosomes.  
Pericentrin-B as an anchor for APC at mitotic centrosomes?   
In mitosis, PCNT-B is redistributed at the centrosome, dispersing into a meshwork 
interweaved with γ-tubulin without a specific orientation (Mennella et al., 2012; Sonnen 
et al., 2012). This change in morphology is suggestive of a change in its functionality, 
possibly to increase retention of proteins important in spindle formation. Given that the 
centrosome retention of APC was found to increase from ~20% in interphase to ~90% 
in mitosis (see Chapter 3), PCNT-B is a feasible candidate to fulfil this anchorage role. 
While the co-localisation of the APC-PCNT-B complex was not specifically tested at the 
mitotic centrosome, APC is important in the formation of robust mitotic spindles 
(Dikovskaya et al., 2004), and its anchorage implies formation of stable protein 
complexes important for spindle MT elongation, processes for which PCNT-B has also 
been implicated (Shimizu et al., 2008; Takahashi et al., 2002). Moreover, the APC-ARM 
was found to interact with PCNT-B (Fig. 7.4 and 7.5C) and this sequence is common to 
both APC-FL and APC-1-1309, both of which were retained at mitotic centrosomes (see 
Chapter 3). Future experiments using cells arrested in mitosis will be required to 
determine the role of PCNT-B or other proteins (including NuMA, see following sections) 
in mitotic centrosome retention of APC. 
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Implications of the nuclear mitotic apparatus protein interaction with 
APC  
The interaction between APC-ARM and NuMA in the mass spectrometry analysis 
produced one of the highest scores (mascot score =1858), suggestive of a frequent and 
stable interaction (Fig. 7.4). There are three known forms of NuMA that exist throughout 
the cell cycle localised to different stages (Fig. 7.11). In interphase, insoluble NuMA 
resides only in the nucleus as a 220 kDa protein that associates itself with the nuclear 
matrix to regulate nuclear morphology. Cells without NuMA, such as leukocytes, tended 
to produce an elongated nuclear morphology (Merdes and Cleveland, 1998). NuMA 
regulates DNA and has been reported to accumulate at sites of heterochromatin in 
Drosophila S1 cells, but is unlikely to be the main regulator of DNA architecture since its 
depletion in frog extracts elicited no defects in nuclear function with an intact chromatic 
and nuclear structure (Abad et al., 2007; Merdes and Cleveland, 1998). APC too has 
been linked to DNA damage. In the nucleus, APC was reported to accumulate at 
nuclear foci where it co-localised with rRNA of 184A1 mammary epithelial cells (Neufeld 
and White, 1997) . APC is associated with DNA repair by accumulating at sites of DNA 
double-stranded breaks (indicated by presence of the phospho-histone, -H2AX) and 
interacting with DNA repair factors (DNA dependent protein kinase catalytic subunit) in 
HCT116 cells (Kouzmenko et al., 2008). APC can also regulate the base excision repair 
(BER) pathway through interaction with proliferating cell nuclear antigen (PCNA), Pol-B 
and flap endonuclease 1 (Fen-1)(Jaiswal et al., 2012; Narayan et al., 2005), and the 
replication stress response by association with replication protein A (Brocardo et al., 
2011). APC can be found in the nucleus during interphase (Henderson, 2000; Neufeld 
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and White, 1997), and specifically has been detected in the insoluble nuclear matrix 
fractions in which it might also potentially associate with PCNT-B (Brocardo et al., 2011; 
Neufeld et al., 2000).  Further investigation is required to determine whether NuMA and 
APC interact in specific nuclear fractions such as the matrix or interaction is regulated 
by phosphorylation of NuMA. 
APC-ARM was found to associate with the 240 kDa form of NuMA that more 
frequently appears after interphase (Hsu and Yeh, 1996). At the transition from 
interphase to mitosis, as seen in live NRBE cells and human fetal fibroblasts, NuMA is 
 
Figure 7.11 NuMA localisation in the cell cycle (adapted from Schatten and Sun, 
2011). In interphase, NuMA (in green polygons) resides in the nucleus as an insoluble 
220 kDa form, while most of APC exists in the cytoplasm. At the onset of mitosis NuMA 
is phosphorylated by cyclin-B/cdc2 into a 240 kDa protein that localises to the mitotic 
centrosome to regulate mitotic spindles. In mitosis, APC (in orange circles) localises to 
both the centrosome as well as MT tips. NuMA is then transformed into a 180 kDa form 
after mitosis. APC binds the 240 kDa NuMA possibly at the mitotic centrosome.  
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phosphorylated by cdc2 to become a 240 kDa protein transported to the mitotic 
centrosome to tether and organize mitotic MT spindles (Kisurina-Evgenieva et al., 2004; 
Merdes et al., 2000; Xu et al., 2011). Perhaps a more interesting potential scenario is 
that APC binds the newly phosphorylated NuMA 240 kDa protein to transport it to the 
mitotic centrosome (Fig. 7.11).  
 At the mitotic centrosome / spindle pole body, NuMA appears as a crescent 
shape accumulating both at the centrosome and the spindles in a dynein dependent 
manner, thereby anchoring them (Merdes et al., 2000). The presence of NuMA is crucial 
to the focusing of mitotic spindles since spindles become detached from the mitotic 
centrosome in NuMA-depleted Xenopus cells. In  mouse embryo fibroblasts and HeLa 
cells treated with NuMA siRNA to reduce its expression, spindles displayed initial 
focusing, but the continued attachment of spindle fibres under tension ultimately 
became defective producing aberrant chromosome misalignment and separation (Haren 
et al., 2009; Silk et al., 2009). APC has also been heavily implicated in regulating 
chromosome separation (Beamish et al., 2009; Caldwell et al., 2007; Dikovskaya et al., 
2004; Green and Kaplan, 2003). The inhibition or truncation of APC leads to mis-aligned 
chromosomes in mitosis and mitotic spindle mis-regulation (see section 1.5.3), therefore 
it is quite plausible that APC cooperates with NuMA to manage similar functions in 
mitosis. If APC is binding to the 240 kDa NuMA that exists only at the mitotic 
centrosome, NuMA would also represent a likely candidate to retain APC at the mitotic 
spindles. In an initial test of this idea, U2OS cells were treated with siRNA to NuMA 
followed by the removal of soluble proteins using the CSK buffer. The localisation of 
APC remaining was scored at the mitotic centrosome, and the assay was also repeated 
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in SW480 cells. Surprisingly, the retention of APC was unaffected by NuMA depletion 
under these conditions (Fig. 7.10). However, the level of knockdown achieved was only 
~50%, and I cannot formally exclude that sufficient NuMA remained to anchor APC at 
these structures. More efficient means to deplete NuMA are required to more 
conclusively define its role in APC retention.  
Additional candidate APC-binding partners at the centrosome 
A recent updated screening (ie. new software and updated SWISSPROT databases) of 
the original mass spectrometry data identified a few new candidate binding partners of 
the APC-ARM. Of particular interest is the CE350 protein (CEP350 or CAP350), a large 
centrosome protein that can directly bind MTs and associate with mitotic spindle poles 
(Hoppeler-Lebel et al., 2007). The overexpression of CEP350-GFP was found to 
stabilise the whole MT network and make it resistant to nocodazole treatment, where as 
CEP350 depletion by siRNA reduced this stability in HeLa cells. CEP350 localises to 
the centrosome but is phosphorylated in M-phase and has been implicated in MT 
anchorage. In CEP350 depleted HeLa cells subjected to a MT regrowth assay, MT 
asters could start to form at early timepoints (1 min regrowth) but became unfocussed 
after 10 min of regrowth suggesting a loss of MT anchoring (Yan et al., 2006). Finally, 
MAP1A and MAP1B are also interesting MT associating proteins that were found to 
bind to the APC-ARM (Fig. S7.7). MAP1B and APC are known to regulate MT dynamics 
through upstream signalling by GSK3β (at least in neurons), linking APC to MAPs and 
an alternate regulation of MT dynamics (Goold and Gordon-Weeks, 2004; Zhou et al., 
2004). 
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7.3S SUPPLEMENTARY SECTION 
 
Figure S7.1 The optimisation of bacterial lysate induction conditions.  ARM-GST 
was induced using IPTG at different conditions, including the time of induction and 
temperature. The ‘induced’ lysates and pellet was compared to the ‘uninduced’ control 
using SDS-PAGE gel separation. Coomassie staining was performed in parallel to 
Western blot analysis for each condition to find the optimal condition for of ARM-GST 
expression (74kDa band). The condition that produced the best yield was the 
combination of induction at 37oC and addition of IPTG at OD=1.0 bacterial 
concentration.  
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Figure S7.2 The optimisation of stringent washes to reduce background produced 
from bacterial lysates. Several washing conditions were tested to reduce the 
background of eluates and non-specific protein binding to the glutathione sepharose 
beads. ARM-GST was induced using 1mM of IPTG, allowed to bind to beads followed 
by an elution. The standard buffer used to wash the beads was (A) STE which is used 
as a control to compare between other washing buffers with added supplements. (B) 
Beads were washed with RIPA lysis buffer. In (C) and (D) STE buffer was 
supplemented with indicated reagents. Supplemented STE washing buffer that were 
tested did not significantly reduce the background of the beads. Lane “B” was included 
to as a control to illustrate the amount of initial background.  
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Figure S7.3 The optimisation of lysis buffers for U2OS cells to enhance 
centrosome protein detection. RIPA and mild-RIPA (*) buffer (Murawala et al., 
2009)(see section 7.2.6) was used to lyse U2OS to produce total lysates. In parallel, 
lysates were also sonicated for 10 s before sedimentated. 100 g of protein was loaded 
onto a 7.5% SDS-PAGE gel for protein separation and Western blotting. PCNT was 
detected at 380 kD representing PCNT-B using PCNT-B rabbit poly-Ab, γ-tubulin 
detected using γ-tubulin mouse mAb. β-catenin was detected using β-catenin mouse 
mAb, however it was not detected by a modified RIPA* buffer with sonication could be 
due to technical errors.  
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Figure S7.4 Interaction between the PCNT-B antibody and APC by Duolink assay. 
Using the Duolink assay, Ab7 mouse mAb for APC and PCNT-B rabbit poly-Ab for 
PCNT-B was used to test the interaction between APC and PCNT-B in U2OS cells 
(green), respectively. Cells were counter stained with γ-tubulin mouse antibody (red) to 
detect possible localisation of PLA signals at the centrosome. The PCNT-B show 
inconsistencies between experiments due to high background. This figure shows an 
example of one experiment that showed little background, indicating that PCNT-B alone 
interacts with APC.  
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Figure S7.5 Alternative representation of the Duolink interaction between APC 
and γ-tubulin in U2OS and SW480 cells (representative graphs). Duolink interaction 
was performed between APC (Ab7) and PCNT. Z-sections (3 x 0.75 µM thickness) was 
acquired using Olympus FV1000 confocal microscope. The number of dots per cell was 
manually scored. Cells were placed into groups based on the number of Duolink 
interactions found. These are representative graphs of two experimental repeats 
performed (>100 cells per condition per experiment).  Despite some background, there 
was more PLA dots per cell for the interaction between APC and PCNT in both cell 
lines.  
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Figure S7.6 The detection of APC at the centrosome after PCNT-B depletion. 
PCNT does not affect the localisation or anchor APC-FL at the centrosome. U2OS cells 
were transfected with either control or PCNT-A/B targeting siRNA for 48 h, followed by 
fixation with methanol: acetone. Cells were double-stained using Ab7 mAb to detect 
APC and γ-tubulin poly-Ab to mark the centrosome. Series of images was acquired 
using Olympus FV-1000 Confocal microscope. (A) The fluorescence intensity of APC at 
the centrosome in cells with PCNT depletion was measured using the Olympus program 
FV-10. (B) The amount of cell with APC localisation remaining at the centrosome after 
PCNT knockdown was scored, and converted to a percentage (% ± SD). (C) The 
knockdown efficient of PCNT at the centrosome was quantified using 
immunofluorescence. Cells were double stained with PCNT and γ-tubulin, followed by 
imaging using confocal microscopy. Images were used to score for fluorescence 
intensity of PCNT at the centrosome using γ-tubulin as the marker.  
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Figure S7.7 APC and MAP1B interaction confirmed. (A) A complex between APC-FL 
and APC-1-1337 was detected by immunoprecipitation using Ab5 mouse mAb. MAP1B 
rabbit poly-Ab was used to detect a 270kDa band by Western blot. An interaction was 
clearly detectable in SW480 cells while it was less detectable in U2OS cells. This could 
be attributed to a better pull-down indicated by the bands shown when APC was 
detected in either cell line. (B) Interaction between APC-FL and MAP1B was confirmed 
in U2OS cells using the Duolink assay. Ab7 was used to detect APC and MAP1B. Some 
background was produced with MAP1B antibody alone, but PLA signals was detected in 
more cells when two antibodies were mixed suggesting that APC and MAP1B interact to 
some degree. These are preliminary experiments and additional experiments will need 
to be performed to confirm these findings.  
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Figure S7.8 (Table) Details of novel APC-ARM binding partners from the initial 
data 
Protein Other ALIAS Description 
NUMA1_
HUMAN 
(239kDa) 
Nuclear mitotic 
apparatus protein 1 
(aka. NuMA) 
 
 NuMA Complexes with LGN for spindle movements and 
regulates the dynamics of spindle orientation. 
 Maintains the planar alignment of the mitotic spindle for 
proper cell division  in epithelial cells. (Peyre et al., 2011) 
 NuMA locates at the nucleus of fibroblasts and oocytes, 
relocates to spindle poles during mitosis and meiosis, and 
aggregates in reformed spindle poles at metaphase. That 
is, NuMA maintains spindle morphology in Somatic Cell 
Nuclear Transfer embryos. (Xu et al., 2011) 
 NuMA is essential for spindle assembly, especially 
organization of MTat the spindle poles. Roles in spindle 
maintenance by tethering MT to centrosomes through the 
dynein/dynactin complex to accumulate at the minus ends 
(Godin and Humbert, 2011). 
 
RRBP1_
HUMAN 
(152kDa) 
Ribosome-binding 
protein 1 
(aka. ES; ES130; 
ES/130; FLJ36146; 
MGC157720; 
MGC157721; 
DKFZp586A1420) 
 
 ES130/p180 is a ribosome receptor which is an integral ER 
membrane protein (Ogawa-Goto et al., 2002). 
 Analysis of cDNA clones indicates that ribosome binding 
protein 1 may exist in different forms due to removal of 
tandem repeats, or partial intraexonic splicing of RRBP1. 
 RRBP1 has been excluded as a candidate gene in the 
cause of Alagille syndrome. Alternate splicing results in 
multiple transcript variants (Gene database PuBMED). 
SPTA2_
HUMAN 
(285kDa) 
 
Spectrin alpha chain, 
brain 
(aka. NEAS; EIEE5; 
SPTA2; FLJ17738; 
FLJ44613) 
 
 Spectrins are a family of filamentous cytoskeletal proteins 
that function as essential scaffold proteins that stabilize the 
plasma membrane and organize intracellular organelles. 
 Spectrins are composed of alpha and beta dimers that 
associate to form tetramers linked in a head-to-head 
arrangement. 
 The encoded protein has been implicated in other cellular 
functions including DNA repair and cell cycle regulation. 
 Mutations in this gene are the cause of early infantile 
epileptic encephalopathy-5. Alternate splicing results in 
multiple transcript variants. 
 
 
SPTB2_
HUMAN 
(275kDa) 
 
Spectrin beta chain, 
brain 1 
(aka. ELF; SPTB2; 
betaSpII) 
 
 spectrin is an actin crosslinking and molecular scaffold 
protein that links the plasma membrane to the actin 
cytoskeleton, and functions in the determination of cell 
shape, arrangement of transmembrane proteins, and 
organization of organelles. 
 It is composed of two antiparallel dimers of alpha- and 
beta- subunits. This gene is one member of a family of 
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beta-spectrin genes. 
ZN638_H
UMAN 
(221kDa) 
 
Zinc finger protein 638 
(aka. ZFML; NP220; 
Zfp638; MGC26130; 
MGC90196; 
DKFZp686P1231) 
 
 The protein encoded by this gene is a nucleoplasmic 
protein. It binds cytidine-rich sequences in double-
stranded DNA. 
 It is associated with packaging, transferring, or processing 
transcripts. 
Mild 
buffer 
MACF1_
HUMAN 
(623kDa) 
 
Microtubule-actin 
cross-linking factor 1, 
isoforms 
(aka. ACF7; MACF; 
OFC4; ABP620; 
FLJ45612; FLJ46776; 
KIAA0465; KIAA1251) 
 APC(2744-2843) and MACFs compete for EB1 binding 
site.  APC binds EB1 at its COOH-terminal domain. A 
similar sequence also found in members of MACFs 
(spectraplakins). EB1 binds both MACFs and APC (Slep et 
al., 2005). 
 In the absence of Wnt, MACF1 associates with the 
destruction complex. Upon Wnt activation, MACF1 is 
involved in the traslocaion and subsequent binding of the 
complex to LRP6 at the cell membrane. 
 reduction of MACF1 with siRNA decreased the amount of 
B-cat in the nucleus, leading to inhibition of Wnt-induced 
TCF/b-cat dependent transcription.  (Chen et al., 2006). 
 
MACF4_
HUMAN 
(673kDa) 
 
Microtubule-actin 
cross-linking factor 1, 
isoform 4 
(not found in gene 
database) 
 
NA 
 
 
PRC2C_
HUMAN 
PRRC2C
_HUMAN 
(317kDa) 
 
Protein PRRC2C 
(aka. XTP2; BAT2D1; 
BAT2L2; BAT2-iso) 
 
 -XTP2 (X transactivated protein 2) – a proliferation related 
protein which may function with HiNF-P. XTP2 directly 
interacts with HiNF at 3 sites (histone nuclear factors) in 
cell cycle regulation (Miele et al., 2007). 
MAP1B_
HUMAN 
(271kDa) 
Microtubule-
associated protein 1B 
(aka. Mtap1b) 
 
 Regulates axonal development by modulating Pho-GTPase 
Rac1 activity (Jausoro et al., 2010). 
 MAP1B stabilizes MTs. (Yao et al., 2010) 
PRKDC_
HUMAN 
DNA-dependent 
protein kinase catalytic 
subunit 
 This gene encodes the catalytic subunit of the DNA-
dependent protein kinase (DNA-PK). It functions with the 
Ku70/Ku80 heterodimer protein in DNA double strand 
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(473kDa) 
 
 
(aka. HYRC; p350; 
DNAPK; DNPK1; 
HYRC1; XRCC7; 
DNA-PKcs) 
break repair and recombination. The protein encoded is a 
member of the PI3/PI4-kinase family. (pubmed protein 
database). 
 DNA-PKcs phos and kinase activity are critical 
determinants of radiosensitivity. (Nagasawa et al., 2011). 
 DNA-PK is a protein kinase important in DNA-damage 
repair pathways. Including roels in: homeostasis of cell 
proliferation, metabolic gene regulation, radiation 
sensitivity, recombination repair, en-joining repair. (Kong et 
al., 2011 review). 
SON_HU
MAN 
 
(264kDa) 
Protein SON 
OS=Homo sapiens 
GN=SON PE=1 SV=4 
 
(aka. SON3; BASS1; 
DBP-5; NREBP; 
C21orf50; FLJ21099; 
FLJ33914; KIAA1019) 
 
 The protein shows sequence similarities with other DNA-
binding structural proteins such as gallin, oncoproteins of 
the MYC family, and the oncoprotein MOS. It may also be 
involved in protecting cells from apoptosis and in pre-
mRNA splicing. (Pubmed gene search database). 
 
Pericentr
in-B 
(380kDa) 
Pericentrin B isoform 
 
(Aka. Kendrin) 
 PCNT-B works with CG-NAP to provide MT nucleation 
sites by anchoring the g-tuRC. The inhibition of PCNT-B by 
ab inhibits MT nucleation in isolated interphase 
centrosomesof CHO cells (Takahashi et al., 2002) 
 PCNTB localise at the centrosome throughout the cell 
cycle, but its depletion does not alter MT nucleation in CHO 
cells in vitro (blocking using PCNTB antisera) (Li et al., 
2001) 
 PCNT-B interacts with NeK2A to maintain centrosome 
cohesion in human cell lines including U2OS, HeLa, COS7 
and HEK2933T(Matsuo 2010) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 7 
315 | P a g e  
 
Figure S7.9 (Table) Mass Spectrometry novel binding partners using the 2014 
database of proteins (SwissProt). FDR was adjusted to 1% in the screening. 
Protein Full name Size 
Cytoskeletal 
MAP1A Microtubule associated protein 1A 307 
MAP1B Microtubule associated protein 1B 272 
MACF1 Microtubule actin cross linking factor 1 624 
MACF4 Microtubule actin cross linking factor 4 674 
KIF1B Kinesin-like protein KIF1B 205 
KIF11 Kinesin-like protein KIF11 120 
FLNC Filamin-C 293 
FLNA Filamin-A 283 
PCDH7 Protocadherin-7 117 
PCDG7 Protocadeherin gamma A7 102 
PCDGJ Protocadherin gamma-B7 101 
Mitotic/centrosome 
CENPJ Centromere protein J 154 
CE350 Centrosome associated protein 350 352 
NUMA1 Nuclear mitotic apparatus protein 1 239 
DNA related 
PRC2 PRRC2C 318 
UBP28 Ubiqutin carboxyl-terminal hydrolase 28 123 
UBP34 Ubiquitin carboxyl-terminal hydrolase 34 409 
UBP47 Ubiquitin carboxyl-terminal hydrolase 47 158 
ZN638 Zinc finger protein 638 221 
ZN7831 Zinc finger protein 831 179 
RNF17 RING finger protein 17 187 
AKA28 A-kinase anchor protein 14 230 
CHD4 Chromodomain-helicase DNA-binding protein 4 219 
CHD5 Chromodomain-helicase DNA-binding protein 5 224 
CHD2 Chromodomain-helicase-DNA binding protein 212 
DNLI1 DNA ligase 1 105 
PRKDAC DNA-dependent protein kinase catalytic subunit 474 
R1AB Replicase polyprotein 1ab 803 
DHX36 Probable ATP-depenent RNA helicase DHX36 115 
RRBP1 Ribosome binding protein 1 152 
Structural 
EPIPL Epiplakin 557 
PLXA4 Plexin-A4 215 
PLEC Plectin  533 
SPTA1 Spectrin alpha chain, erythrocyte 281 
SPTB2 Spectin beta chain, brain 1 275 
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SPTA2 Spectrin beta chain, brain 285 
SMHD1 Structural maintenance of chromosomes 
flexible hinge domain-containing protein 1 
227 
Receptors 
ITPR2 Inositol 1,4, 5-triphosphate receptor type 2 311 
TGFA1 Transforming growth factor-beta receptor 98 
NMDE1 Glutamate [NMDA] receptor subunit epsilon-1 166 
TBCD4 TBC1 domain family member 4 148 
KIT Mast/stem cell growth factor receptor 111 
UNC5B Netrin receptor UNC5B 105 
Kinase/ligase 
RBP2 E3 SUMO-protein ligase RanBP2 362 
HERC2 E3 ubbiquitin-protein ligase HERC2 534 
HECD1 E3 ubiquitin-protein ligase HECTD1 292 
UBR4 E3 ubiquitin-protein ligase UBR4 580 
PKN3 Serine/threonic-protein kinase N3 100 
NEK10 Serine/threonin-protein kinase Nek 10 134 
ABL2 Tyrosine-protein kinase ABL2 129 
JAK1 Tyrosine-protein kinase JAK1 135 
RHGBA Rho GTPase-activating protein 11A 114 
FAS Fatty acid synthase  275 
FA8 Coagulation factor VIII 268 
GCSP Glycine dehydrogenase  114 
VGFR1 Vascular endothelial growth factor receptor 1 152 
SART3 Squamous cell carcinoma antigen recognized 
by T-cells 3 
110 
Motor proteins 
DYST Dystonin 866 
DYH9 Dynenin heavy chain 9, axonemal 515 
DYHC1 Cytoplasmic dynein 1 heavy chain 1 535 
MYTH6 Myosin 6 228 
MYTH7B Myosin-7B  222 
MYTH9 Myosin 9 227 
MYTH10 Myosin 10 229 
MYTH11 Myosin 11 228 
MYTH13 Myosin 13 224 
MYTH14 Myosin 14 224 
MY18A Myosin-XVIIIa 234 
Micellaneous proteins 
APC Adenomatous polyposis coli 314 
APC2 Adenomatous polyposis coli 2 246 
LYPD4 Ly6/PLAUR domain-containing protein 4 275 
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SON Protein SON 264 
GREB1 Protein GREB1 219 
RRP5 Protein RRP5 homolog 209 
TANC2 Protein TANC2 220 
SDK2 Protein sidekick 2 240 
PRG4 Proteoglycan 4 152 
CRUM1 Crumbs homolog 1 161 
FKB15 FK506-binding protein 15 1034 
COEA1 Collagen alpha-1 (XIV) chain 194 
UT2 Urea transporter 2 102 
HEAT6 HEAT repeat-containing protein 6 130 
ANR17 Ankyrin repeat domain-containing protein 17 275 
BIRC6 Baculoviral IAP repeat-containing protein 6 536 
ITH5L Inter-alpha-trypsin inhibitor heay chain H5-like 
protein  
143 
UBN2 Ubinuclein-2 146 
UTP20 Small subunit processome component 20 
homolog 
320 
K1383 Uncharacterised protein KIAA1383 101 
GPR98 G-protein coupled receptor 98 694 
PCLO Protein piccolo 554 
E41L2 Band 4.1 like protein 2 113 
ANK2 Ankyrin-2 432 
SCAFB Protein SCAF11 166 
KO649 Protein KIAA0649 128 
ANKAR Ankyrin and armadillo-repeat containing protein 163 
F184A Protein FAM184A 133 
EXTL3 Exostosin-like 3 107 
Antigens and growth factors 
K167 Antigen KI-67 360 
MIA3 Melanoma inhibitory activity protein 3  214 
GREB1 Protein GREB1 219 
AHNK Neuronblast differentiation-associated protein  630 
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8.1 Introduction  
APC has been known for some time to regulate MTs at mitotic centrosomes whereas its 
role at interphase centrosomes has remained poorly defined (see section 1.5).  This 
thesis is comprised of five result chapters that characterise various aspects of APC and 
its relationship with the interphase centrosome including targeting, retention and 
dynamics of full-length APC (APC-FL) and its mutant form (ectopic APC1-1309; 
endogenous APC1-1337). The effect of APC on microtubule (MT) nucleation, elongation 
and stabilisation was also studied, in addition to other centrosome regulatory functions. 
Novel interactions between APC and the centrosome proteins, CEP110, pericentrin-B 
(PCNT-B) and NuMA were discovered and clarified for γ-tubulin.  This chapter 
endeavours to integrate these new data and discuss how the key findings in each 
chapter add to our understanding of the role of APC at the centrosome.  
8.2 APC is part of a positive feedback loop where its transport to the 
centrosome could affect microtubule stimulation  
APC was previously shown  to localise at the centrosome independent of MTs (Louie et 
al., 2004), however new information presented here derived from confocal 
photobleaching FRAP experiments (Chapter 3) indicates that APC is not an integral 
component of the interphase centrosome as previously suggested (Louie et al., 2004), 
but rather the majority of centrosomal APC (~86%) is in fact highly mobile. Moreover, 
the rate of recruitment of APC-FL is slowed in the absence of MTs (Fig. 3.8). In 
conjunction with the fact that the rate of MT aster formation and elongation at 
centrosomes is stunted in the absence of APC, or when the APC C-terminus is deleted 
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by gene mutations (Chapter 4), I propose that the recruitment efficiency of APC to the 
centrosome is linked to the rate of MT nucleation, thereby forming a positive feedback 
loop (Fig. 8.1).  
γ-tubulin is a potent MT nucleator that exists mostly in a soluble form (Moudjou et 
al., 1996), and at least 50% of this pool is recruited to the interphase centrosome 
(Khodjakov and Rieder, 1999). In addition to the knowledge that APC binds to γ-tubulin 
in a large sedimentation complex in gradient fractions from HCT116 cells 
(Mahadevaiyer et al., 2007), these complexes were visualized throughout the cell as 
scattered PLA signals in both U2OS and SW480 cells (Figs. 5.2 and 5.3). A similar 
 
Figure 8.1 Model : Full-length APC is part of a positive feedback loop to facilitate 
MT regrowth. There is a stable pool (14%) of APC (orange) at the centrosome (solid 
blue circle) and a dominant mobile pool (86%) of APC that is in constant exchange 
between the centrosome and the cytoplasm (green dotted lines). (B) APC relies on the 
MTs to efficiently be efficiently transported to the centrosome as the rate of APC entry 
to the centrosome is slowed when treated with MT poison (nocodazole). APC-FL is 
required to efficiently stimulate MT nucleation. (C) When nocodazole is washed out, 
APC could again travel to the centrosome efficiently, thereby positively stimulate MT 
nucleation and subsequent elongation (D). The APC retained pool could possibly 
contribute to the stimulus (green solid lines).   
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distribution of APC-positive PLA dots (>20 dots per cell) was also observed for another 
regulator of MT nucleation, PCNT-B (Chapter 7). While both full-length and C-terminal 
truncated forms of APC bind to γ-tubulin and PCNT-B, only APC-FL was fully functional 
indicating that the C-terminus is required to stimulate MT growth. This was evident 
when comparing SW480 colorectal cancer (CRC) cells (express APC1-1337) with 
U2OS cells (express APC-FL) and observing a reduced ability to promote MT aster 
formation or elongation (Chapter 4), a defect that was rescued by the re-expression of 
APC-FL in SW480 cells (Fig. 4.6). This is the first study to illustrate the importance on 
MT nucleation of the C-terminal region of APC and is consistent with its role in 
regulating the stability of mature MTs (see section 1.4).  
Protein dynamics at the centrosome often correlates with function; for example, 
FRAP studies of γ-tubulin indicated a higher degree of mobility (100% mobile) at the 
mitotic centrosome compared to the interphase centrosome (50% mobile) (Khodjakov 
and Rieder, 1999). It was hypothesised that a high level of γ-tubulin turnover is required 
to accommodate the sudden demand of mitotic spindle MT production (Bouissou et al., 
2009; Khodjakov and Rieder, 1999). Conversely, one presumes that such a large 
retained pool of γ-tubulin at interphase centrosomes is important for nucleation and 
anchorage of the MT network. APC itself is a highly mobile protein that has been shown 
to shuttle between nucleus and cytoplasm in mammalian cells (Henderson, 2000; 
Neufeld et al., 2000), E-APC (associates with E-cadherin) at zonula adherens cell 
junctions of live Drosophila embryos (Cliffe et al., 2004) and MT protrusions at the 
plasma membrane of MDCK cells (Kita et al., 2006). Here it was discovered that both 
APC-FL and APC1-1309 show rapid dynamics at the interphase centrosome, where 
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~86% is highly mobile and exchanging with a T1/2 of only ~ 3 s (Fig. 3.7; see also Table 
1.2). It is intriguing that the rate of recruitment of APC-FL was partly delayed by the loss 
of MTs (Fig. 3.8). In the presence of nocodazole, the APC-FL fluorescence recovery T1/2 
was increased by ~3-fold compared to untreated cells consistent with slower movement 
(Fig. 3.8). More importantly, this delay in recovery rate preferentially affected APC-FL 
but also affected mutant APC (Figs. 3.8 and 3.9). This suggests that the MT system 
normally stimulates the rate of APC delivery to the centrosome where it can associate 
with the resident pools of γ-tubulin and PCNT-B through its N-terminal sequence. One 
possibility (to be discussed more later) is that the APC C-terminus is then made 
available to bind and stabilise the de novo synthesised MTs as it does mature MTs 
(Munemitsu et al., 1994), which in turn would help recruit more APC to sites of 
nucleation (see Fig. 8.1 ). This novel scenario of positive feedback is strengthened by 
the observation that loss of γ-tubulin expression caused a similar delay in APC 
recruitment rate as did the loss of MTs (Fig. 5.6). This working hypothesis does not 
exclude the possibility that some APC-γ-tubulin or APC-PCNT-B complexes assembled 
in the cytoplasm move to the centrosome in a MT-regulated manner (see Fig. 8.2).  
There are more than 200 proteins that transiently or integrally associate with the 
centrosome (Andersen et al., 2003; Jakobsen et al., 2011), and the MT system is only 
one form of recruitment machinery. Retrograde movement of APC toward the minus 
ends of MTs has not previously been described, but remains a possibility. The binding 
of APC to the kinesin KAP3A, and consequently the  KIFs immediately offers an indirect 
association with dynein since KIF3A interacts with the dynein subunit p150 glued that is 
known to recruit the MT anchoring protein, ninein (Jimbo et al., 2002; Kodani et al., 
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2013).  In fact, APC has been reported to move in the retrograde direction in live cells. 
When COS-7 cells were subjected to time-lapse microscopy, GFP tagged APC-FL were 
visualised as APC puncta that could undergo retrograde movement along MTs with an 
average velocity of 21.6 µm/min (Langford et al., 2006). Moreover, the mass 
spectrometry screening for APC binding partners performed in chapter 7 revealed that 
APC-ARM sequence can associate with dynein heavy chain 9, axonemal (DYH9) and 
cytoplasmic dynein 1 heavy chain 1 (DYHC1) (Fig. S7.9), supporting the possibility of 
dynein mediated retrograde transport of APC. This latter observation is also intriguing 
given that the APC-ARM domain was mapped as an integral part of the centrosome 
localisation sequence (Fig. 3.5).  
8.3 Possible mechanisms by which APC could regulate microtubule 
nucleation from the centrosome   
γ-tubulin ring complexes (γ-tuRCs) stabilise MTs by capping them at the minus ends to 
prevent spontaneous nucleation in the cytoplasm and this is thought to require 
activation by attachment factors before nucleation can occur (Kollman et al., 2011; 
Lynch et al., 2014; Pereira and Schiebel, 1997). This idea was first suggested when a 
lag-phase was observed during aster formation in Xenopus egg extracts containing 
rhodamine-labeled tubulin (Stearns and Kirschner, 1994). The ring complex possesses 
flexible structures that could act as a switch, shifting in function from resisting to 
enabling MT nucleation. Evidence for this derives from electron microscopy of the 
smaller γ-tuRC subunits, the γ-tuSC structure in Saccharomyces cerevisiae which 
identified  a flexible  hinge  structure in GCP3, and  from  crystallisation  of  the human 
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Figure 8.2 APC and novel binding partners that could stimulate MT regrowth.  (1) 
APC can regulate MT nucleation (purple dotted lines) by interacting with γ-tubulin and 
PCNT-B, both in the cytoplasm and at the centrosome. APC mutant (1-1309) interaction 
with centrosome proteins are modestly reduced. (2) The APC-ARM links APC to various 
MT regulating systems and function. (3) Secondary function of APC at the mother 
centriole. (4) APC and several other Wnt protein components of the -catenin 
degradation complex function at the centrosome possibly to stimulate MT nucleation. 
The APC binding domain of each protein are specified adjacent to the APC proteins 
(yellow). 
 
γ-tuRC that revealed a curved structure for γ-tubulin (Aldaz et al., 2005; Kollman et al., 
2011). One activator of γ-tuRC complexes is PCNT-B, which was described to anchor γ- 
tuRCs in interphase (Takahashi et al., 2002). PCNT-B can bind to all γ-tubulin 
complexes, including GCP2 and GCP3 complexes detected as immunoprecipitable 
complexes in COS cells and yeast-two hybrid screens (Takahashi et al., 2002; 
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Zimmerman et al., 2004). The depletion of PCNT-B with anti-sera in isolated 
centrosomes did not inhibit MT elongation, but did cause a significant reduction in 
nucleation of MTs (Takahashi et al., 2002). In chapter 7, Duolink experiments detected 
APC-PCNT-B complexes at the centrosome in ~50% of U2OS cells and in ~30% of 
SW480 cells (Fig. 7.8). Since APC does bind to PCNT-B at the centrosome, it is 
possible that APC-PCNT-B complexes act to “prime” the activation of γ-tuRCs and that 
this priming is weakened when APC is truncated, thereby reducing MT nucleation 
potential. 
 In line with the above-mentioned role of APC-PCNT-B complexes in MT 
nucleation, it is likely that APC binding can directly modify and accentuate the MT 
nucleation activity of γ-tubulin and of γ-tuRCs at the centrosome (see also section 5.4). 
This is supported by the detection of APC-γ-tubulin complexes at the centrosome itself 
(albeit not a strong detection), and the fact that loss of γ-tubulin decreased the rate of 
APC recruitment to the centrosome, consistent with loss of a modest-affinity interaction 
(Chapter 5). Alternatively, it is possible that the low detection of APC-γ-tubulin 
complexes at the centrosome, as visualized by PLA signals (<10% of SW480 cells, Fig. 
5.4), reflect a different role(s) for the APC-γ-tubulin complexes away from the 
centrosome. One such role might be to regulate MT stability in the cytoplasm. In 
interphase, γ-tuRCs cap and stabilise MTs to resist MT catastrophe (Bouissou et al., 
2009). In live Drosophila S2 cells, a majority (85%) of MTs with γ-tubulin localised to 
sites that show a pause in MT dynamics while the MT organisation was unperturbed 
(Bouissou et al., 2009). Similarly, APC-decorated MTs show a decreased rate of 
catastrophe compared to non-decorated MTs in live MDCK cells (Kita et al., 2006). It is 
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thus tempting to speculate that the binding of APC to γ-tubulin could result in 
stabilisation of MTs, and this alternative functionality, independent  of the centrosome, is 
somewhat consistent with a previous report detecting γ-tubulin, α-tubulin and APC in the 
same soluble complex with a sedimentation value of 60S in HCT116 cell fractions 
(Mahadevaiyer et al., 2007). Hence, future studies might investigate whether γ-tubulin 
and APC co-operate to regulate not only MT nucleation, but also MT stability.  
The MT nucleation and stabilising function of APC could extend to the mitotic 
spindles, where APC is likely to bind not only γ-tubulin but also NuMA. In preliminary 
experiments (Chapter 7), APC was found to associate with the 240 kDa form of NuMA 
that is found only at the onset of mitosis (Fig. 7.8) (Hsu and Yeh, 1996). There is 
extensive research defining the activity of APC at mitotic spindles and proposing that it 
localises both at the mitotic spindle pole (mitotic centrosome) and at centromeres to 
help tether mitotic MTs at the kinetochores in metaphase (Compton and Cleveland, 
1993; Fant et al., 2004; Silk et al., 2009). Given the important roles of NuMA in 
stabilising mitotic spindle MTs at the mitotic centrosome, a complex between NuMA and 
APC is predicted to help regulate MT nucleation and stability. Further experiments are 
required to determine how NuMA and APC affect the dynamics and function of one 
another during mitosis.  
8.4 How does APC truncation at the centrosome relate to cancer?  
APC mutations elicit a multitude of effects on the cell, and with regard to the 
centrosome, cause reduction in the rate of MT nucleation and growth (Chapter 4). The 
loss of C-terminal half of APC is also known to impede the localisation of APC to 
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membrane clusters at the cell protrusions (Sharma et al., 2006). As already discussed, 
loss of the APC C-terminus (in particular the “basic” domain) can impact on the ability of 
APC to stabilise MT polymers and ultimately affects cell polarity and migration (Green 
and Kaplan, 2003; Munemitsu et al., 1994). 
 Perturbations in cell polarisation (ie. directionality) and cell migration are 
hallmarks of invasive tumorigenesis (Ellenbroek and van Rheenen, 2014; Hanahan and 
Weinberg, 2011). A number of oncogenic pathways cause mis-regulation of cell-
polarisation, leading to asymmetric cell division, abnormal differentiation and de-
regulated cell migration (Etienne-Manneville, 2008; Lee and Vasioukhin, 2008; Royer 
and Lu, 2011; Song et al., 2014).  APC can mediate neuronal polarity by facilitating the 
accumulation of mPar3 (member of a cell polarity complex) to the nascent axon tips in 
developing neurons via MTs through mPar3/APC/KIF3A, however this localisation can 
be abolished by ectopic expression of truncated APC1-1388. This data suggests that 
APC-FL-dependent polarisation is sensitive to cancer mutations, at least in neurons (Shi 
et al., 2004). More recent studies have further shown that truncated APC mutants exert 
a dominant negative effect on directed cell migration, and in several cell model systems 
caused a random deregulated cell movement consistent with defects seen in colon 
tumour tissue (Nelson et al., 2012). The polarity function of APC has frequently been 
attributed to the localisation of APC at the MT plus-ends or at membrane clusters, 
however it is ultimately the centrosome that orchestrates the MT network starting with 
efficient MT nucleation (Siegrist and Doe, 2007). Thus, APC may contribute to directed 
cell movement (ie. polarity) at multiple levels. 
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A fascinating aspect of the Wnt pathway is that most components of the so-called 
‘β-catenin destruction complex’ not only accumulate at the interphase centrosome, but 
contribute to the process of MT nucleation to varying degrees (Fig. 8.2). Others reported 
that depletion of axin, β-catenin and GSK3β  in human cells and rat fibroblasts caused a 
~3-5 fold reduction in either fluorescence intensity of MTs at centrosomes, or MT growth 
density (Fumoto et al., 2006; Fumoto et al., 2009; Huang et al., 2007), and the same 
has now been demonstrated for APC (Chapter 4). It is unclear whether these Wnt 
proteins act together at the centrosome to mediate the same function, but it is possible 
that each contributes to aberrant MT growth and cell polarisation when Wnt is activated. 
GSK3β can mediate cell polarity through APC in a cdc42-dependent manner via the 
Par6/PKC pathway, rather than by directly orienting the centrosome (Etienne-
Manneville and Hall, 2003; Schlessinger et al., 2007). It will prove interesting to 
determine the degree of overlap, if any, between APC and the other Wnt components in 
centrosome-dependent MT assembly. 
8.5 Mother centriole and future directions 
APC preferentially localises to, and is retained at the mother centriole (Louie et al., 
2004)(Fig. 6.1), but although APC mediates MT nucleation it is unlikely to mediate its 
anchorage since no interactions were detected with the MT-anchorage factor, ninein 
(Chapter 6). On the other hand, APC-CEP110 PLA-positive complexes were scored at 
the centrosome in ~20% of U2OS cells, and a lesser number in SW480 cells, 
suggesting a reduced binding of CEP110 to mutant APC (Chapter 6). One function 
ascribed to CEP110 is a role in post-mitotic assembly of the centrosome. Upon the 
Chapter 8 
329 | P a g e  
 
injection of anti-CEP110 antibody, 17% of cells displayed multiple foci, and centrosome 
proteins including PCNT, γ-tubulin, ninein and CNAP-1 could not be correctly 
assembled preventing proper MT formation (Ou et al., 2002). However, it is not yet 
known whether the APC-CEP110 interaction is involved in MT nucleation or growth. 
Another possibility is a function in mother centriole co-ordinated cell geometry as 
described in Chlamydomonas, thereby contributing to cell polarisation (Feldman 2007). 
Additional experiments such as immunofluorescence microscopy of various mother 
centriole compartments in combination with super resolution microscopy such as SIM 
and STORM would enable improved localisation of APC and enlighten the functions of 
APC at the mother centriole.  
 While this study has illustrated the novel role of APC at interphase centrosomes, 
mechanisms of how APC regulates MT nucleation and other centrosomal processes still 
require clarification. Future studies could assess the interactions of APC with other 
components of γ-tuRCs at centrosomes. Furthermore, this study has identified a range 
of interesting novel binding partners of APC that bind the centrosome targeting region 
(APC-ARM), and further exploration of their interaction with and modulation of APC will 
provide new insights into how APC regulates the centrosome.  
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